group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00044,FUN_000272-T1,Peve_00027798,Pocillopora_meandrina_HIv1___RNAseq.g28985.t1,three_way,70.59733333333334,FUN_000272-T1,O75031,HSF2B_HUMAN,,Heat shock factor 2-binding protein,Homo sapiens (Human),43.2,190.0,5.9e-32,139.0,sp|O75031|HSF2B_HUMAN Heat shock factor 2-binding protein OS=Homo sapiens OX=9606 GN=HSF2BP PE=1 SV=1,GO:0005654; GO:0005694; GO:0005829; GO:0006366; GO:0007141; GO:0007144; GO:0007283; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006351; GO:0022414; GO:0043226; GO:0140013,nucleoplasm; chromosome; cytosol; DNA repair; DNA-templated transcription; reproductive process; organelle; meiotic nuclear division
OG_00086,FUN_000437-T1,Peve_00011193,Pocillopora_meandrina_HIv1___RNAseq.g2323.t1,three_way,77.881,FUN_000437-T1,F1MNN4,FBXW7_BOVIN,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7),Bos taurus (Bovine),36.4,195.0,1.9999999999999998e-26,122.5,sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0030163; GO:0043226; GO:0060090; GO:0098772,nucleus; nucleoplasm; chromosome; DNA repair; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_00107,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_00142,FUN_000582-T1,Peve_00034702,Pocillopora_meandrina_HIv1___TS.g6501.t1,three_way,59.576166666666666,FUN_000582-T1,D2X8K2,PA2_CONGI,,Phospholipase A2 A2-actitoxin-Cgg2a (A2-AITX-Cgg2a) (EC 3.1.1.4) (CgPLA2) (Phosphatidylcholine 2-acylhydrolase),Condylactis gigantea (Giant Caribbean anemone) (Condylactis passiflora),43.7,119.0,3.5e-25,116.3,sp|D2X8K2|PA2_CONGI Phospholipase A2 A2-actitoxin-Cgg2a OS=Condylactis gigantea OX=47073 PE=1 SV=1,GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0042151; GO:0044398; GO:0044470; GO:0044522; GO:0047498; GO:0050482; GO:0090729,arachidonate secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; venom-mediated edema in another organism [GO:0044398]; venom-mediated myocyte killing in another organism [GO:0044522]; venom-mediated suppression of blood coagulation [GO:0044470],extracellular region [GO:0005576]; nematocyst [GO:0042151],calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729],GO:0003824; GO:0005576; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0090729,catalytic activity; extracellular region; lipid metabolic process; lipid binding; hydrolase activity; organelle; toxin activity
OG_00192,FUN_000898-T1,Peve_00009741,Pocillopora_meandrina_HIv1___RNAseq.g29449.t1,three_way,80.12233333333333,FUN_000898-T1,O43903,GAS2_HUMAN,,Growth arrest-specific protein 2 (GAS-2),Homo sapiens (Human),42.6,256.0,1.3e-48,194.9,sp|O43903|GAS2_HUMAN Growth arrest-specific protein 2 OS=Homo sapiens OX=9606 GN=GAS2 PE=1 SV=1,GO:0001544; GO:0001547; GO:0001725; GO:0005829; GO:0005884; GO:0006915; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711,actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; microtubule binding [GO:0008017],GO:0005829; GO:0008092; GO:0012501; GO:0022414; GO:0030198,cytosol; cytoskeletal protein binding; programmed cell death; reproductive process; extracellular matrix organization
OG_00195,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00207,FUN_000926-T1,Peve_00009718,Pocillopora_meandrina_HIv1___RNAseq.g29467.t1,three_way,63.42333333333334,FUN_000926-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),29.5,319.0,9.1e-33,142.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_00237,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_00248,FUN_001011-T1,Peve_00041060,Pocillopora_meandrina_HIv1___RNAseq.g29164.t1,three_way,70.763,FUN_001011-T1,Q6ZUX7,LHPL2_HUMAN,,LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein),Homo sapiens (Human),43.1,232.0,6.4e-43,175.6,sp|Q6ZUX7|LHPL2_HUMAN LHFPL tetraspan subfamily member 2 protein OS=Homo sapiens OX=9606 GN=LHFPL2 PE=1 SV=2,GO:0005886; GO:0007338; GO:0016020; GO:0031092; GO:0046545; GO:0046546; GO:1905516,development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338],membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092],,GO:0005886; GO:0022414,plasma membrane; reproductive process
OG_00264,FUN_001041-T1,Peve_00028475,Pocillopora_meandrina_HIv1___TS.g6804.t1,three_way,83.21833333333333,FUN_001041-T1,Q7Z5V6,SAXO4_HUMAN,,Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32),Homo sapiens (Human),33.2,455.0,1.1e-62,242.3,sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1,GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126],phosphatase binding [GO:0019902],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00268,FUN_001047-T1,Peve_00017182,Pocillopora_meandrina_HIv1___RNAseq.g4933.t1,three_way,56.60166666666667,FUN_001047-T1,Q7ZTV5,FSHR_CAIMO,,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),Cairina moschata (Muscovy duck),25.5,322.0,7.3e-08,60.5,sp|Q7ZTV5|FSHR_CAIMO Follicle-stimulating hormone receptor OS=Cairina moschata OX=8855 GN=FSHR PE=2 SV=1,GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_00281,FUN_001067-T1,Peve_00029706,Pocillopora_meandrina_HIv1___RNAseq.g29656.t1,three_way,64.9165,FUN_001067-T1,A0AVK6,E2F8_HUMAN,,Transcription factor E2F8 (E2F-8),Homo sapiens (Human),40.1,304.0,1.1e-41,173.3,sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837,cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0000278; GO:0003677; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,mitotic cell cycle; DNA binding; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00289,FUN_001079-T1,Peve_00037394,Pocillopora_meandrina_HIv1___RNAseq.g2713.t1,three_way,65.095,FUN_001079-T1,P19440,GGT1_HUMAN,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Homo sapiens (Human),38.9,542.0,5.2e-92,340.1,sp|P19440|GGT1_HUMAN Glutathione hydrolase 1 proenzyme OS=Homo sapiens OX=9606 GN=GGT1 PE=1 SV=2,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; organelle; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_00311,FUN_001114-T1,Peve_00029361,Pocillopora_meandrina_HIv1___RNAseq.g29359.t2,three_way,76.712,FUN_001114-T1,P56597,NDK5_HUMAN,,Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (3'-5' exonuclease NME5) (EC 3.1.-.-) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5),Homo sapiens (Human),61.8,207.0,6.7000000000000004e-74,278.5,sp|P56597|NDK5_HUMAN Nucleoside diphosphate kinase homolog 5 OS=Homo sapiens OX=9606 GN=NME5 PE=1 SV=1,GO:0001534; GO:0003341; GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0008408; GO:0009116; GO:0021591; GO:0036126; GO:0051649; GO:0060271; GO:0097729; GO:1902176,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591],9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],3'-5' exonuclease activity [GO:0008408]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0055086; GO:1901135,catalytic activity; extracellular region; cilium; microtubule-based movement; transferase activity; hydrolase activity; reproductive process; organelle; cilium organization; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00313,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00334,FUN_001155-T1,Peve_00002861,Pocillopora_meandrina_HIv1___RNAseq.g29319.t1,three_way,85.69133333333333,FUN_001155-T1,O08734,BAK_MOUSE,,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK),Mus musculus (Mouse),46.4,112.0,3.1e-24,113.2,sp|O08734|BAK_MOUSE Bcl-2 homologous antagonist/killer OS=Mus musculus OX=10090 GN=Bak1 PE=1 SV=3,GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1901029; GO:1901030; GO:1902262,animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],BAK complex [GO:0097145]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930],BH domain binding [GO:0051400]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0005215; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0012501; GO:0022414; GO:0043226; GO:0048856; GO:0055085; GO:0061024,immune system process; transporter activity; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; programmed cell death; reproductive process; organelle; anatomical structure development; transmembrane transport; membrane organization
OG_00338,FUN_001160-T1,Peve_00043472,Pocillopora_meandrina_HIv1___RNAseq.g29219.t1,three_way,80.853,FUN_001160-T1,P50416,CPT1A_HUMAN,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Homo sapiens (Human),40.4,798.0,1.7e-154,548.1,"sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0055085; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; transmembrane transport; molecular adaptor activity
OG_00355,FUN_001185-T1,Peve_00040986,Pocillopora_meandrina_HIv1___RNAseq.g29540.t1,three_way,52.84166666666667,FUN_001185-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),41.7,412.0,3.4e-63,245.0,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_00360,FUN_001193-T1,Peve_00006937,Pocillopora_meandrina_HIv1___RNAseq.g29527.t1,three_way,63.272,FUN_001193-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),34.4,326.0,6.6e-40,166.4,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_00365,FUN_001204-T1,Peve_00033826,Pocillopora_meandrina_HIv1___RNAseq.g29520.t1,three_way,71.753,FUN_001204-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),40.4,396.0,2.8000000000000002e-89,330.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_00395,FUN_001256-T1,Peve_00008794,Pocillopora_meandrina_HIv1___RNAseq.g2171.t1,three_way,58.515,FUN_001256-T1,Q8C0V1,TERB1_MOUSE,,Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79),Mus musculus (Mouse),29.2,380.0,6.3999999999999995e-31,137.1,sp|Q8C0V1|TERB1_MOUSE Telomere repeats-binding bouquet formation protein 1 OS=Mus musculus OX=10090 GN=Terb1 PE=1 SV=2,GO:0000781; GO:0005635; GO:0005637; GO:0007129; GO:0045141; GO:0070197; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141],"chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]",,GO:0005635; GO:0006281; GO:0022414,nuclear envelope; DNA repair; reproductive process
OG_00400,FUN_001271-T1,Peve_00008757,Pocillopora_meandrina_HIv1___RNAseq.g2184.t1,three_way,83.30966666666667,FUN_001271-T1,P0C605,KGP1_MOUSE,,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),Mus musculus (Mouse),58.6,630.0,9.7e-210,731.5,sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1,GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224,cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003012; GO:0003824; GO:0005654; GO:0005794; GO:0005886; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"muscle system process; catalytic activity; nucleoplasm; Golgi apparatus; plasma membrane; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00428,FUN_001336-T1,Peve_00036943,Pocillopora_meandrina_HIv1___RNAseq.g2286.t1,three_way,80.96633333333334,FUN_001336-T1,Q86UD5,SL9B2_HUMAN,,Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Homo sapiens (Human),47.8,485.0,6.2e-115,416.0,sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2,GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility; transmembrane transport
OG_00430,FUN_001338-T1,Peve_00036941,Pocillopora_meandrina_HIv1___TS.g4798.t2,three_way,67.19033333333333,FUN_001338-T1,Q8C9W3,ATS2_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI),Mus musculus (Mouse),31.2,954.0,4.4e-135,484.6,sp|Q8C9W3|ATS2_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Mus musculus OX=10090 GN=Adamts2 PE=1 SV=2,GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588,collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00431,FUN_001341-T1,Peve_00036939,Pocillopora_meandrina_HIv1___RNAseq.g2290.t1,three_way,95.667,FUN_001341-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),95.2,147.0,5.000000000000001e-81,301.6,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_00432,FUN_001342-T1,Peve_00036938,Pocillopora_meandrina_HIv1___RNAseq.g12407.t1,three_way,61.44533333333334,FUN_001342-T1,Q923E4,SIR1_MOUSE,,NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)],Mus musculus (Mouse),46.3,546.0,7.9e-130,466.1,sp|Q923E4|SIR1_MOUSE NAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2,GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004857; GO:0005634; GO:0005637; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006476; GO:0006642; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008047; GO:0008284; GO:0008630; GO:0009267; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032041; GO:0032071; GO:0032088; GO:0032436; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035331; GO:0035356; GO:0035358; GO:0042149; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060766; GO:0060907; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0071356; GO:0071456; GO:0071479; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140416; GO:0140861; GO:0140937; GO:0141208; GO:0160012; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000481; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781,"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553],"bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone H3K14 deacetylase activity, NAD-dependent [GO:0032041]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein lysine delactylase activity [GO:0141208]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00439,FUN_001350-T1,Peve_00023405,Pocillopora_meandrina_HIv1___RNAseq.g1875.t1,three_way,48.55,FUN_001350-T1,Q8BM75,ARI5B_MOUSE,,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2),Mus musculus (Mouse),24.0,758.0,3.3e-43,179.1,sp|Q8BM75|ARI5B_MOUSE AT-rich interactive domain-containing protein 5B OS=Mus musculus OX=10090 GN=Arid5b PE=1 SV=3,GO:0000122; GO:0000976; GO:0001822; GO:0003713; GO:0005634; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830,adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_00456,FUN_001385-T1,Peve_00019351,Pocillopora_meandrina_HIv1___RNAseq.g2129.t1,three_way,85.12266666666667,FUN_001385-T1,O75398,DEAF1_HUMAN,,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),Homo sapiens (Human),43.0,291.0,1.5e-50,202.2,sp|O75398|DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens OX=9606 GN=DEAF1 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0008270; GO:0008542; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0048706; GO:0090575,anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; extracellular region; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_00477,FUN_001416-T1,Peve_00008744,Pocillopora_meandrina_HIv1___RNAseq.g2098.t1,three_way,82.74133333333333,FUN_001416-T1,Q924X7,STK33_MOUSE,,Serine/threonine-protein kinase 33 (EC 2.7.11.1),Mus musculus (Mouse),54.2,345.0,2e-101,370.9,sp|Q924X7|STK33_MOUSE Serine/threonine-protein kinase 33 OS=Mus musculus OX=10090 GN=Stk33 PE=1 SV=2,GO:0002177; GO:0004674; GO:0005524; GO:0007283; GO:0046777; GO:0048471; GO:0106310; GO:1905198,manchette assembly [GO:1905198]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283],manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0140096,"catalytic activity; transferase activity; reproductive process; catalytic activity, acting on a protein"
OG_00479,FUN_001418-T1,Peve_00008742,Pocillopora_meandrina_HIv1___RNAseq.g2097.t1,three_way,81.65133333333334,FUN_001418-T1,P32198,CPT1A_RAT,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Rattus norvegicus (Rat),49.2,765.0,3.5e-218,759.6,"sp|P32198|CPT1A_RAT Carnitine O-palmitoyltransferase 1, liver isoform OS=Rattus norvegicus OX=10116 GN=Cpt1a PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0030674; GO:0030855; GO:0031667; GO:0031998; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_00481,FUN_001423-T1,Peve_00008791,Pocillopora_meandrina_HIv1___RNAseq.g2174.t1,three_way,80.44866666666667,FUN_001423-T1,Q5THR3,EFCB6_HUMAN,,EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP),Homo sapiens (Human),26.7,1522.0,2.7e-164,581.6,sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1,GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005654; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleoplasm; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00486,FUN_001452-T1,Peve_00018443,Pocillopora_meandrina_HIv1___RNAseq.g1955.t1,three_way,69.77166666666668,FUN_001452-T1,O08983,HPS1_MOUSE,,BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein homolog),Mus musculus (Mouse),24.2,615.0,2.3e-23,112.1,sp|O08983|HPS1_MOUSE BLOC-3 complex member HPS1 OS=Mus musculus OX=10090 GN=Hps1 PE=2 SV=2,GO:0000902; GO:0003016; GO:0005085; GO:0005737; GO:0006629; GO:0006882; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0009306; GO:0010467; GO:0016192; GO:0030318; GO:0030324; GO:0031085; GO:0031410; GO:0032816; GO:0033299; GO:0043473; GO:0046907; GO:0048069; GO:0055088; GO:0060041; GO:0060155; GO:0060425; GO:1903232,blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; protein secretion [GO:0009306]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003016; GO:0006629; GO:0006954; GO:0007040; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0098772,respiratory system process; lipid metabolic process; inflammatory response; lysosome organization; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00493,FUN_001463-T1,Peve_00027128,Pocillopora_meandrina_HIv1___RNAseq.g1963.t1,three_way,62.418,FUN_001463-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),28.8,2337.0,8.6e-257,889.4,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00495,FUN_001465-T1,Peve_00027124,Pocillopora_meandrina_HIv1___RNAseq.g1965.t1,three_way,84.74733333333333,FUN_001465-T1,Q6GLP4,RMD5A_XENLA,,E3 ubiquitin-protein ligase RMND5A (EC 2.3.2.27) (Protein RMD5 homolog A),Xenopus laevis (African clawed frog),50.1,391.0,3.7e-115,416.4,sp|Q6GLP4|RMD5A_XENLA E3 ubiquitin-protein ligase RMND5A OS=Xenopus laevis OX=8355 GN=rmnd5a PE=1 SV=1,GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0034657; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00533,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_00534,FUN_001548-T1,Peve_00003913,Pocillopora_meandrina_HIv1___RNAseq.g2065.t1,three_way,79.53066666666668,FUN_001548-T1,Q8N2Z9,CENPS_HUMAN,,Centromere protein S (CENP-S) (Apoptosis-inducing TAF9-like domain-containing protein 1) (FANCM-associated histone fold protein 1) (FANCM-interacting histone fold protein 1) (Fanconi anemia-associated polypeptide of 16 kDa),Homo sapiens (Human),48.0,123.0,1.9e-26,120.2,sp|Q8N2Z9|CENPS_HUMAN Centromere protein S OS=Homo sapiens OX=9606 GN=CENPS PE=1 SV=1,GO:0000712; GO:0000785; GO:0000939; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007059; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0046982; GO:0051301; GO:0071821,cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007059; GO:0022414; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; DNA repair; chromosome segregation; reproductive process; organelle
OG_00569,FUN_001626-T1,Peve_00042512,Pocillopora_meandrina_HIv1___RNAseq.g2166.t1,three_way,64.553,FUN_001626-T1,Q5UEM7,CR3L4_RAT,,Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4],Rattus norvegicus (Rat),48.4,122.0,2.9e-21,104.0,sp|Q5UEM7|CR3L4_RAT Cyclic AMP-responsive element-binding protein 3-like protein 4 OS=Rattus norvegicus OX=10116 GN=Creb3l4 PE=2 SV=1,GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0006986; GO:0007283; GO:0031965; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005794; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_00612,FUN_001778-T1,Peve_00035593,Pocillopora_meandrina_HIv1___RNAseq.g2685.t1,three_way,54.77516666666666,FUN_001778-T1,Q80VL1,TDRKH_MOUSE,,Tudor and KH domain-containing protein (Tudor domain-containing protein 2),Mus musculus (Mouse),31.1,549.0,2.7e-66,255.4,sp|Q80VL1|TDRKH_MOUSE Tudor and KH domain-containing protein OS=Mus musculus OX=10090 GN=Tdrkh PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0034587; GO:0071546; GO:0071547,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547],RNA binding [GO:0003723],GO:0003723; GO:0005739; GO:0005829; GO:0022414; GO:0030154; GO:0043226; GO:0140013,RNA binding; mitochondrion; cytosol; reproductive process; cell differentiation; organelle; meiotic nuclear division
OG_00625,FUN_001841-T2,Peve_00006792,Pocillopora_meandrina_HIv1___TS.g5135.t1,three_way,79.20983333333334,FUN_001841-T2,Q69CM7,MYBPP_RAT,,MYCBP-associated protein (Organ of Corti membrane-associated protein of 106 kDa),Rattus norvegicus (Rat),29.3,941.0,1.6e-91,339.0,sp|Q69CM7|MYBPP_RAT MYCBP-associated protein OS=Rattus norvegicus OX=10116 GN=Mycbpap PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005886; GO:0006897; GO:0007268; GO:0007283; GO:0019897; GO:0030125; GO:0030154; GO:0030276,cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; spermatogenesis [GO:0007283],clathrin vesicle coat [GO:0030125]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226,endosome; plasma membrane; lipid binding; vesicle-mediated transport; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle
OG_00635,FUN_001860-T1,Peve_00032178,Pocillopora_meandrina_HIv1___RNAseq.g2600.t1,three_way,73.505,FUN_001860-T1,Q10741,ADA10_BOVIN,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c),Bos taurus (Bovine),45.6,754.0,1.3e-175,618.2,sp|Q10741|ADA10_BOVIN Disintegrin and metalloproteinase domain-containing protein 10 OS=Bos taurus OX=9913 GN=ADAM10 PE=1 SV=1,GO:0000139; GO:0001701; GO:0002315; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; marginal zone B cell differentiation [GO:0002315]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_00673,FUN_002084-T1,Peve_00006417,Pocillopora_meandrina_HIv1___RNAseq.g1717.t2,three_way,43.899,FUN_002084-T1,P37237,FGF8_MOUSE,,Fibroblast growth factor 8 (FGF-8) (Androgen-induced growth factor) (AIGF) (Heparin-binding growth factor 8) (HBGF-8),Mus musculus (Mouse),31.5,143.0,7.9e-17,89.0,sp|P37237|FGF8_MOUSE Fibroblast growth factor 8 OS=Mus musculus OX=10090 GN=Fgf8 PE=1 SV=1,GO:0000165; GO:0001569; GO:0001656; GO:0001658; GO:0001759; GO:0001822; GO:0001839; GO:0001947; GO:0001974; GO:0003007; GO:0003148; GO:0003151; GO:0003198; GO:0005576; GO:0006915; GO:0006979; GO:0007368; GO:0007507; GO:0008045; GO:0008078; GO:0008083; GO:0008283; GO:0008284; GO:0008406; GO:0008543; GO:0009410; GO:0009792; GO:0009897; GO:0010628; GO:0021537; GO:0021543; GO:0021544; GO:0021798; GO:0021846; GO:0021884; GO:0023019; GO:0030324; GO:0030539; GO:0030878; GO:0030916; GO:0030917; GO:0033563; GO:0035050; GO:0035108; GO:0035116; GO:0035265; GO:0035909; GO:0042056; GO:0042472; GO:0042476; GO:0042487; GO:0043066; GO:0043524; GO:0045165; GO:0045745; GO:0045840; GO:0046622; GO:0048699; GO:0048702; GO:0048853; GO:0051402; GO:0051781; GO:0055026; GO:0060037; GO:0060128; GO:0060129; GO:0060348; GO:0060425; GO:0060445; GO:0070374; GO:0071542; GO:0072089; GO:0090134; GO:0120223; GO:0140014; GO:2000648,aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; determination of left/right symmetry [GO:0007368]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axon guidance [GO:0033563]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; mitotic nuclear division [GO:0140014]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuron apoptotic process [GO:0051402]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of stem cell proliferation [GO:2000648]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell proliferation [GO:0072089]; subpallium development [GO:0021544]; telencephalon development [GO:0021537]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083],GO:0005576; GO:0012501; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140014,extracellular region; programmed cell death; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; mitotic nuclear division
OG_00693,FUN_002382-T1,Peve_00034022,Pocillopora_meandrina_HIv1___RNAseq.g14908.t1,three_way,68.7255,FUN_002382-T1,Q4R2Y9,ABHD2_MACFA,,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Triacylglycerol lipase) (EC 3.1.1.79),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.2,408.0,1.7e-86,321.2,sp|Q4R2Y9|ABHD2_MACFA Monoacylglycerol lipase ABHD2 OS=Macaca fascicularis OX=9541 GN=ABHD2 PE=2 SV=1,GO:0001669; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0032570; GO:0036126; GO:0042562; GO:0043401; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524; GO:0120516,acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone receptor signaling pathway [GO:0043401],acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524],acetylesterase activity [GO:0008126]; diacylglycerol lipase activity [GO:0120516]; hormone binding [GO:0042562]; monoacylglycerol lipase activity [GO:0047372]; nuclear steroid receptor activity [GO:0003707]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005886; GO:0005929; GO:0006629; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0060089; GO:0140110,catalytic activity; plasma membrane; cilium; lipid metabolic process; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; cell motility; molecular transducer activity; transcription regulator activity
OG_00708,FUN_002469-T1,Peve_00034012,Pocillopora_meandrina_HIv1___TS.g4051.t1,three_way,74.81733333333334,FUN_002469-T1,Q7TMY8,HUWE1_MOUSE,,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",Mus musculus (Mouse),41.0,4757.0,0.0,2664.4,sp|Q7TMY8|HUWE1_MOUSE E3 ubiquitin-protein ligase HUWE1 OS=Mus musculus OX=10090 GN=Huwe1 PE=1 SV=5,GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006284; GO:0006513; GO:0030154; GO:0031398; GO:0032922; GO:0035359; GO:0043123; GO:0043161; GO:0061630; GO:0070936; GO:0140852; GO:0141198,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00746,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.4e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00751,FUN_002808-T1,Peve_00044269,Pocillopora_meandrina_HIv1___RNAseq.g14968.t1,three_way,67.566,FUN_002808-T1,Q9UNF1,MAGD2_HUMAN,,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),Homo sapiens (Human),35.8,201.0,2.1e-32,141.0,sp|Q9UNF1|MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2,GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294,female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294],cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093],,GO:0003014; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0043226,renal system process; extracellular region; nucleus; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle
OG_00756,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_00760,FUN_003166-T1,Peve_00013723,Pocillopora_meandrina_HIv1___RNAseq.g6223.t1,three_way,65.014,FUN_003166-T1,C0HAC0,FBXL5_SALSA,,F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5),Salmo salar (Atlantic salmon),34.3,759.0,7.2e-78,293.1,sp|C0HAC0|FBXL5_SALSA F-box/LRR-repeat protein 5 OS=Salmo salar OX=8030 GN=fbxl5 PE=2 SV=1,GO:0005506; GO:0005634; GO:0006879; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051536,intracellular iron ion homeostasis [GO:0006879]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536],GO:0005634; GO:0030163; GO:0043226,nucleus; protein catabolic process; organelle
OG_00788,FUN_003901-T1,Peve_00012083,Pocillopora_meandrina_HIv1___RNAseq.g17185.t1,three_way,78.26033333333334,FUN_003901-T1,Q4KM73,KCY_RAT,,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),Rattus norvegicus (Rat),58.6,191.0,3.2e-57,223.0,sp|Q4KM73|KCY_RAT UMP-CMP kinase OS=Rattus norvegicus OX=10116 GN=Cmpk1 PE=1 SV=2,GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0006227; GO:0006240; GO:0009041; GO:0018963; GO:0022602; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0050145,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; dCDP biosynthetic process [GO:0006240]; dUDP biosynthetic process [GO:0006227]; ovulation cycle process [GO:0022602]; phthalate metabolic process [GO:0018963]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; UMP/dUMP kinase activity [GO:0009041],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; reproductive process; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00795,FUN_003978-T1,Peve_00009042,Pocillopora_meandrina_HIv1___RNAseq.g11761.t1,three_way,85.38833333333334,FUN_003978-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.5,40.0,1.8e-06,54.7,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_00801,FUN_003999-T1,Peve_00034334,Pocillopora_meandrina_HIv1___RNAseq.g11693.t1,three_way,63.882666666666665,FUN_003999-T1,P21956,MFGM_MOUSE,,Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47),Mus musculus (Mouse),32.1,346.0,3.3e-32,141.0,sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0043277; GO:0050766; GO:0062023,"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]",acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786],GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0061024,extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; membrane organization
OG_00802,FUN_004000-T1,Peve_00034331,Pocillopora_meandrina_HIv1___RNAseq.g11698.t1,three_way,63.14333333333333,FUN_004000-T1,Q8CJ12,AGRG2_MOUSE,,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]",Mus musculus (Mouse),34.0,379.0,1.9e-50,203.4,sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1,GO:0004930; GO:0005829; GO:0007166; GO:0007189; GO:0007286; GO:0016324,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; spermatid development [GO:0007286],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0022414; GO:0048856; GO:0060089,cytosol; reproductive process; anatomical structure development; molecular transducer activity
OG_00827,FUN_004056-T1,Peve_00007130,Pocillopora_meandrina_HIv1___TS.g18499.t1,three_way,72.9045,FUN_004056-T1,Q6P0Q8,MAST2_HUMAN,,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),Homo sapiens (Human),43.5,1429.0,1.8999999999999997e-236,821.2,sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310,cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_00831,FUN_004062-T1,Peve_00024030,Pocillopora_meandrina_HIv1___RNAseq.g12604.t1,three_way,78.593,FUN_004062-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,212.0,1.2e-19,98.2,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_00844,FUN_004095-T1,Peve_00028986,Pocillopora_meandrina_HIv1___RNAseq.g11568.t1,three_way,55.16966666666666,FUN_004095-T1,Q96S53,TESK2_HUMAN,,Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2),Homo sapiens (Human),50.5,287.0,5.2e-76,287.0,sp|Q96S53|TESK2_HUMAN Dual specificity testis-specific protein kinase 2 OS=Homo sapiens OX=9606 GN=TESK2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310,actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0007010; GO:0016740; GO:0022414; GO:0034330; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton organization; transferase activity; reproductive process; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_00849,FUN_004100-T1,Peve_00030718,Pocillopora_meandrina_HIv1___RNAseq.g11660.t1,three_way,75.31516666666667,FUN_004100-T1,Q32NH8,PLCD4_XENLA,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)",Xenopus laevis (African clawed frog),41.4,749.0,1e-145,518.8,"sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1",GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556,intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005634; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nucleus; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_00853,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_00854,FUN_004117-T1,Peve_00038521,Pocillopora_meandrina_HIv1___RNAseq.g11674.t1,three_way,85.43533333333333,FUN_004117-T1,F1Q8K0,RAD54_DANRE,,DNA repair and recombination protein RAD54-like (EC 3.6.4.12),Danio rerio (Zebrafish) (Brachydanio rerio),66.8,744.0,3.7e-292,1005.4,sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131],nucleus [GO:0005634],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00872,FUN_004160-T1,Peve_00031557,Pocillopora_meandrina_HIv1___RNAseq.g16770.t1,three_way,82.089,FUN_004160-T1,Q6QI06,RICTR_MOUSE,,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo),Mus musculus (Mouse),48.6,1035.0,4.7e-280,966.5,sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2,GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0140767; GO:1902554; GO:2000114,actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0006629; GO:0007010; GO:0043226; GO:0048856; GO:0060090; GO:0098772,lysosome; vacuole; endoplasmic reticulum; plasma membrane; lipid metabolic process; cytoskeleton organization; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_00893,FUN_004208-T2,Peve_00011048,Pocillopora_meandrina_HIv1___RNAseq.g11218.t1,three_way,83.40266666666666,FUN_004208-T2,P51688,SPHM_HUMAN,,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),Homo sapiens (Human),63.4,432.0,4.3e-168,592.4,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062,determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_00935,FUN_004284-T1,Peve_00030010,Pocillopora_meandrina_HIv1___RNAseq.g12512.t1,three_way,59.60416666666666,FUN_004284-T1,Q9V576,WUN_DROME,,Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen),Drosophila melanogaster (Fruit fly),35.2,261.0,1.2999999999999998e-43,178.3,sp|Q9V576|WUN_DROME Putative phosphatidate phosphatase OS=Drosophila melanogaster OX=7227 GN=wun PE=1 SV=2,GO:0005886; GO:0005918; GO:0006644; GO:0007165; GO:0007424; GO:0008195; GO:0008354; GO:0016328; GO:0016791; GO:0019991; GO:0030703; GO:0035233; GO:0035234; GO:0045177; GO:0045824; GO:0046839; GO:0050829,defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; eggshell formation [GO:0030703]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165],apical part of cell [GO:0045177]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; septate junction [GO:0005918],phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195],GO:0003824; GO:0005886; GO:0006629; GO:0012501; GO:0016787; GO:0022414; GO:0034330; GO:0048856; GO:0048870,catalytic activity; plasma membrane; lipid metabolic process; programmed cell death; hydrolase activity; reproductive process; cell junction organization; anatomical structure development; cell motility
OG_00946,FUN_004303-T1,Peve_00033932,Pocillopora_meandrina_HIv1___RNAseq.g11775.t1,three_way,66.79366666666667,FUN_004303-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),39.8,698.0,4.9e-140,500.0,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00968,FUN_004339-T1,Peve_00016482,Pocillopora_meandrina_HIv1___RNAseq.g12538.t1,three_way,82.318,FUN_004339-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),45.6,320.0,2.4e-68,261.2,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_00972,FUN_004346-T1,Peve_00016493,Pocillopora_meandrina_HIv1___RNAseq.g16896.t1,three_way,82.173,FUN_004346-T1,Q8BRK8,AAPK2_MOUSE,,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),Mus musculus (Mouse),58.6,561.0,3.1e-179,629.8,sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus OX=10090 GN=Prkaa2 PE=1 SV=3,GO:0003682; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044,autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634],[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; lipid metabolic process; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00974,FUN_004350-T1,Peve_00016543,Pocillopora_meandrina_HIv1___RNAseq.g12505.t1,three_way,81.94066666666667,FUN_004350-T1,P28288,ABCD3_HUMAN,,ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70),Homo sapiens (Human),66.0,617.0,2.3e-245,849.7,sp|P28288|ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0047617; GO:0140359; GO:1903512,bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_00975,FUN_004351-T1,Peve_00016542,Pocillopora_meandrina_HIv1___RNAseq.g12503.t1,three_way,91.29333333333334,FUN_004351-T1,Q5NC57,CF144_MOUSE,,Cilia- and flagella-associated protein 144 (Testis highly expressed protein 6),Mus musculus (Mouse),44.4,117.0,3.8e-19,95.9,sp|Q5NC57|CF144_MOUSE Cilia- and flagella-associated protein 144 OS=Mus musculus OX=10090 GN=Cfap144 PE=1 SV=2,GO:0005813; GO:0030317; GO:0036064; GO:0036126; GO:0097546; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; sperm flagellum [GO:0036126],,GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00977,FUN_004356-T1,Peve_00016494,Pocillopora_meandrina_HIv1___RNAseq.g12547.t1,three_way,92.93433333333331,FUN_004356-T1,Q9R1K5,FZR1_MOUSE,,Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog),Mus musculus (Mouse),72.8,500.0,3.4e-203,709.1,sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1,GO:0005654; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051603; GO:0070306; GO:0097027; GO:1904668; GO:1990756; GO:2000773,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020],nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],anaphase-promoting complex binding [GO:0010997]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005654; GO:0006281; GO:0030154; GO:0030163; GO:0060090; GO:0098772,nucleoplasm; DNA repair; cell differentiation; protein catabolic process; molecular adaptor activity; molecular function regulator activity
OG_00984,FUN_004368-T1,Peve_00024412,Pocillopora_meandrina_HIv1___RNAseq.g4893.t1,three_way,74.18766666666667,FUN_004368-T1,Q60928,GGT1_MOUSE,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Mus musculus (Mouse),40.7,562.0,8.2e-101,369.4,sp|Q60928|GGT1_MOUSE Glutathione hydrolase 1 proenzyme OS=Mus musculus OX=10090 GN=Ggt1 PE=1 SV=1,GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068,cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00985,FUN_004371-T1,Peve_00010721,Pocillopora_meandrina_HIv1___RNAseq.g16617.t1,three_way,61.81466666666667,FUN_004371-T1,P18505,GBRB1_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) (GABAAR subunit beta-1),Homo sapiens (Human),36.7,294.0,6.199999999999999e-53,209.9,sp|P18505|GBRB1_HUMAN Gamma-aminobutyric acid receptor subunit beta-1 OS=Homo sapiens OX=9606 GN=GABRB1 PE=1 SV=2,GO:0004890; GO:0005635; GO:0005886; GO:0006811; GO:0007165; GO:0007214; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0032570; GO:0034707; GO:0042698; GO:0048787; GO:0050811; GO:0071420; GO:0098685; GO:0098982; GO:0099507; GO:0099634; GO:0150047; GO:1902476; GO:1902711; GO:1904315,cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; monoatomic ion transport [GO:0006811]; ovulation cycle [GO:0042698]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005635; GO:0005886; GO:0022414; GO:0023052; GO:0048856; GO:0055085; GO:0060089,transporter activity; nuclear envelope; plasma membrane; reproductive process; signaling; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00987,FUN_004374-T1,Peve_00008061,Pocillopora_meandrina_HIv1___RNAseq.g16620.t1,three_way,61.492666666666665,FUN_004374-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),58.1,210.0,8.2e-11,68.9,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_00996,FUN_004405-T1,Peve_00009337,Pocillopora_meandrina_HIv1___RNAseq.g4938.t1,three_way,84.16833333333334,FUN_004405-T1,P55809,SCOT1_HUMAN,,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",Homo sapiens (Human),70.6,490.0,9.6e-204,711.1,"sp|P55809|SCOT1_HUMAN Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1",GO:0005739; GO:0005759; GO:0007507; GO:0007584; GO:0008260; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046952; GO:0060612; GO:1902224,adipose tissue development [GO:0060612]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; succinyl-CoA:3-oxo-acid CoA-transferase activity [GO:0008260],GO:0003824; GO:0005739; GO:0006091; GO:0006629; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; transferase activity; organelle; anatomical structure development
OG_01004,FUN_004424-T1,Peve_00024113,Pocillopora_meandrina_HIv1___RNAseq.g16706.t1,three_way,72.08833333333334,FUN_004424-T1,P63080,GBRB3_MOUSE,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Mus musculus (Mouse),29.6,433.0,4.2e-51,203.8,sp|P63080|GBRB3_MOUSE Gamma-aminobutyric acid receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Gabrb3 PE=1 SV=1,GO:0004890; GO:0005216; GO:0005886; GO:0007214; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_01029,FUN_004464-T1,Peve_00007170,Pocillopora_meandrina_HIv1___RNAseq.g4957.t1,three_way,65.17666666666668,FUN_004464-T1,P54726,RD23A_MOUSE,,UV excision repair protein RAD23 homolog A (HR23A) (mHR23A),Mus musculus (Mouse),56.6,373.0,1.9e-52,208.0,sp|P54726|RD23A_MOUSE UV excision repair protein RAD23 homolog A OS=Mus musculus OX=10090 GN=Rad23a PE=1 SV=2,GO:0000502; GO:0003684; GO:0005654; GO:0005794; GO:0005829; GO:0006289; GO:0006974; GO:0019900; GO:0031593; GO:0031648; GO:0032436; GO:0043161; GO:0045070; GO:0045787; GO:1990381,DNA damage response [GO:0006974]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502],damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-specific protease binding [GO:1990381],GO:0003677; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0030163; GO:0043226,DNA binding; nucleoplasm; Golgi apparatus; cytosol; DNA repair; protein catabolic process; organelle
OG_01034,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_01053,FUN_004503-T1,Peve_00026071,Pocillopora_meandrina_HIv1___RNAseq.g12523.t1,three_way,43.45516666666667,FUN_004503-T1,Q5VXU9,SHOC1_HUMAN,,Protein shortage in chiasmata 1 ortholog (EC 3.6.-.-) (Protein ZIP2 homolog) (MZIP2),Homo sapiens (Human),24.5,538.0,1.3e-17,93.6,sp|Q5VXU9|SHOC1_HUMAN Protein shortage in chiasmata 1 ortholog OS=Homo sapiens OX=9606 GN=SHOC1 PE=1 SV=1,GO:0000712; GO:0000794; GO:0003697; GO:0005694; GO:0007130; GO:0007131; GO:0016887,reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794],ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006310; GO:0016787; GO:0022414; GO:0043226,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA recombination; hydrolase activity; reproductive process; organelle
OG_01065,FUN_004525-T1,Peve_00003214,Pocillopora_meandrina_HIv1___RNAseq.g11634.t1,three_way,83.67433333333334,FUN_004525-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),49.4,857.0,3.7e-242,839.3,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_01067,FUN_004547-T1,Peve_00042940,Pocillopora_meandrina_HIv1___RNAseq.g7627.t1,three_way,64.15966666666667,FUN_004547-T1,Q8IPH9,SLOB_DROME,,Slowpoke-binding protein,Drosophila melanogaster (Fruit fly),34.8,342.0,2.8e-48,194.5,sp|Q8IPH9|SLOB_DROME Slowpoke-binding protein OS=Drosophila melanogaster OX=7227 GN=Slob PE=1 SV=2,GO:0004672; GO:0005737; GO:0007274; GO:0042391; GO:0042594; GO:0045202; GO:0050804,modulation of chemical synaptic transmission [GO:0050804]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594],cytoplasm [GO:0005737]; synapse [GO:0045202],protein kinase activity [GO:0004672],GO:0003824; GO:0016740; GO:0023052; GO:0140096,"catalytic activity; transferase activity; signaling; catalytic activity, acting on a protein"
OG_01075,FUN_004561-T1,Peve_00016041,Pocillopora_meandrina_HIv1___RNAseq.g8227.t1,three_way,96.68433333333334,FUN_004561-T1,Q3ZCF6,APC11_BOVIN,,Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11),Bos taurus (Bovine),85.7,77.0,1.4999999999999999e-40,166.4,sp|Q3ZCF6|APC11_BOVIN Anaphase-promoting complex subunit 11 OS=Bos taurus OX=9913 GN=ANAPC11 PE=3 SV=1,GO:0005634; GO:0005680; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0061630; GO:0070936; GO:0070979; GO:0097602; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; nucleus [GO:0005634],cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_01079,FUN_004567-T1,Peve_00016037,Pocillopora_meandrina_HIv1___RNAseq.g8223.t1,three_way,80.84933333333333,FUN_004567-T1,Q9UGJ1,GCP4_HUMAN,,Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76),Homo sapiens (Human),49.0,670.0,2.8e-171,603.6,sp|Q9UGJ1|GCP4_HUMAN Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4 PE=1 SV=1,GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003,cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005768; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0022414; GO:0031410; GO:0043226; GO:0065003,mitotic cell cycle; structural molecule activity; endosome; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_01099,FUN_004599-T1,Peve_00012408,Pocillopora_meandrina_HIv1___RNAseq.g6587.t1,three_way,88.329,FUN_004599-T1,Q7Z7E8,UB2Q1_HUMAN,,Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1),Homo sapiens (Human),48.1,397.0,5.3e-95,349.4,sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1,GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459,embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967],cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01121,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_01168,FUN_004791-T1,Peve_00010255,Pocillopora_meandrina_HIv1___RNAseq.g8522.t1,three_way,63.762,FUN_004791-T1,P56705,WNT4_HUMAN,,Protein Wnt-4,Homo sapiens (Human),39.4,322.0,1.9e-62,241.1,sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4,GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234,adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048856; GO:0060090; GO:0098772; GO:0140013; GO:0140110,immune system process; extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity; meiotic nuclear division; transcription regulator activity
OG_01174,FUN_004803-T2,Peve_00023849,Pocillopora_meandrina_HIv1___RNAseq.g8569.t1,three_way,51.61816666666667,FUN_004803-T2,A7E2V4,ZSWM8_HUMAN,,Zinc finger SWIM domain-containing protein 8,Homo sapiens (Human),29.1,453.0,2.6e-39,166.4,sp|A7E2V4|ZSWM8_HUMAN Zinc finger SWIM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZSWIM8 PE=1 SV=1,GO:0005829; GO:0006515; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:0140958; GO:1990756; GO:2000627,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_01193,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_01222,FUN_004904-T1,Peve_00028659,Pocillopora_meandrina_HIv1___RNAseq.g8332.t1,three_way,63.89233333333333,FUN_004904-T1,Q8BGZ3,DCA12_MOUSE,,DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A),Mus musculus (Mouse),41.8,411.0,4.5e-81,303.1,sp|Q8BGZ3|DCA12_MOUSE DDB1- and CUL4-associated factor 12 OS=Mus musculus OX=10090 GN=Dcaf12 PE=2 SV=1,GO:0005634; GO:0005813; GO:0005829; GO:0010506; GO:0016567; GO:0042110; GO:0080008; GO:0140627; GO:1990756,protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0060090,immune system process; nucleus; microtubule organizing center; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_01248,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_01264,FUN_005029-T2,Peve_00028655,Pocillopora_meandrina_HIv1___RNAseq.g8322.t1,three_way,73.07566666666666,FUN_005029-T2,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),30.9,278.0,3.5000000000000003e-34,147.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_01282,FUN_005063-T1,Peve_00030190,Pocillopora_meandrina_HIv1___RNAseq.g8293.t1,three_way,74.4175,FUN_005063-T1,B2RR83,YTDC2_MOUSE,,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),Mus musculus (Mouse),47.1,1526.0,0.0,1282.7,sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1,GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247,"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0003824; GO:0005783; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0140098; GO:0140657,"RNA binding; catalytic activity; endoplasmic reticulum; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01290,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_01294,FUN_005118-T1,Peve_00026683,Pocillopora_meandrina_HIv1___RNAseq.g8264.t1,three_way,92.74866666666668,FUN_005118-T1,Q9VQ93,GOLP3_DROME,,Golgi phosphoprotein 3 homolog sauron (Protein rotini),Drosophila melanogaster (Fruit fly),72.3,267.0,1.4000000000000003e-111,404.1,sp|Q9VQ93|GOLP3_DROME Golgi phosphoprotein 3 homolog sauron OS=Drosophila melanogaster OX=7227 GN=sau PE=1 SV=1,GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0031267; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0046718; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307; GO:0140312; GO:0140450,"actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; protein targeting to Golgi apparatus [GO:0140450]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]; symbiont entry into host cell [GO:0046718]",cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],cargo adaptor activity [GO:0140312]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; small GTPase binding [GO:0031267],GO:0000910; GO:0005794; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0072659,cytokinesis; Golgi apparatus; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_01353,FUN_005265-T1,Peve_00003353,Pocillopora_meandrina_HIv1___RNAseq.g8152.t1,three_way,57.54216666666667,FUN_005265-T1,Q8BH97,RCN3_MOUSE,,Reticulocalbin-3,Mus musculus (Mouse),34.2,149.0,1.2e-11,72.0,sp|Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus musculus OX=10090 GN=Rcn3 PE=1 SV=1,GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509],GO:0005783; GO:0030163; GO:0043226; GO:0048856,endoplasmic reticulum; protein catabolic process; organelle; anatomical structure development
OG_01363,FUN_005306-T1,Peve_00003318,Pocillopora_meandrina_HIv1___TS.g19913.t1,three_way,62.791500000000006,FUN_005306-T1,O35598,ADA10_MOUSE,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),Mus musculus (Mouse),33.5,487.0,1.4999999999999998e-68,261.9,sp|O35598|ADA10_MOUSE Disintegrin and metalloproteinase domain-containing protein 10 OS=Mus musculus OX=10090 GN=Adam10 PE=1 SV=2,GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042169; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0062023; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0006913; GO:0016787; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01364,FUN_005307-T1,Peve_00003314,Pocillopora_meandrina_HIv1___RNAseq.g8172.t1,three_way,66.42383333333333,FUN_005307-T1,A7YSY2,AFG2B_BOVIN,,ATPase family gene 2 protein homolog B (EC 3.6.4.10) (AFG2 AAA ATPase homolog B) (Ribosome biogenesis protein SPATA5L1) (Spermatogenesis-associated protein 5-like protein 1),Bos taurus (Bovine),41.4,789.0,4.1000000000000005e-161,570.1,sp|A7YSY2|AFG2B_BOVIN ATPase family gene 2 protein homolog B OS=Bos taurus OX=9913 GN=AFG2B PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0016887; GO:0030970; GO:0031593; GO:0034098; GO:0042273; GO:0042802; GO:0043161; GO:0051228; GO:0097352; GO:1990275,"autophagosome maturation [GO:0097352]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0007010; GO:0016787; GO:0030163; GO:0043226,catalytic activity; nucleus; cytosol; intracellular protein transport; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle
OG_01370,FUN_005320-T1,Peve_00003308,Pocillopora_meandrina_HIv1___RNAseq.g8181.t1,three_way,77.714,FUN_005320-T1,Q9GZV8,PRD14_HUMAN,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Homo sapiens (Human),41.4,116.0,6.2e-22,107.1,sp|Q9GZV8|PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens OX=9606 GN=PRDM14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0043231; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]",intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_01380,FUN_005337-T1,Peve_00035211,Pocillopora_meandrina_HIv1___RNAseq.g8198.t1,three_way,71.58449999999999,FUN_005337-T1,Q0II22,RN126_BOVIN,,E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126),Bos taurus (Bovine),38.8,291.0,3.2e-43,176.8,sp|Q0II22|RN126_BOVIN E3 ubiquitin-protein ligase RNF126 OS=Bos taurus OX=9913 GN=RNF126 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0008270; GO:0016567; GO:0035519; GO:0042059; GO:0042127; GO:0042147; GO:0043161; GO:0043162; GO:0044314; GO:0061630; GO:0070534; GO:0070936; GO:0071629; GO:1905168,"cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016192; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; vesicle-mediated transport; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_01404,FUN_005470-T1,Peve_00002032,Pocillopora_meandrina_HIv1___RNAseq.g6626.t1,three_way,74.86033333333333,FUN_005470-T1,Q07817,B2CL1_HUMAN,,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),Homo sapiens (Human),38.9,126.0,2.2e-19,97.1,sp|Q07817|B2CL1_HUMAN Bcl-2-like protein 1 OS=Homo sapiens OX=9606 GN=BCL2L1 PE=1 SV=1,GO:0001541; GO:0001701; GO:0001836; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0007281; GO:0007283; GO:0008584; GO:0008630; GO:0008637; GO:0009566; GO:0010507; GO:0015267; GO:0019901; GO:0030672; GO:0031965; GO:0032465; GO:0032946; GO:0034097; GO:0035234; GO:0040008; GO:0042802; GO:0043065; GO:0043066; GO:0043524; GO:0044565; GO:0046898; GO:0046902; GO:0050673; GO:0051093; GO:0051402; GO:0051434; GO:0051607; GO:0051881; GO:0071230; GO:0071312; GO:0071480; GO:0071839; GO:0090201; GO:0097048; GO:0097136; GO:0097192; GO:0097284; GO:1900118; GO:1901029; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:2000242; GO:2000669; GO:2000811; GO:2001240; GO:2001243,apoptotic mitochondrial changes [GO:0008637]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; defense response to virus [GO:0051607]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mononuclear cell proliferation [GO:0032946]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283],Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],GO:0005215; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0007005; GO:0012501; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0061024,transporter activity; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; mitochondrion organization; programmed cell death; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; membrane organization
OG_01406,FUN_005474-T1,Peve_00002031,Pocillopora_meandrina_HIv1___RNAseq.g6629.t1,three_way,83.245,FUN_005474-T1,Q5ZJH6,ULK3_CHICK,,Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3),Gallus gallus (Chicken),55.8,439.0,4.3e-137,489.6,sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus OX=9031 GN=ULK3 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0010506; GO:0034045; GO:0034727; GO:0042594; GO:0045879; GO:0045880; GO:0046777; GO:0061709; GO:0106310,autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of smoothened signaling pathway [GO:0045879]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01426,FUN_005814-T1,Peve_00004967,Pocillopora_meandrina_HIv1___RNAseq.g19530.t1,three_way,80.68183333333334,FUN_005814-T1,Q06187,BTK_HUMAN,,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),Homo sapiens (Human),41.3,658.0,7.8e-147,522.3,sp|Q06187|BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens OX=9606 GN=BTK PE=1 SV=3,GO:0001780; GO:0001805; GO:0001812; GO:0002250; GO:0002344; GO:0002553; GO:0002639; GO:0002721; GO:0002755; GO:0002902; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007498; GO:0008270; GO:0016004; GO:0018108; GO:0019722; GO:0030167; GO:0030889; GO:0030890; GO:0031410; GO:0032496; GO:0032693; GO:0032755; GO:0032760; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043123; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0048469; GO:0048471; GO:0050766; GO:0050852; GO:0050853; GO:0051092; GO:0061516; GO:0071226; GO:0097190; GO:0098761; GO:0141111; GO:0150153; GO:1900227; GO:1901647; GO:1990959,adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008289; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0098542; GO:0098772; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid binding; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01435,FUN_005856-T1,Peve_00034053,Pocillopora_meandrina_HIv1___TS.g29054.t1,three_way,52.05916666666666,FUN_005856-T1,P41221,WNT5A_HUMAN,,Protein Wnt-5a,Homo sapiens (Human),41.0,376.0,1.5e-79,298.1,sp|P41221|WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens OX=9606 GN=WNT5A PE=1 SV=2,GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001843; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003281; GO:0003283; GO:0003323; GO:0003344; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006954; GO:0007200; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010463; GO:0010595; GO:0010628; GO:0010631; GO:0010742; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043410; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051216; GO:0051885; GO:0051897; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060809; GO:0060907; GO:0061036; GO:0062009; GO:0070062; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090090; GO:0090103; GO:0097325; GO:0098685; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099170; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1900020; GO:1902035; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904948; GO:2000049; GO:2000052; GO:2001235,"anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to type II interferon [GO:0071346]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inflammatory response [GO:0006954]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midbrain dopaminergic neuron differentiation [GO:1904948]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; pericardium morphogenesis [GO:0003344]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventricular septum development [GO:0003281]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]",cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115],GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0006954; GO:0007163; GO:0008289; GO:0012501; GO:0022414; GO:0023052; GO:0030154; GO:0030312; GO:0031012; GO:0034330; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140013,extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; inflammatory response; establishment or maintenance of cell polarity; lipid binding; programmed cell death; reproductive process; signaling; cell differentiation; external encapsulating structure; extracellular matrix; cell junction organization; wound healing; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; meiotic nuclear division
OG_01452,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_01463,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01470,FUN_006007-T1,Peve_00032351,Pocillopora_meandrina_HIv1___RNAseq.g19921.t1,three_way,81.028,FUN_006007-T1,Q3SZW1,TSSK1_BOVIN,,Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1),Bos taurus (Bovine),50.7,268.0,1.2e-68,261.5,sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1,GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005929; GO:0007010; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cilium; cytoskeleton organization; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01482,FUN_006116-T1,Peve_00011320,Pocillopora_meandrina_HIv1___RNAseq.g20399.t1,three_way,43.202666666666666,FUN_006116-T1,A0A0K3AV08,MLK1_CAEEL,,Mitogen-activated protein kinase kinase kinase mlk-1 (EC 2.7.11.25) (Mixed lineage kinase homolog 1),Caenorhabditis elegans,29.0,207.0,7.1e-10,67.4,sp|A0A0K3AV08|MLK1_CAEEL Mitogen-activated protein kinase kinase kinase mlk-1 OS=Caenorhabditis elegans OX=6239 GN=mlk-1 PE=1 SV=1,GO:0000165; GO:0001934; GO:0004672; GO:0004709; GO:0005080; GO:0005524; GO:0005737; GO:0007165; GO:0007254; GO:0008340; GO:0019901; GO:0030971; GO:0031103; GO:0038066; GO:0042594; GO:0046688; GO:0046872; GO:0048680; GO:0048691; GO:0050829; GO:0097110; GO:0106310,axon regeneration [GO:0031103]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein phosphorylation [GO:0001934]; response to copper ion [GO:0046688]; response to starvation [GO:0042594]; signal transduction [GO:0007165],cytoplasm [GO:0005737],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_01525,FUN_006321-T1,Peve_00021265,Pocillopora_meandrina_HIv1___RNAseq.g20358.t1,three_way,74.99366666666667,FUN_006321-T1,Q3KNI6,DAAF6_MOUSE,,Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3),Mus musculus (Mouse),34.6,185.0,4.4e-21,102.8,sp|Q3KNI6|DAAF6_MOUSE Dynein axonemal assembly factor 6 OS=Mus musculus OX=10090 GN=Dnaaf6 PE=1 SV=1,GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286,axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802],dynein intermediate chain binding [GO:0045505]; protein-folding chaperone binding [GO:0051087],GO:0007018; GO:0022414; GO:0048870; GO:0065003,microtubule-based movement; reproductive process; cell motility; protein-containing complex assembly
OG_01575,FUN_006580-T1,Peve_00015619,Pocillopora_meandrina_HIv1___RNAseq.g20273.t1,three_way,43.7885,FUN_006580-T1,Q04589,FGFR1_RAT,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Rattus norvegicus (Rat),33.2,675.0,2.7000000000000002e-89,332.8,sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Fgfr1 PE=1 SV=1,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0002931; GO:0004713; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007565; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010966; GO:0010976; GO:0017134; GO:0019827; GO:0021769; GO:0021827; GO:0021847; GO:0021954; GO:0022028; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0031667; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0043536; GO:0043583; GO:0044344; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050839; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071222; GO:0071344; GO:0071420; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:1990090; GO:2000491; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to histamine [GO:0071420]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nerve growth factor stimulus [GO:1990090]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; female pregnancy [GO:0007565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postnatal olfactory bulb interneuron migration [GO:0021827]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; regulation of stem cell proliferation [GO:0072091]; response to ischemia [GO:0002931]; response to nutrient levels [GO:0031667]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_01592,FUN_006632-T1,Peve_00040842,Pocillopora_meandrina_HIv1___RNAseq.g20164.t1,three_way,91.31466666666668,FUN_006632-T1,Q8IYE0,CC146_HUMAN,,Coiled-coil domain-containing protein 146,Homo sapiens (Human),47.2,932.0,2e-175,617.8,sp|Q8IYE0|CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens OX=9606 GN=CCDC146 PE=1 SV=2,GO:0000902; GO:0005813; GO:0005814; GO:0005856; GO:0005930; GO:0006997; GO:0007286; GO:0007288; GO:0007338; GO:0008283; GO:0010467; GO:0030496; GO:0036064; GO:0036126; GO:0044877; GO:0120212; GO:0120316; GO:1905198,cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; manchette assembly [GO:1905198]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; midbody [GO:0030496]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],protein-containing complex binding [GO:0044877],GO:0005815; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; cilium organization; anatomical structure development
OG_01606,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01647,FUN_006799-T1,Peve_00019091,Pocillopora_meandrina_HIv1___RNAseq.g20493.t1,three_way,63.5435,FUN_006799-T1,O08623,SQSTM_RAT,,Sequestosome-1 (Protein kinase C-zeta-interacting protein) (PKC-zeta-interacting protein) (Ubiquitin-binding protein p62),Rattus norvegicus (Rat),22.9,462.0,1.0999999999999998e-24,115.9,sp|O08623|SQSTM_RAT Sequestosome-1 OS=Rattus norvegicus OX=10116 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0033554; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0045202; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140313; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; cellular response to stress [GO:0033554]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; inclusion body [GO:0016234]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; synapse [GO:0045202],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; molecular sequestering activity [GO:0140313]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; molecular sequestering activity
OG_01676,FUN_006873-T1,Peve_00039241,Pocillopora_meandrina_HIv1___RNAseq.g19799.t2,three_way,50.80566666666667,FUN_006873-T1,P31371,FGF9_HUMAN,,Fibroblast growth factor 9 (FGF-9) (Glia-activating factor) (GAF) (Heparin-binding growth factor 9) (HBGF-9),Homo sapiens (Human),34.6,127.0,1.1e-14,81.6,sp|P31371|FGF9_HUMAN Fibroblast growth factor 9 OS=Homo sapiens OX=9606 GN=FGF9 PE=1 SV=3,GO:0000122; GO:0001525; GO:0001649; GO:0001654; GO:0002053; GO:0002062; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0006606; GO:0007165; GO:0007224; GO:0007267; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008584; GO:0010463; GO:0010628; GO:0021762; GO:0022008; GO:0030178; GO:0030238; GO:0030326; GO:0030334; GO:0030949; GO:0032924; GO:0032927; GO:0042472; GO:0043410; GO:0045880; GO:0048010; GO:0048505; GO:0048566; GO:0048706; GO:0050679; GO:0051781; GO:0060011; GO:0060038; GO:0060045; GO:0060070; GO:0060484; GO:0072089; GO:0090263; GO:1904707; GO:1904754; GO:1905931; GO:2000648,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell proliferation [GO:0060038]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; mesenchymal cell proliferation [GO:0010463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; negative regulation of Wnt signaling pathway [GO:0030178]; neurogenesis [GO:0022008]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; Sertoli cell proliferation [GO:0060011]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201],GO:0005576; GO:0005615; GO:0006355; GO:0006886; GO:0006913; GO:0022414; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; reproductive process; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01680,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01711,FUN_006985-T1,Peve_00045265,Pocillopora_meandrina_HIv1___RNAseq.g20222.t1,three_way,77.84,FUN_006985-T1,Q05086,UBE3A_HUMAN,,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),53.1,755.0,9.8e-221,768.1,sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016192; GO:0016740; GO:0022414; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_01719,FUN_007005-T2,Peve_00016928,Pocillopora_meandrina_HIv1___TS.g29423.t1a,three_way,82.74166666666666,FUN_007005-T2,Q9P2G9,KLHL8_HUMAN,,Kelch-like protein 8,Homo sapiens (Human),42.3,338.0,7.9e-79,296.2,sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4,GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0030163; GO:0060090,nucleoplasm; protein catabolic process; molecular adaptor activity
OG_01757,FUN_007100-T1,Peve_00033790,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1b,three_way,84.0445,FUN_007100-T1,O95714,HERC2_HUMAN,,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),Homo sapiens (Human),53.6,4960.0,0.0,4944.0,sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; intracellular protein transport; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01762,FUN_007117-T1,Peve_00043801,Pocillopora_meandrina_HIv1___RNAseq.g18998.t1,three_way,71.51549999999999,FUN_007117-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),30.2,129.0,4.2e-10,67.0,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01777,FUN_007148-T1,Peve_00028252,Pocillopora_meandrina_HIv1___RNAseq.g19712.t1,three_way,76.93933333333332,FUN_007148-T1,Q4R6T7,IQUB_MACFA,,IQ motif and ubiquitin-like domain-containing protein,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),50.9,633.0,6.800000000000001e-178,625.9,sp|Q4R6T7|IQUB_MACFA IQ motif and ubiquitin-like domain-containing protein OS=Macaca fascicularis OX=9541 GN=IQUB PE=2 SV=2,GO:0001534; GO:0001669; GO:0007618; GO:0030317; GO:0036126; GO:0060271; GO:0097729,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; mating [GO:0007618],9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782; GO:0048870,cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization; cell motility
OG_01789,FUN_007169-T1,Peve_00026948,Pocillopora_meandrina_HIv1___RNAseq.g19749.t1,three_way,52.4205,FUN_007169-T1,P51587,BRCA2_HUMAN,,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),Homo sapiens (Human),31.1,1439.0,3.1e-152,542.3,sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens OX=9606 GN=BRCA2 PE=1 SV=4,GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0007141; GO:0007283; GO:0007420; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0030330; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0045893; GO:0045931; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001,"brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA-templated transcription [GO:0006355]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006355; GO:0008092; GO:0016740; GO:0022414; GO:0031410; GO:0032200; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; reproductive process; cytoplasmic vesicle; telomere organization; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_01806,FUN_007605-T1,Peve_00044474,Pocillopora_meandrina_HIv1___RNAseq.g5807.t1,three_way,74.639,FUN_007605-T1,Q86W24,NAL14_HUMAN,,"NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)",Homo sapiens (Human),29.0,217.0,7.6e-06,52.8,"sp|Q86W24|NAL14_HUMAN NACHT, LRR and PYD domains-containing protein 14 OS=Homo sapiens OX=9606 GN=NLRP14 PE=1 SV=1",GO:0005524; GO:0005737; GO:0007283; GO:0030154; GO:0050727,cell differentiation [GO:0030154]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737],ATP binding [GO:0005524],GO:0022414; GO:0030154,reproductive process; cell differentiation
OG_01845,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01917,FUN_007944-T1,Peve_00040700,Pocillopora_meandrina_HIv1___RNAseq.g18121.t1,three_way,72.07933333333334,FUN_007944-T1,Q6DC77,MPRGB_DANRE,,Membrane progestin receptor gamma-B (mPR gamma-B) (Progestin and adipoQ receptor family member V-B),Danio rerio (Zebrafish) (Brachydanio rerio),35.7,325.0,5.9e-45,183.0,sp|Q6DC77|MPRGB_DANRE Membrane progestin receptor gamma-B OS=Danio rerio OX=7955 GN=paqr5b PE=2 SV=1,GO:0005496; GO:0016020; GO:0038023; GO:0048477,oogenesis [GO:0048477],membrane [GO:0016020],signaling receptor activity [GO:0038023]; steroid binding [GO:0005496],GO:0008289; GO:0022414; GO:0048856; GO:0060089,lipid binding; reproductive process; anatomical structure development; molecular transducer activity
OG_01958,FUN_008028-T1,Peve_00011346,Pocillopora_meandrina_HIv1___RNAseq.g30353.t1,three_way,77.145,FUN_008028-T1,P48556,PSMD8_HUMAN,,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31),Homo sapiens (Human),58.9,263.0,2.9999999999999996e-84,313.2,sp|P48556|PSMD8_HUMAN 26S proteasome non-ATPase regulatory subunit 8 OS=Homo sapiens OX=9606 GN=PSMD8 PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0022624; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]",,GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_01961,FUN_008036-T1,Peve_00045157,Pocillopora_meandrina_HIv1___TS.g22662.t1,three_way,59.35066666666667,FUN_008036-T1,A1A5Z0,G6PC3_DANRE,,Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 3.1.3.9),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,355.0,4.799999999999999e-53,209.9,sp|A1A5Z0|G6PC3_DANRE Glucose-6-phosphatase 3 OS=Danio rerio OX=7955 GN=g6pc3 PE=2 SV=1,GO:0002244; GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0051156,gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; hematopoietic progenitor cell differentiation [GO:0002244],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose-6-phosphatase activity [GO:0004346],GO:0003824; GO:0005975; GO:0016787; GO:0030154; GO:1901135,catalytic activity; carbohydrate metabolic process; hydrolase activity; cell differentiation; carbohydrate derivative metabolic process
OG_01977,FUN_008084-T1,Peve_00041226,Pocillopora_meandrina_HIv1___RNAseq.g18089.t1,three_way,77.60133333333333,FUN_008084-T1,Q9VAI1,CIA30_DROME,,"Complex I intermediate-associated protein 30, mitochondrial (NADH:ubiquinone oxidoreductase complex assembly factor 1)",Drosophila melanogaster (Fruit fly),35.7,213.0,1.6e-28,127.9,"sp|Q9VAI1|CIA30_DROME Complex I intermediate-associated protein 30, mitochondrial OS=Drosophila melanogaster OX=7227 GN=NdufAF1 PE=1 SV=1",GO:0001666; GO:0005739; GO:0006120; GO:0009408; GO:0032981; GO:0042594; GO:0051082; GO:0055093; GO:1990204,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to starvation [GO:0042594]",mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204],unfolded protein binding [GO:0051082],GO:0005739; GO:0006091; GO:0043226; GO:0065003,mitochondrion; generation of precursor metabolites and energy; organelle; protein-containing complex assembly
OG_01985,FUN_008093-T1,Peve_00038989,Pocillopora_meandrina_HIv1___RNAseq.g30098.t1,three_way,63.867666666666665,FUN_008093-T1,Q8BGQ1,SPE39_MOUSE,,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),Mus musculus (Mouse),38.4,385.0,1.5e-67,258.8,sp|Q8BGQ1|SPE39_MOUSE Spermatogenesis-defective protein 39 homolog OS=Mus musculus OX=10090 GN=Vipas39 PE=1 SV=1,GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007283; GO:0008333; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0055037; GO:0099023,cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023],protein-containing complex binding [GO:0044877],GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle
OG_02029,FUN_008230-T1,Peve_00039952,Pocillopora_meandrina_HIv1___RNAseq.g30197.t1,three_way,57.42633333333333,FUN_008230-T1,P35363,5HT2A_MOUSE,,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),Mus musculus (Mouse),28.6,325.0,1.2e-20,102.4,sp|P35363|5HT2A_MOUSE 5-hydroxytryptamine receptor 2A OS=Mus musculus OX=10090 GN=Htr2a PE=1 SV=1,GO:0001587; GO:0001659; GO:0002720; GO:0004993; GO:0005883; GO:0005901; GO:0006096; GO:0006874; GO:0007204; GO:0007208; GO:0007613; GO:0008284; GO:0009410; GO:0010513; GO:0014059; GO:0014824; GO:0014832; GO:0030296; GO:0030424; GO:0031410; GO:0031652; GO:0042734; GO:0042802; GO:0043025; GO:0043198; GO:0043267; GO:0043525; GO:0044380; GO:0044877; GO:0045211; GO:0045600; GO:0045821; GO:0045907; GO:0046960; GO:0048148; GO:0050729; GO:0050965; GO:0050966; GO:0051209; GO:0051378; GO:0051967; GO:0070374; GO:0070852; GO:0071886; GO:0098666; GO:0098978; GO:0099171; GO:0099589; GO:1900119; GO:1901731; GO:2000573,"artery smooth muscle contraction [GO:0014824]; behavioral response to cocaine [GO:0048148]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; glycolytic process [GO:0006096]; intracellular calcium ion homeostasis [GO:0006874]; memory [GO:0007613]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of heat generation [GO:0031652]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of vasoconstriction [GO:0045907]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization to cytoskeleton [GO:0044380]; regulation of dopamine secretion [GO:0014059]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; temperature homeostasis [GO:0001659]; urinary bladder smooth muscle contraction [GO:0014832]",axon [GO:0030424]; caveola [GO:0005901]; cell body fiber [GO:0070852]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; G protein-coupled serotonin receptor complex [GO:0098666]; glutamatergic synapse [GO:0098978]; neurofilament [GO:0005883]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]",GO:0003012; GO:0003013; GO:0005975; GO:0006091; GO:0031410; GO:0043226; GO:0050877; GO:0055085; GO:0055086; GO:0060089; GO:0098772; GO:1901135,muscle system process; circulatory system process; carbohydrate metabolic process; generation of precursor metabolites and energy; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular transducer activity; molecular function regulator activity; carbohydrate derivative metabolic process
OG_02035,FUN_008237-T1,Peve_00003879,Pocillopora_meandrina_HIv1___RNAseq.g17928.t1,three_way,82.36666666666666,FUN_008237-T1,Q29RK2,PYC_BOVIN,,"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)",Bos taurus (Bovine),65.5,1165.0,0.0,1567.0,"sp|Q29RK2|PYC_BOVIN Pyruvate carboxylase, mitochondrial OS=Bos taurus OX=9913 GN=PC PE=2 SV=2",GO:0004736; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0046872,gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; pyruvate metabolic process [GO:0006090],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; ligase activity; organelle
OG_02049,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02064,FUN_008278-T1,Peve_00001955,Pocillopora_meandrina_HIv1___RNAseq.g17986.t1,three_way,91.496,FUN_008278-T1,Q5RBG4,KAT5_PONAB,,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.0,470.0,1.1e-174,614.4,sp|Q5RBG4|KAT5_PONAB Histone acetyltransferase KAT5 OS=Pongo abelii OX=9601 GN=KAT5 PE=2 SV=1,GO:0000132; GO:0000724; GO:0000776; GO:0000812; GO:0000922; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005737; GO:0006289; GO:0006302; GO:0006974; GO:0007286; GO:0008270; GO:0010508; GO:0010867; GO:0018394; GO:0030330; GO:0032777; GO:0035267; GO:0042149; GO:0042753; GO:0043998; GO:0045087; GO:0045591; GO:0045663; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0061733; GO:0062033; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:1902036; GO:1902425; GO:1905168; GO:1905691,"cellular response to glucose starvation [GO:0042149]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of hematopoietic stem cell differentiation [GO:1902036]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; kinetochore [GO:0000776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; spindle pole [GO:0000922]; Swr1 complex [GO:0000812],chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0007010; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096; GO:0140110,"immune system process; catalytic activity; nucleus; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeleton organization; transferase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein; transcription regulator activity"
OG_02077,FUN_008294-T1,Peve_00012968,Pocillopora_meandrina_HIv1___RNAseq.g18015.t1,three_way,77.446,FUN_008294-T1,Q9NW38,FANCL_HUMAN,,E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL),Homo sapiens (Human),47.3,372.0,1.6e-102,374.4,sp|Q9NW38|FANCL_HUMAN E3 ubiquitin-protein ligase FANCL OS=Homo sapiens OX=9606 GN=FANCL PE=1 SV=2,GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0008270; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; nucleoplasm; cytosol; DNA repair; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_02079,FUN_008296-T1,Peve_00012966,Pocillopora_meandrina_HIv1___RNAseq.g18012.t1,three_way,75.1305,FUN_008296-T1,Q86TM6,SYVN1_HUMAN,,E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1),Homo sapiens (Human),80.5,333.0,1.9e-153,544.3,sp|Q86TM6|SYVN1_HUMAN E3 ubiquitin-protein ligase synoviolin OS=Homo sapiens OX=9606 GN=SYVN1 PE=1 SV=2,GO:0000836; GO:0000839; GO:0002327; GO:0005654; GO:0005783; GO:0005789; GO:0005790; GO:0006511; GO:0008270; GO:0012505; GO:0016020; GO:0016567; GO:0030970; GO:0036503; GO:0036513; GO:0043161; GO:0044322; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:0140297; GO:1902236; GO:1904380; GO:1990381,"endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790],ATPase binding [GO:0051117]; DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005654; GO:0005783; GO:0006886; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleoplasm; endoplasmic reticulum; intracellular protein transport; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02095,FUN_008367-T1,Peve_00014479,Pocillopora_meandrina_HIv1___RNAseq.g5715.t1,three_way,60.782,FUN_008367-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),21.4,1717.0,2.7e-72,276.6,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02102,FUN_008381-T1,Peve_00002115,Pocillopora_meandrina_HIv1___RNAseq.g18435.t2,three_way,41.09916666666667,FUN_008381-T1,Q8IW19,APLF_HUMAN,,Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1),Homo sapiens (Human),30.1,522.0,2.7e-22,109.0,sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1,GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861],3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0016787; GO:0022414; GO:0042393; GO:0043226; GO:0044183; GO:0140097; GO:0140104,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; chromatin organization; hydrolase activity; reproductive process; histone binding; organelle; protein folding chaperone; catalytic activity, acting on DNA; molecular carrier activity"
OG_02136,FUN_008442-T1,Peve_00024978,Pocillopora_meandrina_HIv1___RNAseq.g18060.t1,three_way,83.17033333333333,FUN_008442-T1,Q9C026,TRIM9_HUMAN,,E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9),Homo sapiens (Human),44.3,704.0,9.099999999999999e-175,615.1,sp|Q9C026|TRIM9_HUMAN E3 ubiquitin-protein ligase TRIM9 OS=Homo sapiens OX=9606 GN=TRIM9 PE=1 SV=1,GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0019904; GO:0030425; GO:0042803; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021],protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02164,FUN_008512-T1,Peve_00000372,Pocillopora_meandrina_HIv1___RNAseq.g425.t1,three_way,73.32933333333334,FUN_008512-T1,P51955,NEK2_HUMAN,,Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1),Homo sapiens (Human),69.3,270.0,6e-113,409.1,sp|P51955|NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens OX=9606 GN=NEK2 PE=1 SV=1,GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0006468; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032206; GO:0032991; GO:0036064; GO:0045171; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051988; GO:0090307; GO:0106310; GO:1903126,blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of telomere maintenance [GO:0032206]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000228; GO:0000278; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"nuclear chromosome; mitotic cell cycle; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02190,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02212,FUN_008594-T1,Peve_00002263,Pocillopora_meandrina_HIv1___RNAseq.g12762.t1,three_way,68.02633333333334,FUN_008594-T1,P02469,LAMB1_MOUSE,,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),Mus musculus (Mouse),43.3,1409.0,5.4e-246,853.2,sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3,GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046,cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637],enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0008289; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0050877,structural molecule activity; extracellular region; extracellular space; nucleus; cell adhesion; lipid binding; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; cell motility; nervous system process
OG_02222,FUN_008617-T1,Peve_00015391,Pocillopora_meandrina_HIv1___TS.g89.t1,three_way,78.33666666666666,FUN_008617-T1,Q5XTS1,PLPL8_RABIT,,Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8),Oryctolagus cuniculus (Rabbit),47.3,427.0,2.2000000000000007e-111,404.1,sp|Q5XTS1|PLPL8_RABIT Calcium-independent phospholipase A2-gamma OS=Oryctolagus cuniculus OX=9986 GN=PNPLA8 PE=1 SV=1,GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0008970; GO:0016020; GO:0016042; GO:0019369; GO:0031966; GO:0032048; GO:0047499; GO:0055088; GO:0070328,arachidonate metabolic process [GO:0019369]; cardiolipin metabolic process [GO:0032048]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016787; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; hydrolase activity; organelle
OG_02237,FUN_008649-T1,Peve_00035682,Pocillopora_meandrina_HIv1___RNAseq.g15.t1,three_way,97.37233333333332,FUN_008649-T1,Q32LN1,UBE2H_BOVIN,,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H),Bos taurus (Bovine),73.8,183.0,4.0000000000000004e-72,272.3,sp|Q32LN1|UBE2H_BOVIN Ubiquitin-conjugating enzyme E2 H OS=Bos taurus OX=9913 GN=UBE2H PE=2 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02270,FUN_008729-T1,Peve_00013706,Pocillopora_meandrina_HIv1___TS.g68.t1,three_way,80.84783333333333,FUN_008729-T1,Q80TR8,DCAF1_MOUSE,,DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1),Mus musculus (Mouse),47.6,1400.0,0.0,1181.8,sp|Q80TR8|DCAF1_MOUSE DDB1- and CUL4-associated factor 1 OS=Mus musculus OX=10090 GN=Dcaf1 PE=1 SV=4,GO:0000122; GO:0001650; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043161; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756,B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0006310; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0060090; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; DNA recombination; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02287,FUN_008794-T1,Peve_00042601,Pocillopora_meandrina_HIv1___RNAseq.g12688.t1,three_way,83.54666666666667,FUN_008794-T1,Q9EQX9,UBE2N_RAT,,Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N),Rattus norvegicus (Rat),85.7,147.0,3.8999999999999995e-68,258.8,sp|Q9EQX9|UBE2N_RAT Ubiquitin-conjugating enzyme E2 N OS=Rattus norvegicus OX=10116 GN=Ube2n PE=1 SV=1,GO:0000151; GO:0000209; GO:0000724; GO:0000729; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006301; GO:0006511; GO:0006513; GO:0016567; GO:0031371; GO:0031372; GO:0031625; GO:0032991; GO:0043123; GO:0043130; GO:0043161; GO:0045739; GO:0050852; GO:0061631; GO:0070534; GO:0097027; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:1902523; GO:1902533; GO:1904262; GO:2000781,antiviral innate immune response [GO:0140374]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0016740; GO:0030163; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; transferase activity; protein catabolic process; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02319,FUN_008911-T1,Peve_00019472,Pocillopora_meandrina_HIv1___RNAseq.g3976.t1,three_way,68.34216666666667,FUN_008911-T1,O60266,ADCY3_HUMAN,,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",Homo sapiens (Human),39.5,1100.0,4.3e-204,713.4,sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3,GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322,acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0005886; GO:0005929; GO:0007018; GO:0009975; GO:0016829; GO:0022414; GO:0043226; GO:0048870; GO:0050877; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; plasma membrane; cilium; microtubule-based movement; cyclase activity; lyase activity; reproductive process; organelle; cell motility; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02338,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_02348,FUN_008949-T1,Peve_00011191,Pocillopora_meandrina_HIv1___RNAseq.g4054.t1,three_way,69.88833333333334,FUN_008949-T1,Q2TAA2,IAH1_HUMAN,,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),Homo sapiens (Human),38.6,233.0,6.6e-44,179.1,sp|Q2TAA2|IAH1_HUMAN Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1,GO:0010467; GO:0016042; GO:0016788; GO:0042802,gene expression [GO:0010467]; lipid catabolic process [GO:0016042],,"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]",GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_02365,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.9e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02397,FUN_009033-T3,Peve_00013834,Pocillopora_meandrina_HIv1___RNAseq.g14347.t1,three_way,72.43633333333334,FUN_009033-T3,Q8K135,K319L_MOUSE,,Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR),Mus musculus (Mouse),43.9,807.0,1.4e-171,605.5,sp|Q8K135|K319L_MOUSE Dyslexia-associated protein KIAA0319-like protein OS=Mus musculus OX=10090 GN=Kiaa0319l PE=1 SV=1,GO:0000139; GO:0001675; GO:0001764; GO:0005730; GO:0005802; GO:0005886; GO:0007283; GO:0010996; GO:0019065; GO:0030317; GO:0031410; GO:0120211,acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996]; spermatogenesis [GO:0007283],cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],,GO:0005730; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0061024,nucleolus; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility; membrane organization
OG_02402,FUN_009043-T1,Peve_00033724,Pocillopora_meandrina_HIv1___RNAseq.g14380.t1,three_way,66.07533333333333,FUN_009043-T1,Q6P3K3,FBX9_DANRE,,F-box only protein 9,Danio rerio (Zebrafish) (Brachydanio rerio),39.8,437.0,1.3e-81,305.1,sp|Q6P3K3|FBX9_DANRE F-box only protein 9 OS=Danio rerio OX=7955 GN=fbxo9 PE=2 SV=1,GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006,protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005],,GO:0030163,protein catabolic process
OG_02467,FUN_009661-T1,Peve_00003551,Pocillopora_meandrina_HIv1___RNAseq.g24577.t1,three_way,94.95166666666668,FUN_009661-T1,Q3ZCF3,SKP1_BOVIN,,S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1),Bos taurus (Bovine),84.7,163.0,3.2e-57,222.6,sp|Q3ZCF3|SKP1_BOVIN S-phase kinase-associated protein 1 OS=Bos taurus OX=9913 GN=SKP1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0031467; GO:0097602,protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],cullin family protein binding [GO:0097602],GO:0005634; GO:0005829; GO:0030163; GO:0043226,nucleus; cytosol; protein catabolic process; organelle
OG_02481,FUN_009771-T1,Peve_00002097,Pocillopora_meandrina_HIv1___RNAseq.g24559.t1,three_way,79.394,FUN_009771-T1,Q9WVK7,HCDH_RAT,,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)",Rattus norvegicus (Rat),65.4,286.0,9.4e-104,378.3,"sp|Q9WVK7|HCDH_RAT Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Hadh PE=2 SV=1",GO:0003857; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0007283; GO:0009410; GO:0009725; GO:0014823; GO:0030154; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162,cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403],GO:0003824; GO:0005654; GO:0005739; GO:0006629; GO:0016491; GO:0022414; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; lipid metabolic process; oxidoreductase activity; reproductive process; cell differentiation; organelle
OG_02499,FUN_009842-T1,Peve_00009093,Pocillopora_meandrina_HIv1___RNAseq.g24508.t1,three_way,68.48066666666666,FUN_009842-T1,Q9NY64,SL2A8_HUMAN,,"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)",Homo sapiens (Human),43.6,463.0,1.5e-97,358.2,"sp|Q9NY64|SL2A8_HUMAN Solute carrier family 2, facilitated glucose transporter member 8 OS=Homo sapiens OX=9606 GN=SLC2A8 PE=1 SV=3",GO:0001666; GO:0005353; GO:0005536; GO:0005765; GO:0005886; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0016020; GO:0030669; GO:0033300; GO:0055056; GO:0070837; GO:1904659,carbohydrate metabolic process [GO:0005975]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666],clathrin-coated endocytic vesicle membrane [GO:0030669]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353],GO:0005215; GO:0005886; GO:0005975; GO:0022414; GO:0031410; GO:0043226; GO:0055085; GO:0140013,transporter activity; plasma membrane; carbohydrate metabolic process; reproductive process; cytoplasmic vesicle; organelle; transmembrane transport; meiotic nuclear division
OG_02512,FUN_010555-T1,Peve_00032733,Pocillopora_meandrina_HIv1___RNAseq.g21411.t1,three_way,87.566,FUN_010555-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),25.4,508.0,1.8e-30,137.1,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_02516,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_02520,FUN_010583-T1,Peve_00032748,Pocillopora_meandrina_HIv1___RNAseq.g21517.t1,three_way,94.21833333333332,FUN_010583-T1,Q28FC1,UBE2W_XENTR,,Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (Ubiquitin carrier protein W) (Ubiquitin-protein ligase W),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),73.3,150.0,1.2e-66,253.8,sp|Q28FC1|UBE2W_XENTR Ubiquitin-conjugating enzyme E2 W OS=Xenopus tropicalis OX=8364 GN=ube2w PE=2 SV=1,GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0043161; GO:0061631; GO:0071218,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02524,FUN_010592-T2,Peve_00032705,Pocillopora_meandrina_HIv1___RNAseq.g21509.t1,three_way,78.5945,FUN_010592-T2,E9PVD1,CCD62_MOUSE,,Coiled-coil domain-containing protein 62,Mus musculus (Mouse),29.6,324.0,1.0000000000000001e-29,133.3,sp|E9PVD1|CCD62_MOUSE Coiled-coil domain-containing protein 62 OS=Mus musculus OX=10090 GN=Ccdc62 PE=1 SV=1,GO:0001669; GO:0001835; GO:0003713; GO:0005634; GO:0007286; GO:0030331; GO:0030520; GO:0045944; GO:0071392,blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0006355; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_02564,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02565,FUN_010664-T1,Peve_00031444,Pocillopora_meandrina_HIv1___RNAseq.g21358.t1,three_way,89.18366666666667,FUN_010664-T1,O46629,ECHB_BOVIN,,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",Bos taurus (Bovine),74.7,442.0,6.5e-191,668.3,"sp|O46629|ECHB_BOVIN Trifunctional enzyme subunit beta, mitochondrial OS=Bos taurus OX=9913 GN=HADHB PE=2 SV=1",GO:0003985; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0016507; GO:0050633,fatty acid beta-oxidation [GO:0006635],endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-myristoyltransferase activity [GO:0050633],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_02580,FUN_010696-T1,Peve_00040382,Pocillopora_meandrina_HIv1___RNAseq.g6938.t1,three_way,55.94833333333333,FUN_010696-T1,F4JTS8,NOV_ARATH,,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),Arabidopsis thaliana (Mouse-ear cress),26.4,2000.0,7.3e-152,541.2,sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1,GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364,auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],nucleus [GO:0005634],,GO:0005634; GO:0022414; GO:0043226; GO:0048856,nucleus; reproductive process; organelle; anatomical structure development
OG_02582,FUN_010698-T2,Peve_00012865,Pocillopora_meandrina_HIv1___RNAseq.g21334.t1,three_way,91.03233333333333,FUN_010698-T2,P49721,PSB2_HUMAN,,Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I) (Proteasome subunit beta-4) (beta-4),Homo sapiens (Human),68.1,191.0,9.3e-75,281.2,sp|P49721|PSB2_HUMAN Proteasome subunit beta type-2 OS=Homo sapiens OX=9606 GN=PSMB2 PE=1 SV=1,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0016020; GO:0019774; GO:0043161; GO:0070062,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",,GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_02589,FUN_010709-T1,Peve_00022594,Pocillopora_meandrina_HIv1___RNAseq.g20962.t1,three_way,45.36966666666667,FUN_010709-T1,Q21313,EPI1_CAEEL,,Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1),Caenorhabditis elegans,29.1,110.0,3.4e-06,55.1,sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1,GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0022414; GO:0040017; GO:0042127; GO:0051788; GO:0071711,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproductive process [GO:0022414]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888],basement membrane [GO:0005604]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0007155; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; cell adhesion; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_02627,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02657,FUN_010840-T3,Peve_00014596,Pocillopora_meandrina_HIv1___RNAseq.g21008.t1,three_way,71.34866666666667,FUN_010840-T3,Q05B79,DHX36_BOVIN,,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),Bos taurus (Bovine),49.9,1010.0,5.3e-265,915.6,sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1,GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02685,FUN_010945-T1,Peve_00040401,Pocillopora_meandrina_HIv1___RNAseq.g21808.t1,three_way,86.82433333333333,FUN_010945-T1,P04636,MDHM_RAT,,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",Rattus norvegicus (Rat),65.3,320.0,9.3e-115,414.8,"sp|P04636|MDHM_RAT Malate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mdh2 PE=1 SV=2",GO:0005737; GO:0005739; GO:0005759; GO:0006094; GO:0006099; GO:0006108; GO:0006734; GO:0009060; GO:0016020; GO:0016615; GO:0030060; GO:0042802; GO:0042803; GO:0043490; GO:0046554; GO:0051087,aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; malate-aspartate shuttle [GO:0043490]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; L-malate dehydrogenase (NAD+) activity [GO:0030060]; L-malate dehydrogenase (NADP+) activity [GO:0046554]; malate dehydrogenase activity [GO:0016615]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087],GO:0003824; GO:0005739; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086,catalytic activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_02703,FUN_010978-T1,Peve_00013381,Pocillopora_meandrina_HIv1___RNAseq.g22015.t1,three_way,71.64766666666667,FUN_010978-T1,Q9JMB7,PIWL1_MOUSE,,Piwi-like protein 1 (EC 3.1.26.-),Mus musculus (Mouse),50.6,765.0,4.9e-237,822.4,sp|Q9JMB7|PIWL1_MOUSE Piwi-like protein 1 OS=Mus musculus OX=10090 GN=Piwil1 PE=1 SV=1,GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0007286; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0035092; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:0140990; GO:0140991; GO:0141006; GO:2000765,meiotic cell cycle [GO:0051321]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; primary piRNA processing [GO:0140990]; regulation of cytoplasmic translation [GO:2000765]; regulatory ncRNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186],metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; protein kinase binding [GO:0019901]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_02706,FUN_010982-T1,Peve_00013385,Pocillopora_meandrina_HIv1___RNAseq.g22010.t1,three_way,75.501,FUN_010982-T1,A1A4V9,CF119_HUMAN,,Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189),Homo sapiens (Human),47.2,127.0,1.1e-25,118.2,sp|A1A4V9|CF119_HUMAN Cilia- and flagella-associated protein 119 OS=Homo sapiens OX=9606 GN=CFAP119 PE=1 SV=1,GO:0001534; GO:0001669; GO:0005737; GO:0007338; GO:0010467; GO:0097228; GO:0120316,gene expression [GO:0010467]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; radial spoke [GO:0001534]; sperm principal piece [GO:0097228],,GO:0022414; GO:0031410; GO:0043226; GO:0044782,reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_02771,FUN_011710-T1,Peve_00025140,Pocillopora_meandrina_HIv1___RNAseq.g23816.t1,three_way,86.54816666666667,FUN_011710-T1,Q9JJ31,CUL5_RAT,,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),Rattus norvegicus (Rat),71.6,784.0,0.0,1121.3,sp|Q9JJ31|CUL5_RAT Cullin-5 OS=Rattus norvegicus OX=10116 GN=Cul5 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005000; GO:0005634; GO:0016567; GO:0019005; GO:0021799; GO:0021942; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038026; GO:0043161; GO:0051480; GO:0070979; GO:0090734; GO:0160072; GO:2001222,cerebral cortex radially oriented cell migration [GO:0021799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; reelin-mediated signaling pathway [GO:0038026]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; vasopressin receptor activity [GO:0005000],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0048870; GO:0060089; GO:0060090; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; cell motility; molecular transducer activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02791,FUN_011747-T1,Peve_00034099,Pocillopora_meandrina_HIv1___RNAseq.9509_t,three_way,56.78566666666666,FUN_011747-T1,C5H5C4,NOT1A_DANRE,,Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98),Danio rerio (Zebrafish) (Brachydanio rerio),40.0,417.0,7.7e-82,305.8,sp|C5H5C4|NOT1A_DANRE Palmitoleoyl-protein carboxylesterase notum1a OS=Danio rerio OX=7955 GN=notum1a PE=2 SV=1,GO:0004621; GO:0005576; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699,anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005576; GO:0016787; GO:0030163,catalytic activity; extracellular region; hydrolase activity; protein catabolic process
OG_02795,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_02798,FUN_011765-T1,Peve_00035074,Pocillopora_meandrina_HIv1___RNAseq.g23800.t1,three_way,86.81066666666666,FUN_011765-T1,P43246,MSH2_HUMAN,,DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2),Homo sapiens (Human),59.3,934.0,0.0,1095.9,sp|P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1,GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008047; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0140664,B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204],"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; guanine/thymine mispair binding [GO:0032137]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006091; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; generation of precursor metabolites and energy; DNA repair; DNA recombination; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_02807,FUN_011778-T1,Peve_00006120,Pocillopora_meandrina_HIv1___RNAseq.g23294.t1,three_way,92.68933333333334,FUN_011778-T1,Q80Y75,DJB13_MOUSE,,DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein),Mus musculus (Mouse),63.5,315.0,1.6e-116,420.6,sp|Q80Y75|DJB13_MOUSE DnaJ homolog subfamily B member 13 OS=Mus musculus OX=10090 GN=Dnajb13 PE=1 SV=1,GO:0001534; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0006457; GO:0007618; GO:0030317; GO:0031514; GO:0036126; GO:0051082; GO:0097729; GO:0120212; GO:1904158,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; protein folding [GO:0006457],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],unfolded protein binding [GO:0051082],GO:0005576; GO:0005929; GO:0006457; GO:0007018; GO:0022414; GO:0043226; GO:0048870,extracellular region; cilium; protein folding; microtubule-based movement; reproductive process; organelle; cell motility
OG_02817,FUN_011804-T1,Peve_00013011,Pocillopora_meandrina_HIv1___RNAseq.g23249.t1,three_way,75.94800000000001,FUN_011804-T1,Q5BIM8,ERCC8_BOVIN,,DNA excision repair protein ERCC-8,Bos taurus (Bovine),48.9,368.0,1.3e-104,381.3,sp|Q5BIM8|ERCC8_BOVIN DNA excision repair protein ERCC-8 OS=Bos taurus OX=9913 GN=ERCC8 PE=2 SV=1,GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0045739; GO:0051865; GO:0080008; GO:0090734; GO:0097680; GO:1990756,DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0006281; GO:0030163; GO:0043226; GO:0060090,nucleus; DNA repair; protein catabolic process; organelle; molecular adaptor activity
OG_02832,FUN_011847-T1,Peve_00034369,Pocillopora_meandrina_HIv1___RNAseq.g23377.t1,three_way,85.74533333333333,FUN_011847-T1,Q29RZ0,THIL_BOVIN,,"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)",Bos taurus (Bovine),69.6,401.0,2.4e-155,550.1,"sp|Q29RZ0|THIL_BOVIN Acetyl-CoA acetyltransferase, mitochondrial OS=Bos taurus OX=9913 GN=ACAT1 PE=2 SV=1",GO:0003985; GO:0005739; GO:0006635; GO:0046872,fatty acid beta-oxidation [GO:0006635],mitochondrion [GO:0005739],acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_02877,FUN_011927-T1,Peve_00039378,Pocillopora_meandrina_HIv1___RNAseq.g23328.t1,three_way,81.451,FUN_011927-T1,O60476,MA1A2_HUMAN,,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",Homo sapiens (Human),52.3,623.0,1e-183,644.8,"sp|O60476|MA1A2_HUMAN Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB OS=Homo sapiens OX=9606 GN=MAN1A2 PE=1 SV=1",GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0036503; GO:0048286; GO:0070062; GO:1904381,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; protein catabolic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_02878,FUN_011928-T1,Peve_00039387,Pocillopora_meandrina_HIv1___RNAseq.g23329.t1,three_way,69.43666666666667,FUN_011928-T1,Q5E9H9,ABHDA_BOVIN,,"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)",Bos taurus (Bovine),44.6,251.0,9.7e-64,245.0,"sp|Q5E9H9|ABHDA_BOVIN Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Bos taurus OX=9913 GN=ABHD10 PE=2 SV=1",GO:0002084; GO:0004553; GO:0005739; GO:0008474; GO:0102390,protein depalmitoylation [GO:0002084],mitochondrion [GO:0005739],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474]",GO:0003824; GO:0005739; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02889,FUN_011944-T1,Peve_00016922,Pocillopora_meandrina_HIv1___RNAseq.g9188.t1,three_way,71.43466666666666,FUN_011944-T1,Q6Q759,SPG17_HUMAN,,Sperm-associated antigen 17 (Projection protein PF6 homolog),Homo sapiens (Human),31.0,2357.0,6.9000000000000005e-174,614.0,sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514],,GO:0005576; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,extracellular region; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_02895,FUN_011952-T1,Peve_00010553,Pocillopora_meandrina_HIv1___RNAseq.g24084.t1,three_way,79.57983333333334,FUN_011952-T1,Q6ZTR5,CFA47_HUMAN,,Cilia- and flagella-associated protein 47,Homo sapiens (Human),33.2,3239.0,0.0,1751.5,sp|Q6ZTR5|CFA47_HUMAN Cilia- and flagella-associated protein 47 OS=Homo sapiens OX=9606 GN=CFAP47 PE=1 SV=5,GO:0005737; GO:0005856; GO:0005929; GO:0007288; GO:0031514; GO:0060271; GO:0120212,cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm head-tail coupling apparatus [GO:0120212],,GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0044782,cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; cilium organization
OG_02916,FUN_011998-T1,Peve_00000538,Pocillopora_meandrina_HIv1___RNAseq.g24022.t1,three_way,87.02483333333333,FUN_011998-T1,A5PK71,PACRG_BOVIN,,Parkin coregulated gene protein,Bos taurus (Bovine),82.6,201.0,4.8e-99,362.1,sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1,GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112,flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; spermatid development [GO:0007286],axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982],actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625],GO:0005829; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytosol; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility
OG_02952,FUN_012072-T1,Peve_00025864,Pocillopora_meandrina_HIv1___RNAseq.g23632.t1,three_way,87.756,FUN_012072-T1,Q32L77,CFA95_BOVIN,,Cilia- and flagella-associated protein 95,Bos taurus (Bovine),41.5,200.0,4.3e-36,152.9,sp|Q32L77|CFA95_BOVIN Cilia- and flagella-associated protein 95 OS=Bos taurus OX=9913 GN=CFAP95 PE=1 SV=1,GO:0005737; GO:0005879; GO:0005886; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126],,GO:0005886; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,plasma membrane; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_02955,FUN_012100-T1,Peve_00007424,Pocillopora_meandrina_HIv1___RNAseq.g23948.t1,three_way,81.48233333333333,FUN_012100-T1,B4F7A7,CEP57_RAT,,Centrosomal protein of 57 kDa (Cep57) (Translokin),Rattus norvegicus (Rat),36.2,447.0,2.8e-56,221.1,sp|B4F7A7|CEP57_RAT Centrosomal protein of 57 kDa OS=Rattus norvegicus OX=10116 GN=Cep57 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260,fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634],fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005794; GO:0005815; GO:0005829; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0065003,nucleus; Golgi apparatus; microtubule organizing center; cytosol; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_02969,FUN_012132-T1,Peve_00035465,Pocillopora_meandrina_HIv1___RNAseq.g23782.t1,three_way,56.359,FUN_012132-T1,Q07113,MPRI_MOUSE,,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),Mus musculus (Mouse),30.7,2462.0,7.5e-280,966.1,sp|Q07113|MPRI_MOUSE Cation-independent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=Igf2r PE=1 SV=1,GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005802; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:1904772; GO:1905394,animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023],GO:0005615; GO:0005634; GO:0005768; GO:0008289; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060089,extracellular space; nucleus; endosome; lipid binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity
OG_02974,FUN_012139-T1,Peve_00001103,Pocillopora_meandrina_HIv1___RNAseq.g23864.t3,three_way,77.9845,FUN_012139-T1,Q8N7X0,ADGB_HUMAN,,Androglobin,Homo sapiens (Human),29.8,1939.0,1.4e-185,652.5,sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3,GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227,proteolysis [GO:0006508]; spermatid development [GO:0007286],sperm annulus [GO:0097227]; sperm midpiece [GO:0097225],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825],GO:0003824; GO:0016787; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_02978,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_02980,FUN_012150-T1,Peve_00035454,Pocillopora_meandrina_HIv1___RNAseq.9397_t,three_way,84.231,FUN_012150-T1,Q00796,DHSO_HUMAN,,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",Homo sapiens (Human),58.6,263.0,1.2e-85,317.8,sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0008270; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; sorbitol catabolic process [GO:0006062]; xylitol catabolic process [GO:0051160]; xylitol metabolic process [GO:0051164],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],"(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase (NAD+) activity [GO:0050255]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005829; GO:0005929; GO:0005975; GO:0007018; GO:0016491; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; extracellular space; cytosol; cilium; carbohydrate metabolic process; microtubule-based movement; oxidoreductase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_02992,FUN_012168-T1,Peve_00008634,Pocillopora_meandrina_HIv1___RNAseq.g23451.t1,three_way,70.15,FUN_012168-T1,Q8WV93,AFG1L_HUMAN,,AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog),Homo sapiens (Human),50.5,289.0,2.5000000000000003e-78,293.9,sp|Q8WV93|AFG1L_HUMAN AFG1-like ATPase OS=Homo sapiens OX=9606 GN=AFG1L PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0007005; GO:0016887; GO:0031966; GO:0035694; GO:0141164,mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein quality control [GO:0141164]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0043226,catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; organelle
OG_03002,FUN_012186-T1,Peve_00027770,Pocillopora_meandrina_HIv1___RNAseq.g23458.t1,three_way,82.305,FUN_012186-T1,Q9Z0V5,PRDX4_RAT,,Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4),Rattus norvegicus (Rat),71.4,245.0,1.3e-97,357.5,sp|Q9Z0V5|PRDX4_RAT Peroxiredoxin-4 OS=Rattus norvegicus OX=10116 GN=Prdx4 PE=2 SV=1,GO:0005615; GO:0005737; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0060090; GO:0072593; GO:0140313; GO:2000255,cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; smooth endoplasmic reticulum [GO:0005790],identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular sequestering activity [GO:0140313]; thioredoxin peroxidase activity [GO:0008379],GO:0003824; GO:0005615; GO:0005783; GO:0005829; GO:0016209; GO:0016491; GO:0022414; GO:0030198; GO:0043226; GO:0048856; GO:0060090; GO:0140313,catalytic activity; extracellular space; endoplasmic reticulum; cytosol; antioxidant activity; oxidoreductase activity; reproductive process; extracellular matrix organization; organelle; anatomical structure development; molecular adaptor activity; molecular sequestering activity
OG_03013,FUN_012233-T1,Peve_00020570,Pocillopora_meandrina_HIv1___RNAseq.g23532.t1,three_way,77.52283333333334,FUN_012233-T1,Q1WG82,ZGLP1_MOUSE,,GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1),Mus musculus (Mouse),51.1,88.0,2.1e-17,91.3,sp|Q1WG82|ZGLP1_MOUSE GATA-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Zglp1 PE=2 SV=1,GO:0000122; GO:0000981; GO:0005634; GO:0007283; GO:0008270; GO:0043565; GO:0045944; GO:0048599,negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_03030,FUN_012261-T1,Peve_00036354,Pocillopora_meandrina_HIv1___RNAseq.g23549.t1,three_way,84.05866666666667,FUN_012261-T1,E1BNG3,ASCC3_BOVIN,,Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4),Bos taurus (Bovine),60.5,2206.0,0.0,2650.5,sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1,GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:1990116,DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; isomerase activity; protein catabolic process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03036,FUN_012274-T1,Peve_00026376,Pocillopora_meandrina_HIv1___RNAseq.g23878.t1,three_way,73.09366666666666,FUN_012274-T1,Q76I89,NDC80_CHICK,,Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2),Gallus gallus (Chicken),35.0,491.0,2.9e-69,264.6,sp|Q76I89|NDC80_CHICK Kinetochore protein NDC80 homolog OS=Gallus gallus OX=9031 GN=NDC80 PE=1 SV=1,GO:0000132; GO:0000776; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0008017; GO:0008315; GO:0014841; GO:0016607; GO:0030332; GO:0031262; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057],centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nuclear speck [GO:0016607],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017],GO:0005815; GO:0005829; GO:0007010; GO:0007059; GO:0008092; GO:0022414; GO:0043226; GO:0060090,microtubule organizing center; cytosol; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; reproductive process; organelle; molecular adaptor activity
OG_03041,FUN_012280-T1,Peve_00014713,Pocillopora_meandrina_HIv1___RNAseq.g23568.t1,three_way,69.50166666666667,FUN_012280-T1,Q9JJZ4,UB2J1_MOUSE,,Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1),Mus musculus (Mouse),62.2,222.0,5.8e-73,276.2,sp|Q9JJZ4|UB2J1_MOUSE Ubiquitin-conjugating enzyme E2 J1 OS=Mus musculus OX=10090 GN=Ube2j1 PE=1 SV=2,GO:0000836; GO:0005524; GO:0007286; GO:0010935; GO:0016567; GO:0018279; GO:0031625; GO:0032680; GO:0036503; GO:0061631; GO:1904153,"ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]",Hrd1p ubiquitin ligase complex [GO:0000836],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0009101; GO:0016740; GO:0022414; GO:0030163; GO:0048856; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; reproductive process; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03063,FUN_012329-T1,Peve_00023485,Pocillopora_meandrina_HIv1___RNAseq.g23753.t1,three_way,67.88033333333334,FUN_012329-T1,Q6GMR7,FAAH2_HUMAN,,Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2),Homo sapiens (Human),47.5,495.0,4e-120,433.3,sp|Q6GMR7|FAAH2_HUMAN Fatty-acid amide hydrolase 2 OS=Homo sapiens OX=9606 GN=FAAH2 PE=1 SV=1,GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369,arachidonate metabolic process [GO:0019369]; lipid catabolic process [GO:0016042],lipid droplet [GO:0005811]; membrane [GO:0016020],fatty acid amide hydrolase activity [GO:0017064],GO:0003824; GO:0005811; GO:0006629; GO:0016787; GO:0043226,catalytic activity; lipid droplet; lipid metabolic process; hydrolase activity; organelle
OG_03077,FUN_012349-T1,Peve_00021548,Pocillopora_meandrina_HIv1___RNAseq.9691_t,three_way,89.12533333333333,FUN_012349-T1,B3EX35,KATL1_SORAR,,Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1),Sorex araneus (Eurasian common shrew) (European shrew),62.4,519.0,1.3e-168,594.3,sp|B3EX35|KATL1_SORAR Katanin p60 ATPase-containing subunit A-like 1 OS=Sorex araneus OX=42254 GN=KATNAL1 PE=3 SV=1,GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016887; GO:0051013,microtubule severing [GO:0051013]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568],GO:0003824; GO:0005815; GO:0007010; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140096; GO:0140657,"catalytic activity; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_03126,FUN_012482-T1,Peve_00004001,Pocillopora_meandrina_HIv1___RNAseq.g23996.t2,three_way,49.154,FUN_012482-T1,O15287,FANCG_HUMAN,,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),26.7,243.0,4.6e-08,61.6,sp|O15287|FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens OX=9606 GN=FANCG PE=1 SV=1,GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0016607; GO:0036297; GO:0043240,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684],GO:0003677; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0007005; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleoplasm; mitochondrion; cytosol; DNA repair; mitochondrion organization; reproductive process; organelle; anatomical structure development
OG_03156,FUN_012547-T1,Peve_00030402,Pocillopora_meandrina_HIv1___RNAseq.g23610.t1,three_way,79.964,FUN_012547-T1,O00628,PEX7_HUMAN,,Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7),Homo sapiens (Human),54.8,157.0,6.7e-51,202.6,sp|O00628|PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens OX=9606 GN=PEX7 PE=1 SV=1,GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803,endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803],GO:0005777; GO:0005829; GO:0006629; GO:0006886; GO:0007031; GO:0043226; GO:0048870; GO:0055085,peroxisome; cytosol; lipid metabolic process; intracellular protein transport; peroxisome organization; organelle; cell motility; transmembrane transport
OG_03165,FUN_012571-T1,Peve_00015689,Pocillopora_meandrina_HIv1___RNAseq.g12855.t1,three_way,43.12116666666667,FUN_012571-T1,P0C6Y7,PRDM9_RAT,,Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361),Rattus norvegicus (Rat),40.5,173.0,1.4e-32,143.3,sp|P0C6Y7|PRDM9_RAT Histone-lysine N-methyltransferase PRDM9 OS=Rattus norvegicus OX=10116 GN=Prdm9 PE=3 SV=1,GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03180,FUN_012628-T1,Peve_00040111,Pocillopora_meandrina_HIv1___RNAseq.g13728.t1,three_way,73.136,FUN_012628-T1,Q5BKR2,SL9B2_MOUSE,,Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Mus musculus (Mouse),50.6,451.0,9.2e-114,412.1,sp|Q5BKR2|SL9B2_MOUSE Sodium/hydrogen exchanger 9B2 OS=Mus musculus OX=10090 GN=Slc9b2 PE=1 SV=2,GO:0005765; GO:0005886; GO:0010008; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0046872; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; lithium ion transport [GO:0010351]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; metal ion binding [GO:0046872]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_03198,FUN_012677-T1,Peve_00042301,Pocillopora_meandrina_HIv1___RNAseq.g22878.t1,three_way,73.87016666666666,FUN_012677-T1,Q9C0J8,WDR33_HUMAN,,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa),Homo sapiens (Human),74.4,406.0,2.2e-161,571.2,sp|Q9C0J8|WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2,GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0007283; GO:0031124,mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283],collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0016071; GO:0022414; GO:0043226,RNA binding; nucleus; nucleoplasm; DNA repair; mRNA metabolic process; reproductive process; organelle
OG_03210,FUN_012706-T2,Peve_00023540,Pocillopora_meandrina_HIv1___RNAseq.g12890.t1,three_way,85.963,FUN_012706-T2,Q53EV4,LRC23_HUMAN,,Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7),Homo sapiens (Human),51.4,276.0,3.3e-48,193.7,sp|Q53EV4|LRC23_HUMAN Leucine-rich repeat-containing protein 23 OS=Homo sapiens OX=9606 GN=LRRC23 PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0030317; GO:0036126; GO:0062177,flagellated sperm motility [GO:0030317]; radial spoke assembly [GO:0062177],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sperm flagellum [GO:0036126],,GO:0005829; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0065003,cytosol; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cell motility; protein-containing complex assembly
OG_03214,FUN_012711-T1,Peve_00000958,Pocillopora_meandrina_HIv1___RNAseq.g12836.t1c,three_way,66.162,FUN_012711-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.7,284.0,9.999999999999999e-33,142.9,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_03224,FUN_012764-T2,Peve_00006134,Pocillopora_meandrina_HIv1___TS.g16045.t1,three_way,49.54133333333333,FUN_012764-T2,Q5RFG8,UBE3D_PONAB,,E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,359.0,8.100000000000001e-28,126.3,sp|Q5RFG8|UBE3D_PONAB E3 ubiquitin-protein ligase E3D OS=Pongo abelii OX=9601 GN=UBE3D PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0051865; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03232,FUN_012776-T1,Peve_00017056,Pocillopora_meandrina_HIv1___RNAseq.g12856.t1,three_way,72.44733333333333,FUN_012776-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),31.8,349.0,3.9e-40,167.5,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_03244,FUN_012875-T1,Peve_00003564,Pocillopora_meandrina_HIv1___RNAseq.g12950.t1,three_way,90.85866666666666,FUN_012875-T1,Q8UW59,PARK7_CHICK,,Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Parkinson disease protein 7 homolog) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1),Gallus gallus (Chicken),56.5,184.0,2.8e-52,206.5,sp|Q8UW59|PARK7_CHICK Protein/nucleic acid deglycase DJ-1 OS=Gallus gallus OX=9031 GN=PARK7 PE=2 SV=1,GO:0001963; GO:0002866; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005886; GO:0006281; GO:0006508; GO:0006914; GO:0006954; GO:0006979; GO:0007338; GO:0008233; GO:0008344; GO:0016684; GO:0030073; GO:0033864; GO:0034599; GO:0036524; GO:0042542; GO:0042593; GO:0042803; GO:0043523; GO:0045121; GO:0046295; GO:0050821; GO:0051583; GO:0061691; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:1903189; GO:1903427; GO:2000277,"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to oxidative stress [GO:0034599]; detoxification of hydrogen peroxide [GO:0061691]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0006281; GO:0006914; GO:0006954; GO:0016491; GO:0016787; GO:0022414; GO:0023052; GO:0043226; GO:0055086; GO:0098754; GO:0140096,"RNA binding; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; plasma membrane; DNA repair; autophagy; inflammatory response; oxidoreductase activity; hydrolase activity; reproductive process; signaling; organelle; nucleobase-containing small molecule metabolic process; detoxification; catalytic activity, acting on a protein"
OG_03249,FUN_012969-T1,Peve_00000418,Pocillopora_meandrina_HIv1___RNAseq.g12970.t1,three_way,89.426,FUN_012969-T1,Q02978,M2OM_HUMAN,,Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (alpha-oxoglutarate carrier) (Solute carrier family 25 member 11) (SLC25A11),Homo sapiens (Human),72.0,286.0,6.6e-120,431.8,sp|Q02978|M2OM_HUMAN Mitochondrial 2-oxoglutarate/malate carrier protein OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=3,GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005886; GO:0006094; GO:0006869; GO:0015367; GO:0022857; GO:0043490,gluconeogenesis [GO:0006094]; lipid transport [GO:0006869]; malate-aspartate shuttle [GO:0043490],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; transmembrane transporter activity [GO:0022857],GO:0003723; GO:0005215; GO:0005634; GO:0005739; GO:0005886; GO:0005975; GO:0043226; GO:0055086,RNA binding; transporter activity; nucleus; mitochondrion; plasma membrane; carbohydrate metabolic process; organelle; nucleobase-containing small molecule metabolic process
OG_03250,FUN_012970-T1,Peve_00000426,Pocillopora_meandrina_HIv1___RNAseq.g12971.t1,three_way,92.84033333333332,FUN_012970-T1,A1Z6E0,GUS_DROME,,Protein gustavus,Drosophila melanogaster (Fruit fly),59.8,281.0,4.3e-97,355.9,sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2,GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005],,GO:0005634; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0048870,nucleus; reproductive process; protein catabolic process; organelle; anatomical structure development; cell motility
OG_03267,FUN_013135-T1,Peve_00013805,Pocillopora_meandrina_HIv1___TS.g15910.t1,three_way,63.35666666666666,FUN_013135-T1,P05208,CEL2A_MOUSE,,Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2) (Elastase-2A),Mus musculus (Mouse),37.8,275.0,4.1999999999999996e-47,189.9,sp|P05208|CEL2A_MOUSE Chymotrypsin-like elastase family member 2A OS=Mus musculus OX=10090 GN=Cela2a PE=1 SV=1,GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0017171; GO:0032868; GO:0036457; GO:0050796; GO:0061436; GO:0062023; GO:0090330; GO:1901143,establishment of skin barrier [GO:0061436]; insulin catabolic process [GO:1901143]; proteolysis [GO:0006508]; regulation of insulin secretion [GO:0050796]; regulation of platelet aggregation [GO:0090330]; response to insulin [GO:0032868],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457],endopeptidase activity [GO:0004175]; serine hydrolase activity [GO:0017171]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0030163; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein"
OG_03270,FUN_013139-T1,Peve_00042385,Pocillopora_meandrina_HIv1___RNAseq.g23012.t1,three_way,50.720333333333336,FUN_013139-T1,Q63341,MMP12_RAT,,Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12),Rattus norvegicus (Rat),36.7,267.0,1.2e-34,148.7,sp|Q63341|MMP12_RAT Macrophage metalloelastase OS=Rattus norvegicus OX=10116 GN=Mmp12 PE=2 SV=1,GO:0000122; GO:0001046; GO:0001666; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0009410; GO:0010628; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050679; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1901163; GO:1904905,"bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; wound healing, spreading of epidermal cells [GO:0035313]",cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005615; GO:0005634; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030163; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096; GO:1901135,"DNA binding; catalytic activity; extracellular space; nucleus; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03279,FUN_013160-T1,Peve_00022443,Pocillopora_meandrina_HIv1___RNAseq.g12985.t1,three_way,77.27183333333333,FUN_013160-T1,Q9ES00,UBE4B_MOUSE,,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),Mus musculus (Mouse),42.6,1179.0,4.6000000000000005e-243,842.8,sp|Q9ES00|UBE4B_MOUSE Ubiquitin conjugation factor E4 B OS=Mus musculus OX=10090 GN=Ube4b PE=1 SV=3,GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051865; GO:0061630,ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005634; GO:0006457; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; protein folding; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03292,FUN_013354-T2,Peve_00041984,Pocillopora_meandrina_HIv1___RNAseq.g13178.t1,three_way,92.6225,FUN_013354-T2,P42345,MTOR_HUMAN,,Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2),Homo sapiens (Human),64.6,2550.0,0.0,3192.9,sp|P42345|MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1,GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031529; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1902554; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785,"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0003677; GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0006091; GO:0006355; GO:0006914; GO:0006954; GO:0007010; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0140096,"immune system process; muscle system process; DNA binding; catalytic activity; nucleus; nuclear envelope; nucleoplasm; lysosome; vacuole; endoplasmic reticulum; cytosol; plasma membrane; generation of precursor metabolites and energy; regulation of DNA-templated transcription; autophagy; inflammatory response; cytoskeleton organization; programmed cell death; transferase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_03304,FUN_013376-T1,Peve_00020453,Pocillopora_meandrina_HIv1___RNAseq.g22987.t1,three_way,90.733,FUN_013376-T1,Q9H0C1,ZMY12_HUMAN,,Zinc finger MYND domain-containing protein 12,Homo sapiens (Human),50.7,363.0,1.6e-96,354.4,sp|Q9H0C1|ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ZMYND12 PE=1 SV=3,GO:0007288; GO:0008270; GO:0030317; GO:0036126,flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288],sperm flagellum [GO:0036126],zinc ion binding [GO:0008270],GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility
OG_03321,FUN_013400-T1,Peve_00028081,Pocillopora_meandrina_HIv1___RNAseq.g22939.t1,three_way,70.60533333333333,FUN_013400-T1,B5DE31,YBOX1_DANRE,,Y-box-binding protein 1 (YB-1) (ZfY1) (Y-box transcription factor),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,107.0,1e-40,168.7,sp|B5DE31|YBOX1_DANRE Y-box-binding protein 1 OS=Danio rerio OX=7955 GN=ybx1 PE=1 SV=1,GO:0000932; GO:0001556; GO:0003676; GO:0003723; GO:0005634; GO:0006397; GO:0007343; GO:0008190; GO:0008327; GO:0008380; GO:0008544; GO:0010468; GO:0017148; GO:0035198; GO:0043009; GO:0045947; GO:0048025; GO:0048255; GO:0048598; GO:0050658; GO:0050686; GO:0051031; GO:0051236; GO:0062153; GO:0070062; GO:1990428; GO:2000773,"chordate embryonic development [GO:0043009]; egg activation [GO:0007343]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; establishment of RNA localization [GO:0051236]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of mRNA processing [GO:0050686]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte maturation [GO:0001556]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; P-body [GO:0000932],C5-methylcytidine-containing RNA reader activity [GO:0062153]; eukaryotic initiation factor 4E binding [GO:0008190]; methyl-CpG binding [GO:0008327]; miRNA binding [GO:0035198]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090,DNA binding; RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity
OG_03325,FUN_013405-T1,Peve_00028076,Pocillopora_meandrina_HIv1___TS.g15827.t1a,three_way,51.6765,FUN_013405-T1,P29594,CASP2_MOUSE,,Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12],Mus musculus (Mouse),27.8,460.0,3.1e-36,154.5,sp|P29594|CASP2_MOUSE Caspase-2 OS=Mus musculus OX=10090 GN=Casp2 PE=1 SV=5,GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005730; GO:0005737; GO:0006974; GO:0016485; GO:0019904; GO:0030330; GO:0035234; GO:0042802; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097190; GO:0097192; GO:1905369; GO:2001235,"apoptotic signaling pathway [GO:0097190]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]",cytoplasm [GO:0005737]; endopeptidase complex [GO:1905369]; nucleolus [GO:0005730]; nucleus [GO:0005634],cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904],GO:0003824; GO:0005634; GO:0005730; GO:0012501; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; nucleus; nucleolus; programmed cell death; hydrolase activity; reproductive process; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_03358,FUN_013595-T1,Peve_00034270,Pocillopora_meandrina_HIv1___RNAseq.g13485.t1,three_way,69.64366666666666,FUN_013595-T1,P21728,DRD1_HUMAN,,D(1A) dopamine receptor (Dopamine D1 receptor),Homo sapiens (Human),25.8,368.0,3.4e-16,87.4,sp|P21728|DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD1 PE=1 SV=1,GO:0001588; GO:0001659; GO:0001661; GO:0001662; GO:0001965; GO:0001975; GO:0004930; GO:0004952; GO:0005634; GO:0005789; GO:0005886; GO:0005929; GO:0006606; GO:0007187; GO:0007189; GO:0007191; GO:0007212; GO:0007416; GO:0007613; GO:0007617; GO:0007625; GO:0007628; GO:0008542; GO:0009410; GO:0014002; GO:0015872; GO:0019226; GO:0019228; GO:0021542; GO:0021756; GO:0021853; GO:0030335; GO:0030432; GO:0032795; GO:0035106; GO:0035240; GO:0035249; GO:0042053; GO:0042311; GO:0042417; GO:0042711; GO:0042734; GO:0043197; GO:0043268; GO:0043410; GO:0045211; GO:0046323; GO:0046959; GO:0046960; GO:0048148; GO:0051281; GO:0051584; GO:0051968; GO:0060134; GO:0060158; GO:0060170; GO:0060291; GO:0060292; GO:0071870; GO:0071880; GO:0097648; GO:0097730; GO:0098978; GO:0098982; GO:0099010; GO:0099171; GO:1990763; GO:2001224,"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; cellular response to catecholamine stimulus [GO:0071870]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; D-glucose import [GO:0046323]; dentate gyrus development [GO:0021542]; dopamine metabolic process [GO:0042417]; dopamine transport [GO:0015872]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; grooming behavior [GO:0007625]; habituation [GO:0046959]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; modification of postsynaptic structure [GO:0099010]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein import into nucleus [GO:0006606]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; response to amphetamine [GO:0001975]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]",ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; G protein-coupled receptor complex [GO:0097648]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],"arrestin family protein binding [GO:1990763]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; heterotrimeric G-protein binding [GO:0032795]",GO:0003012; GO:0003013; GO:0005634; GO:0005886; GO:0005929; GO:0006886; GO:0006913; GO:0022414; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0060089,muscle system process; circulatory system process; nucleus; plasma membrane; cilium; intracellular protein transport; nucleocytoplasmic transport; reproductive process; signaling; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular transducer activity
OG_03460,FUN_014539-T1,Peve_00036006,Pocillopora_meandrina_HIv1___RNAseq.g22603.t1,three_way,85.63466666666666,FUN_014539-T1,Q0IIF7,UBP14_BOVIN,,Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14),Bos taurus (Bovine),61.5,496.0,5e-178,625.5,sp|Q0IIF7|UBP14_BOVIN Ubiquitin carboxyl-terminal hydrolase 14 OS=Bos taurus OX=9913 GN=USP14 PE=2 SV=3,GO:0000502; GO:0004843; GO:0005737; GO:0005886; GO:0016579; GO:0043161; GO:0045087; GO:0070628; GO:1904293,innate immune response [GO:0045087]; negative regulation of ERAD pathway [GO:1904293]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502],cysteine-type deubiquitinase activity [GO:0004843]; proteasome binding [GO:0070628],GO:0002376; GO:0003824; GO:0005886; GO:0016787; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; hydrolase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_03469,FUN_014554-T1,Peve_00035992,Pocillopora_meandrina_HIv1___RNAseq.g22696.t1,three_way,75.109,FUN_014554-T1,P0DL28,FBXW8_RAT,,F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8),Rattus norvegicus (Rat),42.7,178.0,5.8e-39,162.2,sp|P0DL28|FBXW8_RAT F-box/WD repeat-containing protein 8 OS=Rattus norvegicus OX=10116 GN=Fbxw8 PE=1 SV=1,GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0006511; GO:0007030; GO:0008283; GO:0016567; GO:0019005; GO:0031467; GO:0032436; GO:0036064; GO:0043161; GO:0046627; GO:0048471; GO:0050775; GO:0060271; GO:0060712; GO:0060716; GO:1990393; GO:1990756,cell population proliferation [GO:0008283]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],3M complex [GO:1990393]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005794; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0044782; GO:0048856; GO:0060090,Golgi apparatus; microtubule organizing center; cytosol; protein catabolic process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_03477,FUN_014570-T1,Peve_00027632,Pocillopora_meandrina_HIv1___TS.g27472.t1,three_way,47.568,FUN_014570-T1,A2AAY5,SPD2B_MOUSE,,SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),Mus musculus (Mouse),39.8,284.0,3e-50,201.4,sp|A2AAY5|SPD2B_MOUSE SH3 and PX domain-containing protein 2B OS=Mus musculus OX=10090 GN=Sh3pxd2b PE=1 SV=1,GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0032266; GO:0040018; GO:0042169; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070161; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888,adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide metabolic process [GO:0006801],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]",GO:0008289; GO:0022414; GO:0043226; GO:0048856; GO:0065003,lipid binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_03504,FUN_014614-T1,Peve_00001898,Pocillopora_meandrina_HIv1___RNAseq.g22758.t1,three_way,90.642,FUN_014614-T1,Q6PC78,RN185_DANRE,,E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185),Danio rerio (Zebrafish) (Brachydanio rerio),75.0,160.0,5.8e-63,241.9,sp|Q6PC78|RN185_DANRE E3 ubiquitin-protein ligase RNF185 OS=Danio rerio OX=7955 GN=rnf185 PE=2 SV=1,GO:0005741; GO:0005789; GO:0006511; GO:0006914; GO:0008270; GO:0036503; GO:0044314; GO:0044390; GO:0045087; GO:0051607; GO:0060340; GO:0061630,autophagy [GO:0006914]; defense response to virus [GO:0051607]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K27-linked ubiquitination [GO:0044314]; ubiquitin-dependent protein catabolic process [GO:0006511],endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0006914; GO:0016740; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; autophagy; transferase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_03550,FUN_014682-T1,Peve_00004258,Pocillopora_meandrina_HIv1___RNAseq.g22590.t1,three_way,83.26683333333334,FUN_014682-T1,Q9UJX3,APC7_HUMAN,,Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7),Homo sapiens (Human),39.4,523.0,2.5000000000000002e-104,380.9,sp|Q9UJX3|APC7_HUMAN Anaphase-promoting complex subunit 7 OS=Homo sapiens OX=9606 GN=ANAPC7 PE=1 SV=5,GO:0000792; GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007346; GO:0007420; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0043231; GO:0045171; GO:0045842; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0140767; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; brain development [GO:0007420]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0030163; GO:0043226; GO:0048856; GO:0060090,nucleus; nucleoplasm; cytosol; cytoskeleton; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity
OG_03560,FUN_014707-T1,Peve_00021214,Pocillopora_meandrina_HIv1___RNAseq.g22533.t1,three_way,80.39150000000001,FUN_014707-T1,P50897,PPT1_HUMAN,,Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.2) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1),Homo sapiens (Human),64.8,273.0,4.1e-106,386.0,sp|P50897|PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0006897; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030672; GO:0031579; GO:0034164; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0052816; GO:0070062; GO:0099523; GO:0120146,adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; endocytosis [GO:0006897]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; sulfatide binding [GO:0120146],GO:0003824; GO:0005576; GO:0005634; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0006629; GO:0006790; GO:0008289; GO:0016192; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0061024; GO:0140096,"catalytic activity; extracellular region; nucleus; lysosome; vacuole; Golgi apparatus; cytosol; lipid metabolic process; sulfur compound metabolic process; lipid binding; vesicle-mediated transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; membrane organization; catalytic activity, acting on a protein"
OG_03592,FUN_014750-T1,Peve_00016985,Pocillopora_meandrina_HIv1___TS.g27214.t1,three_way,76.65533333333333,FUN_014750-T1,Q5F2F2,ABH15_MOUSE,,Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15),Mus musculus (Mouse),36.8,353.0,1.6e-52,208.4,sp|Q5F2F2|ABH15_MOUSE Protein ABHD15 OS=Mus musculus OX=10090 GN=Abhd15 PE=1 SV=1,GO:0005576; GO:0016042; GO:0060612,adipose tissue development [GO:0060612]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576],,GO:0005576; GO:0006629; GO:0048856,extracellular region; lipid metabolic process; anatomical structure development
OG_03628,FUN_014844-T1,Peve_00038815,Pocillopora_meandrina_HIv1___RNAseq.g22389.t1,three_way,69.21433333333333,FUN_014844-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),31.5,305.0,4.3e-34,149.8,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_03649,FUN_014881-T1,Peve_00013647,Pocillopora_meandrina_HIv1___RNAseq.g21050.t1,three_way,51.534666666666666,FUN_014881-T1,P97864,CASP7_MOUSE,,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],Mus musculus (Mouse),34.0,256.0,4.0000000000000003e-29,130.6,sp|P97864|CASP7_MOUSE Caspase-7 OS=Mus musculus OX=10090 GN=Casp7 PE=1 SV=2,GO:0001650; GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007507; GO:0009411; GO:0016485; GO:0030163; GO:0042742; GO:0044346; GO:0051146; GO:0051402; GO:0051604; GO:0070227; GO:0071222; GO:0072734; GO:0097194; GO:1905686,cellular response to lipopolysaccharide [GO:0071222]; cellular response to staurosporine [GO:0072734]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; lymphocyte apoptotic process [GO:0070227]; neuron apoptotic process [GO:0051402]; positive regulation of plasma membrane repair [GO:1905686]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0012501; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"RNA binding; catalytic activity; extracellular space; nucleus; nucleoplasm; cytosol; plasma membrane; programmed cell death; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_03668,FUN_014908-T1,Peve_00003535,Pocillopora_meandrina_HIv1___RNAseq.g21073.t1,three_way,82.90766666666666,FUN_014908-T1,P62253,UB2G1_HUMAN,,"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]",Homo sapiens (Human),76.2,164.0,5.2e-74,278.5,sp|P62253|UB2G1_HUMAN Ubiquitin-conjugating enzyme E2 G1 OS=Homo sapiens OX=9606 GN=UBE2G1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0061631; GO:0070062; GO:0070534; GO:0070936,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03681,FUN_014940-T1,Peve_00037136,Pocillopora_meandrina_HIv1___RNAseq.g21097.t1,three_way,75.71733333333333,FUN_014940-T1,Q8WV93,AFG1L_HUMAN,,AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog),Homo sapiens (Human),35.5,434.0,6.200000000000002e-66,253.4,sp|Q8WV93|AFG1L_HUMAN AFG1-like ATPase OS=Homo sapiens OX=9606 GN=AFG1L PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0007005; GO:0016887; GO:0031966; GO:0035694; GO:0141164,mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein quality control [GO:0141164]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0043226,catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; organelle
OG_03698,FUN_014969-T1,Peve_00006263,Pocillopora_meandrina_HIv1___RNAseq.g21132.t2,three_way,67.03883333333333,FUN_014969-T1,B2RXZ1,PNDC1_MOUSE,,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1),Mus musculus (Mouse),35.4,463.0,4.3e-65,250.4,sp|B2RXZ1|PNDC1_MOUSE Poly(A)-specific ribonuclease PNLDC1 OS=Mus musculus OX=10090 GN=Pnldc1 PE=1 SV=1,GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872,"blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005783; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; endoplasmic reticulum; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_03711,FUN_014985-T1,Peve_00039936,Pocillopora_meandrina_HIv1___RNAseq.g21148.t1,three_way,95.19833333333334,FUN_014985-T1,Q61025,IFT20_MOUSE,,Intraflagellar transport protein 20 homolog (mIFT20),Mus musculus (Mouse),82.0,100.0,1.4e-37,156.8,sp|Q61025|IFT20_MOUSE Intraflagellar transport protein 20 homolog OS=Mus musculus OX=10090 GN=Ift20 PE=1 SV=1,GO:0001669; GO:0001736; GO:0001750; GO:0001822; GO:0002046; GO:0002177; GO:0005737; GO:0005794; GO:0005801; GO:0005813; GO:0005814; GO:0005902; GO:0005929; GO:0007224; GO:0007283; GO:0008542; GO:0022008; GO:0030992; GO:0031267; GO:0031410; GO:0031514; GO:0032391; GO:0032420; GO:0034067; GO:0035720; GO:0035845; GO:0036064; GO:0036372; GO:0042073; GO:0043005; GO:0044292; GO:0045198; GO:0045724; GO:0051642; GO:0055007; GO:0060122; GO:0060271; GO:0060828; GO:0061351; GO:0061512; GO:0071806; GO:0072659; GO:0090102; GO:0097546; GO:1902017; GO:1902636; GO:2000583; GO:2000785,cardiac muscle cell differentiation [GO:0055007]; centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; opsin transport [GO:0036372]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; protein transmembrane transport [GO:0071806]; regulation of autophagosome assembly [GO:2000785]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cilium assembly [GO:1902017]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; visual learning [GO:0008542],acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; kinociliary basal body [GO:1902636]; manchette [GO:0002177]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420],opsin binding [GO:0002046]; small GTPase binding [GO:0031267],GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0007163; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0055085; GO:0072659,Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; establishment or maintenance of cell polarity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; nervous system process; transmembrane transport; protein localization to plasma membrane
OG_03712,FUN_014986-T1,Peve_00039934,Pocillopora_meandrina_HIv1___RNAseq.g21149.t1,three_way,93.70633333333332,FUN_014986-T1,Q9H3F6,BACD3_HUMAN,,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),Homo sapiens (Human),66.9,278.0,1.7e-101,370.5,sp|Q9H3F6|BACD3_HUMAN BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 OS=Homo sapiens OX=9606 GN=KCTD10 PE=1 SV=1,GO:0005112; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; Notch binding [GO:0005112],GO:0005654; GO:0005829; GO:0005886; GO:0030163; GO:0065003,nucleoplasm; cytosol; plasma membrane; protein catabolic process; protein-containing complex assembly
OG_03715,FUN_014989-T1,Peve_00039944,Pocillopora_meandrina_HIv1___RNAseq.g21153.t1,three_way,81.51683333333334,FUN_014989-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.1,482.0,2.6e-59,231.1,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_03716,FUN_014991-T1,Peve_00032857,Pocillopora_meandrina_HIv1___RNAseq.g21154.t2,three_way,83.89333333333333,FUN_014991-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.0,621.0,3.3e-94,347.4,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_03718,FUN_014993-T1,Peve_00031667,Pocillopora_meandrina_HIv1___RNAseq.g21156.t1,three_way,73.09666666666666,FUN_014993-T1,P51659,DHB4_HUMAN,,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",Homo sapiens (Human),53.7,751.0,2e-231,803.5,sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3,GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0006636; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042759; GO:0042803; GO:0044594; GO:0060009; GO:0106386; GO:1901570,alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],"(3R)-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0006790; GO:0016491; GO:0016829; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086,catalytic activity; peroxisome; cytosol; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; lyase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03719,FUN_014995-T1,Peve_00010955,Pocillopora_meandrina_HIv1___RNAseq.g21158.t1,three_way,83.375,FUN_014995-T1,Q23979,MY61F_DROME,,Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C),Drosophila melanogaster (Fruit fly),55.3,1014.0,0.0,1112.4,sp|Q23979|MY61F_DROME Unconventional myosin IC OS=Drosophila melanogaster OX=7227 GN=Myo61F PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030048; GO:0032528; GO:0042742; GO:0048803; GO:0051015,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; endocytosis [GO:0006897]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; reproductive process; organelle; anatomical structure development; ATP-dependent activity
OG_03720,FUN_015005-T1,Peve_00034681,Pocillopora_meandrina_HIv1___RNAseq.g21250.t1,three_way,83.25866666666667,FUN_015005-T1,P20132,SDHL_HUMAN,,L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (Hepatic serine dehydratase) (hSDH) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19),Homo sapiens (Human),53.6,321.0,8.999999999999999e-94,345.1,sp|P20132|SDHL_HUMAN L-serine dehydratase/L-threonine deaminase OS=Homo sapiens OX=9606 GN=SDS PE=1 SV=2,GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0006629; GO:0030170; GO:0042803; GO:0042866,gluconeogenesis [GO:0006094]; L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629]; pyruvate biosynthetic process [GO:0042866],cytosol [GO:0005829]; mitochondrion [GO:0005739],L-serine ammonia-lyase activity [GO:0003941]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; threonine deaminase activity [GO:0004794],GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006520; GO:0006629; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; amino acid metabolic process; lipid metabolic process; lyase activity; organelle
OG_03723,FUN_015008-T1,Peve_00034684,Pocillopora_meandrina_HIv1___RNAseq.g21246.t1,three_way,93.515,FUN_015008-T1,Q08E38,PRP19_BOVIN,,Pre-mRNA-processing factor 19 (EC 2.3.2.27) (PRP19/PSO4 homolog) (RING-type E3 ubiquitin transferase PRP19),Bos taurus (Bovine),72.0,507.0,3.9e-186,652.5,sp|Q08E38|PRP19_BOVIN Pre-mRNA-processing factor 19 OS=Bos taurus OX=9913 GN=PRPF19 PE=2 SV=1,GO:0000077; GO:0000244; GO:0000245; GO:0000398; GO:0000974; GO:0001833; GO:0004842; GO:0005634; GO:0005662; GO:0005737; GO:0005811; GO:0005819; GO:0006303; GO:0008104; GO:0008610; GO:0010498; GO:0016607; GO:0034450; GO:0035861; GO:0042802; GO:0048026; GO:0061630; GO:0070534; GO:0071006; GO:0071007,"DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]",cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005811; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; lipid droplet; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_03749,FUN_015057-T1,Peve_00032169,Pocillopora_meandrina_HIv1___TS.g26024.t1,three_way,87.627,FUN_015057-T1,Q9GZP9,DERL2_HUMAN,,Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa),Homo sapiens (Human),77.8,239.0,6.8e-102,371.7,sp|Q9GZP9|DERL2_HUMAN Derlin-2 OS=Homo sapiens OX=9606 GN=DERL2 PE=1 SV=1,GO:0001967; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0030307; GO:0030968; GO:0030970; GO:0036503; GO:0044877; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]",early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; membrane [GO:0016020],protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047],GO:0005768; GO:0005783; GO:0006886; GO:0030163; GO:0031410; GO:0043226,endosome; endoplasmic reticulum; intracellular protein transport; protein catabolic process; cytoplasmic vesicle; organelle
OG_03759,FUN_015068-T1,Peve_00022389,Pocillopora_meandrina_HIv1___RNAseq.g21285.t1,three_way,87.73183333333334,FUN_015068-T1,Q969V4,TEKT1_HUMAN,,Tektin-1,Homo sapiens (Human),52.9,397.0,1.9e-111,404.1,sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1,GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111,cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,nucleus; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_03760,FUN_015069-T1,Peve_00022383,Pocillopora_meandrina_HIv1___RNAseq.g21194.t1,three_way,77.7035,FUN_015069-T1,O96017,CHK2_HUMAN,,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),Homo sapiens (Human),52.3,442.0,1.4999999999999998e-127,458.0,sp|O96017|CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens OX=9606 GN=CHEK2 PE=1 SV=1,GO:0000077; GO:0000086; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0008630; GO:0016605; GO:0019901; GO:0030163; GO:0030330; GO:0031573; GO:0031625; GO:0033554; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0070242; GO:0071466; GO:0071480; GO:0090307; GO:0090399; GO:0106310; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210; GO:2000785,"cell division [GO:0051301]; cellular response to bisphenol A [GO:1903926]; cellular response to gamma radiation [GO:0071480]; cellular response to stress [GO:0033554]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of anoikis [GO:2000210]; positive regulation of DNA-templated transcription [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of autophagosome assembly [GO:2000785]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; thymocyte apoptotic process [GO:0070242]",cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0007010; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; DNA repair; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03769,FUN_015098-T1,Peve_00009747,Pocillopora_meandrina_HIv1___RNAseq.g22143.t1,three_way,73.82233333333333,FUN_015098-T1,Q8R2J9,RA51C_CRIGR,,DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),53.1,352.0,1e-99,365.2,sp|Q8R2J9|RA51C_CRIGR DNA repair protein RAD51 homolog 3 OS=Cricetulus griseus OX=10029 GN=RAD51C PE=2 SV=1,GO:0000400; GO:0000707; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0048471; GO:0140664,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0065003; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; DNA repair; DNA recombination; hydrolase activity; reproductive process; telomere organization; organelle; protein-containing complex assembly; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03801,FUN_015184-T1,Peve_00023889,Pocillopora_meandrina_HIv1___RNAseq.g22343.t1,three_way,40.410833333333336,FUN_015184-T1,P34331,PLK1_CAEEL,,Serine/threonine-protein kinase plk-1 (EC 2.7.11.21) (Polo-like kinase 1),Caenorhabditis elegans,29.1,292.0,1.2e-19,100.1,sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans OX=6239 GN=plk-1 PE=1 SV=4,GO:0000776; GO:0000793; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007077; GO:0007098; GO:0007147; GO:0030496; GO:0040038; GO:0045132; GO:0051233; GO:0051726; GO:0106310; GO:0110039,centrosome cycle [GO:0007098]; female meiosis II [GO:0007147]; meiotic chromosome segregation [GO:0045132]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of cell cycle [GO:0051726],centrosome [GO:0005813]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0061024; GO:0140013; GO:0140096,"cytokinesis; catalytic activity; nucleus; chromosome; microtubule organizing center; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; membrane organization; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03829,FUN_015262-T1,Peve_00044772,Pocillopora_meandrina_HIv1___RNAseq.g22284.t1,three_way,66.1165,FUN_015262-T1,Q91XW8,FKBP6_MOUSE,,Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36),Mus musculus (Mouse),38.3,298.0,7e-52,206.5,sp|Q91XW8|FKBP6_MOUSE Inactive peptidyl-prolyl cis-trans isomerase FKBP6 OS=Mus musculus OX=10090 GN=Fkbp6 PE=1 SV=1,GO:0000795; GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0015630; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0045070; GO:0045171; GO:0051321; GO:0051879; GO:0141196,cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795],Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802],GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0006457; GO:0022414; GO:0030154; GO:0031047; GO:0043226,nucleoplasm; cytosol; cytoskeleton; chromatin organization; protein folding; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_03834,FUN_015291-T1,Peve_00022865,Pocillopora_meandrina_HIv1___RNAseq.g22113.t1,three_way,61.755,FUN_015291-T1,O75771,RA51D_HUMAN,,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),Homo sapiens (Human),40.4,319.0,2.5e-56,220.7,sp|O75771|RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens OX=9606 GN=RAD51D PE=1 SV=1,GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005815; GO:0006281; GO:0007131; GO:0008094; GO:0016887; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726; GO:0140664,DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0008092; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; cytoskeletal protein binding; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03851,FUN_015343-T1,Peve_00011270,Pocillopora_meandrina_HIv1___TS.g26467.t1,three_way,68.14433333333334,FUN_015343-T1,Q9WTK8,SPO11_MOUSE,,Meiotic recombination protein SPO11 (EC 5.6.2.2),Mus musculus (Mouse),52.6,171.0,1.7e-51,204.5,sp|Q9WTK8|SPO11_MOUSE Meiotic recombination protein SPO11 OS=Mus musculus OX=10090 GN=Spo11 PE=1 SV=2,GO:0000781; GO:0001541; GO:0003677; GO:0003918; GO:0005524; GO:0005654; GO:0007129; GO:0007130; GO:0007131; GO:0007141; GO:0007286; GO:0034502; GO:0042138; GO:0045141; GO:0046872; GO:0048477; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]","ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]",GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006310; GO:0016853; GO:0022414; GO:0048856; GO:0140013; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; DNA repair; DNA recombination; isomerase activity; reproductive process; anatomical structure development; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03858,FUN_015352-T1,Peve_00017515,Pocillopora_meandrina_HIv1___RNAseq.g21698.t1,three_way,68.03,FUN_015352-T1,P07098,LIPF_HUMAN,,Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3),Homo sapiens (Human),53.2,370.0,9.900000000000001e-111,401.7,sp|P07098|LIPF_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens OX=9606 GN=LIPF PE=1 SV=1,GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006641; GO:0008289; GO:0016042; GO:0016615; GO:0043231,lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005576; GO:0005739; GO:0006629; GO:0008289; GO:0016491; GO:0016787; GO:0043226,catalytic activity; extracellular region; mitochondrion; lipid metabolic process; lipid binding; oxidoreductase activity; hydrolase activity; organelle
OG_03864,FUN_015372-T1,Peve_00000220,Pocillopora_meandrina_HIv1___RNAseq.g21694.t1,three_way,63.956,FUN_015372-T1,Q9H6I2,SOX17_HUMAN,,Transcription factor SOX-17,Homo sapiens (Human),47.8,178.0,6.5e-29,129.8,sp|Q9H6I2|SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens OX=9606 GN=SOX17 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001656; GO:0001706; GO:0001714; GO:0001828; GO:0001947; GO:0003142; GO:0003143; GO:0003151; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007493; GO:0007507; GO:0008013; GO:0010467; GO:0010628; GO:0016055; GO:0021903; GO:0023019; GO:0030308; GO:0031648; GO:0035050; GO:0042074; GO:0043279; GO:0045732; GO:0045893; GO:0045944; GO:0045995; GO:0048617; GO:0048866; GO:0050821; GO:0060214; GO:0060913; GO:0060914; GO:0060956; GO:0061009; GO:0061010; GO:0061031; GO:0061629; GO:0072091; GO:0072189; GO:0090090; GO:1903226; GO:1990830; GO:2000035; GO:2000043; GO:2000738,angiogenesis [GO:0001525]; cardiac cell fate determination [GO:0060913]; cardiogenic plate morphogenesis [GO:0003142]; cell migration involved in gastrulation [GO:0042074]; cellular response to leukemia inhibitory factor [GO:1990830]; common bile duct development [GO:0061009]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; endoderm formation [GO:0001706]; endodermal cell fate determination [GO:0007493]; endodermal cell fate specification [GO:0001714]; endodermal digestive tract morphogenesis [GO:0061031]; gallbladder development [GO:0061010]; gene expression [GO:0010467]; heart development [GO:0007507]; heart formation [GO:0060914]; heart looping [GO:0001947]; inner cell mass cellular morphogenesis [GO:0001828]; metanephros development [GO:0001656]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of cardiac cell fate specification [GO:2000043]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of stem cell division [GO:2000035]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; rostrocaudal neural tube patterning [GO:0021903]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; stem cell fate specification [GO:0048866]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03865,FUN_015373-T1,Peve_00000221,Pocillopora_meandrina_HIv1___RNAseq.g10184.t1,three_way,76.64383333333333,FUN_015373-T1,Q01320,TOP2A_MOUSE,,"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)",Mus musculus (Mouse),67.5,1208.0,0.0,1654.4,sp|Q01320|TOP2A_MOUSE DNA topoisomerase 2-alpha OS=Mus musculus OX=10090 GN=Top2a PE=1 SV=2,GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0001673; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008301; GO:0009330; GO:0030261; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1990904,apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]","ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]",GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0007059; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140097; GO:0140657,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; isomerase activity; reproductive process; cell differentiation; organelle; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03892,FUN_015447-T1,Peve_00013023,Pocillopora_meandrina_HIv1___RNAseq.g22267.t1,three_way,56.257333333333335,FUN_015447-T1,P27889,HNF1B_MOUSE,,Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2),Mus musculus (Mouse),49.7,332.0,4.1e-71,270.8,sp|P27889|HNF1B_MOUSE Hepatocyte nuclear factor 1-beta OS=Mus musculus OX=10090 GN=Hnf1b PE=1 SV=2,GO:0000122; GO:0000976; GO:0000981; GO:0000987; GO:0001706; GO:0001714; GO:0001822; GO:0001826; GO:0001889; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006915; GO:0007219; GO:0007492; GO:0009749; GO:0009952; GO:0010467; GO:0010628; GO:0030073; GO:0030111; GO:0030902; GO:0031018; GO:0035565; GO:0039020; GO:0042802; GO:0042803; GO:0043066; GO:0045893; GO:0045944; GO:0048557; GO:0048754; GO:0048806; GO:0050673; GO:0060261; GO:0060429; GO:0060677; GO:0060993; GO:0061017; GO:0061296; GO:0072095; GO:0072164; GO:0072176; GO:0072177; GO:0072179; GO:0072181; GO:1900200; GO:1900212; GO:1990841,anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; embryonic digestive tract morphogenesis [GO:0048557]; endocrine pancreas development [GO:0031018]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; epithelial cell proliferation [GO:0050673]; epithelium development [GO:0060429]; gene expression [GO:0010467]; genitalia development [GO:0048806]; hepatoblast differentiation [GO:0061017]; hindbrain development [GO:0030902]; inner cell mass cell differentiation [GO:0001826]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; mesenchymal cell apoptotic process involved in metanephros development [GO:1900200]; mesonephric duct development [GO:0072177]; mesonephric duct formation [GO:0072181]; mesonephric tubule development [GO:0072164]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis [GO:0061296]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct development [GO:0072176]; nephric duct formation [GO:0072179]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pronephric nephron tubule development [GO:0039020]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of pronephros size [GO:0035565]; regulation of Wnt signaling pathway [GO:0030111]; response to glucose [GO:0009749]; ureteric bud elongation [GO:0060677],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_03893,FUN_015448-T1,Peve_00013022,Pocillopora_meandrina_HIv1___RNAseq.g22266.t1,three_way,60.5595,FUN_015448-T1,Q08E13,RNF10_BOVIN,,E3 ubiquitin-protein ligase RNF10 (EC 2.3.2.27) (RING finger protein 10),Bos taurus (Bovine),39.1,791.0,5.5e-107,390.2,sp|Q08E13|RNF10_BOVIN E3 ubiquitin-protein ligase RNF10 OS=Bos taurus OX=9913 GN=RNF10 PE=2 SV=1,GO:0000976; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0031643; GO:0045944; GO:0061630; GO:1990116,positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein monoubiquitination [GO:0006513]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytoplasm [GO:0005737]; nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03904,FUN_015978-T1,Peve_00024021,Pocillopora_meandrina_HIv1___RNAseq.g21408.t2,three_way,79.68833333333333,FUN_015978-T1,P40939,ECHA_HUMAN,,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (MLCL AT) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]",Homo sapiens (Human),57.7,766.0,5.7e-253,875.2,"sp|P40939|ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2",GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0052816; GO:0070403,cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868],mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; NAD+ binding [GO:0070403],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0016740; GO:0016787; GO:0016829; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; transferase activity; hydrolase activity; lyase activity; organelle
OG_03908,FUN_015984-T1,Peve_00024010,Pocillopora_meandrina_HIv1___RNAseq.g21402.t1,three_way,68.71833333333333,FUN_015984-T1,Q9WTL7,LYPA2_MOUSE,,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) (mLyso II) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),Mus musculus (Mouse),52.0,229.0,5.7e-64,245.7,sp|Q9WTL7|LYPA2_MOUSE Acyl-protein thioesterase 2 OS=Mus musculus OX=10090 GN=Lypla2 PE=1 SV=1,GO:0002084; GO:0004622; GO:0005654; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0008474; GO:0046464; GO:1905344,acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleoplasm [GO:0005654],lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; nucleoplasm; cytosol; lipid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03912,FUN_015993-T1,Peve_00023996,Pocillopora_meandrina_HIv1___RNAseq.g21382.t1,three_way,74.39133333333334,FUN_015993-T1,Q08AE8,SPIR1_HUMAN,,Protein spire homolog 1 (Spir-1),Homo sapiens (Human),29.2,627.0,3.7e-48,194.5,sp|Q08AE8|SPIR1_HUMAN Protein spire homolog 1 OS=Homo sapiens OX=9606 GN=SPIRE1 PE=1 SV=3,GO:0003779; GO:0005654; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0008017; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0045087; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781,actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; innate immune response [GO:0045087]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0000910; GO:0002376; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0061024; GO:0098542,cytokinesis; immune system process; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; membrane organization; defense response to other organism
OG_03936,FUN_016053-T1,Peve_00034141,Pocillopora_meandrina_HIv1___RNAseq.g21629.t1,three_way,79.90766666666667,FUN_016053-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),44.8,556.0,6.6e-127,456.1,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03938,FUN_016055-T1,Peve_00011789,Pocillopora_meandrina_HIv1___RNAseq.g21631.t1,three_way,71.45683333333334,FUN_016055-T1,Q8IYT8,ULK2_HUMAN,,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),Homo sapiens (Human),34.9,1096.0,7e-132,473.4,sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03960,FUN_016106-T1,Peve_00010760,Pocillopora_meandrina_HIv1___TS.g26345.t1,three_way,78.27083333333333,FUN_016106-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),45.9,536.0,3.6e-125,450.3,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03976,FUN_016130-T1,Peve_00022572,Pocillopora_meandrina_HIv1___RNAseq.g21959.t1,three_way,68.79966666666667,FUN_016130-T1,A3KCL7,OXDD_PIG,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Sus scrofa (Pig),40.6,342.0,3.8e-63,243.4,sp|A3KCL7|OXDD_PIG D-aspartate oxidase OS=Sus scrofa OX=9823 GN=DDO PE=1 SV=2,GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006531; GO:0007320; GO:0007625; GO:0008445; GO:0010646; GO:0019478; GO:0042445; GO:0047821; GO:0050877; GO:0071949,aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]; nervous system process [GO:0050877]; regulation of cell communication [GO:0010646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; peroxisome; cytosol; amino acid metabolic process; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_03986,FUN_016151-T3,Peve_00022570,Pocillopora_meandrina_HIv1___RNAseq.g21228.t1,three_way,51.66783333333333,FUN_016151-T3,Q5SW75,SSH2_MOUSE,,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (mSSH-2L),Mus musculus (Mouse),48.9,509.0,4.7e-124,448.0,sp|Q5SW75|SSH2_MOUSE Protein phosphatase Slingshot homolog 2 OS=Mus musculus OX=10090 GN=Ssh2 PE=1 SV=2,GO:0001669; GO:0003779; GO:0004722; GO:0004725; GO:0005856; GO:0005925; GO:0007283; GO:0030154; GO:0030837,cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],actin binding [GO:0003779]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005856; GO:0008092; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; cytoskeletal protein binding; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03987,FUN_016152-T1,Peve_00022569,Pocillopora_meandrina_HIv1___RNAseq.g21229.t1,three_way,62.593833333333336,FUN_016152-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),47.1,425.0,5.6e-104,380.9,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03996,FUN_016280-T2,Peve_00003392,Pocillopora_meandrina_HIv1___RNAseq.g403.t1,three_way,76.21483333333333,FUN_016280-T2,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),42.5,742.0,6.9e-166,585.9,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04003,FUN_016299-T1,Peve_00025246,Pocillopora_meandrina_HIv1___RNAseq.g9888.t1,three_way,47.610166666666665,FUN_016299-T1,Q64337,SQSTM_MOUSE,,Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62),Mus musculus (Mouse),47.7,44.0,4.8e-06,55.5,sp|Q64337|SQSTM_MOUSE Sequestosome-1 OS=Mus musculus OX=10090 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016235; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140110; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; transcription regulator activity; molecular sequestering activity
OG_04007,FUN_016306-T1,Peve_00032291,Pocillopora_meandrina_HIv1___RNAseq.g10039.t1,three_way,79.79733333333333,FUN_016306-T1,Q27350,SO_DROME,,Protein sine oculis,Drosophila melanogaster (Fruit fly),63.4,186.0,2.2e-62,240.7,sp|Q27350|SO_DROME Protein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1,GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001744; GO:0001745; GO:0001746; GO:0005634; GO:0005667; GO:0006357; GO:0007283; GO:0007623; GO:0008347; GO:0009649; GO:0035271; GO:0043565; GO:0045944; GO:0048749,Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; glial cell migration [GO:0008347]; insect visual primordium formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283],nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04032,FUN_016340-T1,Peve_00044576,Pocillopora_meandrina_HIv1___RNAseq.g9730.t1,three_way,73.72266666666667,FUN_016340-T1,Q6P7A2,UBE4A_RAT,,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),Rattus norvegicus (Rat),39.6,1095.0,2.2e-194,681.0,sp|Q6P7A2|UBE4A_RAT Ubiquitin conjugation factor E4 A OS=Rattus norvegicus OX=10116 GN=Ube4a PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0034450; GO:0036503; GO:0061630,ERAD pathway [GO:0036503]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_04057,FUN_016377-T1,Peve_00022920,Pocillopora_meandrina_HIv1___RNAseq.g9741.t1,three_way,46.54933333333334,FUN_016377-T1,Q03372,HMSH_DROME,,Muscle segmentation homeobox (Protein drop) (Protein msh),Drosophila melanogaster (Fruit fly),36.9,111.0,7e-08,59.3,sp|Q03372|HMSH_DROME Muscle segmentation homeobox OS=Drosophila melanogaster OX=7227 GN=Dr PE=1 SV=2,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007389; GO:0007398; GO:0007400; GO:0007417; GO:0007419; GO:0007420; GO:0007450; GO:0007476; GO:0007485; GO:0007517; GO:0009953; GO:0010629; GO:0021782; GO:0035222; GO:0035309; GO:0042659; GO:0043565; GO:0048598,"brain development [GO:0007420]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic morphogenesis [GO:0048598]; glial cell development [GO:0021782]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle organ development [GO:0007517]; negative regulation of gene expression [GO:0010629]; neuroblast fate determination [GO:0007400]; pattern specification process [GO:0007389]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; wing and notum subfield formation [GO:0035309]; wing disc pattern formation [GO:0035222]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04059,FUN_016379-T1,Peve_00022918,Pocillopora_meandrina_HIv1___RNAseq.g9739.t1,three_way,48.443333333333335,FUN_016379-T1,P02836,HMEN_DROME,,Segmentation polarity homeobox protein engrailed,Drosophila melanogaster (Fruit fly),42.7,96.0,4.6e-09,63.2,sp|P02836|HMEN_DROME Segmentation polarity homeobox protein engrailed OS=Drosophila melanogaster OX=7227 GN=en PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007367; GO:0007386; GO:0007388; GO:0007400; GO:0007411; GO:0007418; GO:0007472; GO:0007474; GO:0007487; GO:0008406; GO:0010468; GO:0010629; GO:0035215; GO:0035224; GO:0035277; GO:0035288; GO:0035289; GO:0035290; GO:0043524; GO:0043565; GO:0045944; GO:0048099; GO:0048100,"analia development [GO:0007487]; anterior head segmentation [GO:0035288]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; axon guidance [GO:0007411]; compartment pattern specification [GO:0007386]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; gonad development [GO:0008406]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior compartment specification [GO:0007388]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; trunk segmentation [GO:0035290]; ventral midline development [GO:0007418]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04087,FUN_016423-T1,Peve_00004362,Pocillopora_meandrina_HIv1___RNAseq.g9805.t1,three_way,60.657833333333336,FUN_016423-T1,Q7ZWE3,LARP7_DANRE,,La-related protein 7 (La ribonucleoprotein domain family member 7),Danio rerio (Zebrafish) (Brachydanio rerio),31.0,568.0,1.3e-52,209.1,sp|Q7ZWE3|LARP7_DANRE La-related protein 7 OS=Danio rerio OX=7955 GN=larp7 PE=2 SV=1,GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0060043; GO:0061026; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904,"box C/D sno(s)RNA 3'-end processing [GO:0000494]; cardiac muscle tissue regeneration [GO:0061026]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0016073; GO:0022414; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; snRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development
OG_04092,FUN_016432-T1,Peve_00004351,Pocillopora_meandrina_HIv1___RNAseq.g9813.t3,three_way,72.73966666666666,FUN_016432-T1,P10894,PLCB1_BOVIN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",Bos taurus (Bovine),58.2,490.0,5.7e-156,553.1,"sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1",GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498,G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607],"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0050877; GO:0055085; GO:0098772,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity; organelle; nervous system process; transmembrane transport; molecular function regulator activity
OG_04100,FUN_016446-T1,Peve_00032929,Pocillopora_meandrina_HIv1___RNAseq.g9835.t1,three_way,65.06700000000001,FUN_016446-T1,Q920N1,CMA1A_MOUSE,,Ciliary microtubule associated protein 1A (Outer dense fiber of sperm tails protein 3) (Outer dense fiber protein 3) (Sperm tail protein SHIPPO 1),Mus musculus (Mouse),42.8,236.0,4.9e-46,186.0,sp|Q920N1|CMA1A_MOUSE Ciliary microtubule associated protein 1A OS=Mus musculus OX=10090 GN=Cimap1a PE=1 SV=2,GO:0001520; GO:0005737; GO:0007283; GO:0030154; GO:0030317; GO:0036126,cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; cell differentiation; organelle; cell motility
OG_04162,FUN_016640-T1,Peve_00042751,Pocillopora_meandrina_HIv1___TS.g6976.t1,three_way,78.45166666666667,FUN_016640-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),39.9,286.0,3.6999999999999997e-54,214.9,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_04195,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04214,FUN_016851-T1,Peve_00020504,Pocillopora_meandrina_HIv1___RNAseq.g9942.t1,three_way,81.00866666666666,FUN_016851-T1,D3YVL2,CFA70_MOUSE,,Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18),Mus musculus (Mouse),42.5,1149.0,6.8e-239,828.9,sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2,GO:0000902; GO:0002177; GO:0003341; GO:0005737; GO:0005930; GO:0007338; GO:0008104; GO:0010467; GO:0030317; GO:0031514; GO:0036126; GO:0036157; GO:0044782; GO:0048872; GO:0060271; GO:0065003; GO:0098727; GO:0120316; GO:1905198,cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; maintenance of cell number [GO:0098727]; manchette assembly [GO:1905198]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],axoneme [GO:0005930]; cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0065003,cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility; protein-containing complex assembly
OG_04246,FUN_017768-T1,Peve_00008289,Pocillopora_meandrina_HIv1___RNAseq.g461.t1,three_way,94.55683333333332,FUN_017768-T1,P51665,PSMD7_HUMAN,,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),Homo sapiens (Human),79.5,273.0,5.9999999999999985e-127,455.3,sp|P51665|PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2,GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,extracellular region; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_04251,FUN_017781-T1,Peve_00029908,Pocillopora_meandrina_HIv1___RNAseq.g9515.t1,three_way,87.17483333333334,FUN_017781-T1,P63017,HSP7C_MOUSE,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Mus musculus (Mouse),79.9,646.0,5.9e-296,1017.7,sp|P63017|HSP7C_MOUSE Heat shock cognate 71 kDa protein OS=Mus musculus OX=10090 GN=Hspa8 PE=1 SV=1,GO:0000082; GO:0000398; GO:0000974; GO:0001786; GO:0001822; GO:0001916; GO:0001917; GO:0003723; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005770; GO:0005776; GO:0005829; GO:0005874; GO:0005882; GO:0006457; GO:0006606; GO:0007519; GO:0008021; GO:0009410; GO:0009986; GO:0010045; GO:0010667; GO:0014069; GO:0014823; GO:0016887; GO:0019899; GO:0021549; GO:0030674; GO:0030900; GO:0031686; GO:0031906; GO:0032355; GO:0032570; GO:0032984; GO:0034605; GO:0042026; GO:0042277; GO:0042470; GO:0042594; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0043209; GO:0043531; GO:0044743; GO:0044788; GO:0044829; GO:0044849; GO:0045471; GO:0045862; GO:0045892; GO:0048026; GO:0048471; GO:0050766; GO:0051082; GO:0051085; GO:0051726; GO:0061077; GO:0061635; GO:0061684; GO:0061738; GO:0061740; GO:0070062; GO:0070301; GO:0071276; GO:0072318; GO:0097214; GO:0098684; GO:0098690; GO:0098793; GO:0098880; GO:0098978; GO:0099175; GO:0099634; GO:0140662; GO:1904592; GO:1904593; GO:1904764; GO:1990832; GO:1990833; GO:1990834; GO:1990836; GO:1990904,"cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cerebellum development [GO:0021549]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein folding [GO:0061077]; clathrin coat disassembly [GO:0072318]; estrous cycle [GO:0044849]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; kidney development [GO:0001822]; late endosomal microautophagy [GO:0061738]; maintenance of postsynaptic specialization structure [GO:0098880]; modulation by host of viral process [GO:0044788]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein refolding [GO:1904592]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein folding [GO:0006457]; protein import into nucleus [GO:0006606]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; protein transmembrane import into intracellular organelle [GO:0044743]; protein-containing complex disassembly [GO:0032984]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of protein complex stability [GO:0061635]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to nickel cation [GO:0010045]; response to odorant [GO:1990834]; response to progesterone [GO:0032570]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; slow axonal transport [GO:1990832]",autophagosome [GO:0005776]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; late endosome lumen [GO:0031906]; lysosomal matrix [GO:1990836]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; postsynaptic density [GO:0014069]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195],A1 adenosine receptor binding [GO:0031686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; clathrin-uncoating ATPase activity [GO:1990833]; enzyme binding [GO:0019899]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; prostaglandin binding [GO:1904593]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005768; GO:0005773; GO:0005829; GO:0006355; GO:0006457; GO:0006886; GO:0006913; GO:0006914; GO:0007018; GO:0008289; GO:0016071; GO:0016787; GO:0022414; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0060090; GO:0061024; GO:0140657,RNA binding; catalytic activity; nucleus; nucleolus; endosome; vacuole; cytosol; regulation of DNA-templated transcription; protein folding; intracellular protein transport; nucleocytoplasmic transport; autophagy; microtubule-based movement; lipid binding; mRNA metabolic process; hydrolase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular adaptor activity; membrane organization; ATP-dependent activity
OG_04327,FUN_017932-T1,Peve_00001593,Pocillopora_meandrina_HIv1___RNAseq.g393.t1,three_way,94.81666666666666,FUN_017932-T1,Q99JY9,ARP3_MOUSE,,Actin-related protein 3 (Actin-like protein 3),Mus musculus (Mouse),83.7,418.0,3.9e-216,751.9,sp|Q99JY9|ARP3_MOUSE Actin-related protein 3 OS=Mus musculus OX=10090 GN=Actr3 PE=1 SV=3,GO:0000139; GO:0001726; GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005884; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0007283; GO:0008356; GO:0010592; GO:0010763; GO:0016344; GO:0030027; GO:0030056; GO:0030517; GO:0030838; GO:0032355; GO:0033206; GO:0034314; GO:0035861; GO:0035984; GO:0043519; GO:0045666; GO:0045944; GO:0048471; GO:0048708; GO:0048711; GO:0051015; GO:0051117; GO:0051321; GO:0051491; GO:0051653; GO:0051965; GO:0060076; GO:0060271; GO:0061003; GO:0061825; GO:0061828; GO:0061830; GO:0061831; GO:0061832; GO:0061843; GO:0061851; GO:0071346; GO:0071347; GO:0071356; GO:0071364; GO:0071503; GO:0071560; GO:0090314; GO:0098794; GO:0098974; GO:0098978; GO:1903078; GO:1904171; GO:1905835; GO:1905837,Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to pyrimidine ribonucleotide [GO:1905835]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to triterpenoid [GO:1905837]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of myosin II filament organization [GO:0043519]; response to estradiol [GO:0032355]; response to heparin [GO:0071503]; Sertoli cell barrier remodeling [GO:0061843]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653],actin filament [GO:0005884]; apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; structural constituent of cytoskeleton [GO:0005200],GO:0000910; GO:0005198; GO:0005634; GO:0006355; GO:0007010; GO:0007018; GO:0007163; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0044782,cytokinesis; structural molecule activity; nucleus; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; establishment or maintenance of cell polarity; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; cilium organization
OG_04354,FUN_018004-T1,Peve_00015727,Pocillopora_meandrina_HIv1___RNAseq.g25251.t1,three_way,57.72966666666667,FUN_018004-T1,Q9JI78,NGLY1_MOUSE,,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),Mus musculus (Mouse),41.8,509.0,2.6e-100,367.5,sp|Q9JI78|NGLY1_MOUSE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Mus musculus OX=10090 GN=Ngly1 PE=1 SV=2,GO:0000224; GO:0005634; GO:0005737; GO:0006516; GO:0046872; GO:0062023,glycoprotein catabolic process [GO:0006516],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nucleus [GO:0005634],metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224],GO:0003824; GO:0005634; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; nucleus; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_04356,FUN_018006-T1,Peve_00015728,Pocillopora_meandrina_HIv1___RNAseq.g25258.t1,three_way,74.419,FUN_018006-T1,O43264,ZW10_HUMAN,,Centromere/kinetochore protein zw10 homolog,Homo sapiens (Human),38.4,787.0,2.2e-143,511.1,sp|O43264|ZW10_HUMAN Centromere/kinetochore protein zw10 homolog OS=Homo sapiens OX=9606 GN=ZW10 PE=1 SV=3,GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0051988; GO:0065003; GO:0070939; GO:1990423,"cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922],centromeric DNA binding [GO:0019237],GO:0003677; GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0007010; GO:0007059; GO:0016192; GO:0022414; GO:0043226; GO:0065003,DNA binding; nucleus; endoplasmic reticulum; lipid droplet; cytosol; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; reproductive process; organelle; protein-containing complex assembly
OG_04358,FUN_018008-T1,Peve_00018955,Pocillopora_meandrina_HIv1___RNAseq.g25256.t1,three_way,90.871,FUN_018008-T1,P31327,CPSM_HUMAN,,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)",Homo sapiens (Human),66.8,1481.0,0.0,2053.5,"sp|P31327|CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia], mitochondrial OS=Homo sapiens OX=9606 GN=CPS1 PE=1 SV=2",GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; potassium ion binding [GO:0030955]; protein-containing complex binding [GO:0044877]; small molecule binding [GO:0036094],GO:0003013; GO:0003824; GO:0005730; GO:0005739; GO:0005886; GO:0006520; GO:0006629; GO:0006790; GO:0008289; GO:0016787; GO:0016874; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0071941; GO:0140096,"circulatory system process; catalytic activity; nucleolus; mitochondrion; plasma membrane; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; lipid binding; hydrolase activity; ligase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; nitrogen cycle metabolic process; catalytic activity, acting on a protein"
OG_04362,FUN_018013-T1,Peve_00000400,Pocillopora_meandrina_HIv1___RNAseq.g25252.t1,three_way,77.03966666666666,FUN_018013-T1,Q9JI78,NGLY1_MOUSE,,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),Mus musculus (Mouse),44.5,636.0,1.2e-146,521.9,sp|Q9JI78|NGLY1_MOUSE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Mus musculus OX=10090 GN=Ngly1 PE=1 SV=2,GO:0000224; GO:0005634; GO:0005737; GO:0006516; GO:0046872; GO:0062023,glycoprotein catabolic process [GO:0006516],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nucleus [GO:0005634],metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224],GO:0003824; GO:0005634; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; nucleus; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_04365,FUN_018018-T2,Peve_00026633,Pocillopora_meandrina_HIv1___RNAseq.g25292.t1,three_way,78.64166666666667,FUN_018018-T2,P30260,CDC27_HUMAN,,Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC),Homo sapiens (Human),51.0,843.0,4.8e-117,423.7,sp|P30260|CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens OX=9606 GN=CDC27 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0031175; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; neuron projection development [GO:0031175]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; protein catabolic process; organelle
OG_04384,FUN_018090-T1,Peve_00017613,Pocillopora_meandrina_HIv1___RNAseq.g25343.t1,three_way,84.46766666666666,FUN_018090-T1,Q64521,GPDM_MOUSE,,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (Protein TISP38)",Mus musculus (Mouse),62.2,717.0,1.6999999999999998e-259,896.7,"sp|Q64521|GPDM_MOUSE Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Gpd2 PE=1 SV=2",GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0019563; GO:0035264; GO:0043010,camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368],GO:0003824; GO:0005739; GO:0005975; GO:0016491; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04399,FUN_018404-T1,Peve_00031698,Pocillopora_meandrina_HIv1___RNAseq.g10163.t1,three_way,62.86966666666667,FUN_018404-T1,Q5S006,LRRK2_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),Mus musculus (Mouse),31.9,138.0,7.2e-09,64.7,sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2,GO:0000139; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007005; GO:0007029; GO:0007030; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0031965; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; multivesicular body, internal vesicle [GO:0097487]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; nucleoplasm; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04400,FUN_018405-T1,Peve_00031697,Pocillopora_meandrina_HIv1___RNAseq.g10164.t1,three_way,90.36766666666666,FUN_018405-T1,Q5JU00,DRC5_HUMAN,,Dynein regulatory complex subunit 5 (T-complex-associated testis-expressed protein 1) (Tcte-1),Homo sapiens (Human),54.5,264.0,6.3000000000000016e-87,322.8,sp|Q5JU00|DRC5_HUMAN Dynein regulatory complex subunit 5 OS=Homo sapiens OX=9606 GN=TCTE1 PE=1 SV=1,GO:0005737; GO:0005856; GO:0007018; GO:0030317; GO:0036126,flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],,GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_04414,FUN_018521-T1,Peve_00007312,Pocillopora_meandrina_HIv1___RNAseq.g10181.t1,three_way,76.60266666666666,FUN_018521-T1,Q90ZA1,PARN_XENLA,,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease) (parn-A),Xenopus laevis (African clawed frog),46.5,563.0,2.5e-139,497.3,sp|Q90ZA1|PARN_XENLA Poly(A)-specific ribonuclease PARN OS=Xenopus laevis OX=8355 GN=parn PE=1 SV=1,GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0043169; GO:0046872; GO:0051321; GO:1990431; GO:1990432,meiotic cell cycle [GO:0051321]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; priRNA 3'-end processing [GO:1990431]; siRNA 3'-end processing [GO:1990432],cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_04422,FUN_018531-T1,Peve_00039201,Pocillopora_meandrina_HIv1___RNAseq.g9981.t1,three_way,73.98216666666667,FUN_018531-T1,Q9H9S5,FKRP_HUMAN,,Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase),Homo sapiens (Human),44.4,522.0,2.4e-120,434.1,sp|Q9H9S5|FKRP_HUMAN Ribitol 5-phosphate transferase FKRP OS=Homo sapiens OX=9606 GN=FKRP PE=1 SV=1,GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723,adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403],cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723],"dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003012; GO:0003016; GO:0003824; GO:0005615; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0006575; GO:0006629; GO:0006954; GO:0009101; GO:0016740; GO:0030154; GO:0030198; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0051604; GO:0055086; GO:0065003; GO:1901135,muscle system process; respiratory system process; catalytic activity; extracellular space; nucleoplasm; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; inflammatory response; glycoprotein biosynthetic process; transferase activity; cell differentiation; extracellular matrix organization; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; protein maturation; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_04447,FUN_018948-T1,Peve_00035804,Pocillopora_meandrina_HIv1___RNAseq.g366.t1,three_way,49.209500000000006,FUN_018948-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.7,266.0,6.8e-57,223.8,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04449,FUN_019015-T1,Peve_00035805,Pocillopora_meandrina_HIv1___RNAseq.g384.t1,three_way,68.97266666666667,FUN_019015-T1,Q03336,RGN_RAT,,Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30),Rattus norvegicus (Rat),49.3,134.0,6.5e-34,145.6,sp|Q03336|RGN_RAT Regucalcin OS=Rattus norvegicus OX=10116 GN=Rgn PE=1 SV=3,GO:0001822; GO:0001889; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0007283; GO:0008270; GO:0010558; GO:0010867; GO:0010907; GO:0019853; GO:0030234; GO:0032781; GO:0043066; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0097421; GO:1901318; GO:1902679; GO:1903011; GO:1903052; GO:1903625; GO:2000279,intracellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of macromolecule biosynthetic process [GO:0010558]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005975; GO:0006766; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; carbohydrate metabolic process; vitamin metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_04497,FUN_021932-T1,Peve_00023933,Pocillopora_meandrina_HIv1___RNAseq.g2963.t1,three_way,94.748,FUN_021932-T1,Q13616,CUL1_HUMAN,,Cullin-1 (CUL-1),Homo sapiens (Human),78.6,776.0,0.0,1172.1,sp|Q13616|CUL1_HUMAN Cullin-1 OS=Homo sapiens OX=9606 GN=CUL1 PE=1 SV=2,GO:0000082; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006513; GO:0008283; GO:0009887; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031625; GO:0043123; GO:0043161; GO:0070936; GO:0097193; GO:0160072; GO:1990452,animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0030163; GO:0043226; GO:0060090,nucleus; nucleoplasm; cytosol; plasma membrane; protein catabolic process; organelle; molecular adaptor activity
OG_04542,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_04543,FUN_022104-T2,Peve_00009726,Pocillopora_meandrina_HIv1___RNAseq.g4104.t1,three_way,90.09683333333334,FUN_022104-T2,Q9JHD2,KAT2A_MOUSE,,Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (MmGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A),Mus musculus (Mouse),63.9,758.0,4.4999999999999997e-293,1008.4,sp|Q9JHD2|KAT2A_MOUSE Histone acetyltransferase KAT2A OS=Mus musculus OX=10090 GN=Kat2a PE=1 SV=2,GO:0000122; GO:0000123; GO:0000124; GO:0001701; GO:0001756; GO:0001819; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005813; GO:0006094; GO:0006282; GO:0006355; GO:0006357; GO:0007399; GO:0007507; GO:0007616; GO:0008080; GO:0010484; GO:0016407; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035264; GO:0042826; GO:0043484; GO:0043992; GO:0043993; GO:0043997; GO:0045252; GO:0045589; GO:0045721; GO:0045722; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048144; GO:0048167; GO:0048312; GO:0050863; GO:0051302; GO:0051726; GO:0060173; GO:0061035; GO:0071356; GO:0072686; GO:0106078; GO:0106227; GO:0106229; GO:0140297; GO:0140672; GO:1903010; GO:1990090; GO:2000036; GO:2000727,cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; fibroblast proliferation [GO:0048144]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537],ATAC complex [GO:0140672]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone succinyltransferase activity [GO:0106078]; N-acetyltransferase activity [GO:0008080]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005975; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; carbohydrate metabolic process; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04564,FUN_022206-T1,Peve_00008604,Pocillopora_meandrina_HIv1___RNAseq.g4803.t1,three_way,63.762,FUN_022206-T1,Q80X71,T106B_MOUSE,,Transmembrane protein 106B,Mus musculus (Mouse),31.3,198.0,5.4e-20,99.8,sp|Q80X71|T106B_MOUSE Transmembrane protein 106B OS=Mus musculus OX=10090 GN=Tmem106b PE=1 SV=1,GO:0005764; GO:0005765; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0031902; GO:0032418; GO:0048813; GO:0051117; GO:0070050; GO:1900006; GO:1905146; GO:1905671,dendrite morphogenesis [GO:0048813]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neuron cellular homeostasis [GO:0070050]; positive regulation of dendrite development [GO:1900006]; regulation of lysosome organization [GO:1905671],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],ATPase binding [GO:0051117],GO:0005764; GO:0005773; GO:0005886; GO:0007040; GO:0030163; GO:0043226,lysosome; vacuole; plasma membrane; lysosome organization; protein catabolic process; organelle
OG_04573,FUN_022221-T1,Peve_00033927,Pocillopora_meandrina_HIv1___RNAseq.g4738.t1,three_way,56.5145,FUN_022221-T1,Q3V2A7,QRIC2_MOUSE,,Glutamine-rich protein 2,Mus musculus (Mouse),29.7,353.0,6.5e-34,147.5,sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_04597,FUN_022282-T1,Peve_00027183,Pocillopora_meandrina_HIv1___RNAseq.g4699.t1,three_way,41.48266666666667,FUN_022282-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),37.2,261.0,9.6e-40,167.5,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_04603,FUN_022292-T1,Peve_00003687,Pocillopora_meandrina_HIv1___RNAseq.g4692.t1,three_way,84.67733333333334,FUN_022292-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),34.6,315.0,7.4e-50,199.1,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_04616,FUN_022315-T1,Peve_00021692,Pocillopora_meandrina_HIv1___RNAseq.g4632.t1,three_way,88.54166666666667,FUN_022315-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,218.0,3.2e-15,83.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_04625,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_04636,FUN_022359-T1,Peve_00021994,Pocillopora_meandrina_HIv1___TS.g22004.t1,three_way,71.571,FUN_022359-T1,Q9Y238,DLEC1_HUMAN,,Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1),Homo sapiens (Human),34.6,1713.0,1.3999999999999998e-264,914.8,sp|Q9Y238|DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens OX=9606 GN=DLEC1 PE=1 SV=2,GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487,cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631],GO:0005829; GO:0005929; GO:0008092; GO:0022414; GO:0030154; GO:0043226,cytosol; cilium; cytoskeletal protein binding; reproductive process; cell differentiation; organelle
OG_04650,FUN_022383-T1,Peve_00013221,Pocillopora_meandrina_HIv1___RNAseq.g9308.t1,three_way,67.081,FUN_022383-T1,P20009,DLL_DROME,,Homeotic protein distal-less (Protein brista),Drosophila melanogaster (Fruit fly),47.1,174.0,6.900000000000001e-28,125.9,sp|P20009|DLL_DROME Homeotic protein distal-less OS=Drosophila melanogaster OX=7227 GN=Dll PE=2 SV=3,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0030154; GO:0035114; GO:0035215; GO:0045893; GO:0048264; GO:0048728,"analia development [GO:0007487]; antennal development [GO:0007469]; cell differentiation [GO:0030154]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04652,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.5e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04654,FUN_022393-T1,Peve_00037599,Pocillopora_meandrina_HIv1___TS.g19612.t1,three_way,78.64883333333333,FUN_022393-T1,P63080,GBRB3_MOUSE,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Mus musculus (Mouse),37.8,463.0,6.3e-77,289.7,sp|P63080|GBRB3_MOUSE Gamma-aminobutyric acid receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Gabrb3 PE=1 SV=1,GO:0004890; GO:0005216; GO:0005886; GO:0007214; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_04660,FUN_022403-T2,Peve_00037588,Pocillopora_meandrina_HIv1___RNAseq.g4547.t1,three_way,80.267,FUN_022403-T2,Q0VFZ6,CF210_HUMAN,,Cilia- and flagella- associated protein 210 (Coiled-coil domain-containing protein 173),Homo sapiens (Human),30.4,529.0,3.1e-35,151.4,sp|Q0VFZ6|CF210_HUMAN Cilia- and flagella- associated protein 210 OS=Homo sapiens OX=9606 GN=CFAP210 PE=1 SV=2,GO:0005879; GO:0030317; GO:0036126; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_04662,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04705,FUN_022506-T1,Peve_00002460,Pocillopora_meandrina_HIv1___RNAseq.g4262.t1,three_way,76.27033333333334,FUN_022506-T1,P58742,AAAS_MOUSE,,Aladin (Adracalin),Mus musculus (Mouse),41.0,493.0,3.7e-115,416.8,sp|P58742|AAAS_MOUSE Aladin OS=Mus musculus OX=10090 GN=Aaas PE=1 SV=1,GO:0000922; GO:0001578; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006749; GO:0006913; GO:0006979; GO:0007612; GO:0009566; GO:0015031; GO:0031965; GO:0035264; GO:0051028; GO:0072686; GO:0090307,fertilization [GO:0009566]; glutathione metabolic process [GO:0006749]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],,GO:0005635; GO:0005654; GO:0005815; GO:0005829; GO:0006575; GO:0006790; GO:0006913; GO:0007010; GO:0022414; GO:0043226; GO:0050877,nuclear envelope; nucleoplasm; microtubule organizing center; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; organelle; nervous system process
OG_04721,FUN_022578-T1,Peve_00020592,Pocillopora_meandrina_HIv1___RNAseq.g4435.t1,three_way,84.55266666666667,FUN_022578-T1,Q9JLI7,SPAG6_MOUSE,,Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog),Mus musculus (Mouse),87.9,506.0,1.2e-81,305.4,sp|Q9JLI7|SPAG6_MOUSE Sperm-associated antigen 6 OS=Mus musculus OX=10090 GN=Spag6 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716,"cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]",acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm principal piece [GO:0097228],microtubule binding [GO:0008017],GO:0003016; GO:0005576; GO:0005829; GO:0007010; GO:0007018; GO:0007155; GO:0007163; GO:0008092; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877,respiratory system process; extracellular region; cytosol; cytoskeleton organization; microtubule-based movement; cell adhesion; establishment or maintenance of cell polarity; cytoskeletal protein binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process
OG_04725,FUN_022590-T1,Peve_00020264,Pocillopora_meandrina_HIv1___RNAseq.g4430.t1,three_way,67.37833333333333,FUN_022590-T1,Q64368,DAZL_MOUSE,,Deleted in azoospermia-like (DAZ-like autosomal) (Deleted in azoospermia-like 1),Mus musculus (Mouse),37.4,139.0,2e-15,84.0,sp|Q64368|DAZL_MOUSE Deleted in azoospermia-like OS=Mus musculus OX=10090 GN=Dazl PE=1 SV=1,GO:0001556; GO:0003730; GO:0005634; GO:0005737; GO:0005840; GO:0007147; GO:0007281; GO:0007283; GO:0008494; GO:0032991; GO:0042802; GO:0045836; GO:0045948,female meiosis II [GO:0007147]; germ cell development [GO:0007281]; oocyte maturation [GO:0001556]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribosome [GO:0005840],identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494],GO:0003723; GO:0005634; GO:0005840; GO:0022414; GO:0043226; GO:0045182; GO:0048856; GO:0140013,RNA binding; nucleus; ribosome; reproductive process; organelle; translation regulator activity; anatomical structure development; meiotic nuclear division
OG_04726,FUN_022591-T1,Peve_00020266,Pocillopora_meandrina_HIv1___RNAseq.g4429.t1,three_way,89.74766666666666,FUN_022591-T1,E2RG47,STT3B_CANLF,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18),Canis lupus familiaris (Dog) (Canis familiaris),69.7,700.0,4.4e-276,951.8,sp|E2RG47|STT3B_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Canis lupus familiaris OX=9615 GN=STT3B PE=1 SV=1,GO:0004579; GO:0006516; GO:0006986; GO:0008250; GO:0018279; GO:0036503; GO:0043686; GO:0043687; GO:0046872; GO:0160227,co-translational protein modification [GO:0043686]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986],oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex B [GO:0160227],dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],GO:0003824; GO:0009101; GO:0016740; GO:0030163; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; protein catabolic process; carbohydrate derivative metabolic process
OG_04731,FUN_022599-T1,Peve_00012273,Pocillopora_meandrina_HIv1___RNAseq.g4424.t2,three_way,83.4855,FUN_022599-T1,F1LZW6,S2513_RAT,,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Solute carrier family 25 member 13)",Rattus norvegicus (Rat),51.9,671.0,7.100000000000001e-186,652.1,"sp|F1LZW6|S2513_RAT Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Rattus norvegicus OX=10116 GN=Slc25a13 PE=3 SV=4",GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006754; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592,aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",GO:0005215; GO:0005739; GO:0005975; GO:0006091; GO:0043226; GO:0055085; GO:0055086; GO:1901135,transporter activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04764,FUN_022664-T2,Peve_00027942,Pocillopora_meandrina_HIv1___RNAseq.g3154.t1,three_way,68.32866666666666,FUN_022664-T2,O19094,OCTC_BOVIN,,Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137),Bos taurus (Bovine),42.1,598.0,9.4e-137,488.8,sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1,GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015936; GO:0051791,carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791],peroxisome [GO:0005777],carnitine O-octanoyltransferase activity [GO:0008458],GO:0003824; GO:0005777; GO:0006091; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; peroxisome; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_04793,FUN_022709-T1,Peve_00006884,Pocillopora_meandrina_HIv1___RNAseq.g4816.t1,three_way,59.685833333333335,FUN_022709-T1,Q32PV5,TCF21_DANRE,,Transcription factor 21 (TCF-21) (Capsulin) (Epicardin) (MyoRa2),Danio rerio (Zebrafish) (Brachydanio rerio),38.7,111.0,5.4e-06,52.8,sp|Q32PV5|TCF21_DANRE Transcription factor 21 OS=Danio rerio OX=7955 GN=tcf21 PE=2 SV=1,GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0006357; GO:0007519; GO:0007530; GO:0014707; GO:0030855; GO:0032502; GO:0032835; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0060840; GO:0070888; GO:0072162; GO:0072277,artery development [GO:0060840]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; skeletal muscle tissue development [GO:0007519]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04805,FUN_022764-T1,Peve_00014654,Pocillopora_meandrina_HIv1___RNAseq.g4808.t1,three_way,73.40683333333334,FUN_022764-T1,Q6QHK4,FIGLA_HUMAN,,Factor in the germline alpha (FIGalpha) (Class C basic helix-loop-helix protein 8) (bHLHc8) (Folliculogenesis-specific basic helix-loop-helix protein) (Transcription factor FIGa),Homo sapiens (Human),45.3,64.0,1.6e-08,61.2,sp|Q6QHK4|FIGLA_HUMAN Factor in the germline alpha OS=Homo sapiens OX=9606 GN=FIGLA PE=1 SV=2,GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0032502; GO:0043425; GO:0046983; GO:0048599; GO:1990837,developmental process [GO:0032502]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04810,FUN_022772-T1,Peve_00043388,Pocillopora_meandrina_HIv1___RNAseq.g4767.t1,three_way,97.277,FUN_022772-T1,P23258,TBG1_HUMAN,,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),Homo sapiens (Human),81.6,451.0,5.9e-221,768.1,sp|P23258|TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2,GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0000931; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005881; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0043005; GO:0045177; GO:0055037; GO:0097730; GO:0140490; GO:1990498,cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052],apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819],GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule nucleator activity [GO:0140490]; structural constituent of cytoskeleton [GO:0005200],GO:0000228; GO:0000278; GO:0005198; GO:0005634; GO:0005694; GO:0005768; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0007059; GO:0022414; GO:0031410; GO:0043226,nuclear chromosome; mitotic cell cycle; structural molecule activity; nucleus; chromosome; endosome; microtubule organizing center; cytosol; cilium; cytoskeleton organization; chromosome segregation; reproductive process; cytoplasmic vesicle; organelle
OG_04830,FUN_022824-T1,Peve_00030469,Pocillopora_meandrina_HIv1___RNAseq.g3440.t1,three_way,97.61033333333332,FUN_022824-T1,B2RW38,CFA58_MOUSE,,Cilia- and flagella-associated protein 58,Mus musculus (Mouse),69.4,788.0,3.3999999999999996e-177,623.6,sp|B2RW38|CFA58_MOUSE Cilia- and flagella-associated protein 58 OS=Mus musculus OX=10090 GN=Cfap58 PE=1 SV=1,GO:0005737; GO:0005813; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317],centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225],,GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_04835,FUN_022833-T1,Peve_00028896,Pocillopora_meandrina_HIv1___RNAseq.g3429.t1,three_way,83.13033333333334,FUN_022833-T1,Q969Q5,RAB24_HUMAN,,Ras-related protein Rab-24 (EC 3.6.5.2),Homo sapiens (Human),69.6,171.0,4.8e-66,252.3,sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1,GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0048471; GO:0140013,attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772; GO:0140013,catalytic activity; GTPase activity; mitochondrion; endosome; vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity; meiotic nuclear division
OG_04847,FUN_022857-T1,Peve_00004025,Pocillopora_meandrina_HIv1___TS.g9560.t1,three_way,73.97733333333333,FUN_022857-T1,Q75Z89,5HT2A_BOVIN,,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),Bos taurus (Bovine),28.6,318.0,4.5e-26,120.2,sp|Q75Z89|5HT2A_BOVIN 5-hydroxytryptamine receptor 2A OS=Bos taurus OX=9913 GN=HTR2A PE=2 SV=1,GO:0001587; GO:0004993; GO:0005886; GO:0005901; GO:0006096; GO:0006874; GO:0007187; GO:0007208; GO:0007210; GO:0007268; GO:0009410; GO:0010513; GO:0030296; GO:0030424; GO:0030425; GO:0030594; GO:0031410; GO:0042802; GO:0044380; GO:0045600; GO:0045821; GO:0051209; GO:0051378; GO:0070374; GO:0071886; GO:0098666; GO:0098793; GO:0099589,"chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glycolytic process [GO:0006096]; intracellular calcium ion homeostasis [GO:0006874]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein localization to cytoskeleton [GO:0044380]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; serotonin receptor signaling pathway [GO:0007210]",axon [GO:0030424]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; protein tyrosine kinase activator activity [GO:0030296]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]",GO:0005886; GO:0005975; GO:0006091; GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0055086; GO:0060089; GO:0098772; GO:1901135,plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; signaling; cytoplasmic vesicle; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular transducer activity; molecular function regulator activity; carbohydrate derivative metabolic process
OG_04849,FUN_022861-T1,Peve_00025611,Pocillopora_meandrina_HIv1___RNAseq.g3605.t1,three_way,79.88833333333334,FUN_022861-T1,O55003,BNIP3_MOUSE,,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,Mus musculus (Mouse),33.5,188.0,1.5e-15,84.3,sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1,GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144,apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0006914; GO:0007005; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0061024,nucleus; nuclear envelope; nucleoplasm; mitochondrion; autophagy; mitochondrion organization; programmed cell death; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; membrane organization
OG_04872,FUN_022900-T1,Peve_00001844,Pocillopora_meandrina_HIv1___TS.g9874.t2,three_way,78.98066666666666,FUN_022900-T1,P14735,IDE_HUMAN,,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),Homo sapiens (Human),57.6,531.0,2.7e-191,669.8,sp|P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=4,GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045732; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0150094; GO:1901142; GO:1901143; GO:1903715,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],GO:0001618; GO:0002376; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"virus receptor activity; immune system process; catalytic activity; extracellular space; nucleus; mitochondrion; peroxisome; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_04874,FUN_022903-T1,Peve_00001842,Pocillopora_meandrina_HIv1___RNAseq.g3702.t1,three_way,81.031,FUN_022903-T1,Q6ZQN7,SO4C1_HUMAN,,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),Homo sapiens (Human),35.1,615.0,6.1e-111,403.3,sp|Q6ZQN7|SO4C1_HUMAN Solute carrier organic anion transporter family member 4C1 OS=Homo sapiens OX=9606 GN=SLCO4C1 PE=1 SV=1,GO:0005886; GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062,cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347],GO:0005215; GO:0005886; GO:0022414; GO:0030154; GO:0043226,transporter activity; plasma membrane; reproductive process; cell differentiation; organelle
OG_04881,FUN_022915-T1,Peve_00001787,Pocillopora_meandrina_HIv1___RNAseq.g3711.t1,three_way,84.37066666666666,FUN_022915-T1,P55036,PSMD4_HUMAN,,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),Homo sapiens (Human),60.6,383.0,1.1e-98,361.7,sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1,GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_04886,FUN_022926-T1,Peve_00008664,Pocillopora_meandrina_HIv1___RNAseq.g3725.t1,three_way,76.998,FUN_022926-T1,Q9UBJ2,ABCD2_HUMAN,,ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR),Homo sapiens (Human),58.7,717.0,1.5e-234,813.9,sp|Q9UBJ2|ABCD2_HUMAN ATP-binding cassette sub-family D member 2 OS=Homo sapiens OX=9606 GN=ABCD2 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0006636; GO:0007031; GO:0009617; GO:0015605; GO:0015910; GO:0015932; GO:0016887; GO:0032000; GO:0036109; GO:0042626; GO:0042759; GO:0042760; GO:0042803; GO:0042887; GO:0043217; GO:0043651; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1901570; GO:1901682; GO:1903427; GO:1990535; GO:2001280,alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleobase-containing compound transmembrane transporter activity [GO:0015932]; organophosphate ester transmembrane transporter activity [GO:0015605]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sulfur compound transmembrane transporter activity [GO:1901682],GO:0003824; GO:0005215; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_04887,FUN_022928-T1,Peve_00004269,Pocillopora_meandrina_HIv1___RNAseq.g3731.t1,three_way,63.60333333333333,FUN_022928-T1,Q6NZC7,S23IP_MOUSE,,SEC23-interacting protein,Mus musculus (Mouse),46.8,763.0,2.5e-179,630.9,sp|Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2,GO:0001675; GO:0005801; GO:0007286; GO:0007338; GO:0012507; GO:0046872; GO:0048471; GO:0070971; GO:0097038,acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286],cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471],metal ion binding [GO:0046872],GO:0022414; GO:0043226; GO:0048856,reproductive process; organelle; anatomical structure development
OG_04917,FUN_022971-T1,Peve_00011907,Pocillopora_meandrina_HIv1___RNAseq.g3757.t1,three_way,63.9935,FUN_022971-T1,A9ULG4,AUP1_XENTR,,Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),35.3,306.0,6.1e-41,169.5,sp|A9ULG4|AUP1_XENTR Lipid droplet-regulating VLDL assembly factor AUP1 OS=Xenopus tropicalis OX=8364 GN=aup1 PE=2 SV=1,GO:0005789; GO:0005811; GO:0034389; GO:0036503; GO:0043130; GO:0140042; GO:1990044,ERAD pathway [GO:0036503]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; protein localization to lipid droplet [GO:1990044],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811],ubiquitin binding [GO:0043130],GO:0005811; GO:0030163; GO:0043226,lipid droplet; protein catabolic process; organelle
OG_04933,FUN_023003-T1,Peve_00009969,Pocillopora_meandrina_HIv1___RNAseq.g3815.t1,three_way,63.2335,FUN_023003-T1,A9UMP7,ENO4_XENLA,,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),Xenopus laevis (African clawed frog),27.5,462.0,7.399999999999999e-43,176.8,sp|A9UMP7|ENO4_XENLA Enolase 4 OS=Xenopus laevis OX=8355 GN=eno4 PE=2 SV=2,GO:0000015; GO:0000287; GO:0004634; GO:0006096,glycolytic process [GO:0006096],phosphopyruvate hydratase complex [GO:0000015],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634],GO:0003824; GO:0005975; GO:0006091; GO:0016829; GO:0055086; GO:1901135,catalytic activity; carbohydrate metabolic process; generation of precursor metabolites and energy; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04935,FUN_023006-T1,Peve_00010033,Pocillopora_meandrina_HIv1___RNAseq.g3819.t1,three_way,89.79050000000001,FUN_023006-T1,Q9Y297,FBW1A_HUMAN,,F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit),Homo sapiens (Human),76.5,213.0,2.4e-98,360.9,sp|Q9Y297|FBW1A_HUMAN F-box/WD repeat-containing protein 1A OS=Homo sapiens OX=9606 GN=BTRC PE=1 SV=1,GO:0000122; GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045879; GO:0045893; GO:0046983; GO:0048511; GO:0050860; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:1904668; GO:1990756; GO:1990757,branching involved in mammary gland duct morphogenesis [GO:0060444]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005],beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0016740; GO:0016874; GO:0030163; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; transferase activity; ligase activity; protein catabolic process; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04951,FUN_023041-T1,Peve_00008505,Pocillopora_meandrina_HIv1___RNAseq.g3860.t1,three_way,73.58200000000001,FUN_023041-T1,P40692,MLH1_HUMAN,,DNA mismatch repair protein Mlh1 (MutL protein homolog 1),Homo sapiens (Human),53.6,813.0,1.3e-236,820.8,sp|P40692|MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens OX=9606 GN=MLH1 PE=1 SV=1,GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664,double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283],chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0007059; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA repair; DNA recombination; chromosome segregation; mRNA metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_04976,FUN_023085-T1,Peve_00027837,Pocillopora_meandrina_HIv1___RNAseq.g1661.t1,three_way,55.247166666666665,FUN_023085-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),30.7,313.0,4.7e-31,137.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_04977,FUN_023086-T1,Peve_00037477,Pocillopora_meandrina_HIv1___TS.g4174.t3,three_way,63.9085,FUN_023086-T1,Q9Y251,HPSE_HUMAN,,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],Homo sapiens (Human),40.4,498.0,6.6e-93,342.8,sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2,GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0046677; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806,angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to antibiotic [GO:0046677]; vascular wound healing [GO:0061042],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580],beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0007155; GO:0016787; GO:0030163; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0055085; GO:1901135,catalytic activity; extracellular region; extracellular space; nucleus; nucleoplasm; lysosome; vacuole; cell adhesion; hydrolase activity; protein catabolic process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; transmembrane transport; carbohydrate derivative metabolic process
OG_04978,FUN_023097-T1,Peve_00006987,Pocillopora_meandrina_HIv1___RNAseq.g1671.t1,three_way,63.32366666666667,FUN_023097-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),43.6,140.0,6.5e-25,116.3,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_05001,FUN_023137-T1,Peve_00008522,Pocillopora_meandrina_HIv1___RNAseq.g1751.t1,three_way,83.42833333333333,FUN_023137-T1,Q9Z2X8,KEAP1_MOUSE,,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2),Mus musculus (Mouse),32.2,391.0,2.2e-55,218.4,sp|Q9Z2X8|KEAP1_MOUSE Kelch-like ECH-associated protein 1 OS=Mus musculus OX=10090 GN=Keap1 PE=1 SV=1,GO:0000122; GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032991; GO:0034451; GO:0034599; GO:0042802; GO:0043161; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:0140416; GO:1902883; GO:1990756,cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511],actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005783; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleoplasm; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_05014,FUN_023173-T1,Peve_00009976,Pocillopora_meandrina_HIv1___TS.g25350.t1,three_way,83.18433333333333,FUN_023173-T1,O93309,SMC3_XENLA,,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3),Xenopus laevis (African clawed frog),50.2,630.0,2.6e-150,533.9,sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2,GO:0000775; GO:0000785; GO:0003690; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0007064; GO:0016887; GO:0030892; GO:0030893; GO:0051301; GO:0051321,cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0022414; GO:0043226,DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; reproductive process; organelle
OG_05022,FUN_023185-T1,Peve_00027669,Pocillopora_meandrina_HIv1___RNAseq.g667.t1,three_way,92.11933333333332,FUN_023185-T1,Q29RL1,CF206_BOVIN,,Cilia- and flagella-associated protein 206,Bos taurus (Bovine),60.4,627.0,1e-207,724.5,sp|Q29RL1|CF206_BOVIN Cilia- and flagella-associated protein 206 OS=Bos taurus OX=9913 GN=CFAP206 PE=2 SV=2,GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317,axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534],,GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle
OG_05031,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_05038,FUN_023220-T1,Peve_00029814,Pocillopora_meandrina_HIv1___RNAseq.g696.t1,three_way,81.45,FUN_023220-T1,Q8K2C8,GPAT4_MOUSE,,Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7),Mus musculus (Mouse),50.9,432.0,5.8e-122,439.1,sp|Q8K2C8|GPAT4_MOUSE Glycerol-3-phosphate acyltransferase 4 OS=Mus musculus OX=10090 GN=Gpat4 PE=1 SV=1,GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016024; GO:0019432; GO:0030879; GO:0040014; GO:0046339,acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],glycerol-3-phosphate O-acyltransferase activity [GO:0004366],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0048856; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_05069,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05105,FUN_023363-T1,Peve_00005341,Pocillopora_meandrina_HIv1___RNAseq.g17541.t1,three_way,60.940666666666665,FUN_023363-T1,Q24207,BOULE_DROME,,Protein boule,Drosophila melanogaster (Fruit fly),35.0,163.0,3.5e-13,76.6,sp|Q24207|BOULE_DROME Protein boule OS=Drosophila melanogaster OX=7227 GN=bol PE=1 SV=1,GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935,3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204],mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],GO:0003723; GO:0005634; GO:0022414; GO:0030154; GO:0043226; GO:0045182,RNA binding; nucleus; reproductive process; cell differentiation; organelle; translation regulator activity
OG_05108,FUN_023367-T1,Peve_00005352,Pocillopora_meandrina_HIv1___TS.g17123.t1,three_way,73.227,FUN_023367-T1,Q91W97,HKDC1_MOUSE,,Hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1),Mus musculus (Mouse),46.1,447.0,1e-103,378.6,sp|Q91W97|HKDC1_MOUSE Hexokinase HKDC1 OS=Mus musculus OX=10090 GN=Hkdc1 PE=2 SV=1,GO:0001678; GO:0001917; GO:0004340; GO:0005524; GO:0005536; GO:0005739; GO:0006096; GO:0019318; GO:0031966; GO:0051156,glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]; intracellular glucose homeostasis [GO:0001678],mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917],ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; glucokinase activity [GO:0004340],GO:0003824; GO:0005739; GO:0005975; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05137,FUN_023408-T1,Peve_00016095,Pocillopora_meandrina_HIv1___RNAseq.g17551.t1,three_way,72.24833333333333,FUN_023408-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),32.9,286.0,1.6e-26,121.3,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_05208,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05209,FUN_023593-T1,Peve_00039448,Pocillopora_meandrina_HIv1___RNAseq.g3313.t1,three_way,77.99266666666666,FUN_023593-T1,Q6PIW4,FIGL1_HUMAN,,Fidgetin-like protein 1 (EC 3.6.4.-),Homo sapiens (Human),45.8,718.0,3.7e-150,533.5,sp|Q6PIW4|FIGL1_HUMAN Fidgetin-like protein 1 OS=Homo sapiens OX=9606 GN=FIGNL1 PE=1 SV=2,GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243,ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568],GO:0000228; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0055086; GO:0140013; GO:0140096; GO:0140657; GO:1901135,"nuclear chromosome; catalytic activity; nucleus; nucleoplasm; chromosome; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; nucleobase-containing small molecule metabolic process; meiotic nuclear division; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_05210,FUN_023597-T1,Peve_00039446,Pocillopora_meandrina_HIv1___RNAseq.g19748.t1,three_way,71.65633333333334,FUN_023597-T1,P08217,CEL2A_HUMAN,,Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2A),Homo sapiens (Human),39.5,210.0,6.7e-31,135.6,sp|P08217|CEL2A_HUMAN Chymotrypsin-like elastase family member 2A OS=Homo sapiens OX=9606 GN=CELA2A PE=1 SV=1,GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0006508; GO:0017171; GO:0032868; GO:0036457; GO:0050796; GO:0090330; GO:1901143,insulin catabolic process [GO:1901143]; proteolysis [GO:0006508]; regulation of insulin secretion [GO:0050796]; regulation of platelet aggregation [GO:0090330]; response to insulin [GO:0032868],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; keratohyalin granule [GO:0036457],endopeptidase activity [GO:0004175]; serine hydrolase activity [GO:0017171]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005615; GO:0005829; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; extracellular region; extracellular space; cytosol; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_05216,FUN_023625-T1,Peve_00010903,Pocillopora_meandrina_HIv1___RNAseq.g3527.t1,three_way,62.84083333333333,FUN_023625-T1,A2AAY5,SPD2B_MOUSE,,SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),Mus musculus (Mouse),42.8,442.0,2.3e-99,365.5,sp|A2AAY5|SPD2B_MOUSE SH3 and PX domain-containing protein 2B OS=Mus musculus OX=10090 GN=Sh3pxd2b PE=1 SV=1,GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0032266; GO:0040018; GO:0042169; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070161; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888,adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide metabolic process [GO:0006801],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]",GO:0008289; GO:0022414; GO:0043226; GO:0048856; GO:0065003,lipid binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_05219,FUN_023631-T1,Peve_00017456,Pocillopora_meandrina_HIv1___RNAseq.g526.t1,three_way,75.54283333333333,FUN_023631-T1,P57073,SOX8_HUMAN,,Transcription factor SOX-8,Homo sapiens (Human),59.1,110.0,6.7e-28,126.7,sp|P57073|SOX8_HUMAN Transcription factor SOX-8 OS=Homo sapiens OX=9606 GN=SOX8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837,adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone levels [GO:0010817]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_05246,FUN_023692-T1,Peve_00014152,Pocillopora_meandrina_HIv1___RNAseq.g17721.t1,three_way,88.26066666666667,FUN_023692-T1,Q4VC33,MAEA_MOUSE,,E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Erythroblast macrophage protein) (Macrophage erythroblast attacher),Mus musculus (Mouse),51.8,388.0,2.7000000000000004e-110,400.2,sp|Q4VC33|MAEA_MOUSE E3 ubiquitin-protein transferase MAEA OS=Mus musculus OX=10090 GN=Maea PE=1 SV=1,GO:0000151; GO:0003779; GO:0005654; GO:0005819; GO:0005826; GO:0005886; GO:0007010; GO:0007155; GO:0008270; GO:0015629; GO:0016363; GO:0033033; GO:0043161; GO:0043249; GO:0048821; GO:0048822; GO:0051301; GO:0061630,cell adhesion [GO:0007155]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleoplasm; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; transferase activity; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05269,FUN_023922-T1,Peve_00017665,Pocillopora_meandrina_HIv1___TS.g28130.t1a,three_way,66.8095,FUN_023922-T1,Q3UMC0,AFG2A_MOUSE,,ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5),Mus musculus (Mouse),47.8,856.0,3.2e-207,723.4,sp|Q3UMC0|AFG2A_MOUSE ATPase family gene 2 protein homolog A OS=Mus musculus OX=10090 GN=Afg2a PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275,brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; mitochondrion; cytosol; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_05277,FUN_023935-T1,Peve_00017663,Pocillopora_meandrina_HIv1___RNAseq.g18855.t1,three_way,79.559,FUN_023935-T1,Q91X58,ZFN2B_MOUSE,,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),Mus musculus (Mouse),63.0,135.0,4.5e-51,203.0,sp|Q91X58|ZFN2B_MOUSE AN1-type zinc finger protein 2B OS=Mus musculus OX=10090 GN=Zfand2b PE=1 SV=1,GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0031593; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047,"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502],K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],GO:0005783; GO:0006886; GO:0030163; GO:0043226; GO:0055085,endoplasmic reticulum; intracellular protein transport; protein catabolic process; organelle; transmembrane transport
OG_05320,FUN_024005-T1,Peve_00040411,Pocillopora_meandrina_HIv1___RNAseq.g19345.t1,three_way,78.31733333333334,FUN_024005-T1,Q68EH9,CRBN_DANRE,,Protein cereblon (zcrbn),Danio rerio (Zebrafish) (Brachydanio rerio),48.4,382.0,3.4e-97,356.7,sp|Q68EH9|CRBN_DANRE Protein cereblon OS=Danio rerio OX=7955 GN=crbn PE=1 SV=1,GO:0000151; GO:0005634; GO:0005737; GO:0008283; GO:0016567; GO:0031464; GO:0033333; GO:0035118; GO:0043161; GO:0046872; GO:0060173; GO:0071599; GO:0071600,cell population proliferation [GO:0008283]; embryonic pectoral fin morphogenesis [GO:0035118]; fin development [GO:0033333]; limb development [GO:0060173]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872],GO:0005634; GO:0030163; GO:0043226; GO:0048856,nucleus; protein catabolic process; organelle; anatomical structure development
OG_05331,FUN_024037-T1,Peve_00020333,Pocillopora_meandrina_HIv1___RNAseq.g19274.t1,three_way,74.21233333333333,FUN_024037-T1,O00462,MANBA_HUMAN,,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),Homo sapiens (Human),47.2,885.0,1.1999999999999998e-243,844.3,sp|O00462|MANBA_HUMAN Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=3,GO:0004567; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202; GO:0043231,glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211],azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886],beta-mannosidase activity [GO:0004567],GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05339,FUN_024055-T1,Peve_00000165,Pocillopora_meandrina_HIv1___TS.g28634.t1,three_way,68.473,FUN_024055-T1,P25723,TLD_DROME,,Dorsal-ventral patterning protein tolloid (EC 3.4.24.-),Drosophila melanogaster (Fruit fly),44.7,76.0,4.8e-06,53.1,sp|P25723|TLD_DROME Dorsal-ventral patterning protein tolloid OS=Drosophila melanogaster OX=7227 GN=tld PE=2 SV=2,GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0007313; GO:0007378; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030513; GO:0032927; GO:0045464,"amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]",extracellular space [GO:0005615],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0022414; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; reproductive process; protein maturation; catalytic activity, acting on a protein"
OG_05400,FUN_024330-T1,Peve_00016319,Pocillopora_meandrina_HIv1___RNAseq.g18926.t1,three_way,76.277,FUN_024330-T1,O89023,TPP1_MOUSE,,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),Mus musculus (Mouse),50.2,562.0,2.3e-155,550.4,sp|O89023|TPP1_MOUSE Tripeptidyl-peptidase 1 OS=Mus musculus OX=10090 GN=Tpp1 PE=1 SV=2,GO:0004175; GO:0004252; GO:0005739; GO:0005764; GO:0005794; GO:0006508; GO:0007040; GO:0007399; GO:0008233; GO:0008236; GO:0008240; GO:0030855; GO:0035727; GO:0042470; GO:0043171; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070198; GO:0120146; GO:1905146,"bone resorption [GO:0045453]; epithelial cell differentiation [GO:0030855]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]",Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; recycling endosome [GO:0055037],endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007040; GO:0008289; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; mitochondrion; lysosome; endosome; vacuole; Golgi apparatus; lysosome organization; lipid binding; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05450,FUN_024408-T1,Peve_00015478,Pocillopora_meandrina_HIv1___TS.g28030.t1,three_way,67.57766666666666,FUN_024408-T1,Q8I719,KGP_PLAF7,,cGMP-dependent protein kinase (EC 2.7.11.12) (PfPKG),Plasmodium falciparum (isolate 3D7),26.9,245.0,7.8e-13,77.4,sp|Q8I719|KGP_PLAF7 cGMP-dependent protein kinase OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PKG PE=1 SV=1,GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005952; GO:0006468; GO:0007165; GO:0007276; GO:0019898; GO:0030553; GO:0046872; GO:0106310,gamete generation [GO:0007276]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005783; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_05456,FUN_024414-T1,Peve_00027663,Pocillopora_meandrina_HIv1___RNAseq.g18703.t1,three_way,84.054,FUN_024414-T1,O02691,HCD2_BOVIN,,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),Bos taurus (Bovine),64.1,256.0,7.3e-88,325.1,sp|O02691|HCD2_BOVIN 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Bos taurus OX=9913 GN=HSD17B10 PE=1 SV=3,GO:0000049; GO:0003857; GO:0004303; GO:0005739; GO:0006550; GO:0006631; GO:0006635; GO:0006699; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180,androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; protein homotetramerization [GO:0051289],mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739],"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase (NAD+) activity [GO:0008709]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)+] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]",GO:0003723; GO:0003824; GO:0005739; GO:0006399; GO:0006520; GO:0006629; GO:0016491; GO:0043226; GO:0065003; GO:0140053,RNA binding; catalytic activity; mitochondrion; tRNA metabolic process; amino acid metabolic process; lipid metabolic process; oxidoreductase activity; organelle; protein-containing complex assembly; mitochondrial gene expression
OG_05487,FUN_024484-T1,Peve_00010584,Pocillopora_meandrina_HIv1___RNAseq.g19069.t1,three_way,93.02366666666668,FUN_024484-T1,Q8QG64,RBX1_SALSA,,E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (Hyperosmotic protein 21) (sHOP21) (RING-box protein 1) (Rbx1),Salmo salar (Atlantic salmon),92.4,105.0,9.999999999999999e-55,213.8,sp|Q8QG64|RBX1_SALSA E3 ubiquitin-protein ligase RBX1 OS=Salmo salar OX=8030 GN=rbx1 PE=2 SV=2,GO:0004842; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0019005; GO:0031146; GO:0031463; GO:0031464; GO:0031465; GO:0031467; GO:0043161; GO:0045116; GO:0061663; GO:0160240,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; RNA polymerase II transcription initiation surveillance [GO:0160240]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],NEDD8 ligase activity [GO:0061663]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05500,FUN_024559-T1,Peve_00039516,Pocillopora_meandrina_HIv1___RNAseq.g18658.t1,three_way,92.67866666666669,FUN_024559-T1,P70340,SMAD1_MOUSE,,Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (Dwarfin-A) (Dwf-A) (Mothers-against-DPP-related 1) (Mad-related protein 1) (mMad1) (SMAD family member 1) (SMAD 1) (Smad1),Mus musculus (Mouse),70.4,467.0,2.5e-184,646.4,sp|P70340|SMAD1_MOUSE Mothers against decapentaplegic homolog 1 OS=Mus musculus OX=10090 GN=Smad1 PE=1 SV=2,GO:0000165; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0001657; GO:0001673; GO:0001710; GO:0002051; GO:0003700; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0006366; GO:0006879; GO:0006954; GO:0007179; GO:0007276; GO:0008283; GO:0008285; GO:0009880; GO:0010628; GO:0017151; GO:0019901; GO:0030509; GO:0030901; GO:0030902; GO:0031625; GO:0032991; GO:0042592; GO:0042802; GO:0043565; GO:0045669; GO:0045944; GO:0046872; GO:0048863; GO:0051148; GO:0051216; GO:0060038; GO:0060348; GO:0060395; GO:0061036; GO:0070410; GO:0070411; GO:0070878; GO:0071142; GO:0071144; GO:1902895; GO:1903672,BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; DNA-templated transcription [GO:0006351]; embryonic pattern specification [GO:0009880]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell differentiation [GO:0051148]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; male germ cell nucleus [GO:0001673]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]",GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006954; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; RNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; inflammatory response; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05548,FUN_024755-T1,Peve_00041143,Pocillopora_meandrina_HIv1___RNAseq.2312_t,three_way,71.259,FUN_024755-T1,P22304,IDS_HUMAN,,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],Homo sapiens (Human),52.4,510.0,3.2e-146,520.0,sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1,GO:0004423; GO:0005509; GO:0005737; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202,dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200],cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05553,FUN_024761-T1,Peve_00025825,Pocillopora_meandrina_HIv1___RNAseq.g18823.t1,three_way,89.74166666666666,FUN_024761-T1,P49459,UBE2A_HUMAN,,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),Homo sapiens (Human),94.0,149.0,1.8e-78,293.1,sp|P49459|UBE2A_HUMAN Ubiquitin-conjugating enzyme E2 A OS=Homo sapiens OX=9606 GN=UBE2A PE=1 SV=2,GO:0000086; GO:0000209; GO:0000785; GO:0004842; GO:0005524; GO:0005654; GO:0005764; GO:0005770; GO:0005829; GO:0006281; GO:0006301; GO:0006338; GO:0006511; GO:0009411; GO:0031625; GO:0033503; GO:0043130; GO:0043161; GO:0061631; GO:0070936; GO:0070979; GO:1901526,chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of mitophagy [GO:1901526]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; lysosome; endosome; vacuole; cytosol; DNA repair; chromatin organization; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05574,FUN_024863-T1,Peve_00026086,Pocillopora_meandrina_HIv1___TS.g28157.t1,three_way,75.19033333333333,FUN_024863-T1,Q9NVM9,INT13_HUMAN,,Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95),Homo sapiens (Human),42.6,698.0,1.3000000000000002e-145,518.5,sp|Q9NVM9|INT13_HUMAN Integrator complex subunit 13 OS=Homo sapiens OX=9606 GN=INTS13 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016180; GO:0016604; GO:0030317; GO:0032039; GO:0034243; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435; GO:0140297; GO:0160232; GO:0160240,cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180],cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297],GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0007018; GO:0016073; GO:0022414; GO:0043226; GO:0048870,nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; snRNA metabolic process; reproductive process; organelle; cell motility
OG_05603,FUN_025260-T1,Peve_00031287,Pocillopora_meandrina_HIv1___RNAseq.g13591.t1,three_way,87.201,FUN_025260-T1,Q5W041,ARMC3_HUMAN,,Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1),Homo sapiens (Human),51.8,871.0,3.1e-103,377.9,sp|Q5W041|ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMC3 PE=1 SV=2,GO:0007286; GO:0030317; GO:0034517; GO:0070062,flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286],extracellular exosome [GO:0070062],,GO:0006914; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,autophagy; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_05657,FUN_025412-T1,Peve_00030580,Pocillopora_meandrina_HIv1___RNAseq.g13312.t1,three_way,88.07566666666666,FUN_025412-T1,Q3MHN0,PSB6_BOVIN,,Proteasome subunit beta type-6 (EC 3.4.25.1),Bos taurus (Bovine),69.7,208.0,1.3e-83,310.8,sp|Q3MHN0|PSB6_BOVIN Proteasome subunit beta type-6 OS=Bos taurus OX=9913 GN=PSMB6 PE=1 SV=1,GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0019774; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05665,FUN_025439-T1,Peve_00029480,Pocillopora_meandrina_HIv1___RNAseq.g13295.t1,three_way,42.21083333333333,FUN_025439-T1,P14780,MMP9_HUMAN,,Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9],Homo sapiens (Human),49.1,57.0,1.6e-08,62.8,sp|P14780|MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens OX=9606 GN=MMP9 PE=1 SV=3,GO:0001501; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0006915; GO:0007566; GO:0008233; GO:0008237; GO:0008270; GO:0016477; GO:0022617; GO:0030198; GO:0030225; GO:0030574; GO:0035987; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0045742; GO:0048013; GO:0051549; GO:0062023; GO:0070062; GO:0071222; GO:0071492; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258,apoptotic process [GO:0006915]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; extracellular space; programmed cell death; hydrolase activity; reproductive process; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_05670,FUN_025463-T1,Peve_00043840,Pocillopora_meandrina_HIv1___RNAseq.g13243.t1,three_way,97.54233333333332,FUN_025463-T1,Q5E9F9,PRS7_BOVIN,,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),Bos taurus (Bovine),92.2,434.0,7.399999999999999e-234,810.8,sp|Q5E9F9|PRS7_BOVIN 26S proteasome regulatory subunit 7 OS=Bos taurus OX=9913 GN=PSMC2 PE=2 SV=3,GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140657,catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; protein catabolic process; organelle; ATP-dependent activity
OG_05698,FUN_025561-T1,Peve_00019806,Pocillopora_meandrina_HIv1___TS.g2789.t1,three_way,87.92233333333333,FUN_025561-T1,Q6VFT7,FOXL2_BOVIN,,Forkhead box protein L2,Bos taurus (Bovine),89.7,107.0,1.9e-52,207.6,sp|Q6VFT7|FOXL2_BOVIN Forkhead box protein L2 OS=Bos taurus OX=9913 GN=FOXL2 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0009653; GO:0019101; GO:0030154; GO:0031624; GO:0043028; GO:0043065; GO:0045892; GO:0045893; GO:0045944; GO:0048048; GO:0060014; GO:0090543,anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin conjugating enzyme binding [GO:0031624]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_05700,FUN_025570-T2,Peve_00033327,Pocillopora_meandrina_HIv1___RNAseq.g13774.t1,three_way,69.50533333333334,FUN_025570-T2,P63080,GBRB3_MOUSE,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Mus musculus (Mouse),36.5,430.0,7.8e-74,279.3,sp|P63080|GBRB3_MOUSE Gamma-aminobutyric acid receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Gabrb3 PE=1 SV=1,GO:0004890; GO:0005216; GO:0005886; GO:0007214; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_05705,FUN_025578-T1,Peve_00022365,Pocillopora_meandrina_HIv1___RNAseq.g13760.t1,three_way,91.371,FUN_025578-T1,Q2TA03,UB2J2_BOVIN,,Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2),Bos taurus (Bovine),60.8,250.0,3.4e-76,286.2,sp|Q2TA03|UB2J2_BOVIN Ubiquitin-conjugating enzyme E2 J2 OS=Bos taurus OX=9913 GN=UBE2J2 PE=2 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0036503; GO:0061631; GO:0085020,ERAD pathway [GO:0036503]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005783; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05737,FUN_025663-T1,Peve_00042168,Pocillopora_meandrina_HIv1___RNAseq.g23062.t1,three_way,73.4105,FUN_025663-T1,Q9UPW0,FOXJ3_HUMAN,,Forkhead box protein J3,Homo sapiens (Human),43.9,321.0,8.1e-57,223.0,sp|Q9UPW0|FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens OX=9606 GN=FOXJ3 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837,cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; meiotic nuclear division; transcription regulator activity
OG_05743,FUN_025670-T1,Peve_00042194,Pocillopora_meandrina_HIv1___TS.g15944.t1,three_way,81.551,FUN_025670-T1,O09012,PEX5_MOUSE,,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),Mus musculus (Mouse),47.9,645.0,2.2e-117,424.5,sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2,GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006629; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016020; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597,"cell development [GO:0048468]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein carrier chaperone [GO:0140597]; small GTPase binding [GO:0031267],GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0006629; GO:0006886; GO:0006914; GO:0007005; GO:0007031; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0061024; GO:0140104,mitochondrion; peroxisome; Golgi apparatus; cytosol; lipid metabolic process; intracellular protein transport; autophagy; mitochondrion organization; peroxisome organization; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; membrane organization; molecular carrier activity
OG_05766,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_05770,FUN_025730-T1,Peve_00035630,Pocillopora_meandrina_HIv1___RNAseq.g10436.t1,three_way,81.93766666666667,FUN_025730-T1,A5D8W1,CFA69_HUMAN,,Cilia- and flagella-associated protein 69,Homo sapiens (Human),40.2,895.0,9.3e-194,678.7,sp|A5D8W1|CFA69_HUMAN Cilia- and flagella-associated protein 69 OS=Homo sapiens OX=9606 GN=CFAP69 PE=1 SV=3,GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834,flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225],,GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_05812,FUN_025814-T1,Peve_00002523,Pocillopora_meandrina_HIv1___RNAseq.g9336.t1,three_way,66.91966666666667,FUN_025814-T1,O15520,FGF10_HUMAN,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Homo sapiens (Human),32.0,122.0,1.2e-12,74.7,sp|O15520|FGF10_HUMAN Fibroblast growth factor 10 OS=Homo sapiens OX=9606 GN=FGF10 PE=1 SV=1,GO:0000132; GO:0001525; GO:0001656; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007368; GO:0007431; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009880; GO:0009986; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0022008; GO:0030036; GO:0030334; GO:0030538; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032781; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0042056; GO:0042060; GO:0042246; GO:0042475; GO:0042693; GO:0043410; GO:0043616; GO:0045739; GO:0045747; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048536; GO:0048538; GO:0048557; GO:0048754; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050731; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060054; GO:0060174; GO:0060428; GO:0060430; GO:0060436; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; neurogenesis [GO:0022008]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05813,FUN_025815-T1,Peve_00002524,Pocillopora_meandrina_HIv1___RNAseq.g9337.t1,three_way,46.56366666666667,FUN_025815-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),32.5,126.0,2e-11,71.2,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05816,FUN_025823-T1,Peve_00036294,Pocillopora_meandrina_HIv1___RNAseq.g9342.t1,three_way,86.49533333333333,FUN_025823-T1,Q2TCH3,ACLY_SHEEP,,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme),Ovis aries (Sheep),69.7,1104.0,0.0,1583.2,sp|Q2TCH3|ACLY_SHEEP ATP-citrate synthase OS=Ovis aries OX=9940 GN=ACLY PE=2 SV=1,GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872,acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829],ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_05829,FUN_025847-T1,Peve_00012182,Pocillopora_meandrina_HIv1___TS.g13754.t1,three_way,63.074,FUN_025847-T1,Q9NZA1,CLIC5_HUMAN,,Chloride intracellular channel protein 5 (Glutaredoxin-like oxidoreductase CLIC5) (EC 1.8.-.-),Homo sapiens (Human),34.1,223.0,1.5e-20,101.3,sp|Q9NZA1|CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens OX=9606 GN=CLIC5 PE=1 SV=3,GO:0005254; GO:0005739; GO:0005794; GO:0005813; GO:0005938; GO:0006821; GO:0007565; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016491; GO:0032420; GO:0034707; GO:0070062,chloride transport [GO:0006821]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; stereocilium [GO:0032420],chloride channel activity [GO:0005254]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005815; GO:0005856; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; microtubule organizing center; cytoskeleton; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_05867,FUN_025976-T1,Peve_00002325,Pocillopora_meandrina_HIv1___RNAseq.g10506.t1,three_way,64.18716666666667,FUN_025976-T1,Q13873,BMPR2_HUMAN,,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),Homo sapiens (Human),38.1,494.0,1.9e-88,328.2,sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2,GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782,anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235],"activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024]",GO:0003013; GO:0003824; GO:0005615; GO:0005654; GO:0005886; GO:0006355; GO:0009101; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140096; GO:1901135,"circulatory system process; catalytic activity; extracellular space; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; glycoprotein biosynthetic process; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05876,FUN_026025-T1,Peve_00026725,Pocillopora_meandrina_HIv1___RNAseq.g10478.t1,three_way,86.32866666666666,FUN_026025-T1,Q8N0X2,SPG16_HUMAN,,Sperm-associated antigen 16 protein (Pf20 protein homolog),Homo sapiens (Human),40.9,362.0,5.5e-70,266.9,sp|Q8N0X2|SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens OX=9606 GN=SPAG16 PE=1 SV=2,GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716,axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288],axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],,GO:0003016; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0050877,respiratory system process; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; nervous system process
OG_05884,FUN_026037-T1,Peve_00025183,Pocillopora_meandrina_HIv1___RNAseq.g10550.t1,three_way,71.07133333333333,FUN_026037-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),45.3,278.0,2.3e-66,253.8,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_05901,FUN_026079-T1,Peve_00016850,Pocillopora_meandrina_HIv1___RNAseq.g10559.t1,three_way,85.88933333333334,FUN_026079-T1,Q3ZBL4,LZTL1_BOVIN,,Leucine zipper transcription factor-like protein 1,Bos taurus (Bovine),52.5,303.0,2.4e-77,290.4,sp|Q3ZBL4|LZTL1_BOVIN Leucine zipper transcription factor-like protein 1 OS=Bos taurus OX=9913 GN=LZTFL1 PE=2 SV=1,GO:0002177; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0030317; GO:0042802; GO:0044877; GO:1903565; GO:1903568,flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177],identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cytosol; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_05921,FUN_026144-T1,Peve_00014870,Pocillopora_meandrina_HIv1___RNAseq.g3241.t1,three_way,80.867,FUN_026144-T1,Q4G0U5,PCDP1_HUMAN,,Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1),Homo sapiens (Human),36.6,848.0,1.2e-140,502.3,sp|Q4G0U5|PCDP1_HUMAN Cilia- and flagella-associated protein 221 OS=Homo sapiens OX=9606 GN=CFAP221 PE=1 SV=2,GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0044458; GO:0051649; GO:0060271; GO:0090660; GO:0097386; GO:0097729; GO:0120197; GO:0120316,cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; manchette [GO:0002177]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516],GO:0003016; GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0050877,respiratory system process; extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; nervous system process
OG_05928,FUN_026154-T1,Peve_00000925,Pocillopora_meandrina_HIv1___RNAseq.g3213.t1,three_way,86.743,FUN_026154-T1,O60921,HUS1_HUMAN,,Checkpoint protein HUS1 (hHUS1),Homo sapiens (Human),53.2,282.0,1.7e-82,307.4,sp|O60921|HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens OX=9606 GN=HUS1 PE=1 SV=1,GO:0000077; GO:0000723; GO:0000724; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; telomere maintenance [GO:0000723],checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006310; GO:0022414; GO:0032200; GO:0043226; GO:0048856,nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; DNA recombination; reproductive process; telomere organization; organelle; anatomical structure development
OG_05943,FUN_026181-T1,Peve_00022313,Pocillopora_meandrina_HIv1___RNAseq.g3036.t1,three_way,74.56566666666667,FUN_026181-T1,Q9H0H5,RGAP1_HUMAN,,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),Homo sapiens (Human),42.3,636.0,4.8e-117,423.3,sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1,GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358,actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358],acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233],"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270]",GO:0000910; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0007010; GO:0008092; GO:0008289; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0055085; GO:0060090; GO:0098772,cytokinesis; nucleus; nucleoplasm; mitochondrion; cytosol; cytoskeleton organization; cytoskeletal protein binding; lipid binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; transmembrane transport; molecular adaptor activity; molecular function regulator activity
OG_05966,FUN_026369-T2,Peve_00027912,Pocillopora_meandrina_HIv1___RNAseq.g3119.t1,three_way,54.78633333333333,FUN_026369-T2,Q9H8Y5,ANKZ1_HUMAN,,tRNA endonuclease ANKZF1 (EC 3.1.-.-) (Ankyrin repeat and zinc finger domain-containing protein 1) (Zinc finger protein 744),Homo sapiens (Human),36.6,711.0,4.3e-67,257.7,sp|Q9H8Y5|ANKZ1_HUMAN tRNA endonuclease ANKZF1 OS=Homo sapiens OX=9606 GN=ANKZF1 PE=1 SV=1,GO:0004521; GO:0005737; GO:0006515; GO:0008270; GO:0016020; GO:0036503; GO:0070301; GO:0072344; GO:0140101,cellular response to hydrogen peroxide [GO:0070301]; ERAD pathway [GO:0036503]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; rescue of stalled ribosome [GO:0072344],cytoplasm [GO:0005737]; membrane [GO:0016020],"catalytic activity, acting on a tRNA [GO:0140101]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270]",GO:0003824; GO:0030163; GO:0140098,"catalytic activity; protein catabolic process; catalytic activity, acting on RNA"
OG_06002,FUN_026491-T1,Peve_00032989,Pocillopora_meandrina_HIv1___RNAseq.g4193.t1,three_way,81.38333333333334,FUN_026491-T1,E1B836,ENKUR_BOVIN,,Enkurin,Bos taurus (Bovine),51.8,249.0,8.1e-66,251.9,sp|E1B836|ENKUR_BOVIN Enkurin OS=Bos taurus OX=9913 GN=ENKUR PE=1 SV=2,GO:0001669; GO:0005516; GO:0005879; GO:0017124; GO:0030317; GO:0036126; GO:0061966; GO:0097228; GO:0097728; GO:0160112,establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317],9+0 motile cilium [GO:0097728]; acrosomal vesicle [GO:0001669]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228],calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06034,FUN_026626-T1,Peve_00030694,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1b,three_way,49.834833333333336,FUN_026626-T1,P23785,GRN_RAT,,Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)],Rattus norvegicus (Rat),31.6,510.0,1.9e-62,243.0,sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3,GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673,astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488]; trophectodermal cell proliferation [GO:0001834],cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0007040; GO:0016192; GO:0022414; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048018; GO:0048856; GO:0098772,immune system process; extracellular region; extracellular space; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; lysosome organization; vesicle-mediated transport; reproductive process; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06056,FUN_026739-T2,Peve_00021666,Pocillopora_meandrina_HIv1___RNAseq.g9411.t1,three_way,70.781,FUN_026739-T2,P42232,STA5B_MOUSE,,Signal transducer and activator of transcription 5B,Mus musculus (Mouse),32.8,729.0,1e-96,356.3,sp|P42232|STA5B_MOUSE Signal transducer and activator of transcription 5B OS=Mus musculus OX=10090 GN=Stat5b PE=1 SV=1,GO:0000278; GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001787; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008283; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030098; GO:0030155; GO:0030183; GO:0030218; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0033028; GO:0033033; GO:0033077; GO:0035259; GO:0038162; GO:0040014; GO:0040018; GO:0042104; GO:0042267; GO:0042448; GO:0042492; GO:0042803; GO:0043029; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0050798; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531,activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; lymphocyte differentiation [GO:0030098]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000278; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0006629; GO:0006790; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140110,mitotic cell cycle; immune system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; lipid metabolic process; sulfur compound metabolic process; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; defense response to other organism; transcription regulator activity
OG_06067,FUN_026913-T1,Peve_00021652,Pocillopora_meandrina_HIv1___TS.g19727.t2,three_way,92.013,FUN_026913-T1,Q5PPI9,TTLL1_RAT,,Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1),Rattus norvegicus (Rat),71.4,420.0,5.1e-187,655.2,sp|Q5PPI9|TTLL1_RAT Polyglutamylase complex subunit TTLL1 OS=Rattus norvegicus OX=10116 GN=Ttll1 PE=2 SV=1,GO:0000226; GO:0002395; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0007288; GO:0015631; GO:0021702; GO:0030317; GO:0031514; GO:0035082; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438; GO:0120197; GO:0120222,axoneme assembly [GO:0035082]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein modification process [GO:0036211]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0002376; GO:0003016; GO:0003824; GO:0005576; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0140096,"immune system process; respiratory system process; catalytic activity; extracellular region; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; ligase activity; reproductive process; cell differentiation; organelle; cell motility; catalytic activity, acting on a protein"
OG_06071,FUN_026976-T1,Peve_00013247,Pocillopora_meandrina_HIv1___TS.g17924.t2,three_way,66.8675,FUN_026976-T1,Q9NZ56,FMN2_HUMAN,,Formin-2,Homo sapiens (Human),40.8,449.0,2e-89,331.6,sp|Q9NZ56|FMN2_HUMAN Formin-2 OS=Homo sapiens OX=9606 GN=FMN2 PE=1 SV=4,GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0015629; GO:0016192; GO:0016477; GO:0030036; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781,actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytokinesis; nucleus; nucleolus; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; cell motility
OG_06080,FUN_027065-T1,Peve_00012227,Pocillopora_meandrina_HIv1___RNAseq.g2816.t1,three_way,66.86916666666667,FUN_027065-T1,A2AG06,MEIOC_MOUSE,,Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein),Mus musculus (Mouse),46.5,114.0,4.8e-14,80.9,sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192,"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]",cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006281; GO:0022414; GO:0043226; GO:0048856; GO:0140013,nucleus; DNA repair; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_06088,FUN_027087-T1,Peve_00012239,Pocillopora_meandrina_HIv1___RNAseq.g24966.t1,three_way,81.16233333333334,FUN_027087-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),53.8,234.0,2.2e-67,257.7,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_06096,FUN_027270-T1,Peve_00018292,Pocillopora_meandrina_HIv1___TS.g10917.t1,three_way,87.52583333333334,FUN_027270-T1,Q80W99,CTSR3_MOUSE,,Cation channel sperm-associated protein 3 (CatSper3),Mus musculus (Mouse),34.5,383.0,1.4e-53,211.8,sp|Q80W99|CTSR3_MOUSE Cation channel sperm-associated protein 3 OS=Mus musculus OX=10090 GN=Catsper3 PE=1 SV=2,GO:0001669; GO:0005245; GO:0005783; GO:0006814; GO:0030317; GO:0031514; GO:0036128; GO:0048240; GO:0051649,establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240],acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514],voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005783; GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endoplasmic reticulum; cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06098,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06099,FUN_027735-T1,Peve_00036492,Pocillopora_meandrina_HIv1___RNAseq.g13904.t1,three_way,70.82816666666666,FUN_027735-T1,O94888,UBXN7_HUMAN,,UBX domain-containing protein 7,Homo sapiens (Human),41.6,500.0,1e-93,345.5,sp|O94888|UBXN7_HUMAN UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_06100,FUN_027736-T1,Peve_00036491,Pocillopora_meandrina_HIv1___RNAseq.g13903.t1,three_way,88.12533333333333,FUN_027736-T1,Q8WYA0,IFT81_HUMAN,,Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1),Homo sapiens (Human),55.2,677.0,1.5e-180,634.4,sp|Q8WYA0|IFT81_HUMAN Intraflagellar transport protein 81 homolog OS=Homo sapiens OX=9606 GN=IFT81 PE=1 SV=1,GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542; GO:0120316,cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228],tubulin binding [GO:0015631],GO:0005815; GO:0005929; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0044782,microtubule organizing center; cilium; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cilium organization
OG_06104,FUN_027805-T1,Peve_00036485,Pocillopora_meandrina_HIv1___RNAseq.g13898.t1,three_way,81.17733333333334,FUN_027805-T1,Q8BHJ5,TBL1R_MOUSE,,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),Mus musculus (Mouse),58.4,514.0,4.8e-120,433.0,sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1,GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263,adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06106,FUN_027808-T2,Peve_00036480,Pocillopora_meandrina_HIv1___RNAseq.g13894.t1,three_way,79.88533333333334,FUN_027808-T2,P21333,FLNA_HUMAN,,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),Homo sapiens (Human),27.6,1675.0,4.7e-140,501.1,sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4,GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224,"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]",actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018],actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0007010; GO:0007155; GO:0008092; GO:0016071; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0051604; GO:0055085; GO:0072659; GO:0098772; GO:0140313,RNA binding; extracellular region; nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; mRNA metabolic process; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein maturation; transmembrane transport; protein localization to plasma membrane; molecular function regulator activity; molecular sequestering activity
OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06110,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_06157,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_06180,FUN_028087-T1,Peve_00031647,Pocillopora_meandrina_HIv1___RNAseq.g16564.t1,three_way,92.40866666666666,FUN_028087-T1,Q969V4,TEKT1_HUMAN,,Tektin-1,Homo sapiens (Human),42.3,388.0,5.2e-79,296.6,sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1,GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111,cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,nucleus; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_06207,FUN_028143-T1,Peve_00037720,Pocillopora_meandrina_HIv1___TS.g11444.t1,three_way,74.73266666666667,FUN_028143-T1,Q5SZT7,NKAPL_MOUSE,,NKAP-like protein,Mus musculus (Mouse),72.4,123.0,4.9e-41,169.9,sp|Q5SZT7|NKAPL_MOUSE NKAP-like protein OS=Mus musculus OX=10090 GN=Nkapl PE=1 SV=1,GO:0003682; GO:0005634; GO:0007283; GO:0030154,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0022414; GO:0030154; GO:0043226,nucleus; reproductive process; cell differentiation; organelle
OG_06211,FUN_028150-T1,Peve_00042832,Pocillopora_meandrina_HIv1___RNAseq.g15551.t1,three_way,65.80033333333333,FUN_028150-T1,Q68J42,LIPS_PIG,,Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH),Sus scrofa (Pig),33.3,816.0,3.4e-115,417.5,sp|Q68J42|LIPS_PIG Hormone-sensitive lipase OS=Sus scrofa OX=9823 GN=LIPE PE=2 SV=1,GO:0004771; GO:0004806; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0019433; GO:0042134; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0120516,cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; monoacylglycerol lipase activity [GO:0047372]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016787; GO:0043226,RNA binding; catalytic activity; nucleus; mitochondrion; lipid droplet; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_06236,FUN_028192-T1,Peve_00001297,Pocillopora_meandrina_HIv1___TS.g11527.t1,three_way,50.75,FUN_028192-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),37.5,144.0,6.5e-21,104.0,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_06271,FUN_028303-T1,Peve_00027867,Pocillopora_meandrina_HIv1___RNAseq.g15547.t1,three_way,85.15633333333334,FUN_028303-T1,Q32LN4,CFA45_BOVIN,,Cilia- and flagella-associated protein 45,Bos taurus (Bovine),35.3,547.0,1e-17,93.2,sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2,GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112,cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],AMP binding [GO:0016208],GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_06302,FUN_028508-T1,Peve_00008106,Pocillopora_meandrina_HIv1___RNAseq.g14114.t1,three_way,92.56366666666666,FUN_028508-T1,Q66HB3,IFT80_RAT,,Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56),Rattus norvegicus (Rat),63.8,763.0,3.9e-310,1065.1,sp|Q66HB3|IFT80_RAT Intraflagellar transport protein 80 homolog OS=Rattus norvegicus OX=10116 GN=Ift80 PE=2 SV=1,GO:0001501; GO:0001503; GO:0001649; GO:0001958; GO:0002062; GO:0003417; GO:0003418; GO:0005737; GO:0005813; GO:0005929; GO:0006915; GO:0007163; GO:0007224; GO:0007249; GO:0008283; GO:0008543; GO:0009888; GO:0010467; GO:0010498; GO:0010839; GO:0016567; GO:0021510; GO:0030316; GO:0030992; GO:0033687; GO:0035264; GO:0035567; GO:0035630; GO:0036064; GO:0042476; GO:0043491; GO:0043616; GO:0044691; GO:0044782; GO:0048863; GO:0050821; GO:0051216; GO:0060173; GO:0060271; GO:0060348; GO:0060349; GO:0061975; GO:0071895; GO:0072089; GO:0097500; GO:0097731; GO:1902140; GO:1905515; GO:1990079; GO:2000051,apoptotic process [GO:0006915]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; bone mineralization involved in bone maturation [GO:0035630]; bone morphogenesis [GO:0060349]; canonical NF-kappaB signal transduction [GO:0007249]; cartilage development [GO:0051216]; cartilage homeostasis [GO:1990079]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; endochondral ossification [GO:0001958]; establishment or maintenance of cell polarity [GO:0007163]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage development [GO:0003417]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; odontoblast differentiation [GO:0071895]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; receptor localization to non-motile cilium [GO:0097500]; response to inositol [GO:1902140]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; tissue development [GO:0009888]; tooth eruption [GO:0044691],9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992],,GO:0005815; GO:0005929; GO:0007163; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; establishment or maintenance of cell polarity; programmed cell death; cell differentiation; protein catabolic process; organelle; cilium organization; anatomical structure development
OG_06322,FUN_028819-T1,Peve_00031680,Pocillopora_meandrina_HIv1___RNAseq.g20707.t1,three_way,83.64516666666667,FUN_028819-T1,Q3U2S4,OTUD5_MOUSE,,OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA),Mus musculus (Mouse),44.3,447.0,2.4e-87,324.3,sp|Q3U2S4|OTUD5_MOUSE OTU domain-containing protein 5 OS=Mus musculus OX=10090 GN=Otud5 PE=1 SV=2,GO:0004843; GO:0005634; GO:0014033; GO:0016579; GO:0031647; GO:0032496; GO:0032700; GO:0043161; GO:0043374; GO:0061578; GO:0070536; GO:0071108; GO:0072540; GO:0101005; GO:1990380; GO:2000316,"CD8-positive, alpha-beta T cell differentiation [GO:0043374]; negative regulation of interleukin-17 production [GO:0032700]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; regulation of T-helper 17 type immune response [GO:2000316]; response to lipopolysaccharide [GO:0032496]; T-helper 17 cell lineage commitment [GO:0072540]",nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578],GO:0002376; GO:0003824; GO:0005634; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; hydrolase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06326,FUN_028846-T1,Peve_00024569,Pocillopora_meandrina_HIv1___RNAseq.g12799.t1,three_way,61.40933333333333,FUN_028846-T1,Q99999,G3ST1_HUMAN,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Homo sapiens (Human),32.0,394.0,1.4e-48,195.3,sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1,GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665],Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886],galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005886; GO:0006629; GO:0009101; GO:0016740; GO:0022414; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_06380,FUN_028987-T1,Peve_00034521,Pocillopora_meandrina_HIv1___TS.g9080.t1a,three_way,71.96766666666667,FUN_028987-T1,P48052,CBPA2_HUMAN,,Carboxypeptidase A2 (EC 3.4.17.15),Homo sapiens (Human),41.3,409.0,2.6e-87,323.9,sp|P48052|CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens OX=9606 GN=CPA2 PE=1 SV=3,GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270,protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773],carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; vacuole; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06416,FUN_029099-T1,Peve_00038062,Pocillopora_meandrina_HIv1___RNAseq.g25485.t1,three_way,55.33266666666667,FUN_029099-T1,P20105,E74EA_DROME,,Ecdysone-induced protein 74EF isoform A (ETS-related protein E74A),Drosophila melanogaster (Fruit fly),52.4,105.0,3.5e-21,103.6,sp|P20105|E74EA_DROME Ecdysone-induced protein 74EF isoform A OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2,GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048102; GO:0048477,"autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]",nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0006914; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; autophagy; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06471,FUN_029230-T1,Peve_00045062,Pocillopora_meandrina_HIv1___RNAseq.g25548.t1,three_way,60.20133333333334,FUN_029230-T1,Q5QD14,TAAR5_MOUSE,,Trace amine-associated receptor 5 (TaR-5) (Trace amine receptor 5) (mTaar5) (Trimethylamine receptor),Mus musculus (Mouse),28.8,285.0,9.9e-13,75.9,sp|Q5QD14|TAAR5_MOUSE Trace amine-associated receptor 5 OS=Mus musculus OX=10090 GN=Taar5 PE=1 SV=1,GO:0001594; GO:0005886; GO:0007166; GO:0007189; GO:0007606; GO:0007617; GO:0035176; GO:0050890; GO:1990081,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cognition [GO:0050890]; mating behavior [GO:0007617]; sensory perception of chemical stimulus [GO:0007606]; social behavior [GO:0035176],plasma membrane [GO:0005886],trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081],GO:0005886; GO:0022414; GO:0050877; GO:0060089,plasma membrane; reproductive process; nervous system process; molecular transducer activity
OG_06479,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06530,FUN_029360-T1,Peve_00044526,Pocillopora_meandrina_HIv1___RNAseq.g17132.t3,three_way,79.10799999999999,FUN_029360-T1,B2GV50,RFX2_RAT,,DNA-binding protein RFX2 (Regulatory factor X 2),Rattus norvegicus (Rat),57.0,604.0,1.9e-176,620.9,sp|B2GV50|RFX2_RAT DNA-binding protein RFX2 OS=Rattus norvegicus OX=10116 GN=Rfx2 PE=1 SV=1,GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001675; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007286; GO:0045944; GO:0060271; GO:1990830; GO:1990837,acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; cilium organization; anatomical structure development; transcription regulator activity
OG_06542,FUN_029410-T1,Peve_00004978,Pocillopora_meandrina_HIv1___RNAseq.g19537.t1,three_way,82.68033333333334,FUN_029410-T1,Q3T0P6,PGK1_BOVIN,,Phosphoglycerate kinase 1 (EC 2.7.11.1) (EC 2.7.2.3),Bos taurus (Bovine),69.6,411.0,1.9e-162,573.5,sp|Q3T0P6|PGK1_BOVIN Phosphoglycerate kinase 1 OS=Bos taurus OX=9913 GN=PGK1 PE=2 SV=3,GO:0004618; GO:0004674; GO:0005524; GO:0005615; GO:0005759; GO:0005829; GO:0006094; GO:0006096; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0044325; GO:0045121; GO:0046872; GO:0047134; GO:0061621; GO:0071456; GO:0106310; GO:0160218,canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0160218]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639],cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; mitochondrial matrix [GO:0005759],ADP binding [GO:0043531]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoglycerate kinase activity [GO:0004618]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005615; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0016740; GO:0030154; GO:0051604; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; extracellular space; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; transferase activity; cell differentiation; protein maturation; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06592,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_06599,FUN_029673-T1,Peve_00038759,Pocillopora_meandrina_HIv1___RNAseq.g17212.t1,three_way,61.962,FUN_029673-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),38.7,310.0,4.200000000000001e-58,228.0,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06674,FUN_031077-T3,Peve_00028144,Pocillopora_meandrina_HIv1___RNAseq.g30317.t1,three_way,76.78383333333333,FUN_031077-T3,Q3V2A7,QRIC2_MOUSE,,Glutamine-rich protein 2,Mus musculus (Mouse),31.8,337.0,1.4e-27,126.7,sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_06701,FUN_031268-T1,Peve_00036751,Pocillopora_meandrina_HIv1___RNAseq.g5181.t2,three_way,67.62816666666666,FUN_031268-T1,Q9UBV2,SE1L1_HUMAN,,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),Homo sapiens (Human),62.3,579.0,1.3e-73,279.6,sp|Q9UBV2|SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3,GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0030970; GO:0036503; GO:0036513; GO:0050821,"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]",Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839],,GO:0005783; GO:0006629; GO:0006886; GO:0030163; GO:0043226,endoplasmic reticulum; lipid metabolic process; intracellular protein transport; protein catabolic process; organelle
OG_06705,FUN_031276-T1,Peve_00036741,Pocillopora_meandrina_HIv1___RNAseq.g5175.t1,three_way,49.56583333333333,FUN_031276-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),47.1,70.0,5.9e-10,67.8,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06706,FUN_031286-T1,Peve_00036747,Pocillopora_meandrina_HIv1___RNAseq.g5173.t1,three_way,73.2735,FUN_031286-T1,Q8CHB8,TTLL5_MOUSE,,Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5),Mus musculus (Mouse),44.1,870.0,1.4999999999999998e-189,665.2,sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3,GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; ligase activity; reproductive process; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_06709,FUN_031291-T1,Peve_00026523,Pocillopora_meandrina_HIv1___TS.g23886.t1b,three_way,51.8035,FUN_031291-T1,Q5SY80,CTSRE_HUMAN,,Cation channel sperm-associated auxiliary subunit epsilon (CatSper-epsilon) (CatSperepsilon),Homo sapiens (Human),23.7,670.0,1.2e-35,153.3,sp|Q5SY80|CTSRE_HUMAN Cation channel sperm-associated auxiliary subunit epsilon OS=Homo sapiens OX=9606 GN=CATSPERE PE=1 SV=1,GO:0030317; GO:0036128; GO:0048240; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240],CatSper complex [GO:0036128]; sperm principal piece [GO:0097228],,GO:0007018; GO:0022414; GO:0048870,microtubule-based movement; reproductive process; cell motility
OG_06725,FUN_031497-T1,Peve_00044299,Pocillopora_meandrina_HIv1___RNAseq.g5099.t1,three_way,61.17183333333333,FUN_031497-T1,Q5T197,DCST1_HUMAN,,E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase),Homo sapiens (Human),26.0,338.0,8.3e-13,77.8,sp|Q5T197|DCST1_HUMAN E3 ubiquitin-protein ligase DCST1 OS=Homo sapiens OX=9606 GN=DCST1 PE=1 SV=1,GO:0002080; GO:0005886; GO:0006511; GO:0007342; GO:0008270; GO:0016567; GO:0035036; GO:0045087; GO:0060339; GO:0061630,fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein ubiquitination [GO:0016567]; sperm-egg recognition [GO:0035036]; ubiquitin-dependent protein catabolic process [GO:0006511],acrosomal membrane [GO:0002080]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005886; GO:0016740; GO:0022414; GO:0061024; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; transferase activity; reproductive process; membrane organization; defense response to other organism; catalytic activity, acting on a protein"
OG_06732,FUN_031509-T1,Peve_00004815,Pocillopora_meandrina_HIv1___TS.g23836.t1,three_way,71.6965,FUN_031509-T1,A7SIM4,HAP2_NEMVE,,Hapless 2 (Generative cell specific 1),Nematostella vectensis (Starlet sea anemone),51.4,905.0,3.5e-260,899.4,sp|A7SIM4|HAP2_NEMVE Hapless 2 OS=Nematostella vectensis OX=45351 GN=HAP2 PE=1 SV=1,GO:0005886; GO:0007338; GO:0008289,single fertilization [GO:0007338],plasma membrane [GO:0005886],lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0022414,plasma membrane; lipid binding; reproductive process
OG_06748,FUN_031557-T1,Peve_00022779,Pocillopora_meandrina_HIv1___RNAseq.g5089.t1,three_way,81.36666666666666,FUN_031557-T1,Q8BH75,RNF41_MOUSE,,E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1),Mus musculus (Mouse),34.5,197.0,6.9e-21,102.8,sp|Q8BH75|RNF41_MOUSE E3 ubiquitin-protein ligase NRDP1 OS=Mus musculus OX=10090 GN=Rnf41 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010498; GO:0019904; GO:0030336; GO:0030971; GO:0031267; GO:0042802; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000379,autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471],erythropoietin receptor binding [GO:0005128]; identical protein binding [GO:0042802]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0006914; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; autophagy; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_06763,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_06773,FUN_031638-T1,Peve_00032680,Pocillopora_meandrina_HIv1___TS.g24410.t3a,three_way,91.53766666666668,FUN_031638-T1,P25490,TYY1_HUMAN,,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),Homo sapiens (Human),88.5,113.0,4.1e-58,226.5,sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837,anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723],chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; telomere organization; organelle; transcription regulator activity
OG_06805,FUN_031703-T1,Peve_00018219,Pocillopora_meandrina_HIv1___RNAseq.g5760.t1,three_way,62.979,FUN_031703-T1,Q9H1A4,APC1_HUMAN,,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),Homo sapiens (Human),31.9,1180.0,1.5e-145,518.8,sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],molecular adaptor activity [GO:0060090],GO:0005654; GO:0005829; GO:0030163; GO:0060090,nucleoplasm; cytosol; protein catabolic process; molecular adaptor activity
OG_06819,FUN_031725-T1,Peve_00040632,Pocillopora_meandrina_HIv1___RNAseq.g5493.t1,three_way,86.41283333333334,FUN_031725-T1,Q6P2K6,P4R3A_MOUSE,,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),Mus musculus (Mouse),62.4,675.0,1.2e-239,830.9,sp|Q6P2K6|P4R3A_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Mus musculus OX=10090 GN=Ppp4r3a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006094; GO:0016607; GO:0019888; GO:0030289; GO:0045722,gluconeogenesis [GO:0006094]; positive regulation of gluconeogenesis [GO:0045722],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289],protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005815; GO:0005829; GO:0005975; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; carbohydrate metabolic process; organelle; molecular function regulator activity
OG_06824,FUN_031734-T1,Peve_00043416,Pocillopora_meandrina_HIv1___RNAseq.g5511.t1,three_way,50.765,FUN_031734-T1,Q60HG2,TOR1A_MACFA,,Torsin-1A (Dystonia 1 protein) (Torsin ATPase 1) (EC 3.6.4.-) (Torsin family 1 member A),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.1,284.0,9.500000000000001e-58,226.5,sp|Q60HG2|TOR1A_MACFA Torsin-1A OS=Macaca fascicularis OX=9541 GN=TOR1A PE=2 SV=1,GO:0000338; GO:0005524; GO:0005635; GO:0005788; GO:0005789; GO:0005856; GO:0006998; GO:0007155; GO:0008021; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051085; GO:0051584; GO:0061077; GO:0071763; GO:0140662; GO:1900244; GO:2000008,"cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]",cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894],GO:0003824; GO:0005635; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048870; GO:0061024; GO:0140657,catalytic activity; nuclear envelope; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; cell motility; membrane organization; ATP-dependent activity
OG_06860,FUN_031851-T1,Peve_00030297,Pocillopora_meandrina_HIv1___RNAseq.g5613.t1,three_way,88.85733333333333,FUN_031851-T1,P51153,RAB13_HUMAN,,Ras-related protein Rab-13 (EC 3.6.5.2) (Cell growth-inhibiting gene 4 protein),Homo sapiens (Human),59.9,182.0,1.8e-60,233.8,sp|P51153|RAB13_HUMAN Ras-related protein Rab-13 OS=Homo sapiens OX=9606 GN=RAB13 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0005923; GO:0006887; GO:0006893; GO:0008021; GO:0010737; GO:0015031; GO:0016197; GO:0016328; GO:0030027; GO:0030054; GO:0030139; GO:0030140; GO:0030866; GO:0031175; GO:0031410; GO:0032456; GO:0032593; GO:0032869; GO:0035767; GO:0043005; GO:0044795; GO:0055037; GO:0055038; GO:0070062; GO:0070830; GO:0072659; GO:0097368; GO:1902463,bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; trans-Golgi network to recycling endosome transport [GO:0044795],bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0072659,catalytic activity; GTPase activity; endosome; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_06937,FUN_032044-T1,Peve_00013568,Pocillopora_meandrina_HIv1___RNAseq.g5941.t1,three_way,84.47583333333333,FUN_032044-T1,Q91ZR5,CTSR1_MOUSE,,Cation channel sperm-associated protein 1 (CatSper1),Mus musculus (Mouse),47.8,205.0,5.4e-22,106.7,sp|Q91ZR5|CTSR1_MOUSE Cation channel sperm-associated protein 1 OS=Mus musculus OX=10090 GN=Catsper1 PE=1 SV=1,GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0007342; GO:0030154; GO:0030317; GO:0036128; GO:0051924; GO:0060296; GO:0097228,calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; regulation of calcium ion transport [GO:0051924]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; spermatogenesis [GO:0007283],CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228],calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005886; GO:0007018; GO:0022414; GO:0030154; GO:0048870; GO:0061024,transporter activity; plasma membrane; microtubule-based movement; reproductive process; cell differentiation; cell motility; membrane organization
OG_06959,FUN_032088-T1,Peve_00026033,Pocillopora_meandrina_HIv1___RNAseq.g5297.t1,three_way,66.52333333333334,FUN_032088-T1,Q5RBF1,SIR2_PONAB,,NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),59.6,297.0,1.9e-105,384.0,sp|Q5RBF1|SIR2_PONAB NAD-dependent protein deacetylase sirtuin-2 OS=Pongo abelii OX=9601 GN=SIRT2 PE=1 SV=1,GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378,cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042],centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903]",GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006629; GO:0016740; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; microtubule organizing center; cytosol; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06971,FUN_032104-T1,Peve_00011277,Pocillopora_meandrina_HIv1___RNAseq.g6000.t1,three_way,72.7205,FUN_032104-T1,Q8IWV8,UBR2_HUMAN,,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),Homo sapiens (Human),42.3,1795.0,0.0,1350.1,sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1,GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053,cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006310; GO:0006325; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; DNA recombination; chromatin organization; transferase activity; reproductive process; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_06984,FUN_032123-T1,Peve_00040721,Pocillopora_meandrina_HIv1___RNAseq.g5374.t1,three_way,85.32833333333333,FUN_032123-T1,Q8K4B0,MTA1_MOUSE,,Metastasis-associated protein MTA1,Mus musculus (Mouse),52.5,571.0,9.999999999999999e-153,542.3,sp|Q8K4B0|MTA1_MOUSE Metastasis-associated protein MTA1 OS=Mus musculus OX=10090 GN=Mta1 PE=1 SV=1,GO:0000978; GO:0003682; GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005874; GO:0006302; GO:0006338; GO:0008270; GO:0010212; GO:0016581; GO:0032922; GO:0042659; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:1902499; GO:2000736,"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]",cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581],chromatin binding [GO:0003682]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nuclear envelope; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_07043,FUN_032245-T1,Peve_00012762,Pocillopora_meandrina_HIv1___TS.g12783.t1,three_way,92.19866666666668,FUN_032245-T1,P92208,JNK_DROME,,Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket),Drosophila melanogaster (Fruit fly),71.2,354.0,1.2e-151,537.7,sp|P92208|JNK_DROME Stress-activated protein kinase JNK OS=Drosophila melanogaster OX=7227 GN=bsk PE=1 SV=1,GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0008284; GO:0009408; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043065; GO:0043068; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0050829; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:0071963; GO:0106310; GO:0140255; GO:1903688; GO:1903689; GO:1904801,"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; JNK cascade [GO:0007254]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of programmed cell death [GO:0043068]; regulation of cellular response to phosphate starvation [GO:0140255]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]",axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007163; GO:0016740; GO:0022414; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0061024; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; establishment or maintenance of cell polarity; transferase activity; reproductive process; wound healing; organelle; anatomical structure development; cell motility; nervous system process; membrane organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07045,FUN_032247-T1,Peve_00036304,Pocillopora_meandrina_HIv1___RNAseq.g24869.t1,three_way,75.44666666666667,FUN_032247-T1,Q5PQN1,HERC4_RAT,,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),Rattus norvegicus (Rat),48.8,1069.0,3.5000000000000003e-274,946.0,sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1,GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630,cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0140096,"catalytic activity; cytosol; transferase activity; reproductive process; cell differentiation; catalytic activity, acting on a protein"
OG_07077,FUN_032314-T1,Peve_00031926,Pocillopora_meandrina_HIv1___RNAseq.g24787.t1,three_way,73.028,FUN_032314-T1,P83205,CATB_SHEEP,,Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],Ovis aries (Sheep),56.0,336.0,2.5e-107,390.2,sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2,GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471],collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07088,FUN_032345-T1,Peve_00021405,Pocillopora_meandrina_HIv1___RNAseq.g29797.t2,three_way,70.41966666666667,FUN_032345-T1,Q9V3L1,NDST_DROME,,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],Drosophila melanogaster (Fruit fly),46.3,901.0,9.6e-236,818.1,sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1,GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140,"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016],GO:0003824; GO:0005783; GO:0005794; GO:0006790; GO:0009101; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; hydrolase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_07133,FUN_032435-T1,Peve_00020056,Pocillopora_meandrina_HIv1___RNAseq.g24659.t1,three_way,54.922666666666665,FUN_032435-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),46.6,118.0,4.0000000000000004e-23,110.5,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_07171,FUN_032607-T1,Peve_00030641,Pocillopora_meandrina_HIv1___RNAseq.g29785.t1,three_way,97.002,FUN_032607-T1,O00487,PSDE_HUMAN,,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),Homo sapiens (Human),89.8,265.0,1e-135,484.2,sp|O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory subunit 14 OS=Homo sapiens OX=9606 GN=PSMD14 PE=1 SV=1,GO:0000502; GO:0000724; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0034774; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070536; GO:0070628; GO:0140492; GO:1904813,double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]",endopeptidase activator activity [GO:0061133]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628],GO:0003824; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; extracellular region; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07271,FUN_033127-T1,Peve_00043508,Pocillopora_meandrina_HIv1___RNAseq.g29764.t1,three_way,64.51100000000001,FUN_033127-T1,P0C152,MKS3_RAT,,Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67),Rattus norvegicus (Rat),39.0,1006.0,3.6e-183,643.7,sp|P0C152|MKS3_RAT Meckelin OS=Rattus norvegicus OX=10116 GN=Tmem67 PE=1 SV=1,GO:0001822; GO:0005789; GO:0005813; GO:0005930; GO:0007368; GO:0007507; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035845; GO:0035869; GO:0036038; GO:0036503; GO:0048754; GO:0051082; GO:0051787; GO:0060170; GO:0060271; GO:0060322; GO:0060441; GO:1902857; GO:1904294,branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERAD pathway [GO:0036503]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038],filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082],GO:0005815; GO:0008092; GO:0030163; GO:0044782; GO:0048856,microtubule organizing center; cytoskeletal protein binding; protein catabolic process; cilium organization; anatomical structure development
OG_07285,FUN_033611-T1,Peve_00007851,Pocillopora_meandrina_HIv1___TS.g24988.t1b,three_way,76.69316666666667,FUN_033611-T1,Q80TP3,UBR5_MOUSE,,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog)",Mus musculus (Mouse),42.4,2918.0,0.0,1864.0,sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2,GO:0003723; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0043130; GO:0045879; GO:0048471; GO:0050847; GO:0061630; GO:0071596; GO:0071629; GO:0071630; GO:0140861; GO:0141198,cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of gene expression [GO:0010628]; progesterone receptor signaling pathway [GO:0050847]; protein branched polyubiquitination [GO:0141198]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_07301,FUN_033687-T1,Peve_00030755,Pocillopora_meandrina_HIv1___RNAseq.g28834.t1,three_way,70.18366666666667,FUN_033687-T1,P48441,IDUA_MOUSE,,Alpha-L-iduronidase (EC 3.2.1.76),Mus musculus (Mouse),44.5,613.0,6.9e-159,562.8,sp|P48441|IDUA_MOUSE Alpha-L-iduronidase OS=Mus musculus OX=10090 GN=Idua PE=1 SV=2,GO:0000902; GO:0003940; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030198; GO:0030200; GO:0030209; GO:0030211; GO:0035108; GO:0043202; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079,adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542],extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],L-iduronidase activity [GO:0003940],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005975; GO:0007040; GO:0016787; GO:0030163; GO:0030198; GO:0043226; GO:0048856; GO:0050877; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; carbohydrate metabolic process; lysosome organization; hydrolase activity; protein catabolic process; extracellular matrix organization; organelle; anatomical structure development; nervous system process; carbohydrate derivative metabolic process
OG_07314,FUN_033706-T1,Peve_00042860,Pocillopora_meandrina_HIv1___RNAseq.g25900.t1,three_way,65.661,FUN_033706-T1,P07992,ERCC1_HUMAN,,DNA excision repair protein ERCC-1,Homo sapiens (Human),65.2,198.0,5.100000000000001e-74,279.6,sp|P07992|ERCC1_HUMAN DNA excision repair protein ERCC-1 OS=Homo sapiens OX=9606 GN=ERCC1 PE=1 SV=1,GO:0000109; GO:0000110; GO:0000720; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006303; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0008283; GO:0008340; GO:0008584; GO:0009650; GO:0010165; GO:0032205; GO:0035166; GO:0035264; GO:0036297; GO:0045190; GO:0048009; GO:0048477; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090399; GO:0090656; GO:1904431; GO:1905765; GO:1990841,cell population proliferation [GO:0008283]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; mitotic recombination [GO:0006312]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]",damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094],GO:0002376; GO:0003677; GO:0005654; GO:0006281; GO:0006310; GO:0006355; GO:0022414; GO:0032200; GO:0048856,immune system process; DNA binding; nucleoplasm; DNA repair; DNA recombination; regulation of DNA-templated transcription; reproductive process; telomere organization; anatomical structure development
OG_07317,FUN_033710-T1,Peve_00014635,Pocillopora_meandrina_HIv1___RNAseq.g25890.t1,three_way,79.785,FUN_033710-T1,P53369,8ODP_RAT,,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",Rattus norvegicus (Rat),61.4,153.0,6.1e-53,208.4,sp|P53369|8ODP_RAT Oxidized purine nucleoside triphosphate hydrolase OS=Rattus norvegicus OX=10116 GN=Nudt1 PE=1 SV=1,GO:0001669; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0006152; GO:0008413; GO:0008584; GO:0008828; GO:0016818; GO:0030515; GO:0031965; GO:0035539; GO:0042262; GO:0046686; GO:0046872; GO:0047693; GO:0106377; GO:0106378; GO:0106431; GO:0106433,DNA protection [GO:0042262]; male gonad development [GO:0008584]; purine nucleoside catabolic process [GO:0006152]; response to cadmium ion [GO:0046686],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634],"2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP diphosphatase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; N6-methyl-(d)ATP hydrolase activity [GO:0106431]; O6-methyl-dGTP hydrolase activity [GO:0106433]; snoRNA binding [GO:0030515]",GO:0003723; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:1901135,RNA binding; catalytic activity; extracellular space; nucleus; mitochondrion; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07326,FUN_033720-T1,Peve_00027572,Pocillopora_meandrina_HIv1___RNAseq.g25888.t1,three_way,75.48283333333333,FUN_033720-T1,Q8VDL4,ADPGK_MOUSE,,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147),Mus musculus (Mouse),32.2,428.0,2.5e-49,198.0,sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2,GO:0005576; GO:0006006; GO:0006096; GO:0043843; GO:0046872,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],extracellular region [GO:0005576],ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07328,FUN_033729-T1,Peve_00027613,Pocillopora_meandrina_HIv1___RNAseq.g28785.t3,three_way,68.036,FUN_033729-T1,Q9H0J4,QRIC2_HUMAN,,Glutamine-rich protein 2,Homo sapiens (Human),32.9,395.0,4.1e-45,184.5,sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1,GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_07345,FUN_033752-T1,Peve_00004934,Pocillopora_meandrina_HIv1___RNAseq.g28752.t1,three_way,78.085,FUN_033752-T1,Q9JI85,NUCB2_RAT,,Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1],Rattus norvegicus (Rat),51.0,304.0,4.3e-50,200.3,sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1,GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845,insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164],GO:0003677; GO:0005615; GO:0005634; GO:0005783; GO:0043226; GO:0098772,DNA binding; extracellular space; nucleus; endoplasmic reticulum; organelle; molecular function regulator activity
OG_07351,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_07363,FUN_033775-T1,Peve_00005277,Pocillopora_meandrina_HIv1___RNAseq.g26655.t1,three_way,73.41866666666667,FUN_033775-T1,Q64127,TIF1A_MOUSE,,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),Mus musculus (Mouse),28.5,1018.0,1.7e-86,322.4,sp|Q64127|TIF1A_MOUSE Transcription intermediary factor 1-alpha OS=Mus musculus OX=10090 GN=Trim24 PE=1 SV=1,GO:0000791; GO:0001673; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0008270; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043434; GO:0043565; GO:0045892; GO:0045893; GO:0050673; GO:0050680; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796,calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; response to peptide hormone [GO:0043434],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726],chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07366,FUN_033778-T1,Peve_00025001,Pocillopora_meandrina_HIv1___RNAseq.g26651.t1,three_way,74.63816666666666,FUN_033778-T1,O00327,BMAL1_HUMAN,,Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3),Homo sapiens (Human),43.1,634.0,9.999999999999999e-123,442.2,sp|O00327|BMAL1_HUMAN Basic helix-loop-helix ARNT-like protein 1 OS=Homo sapiens OX=9606 GN=BMAL1 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0097009; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; energy homeostasis [GO:0097009]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283],aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],"aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_07371,FUN_033788-T1,Peve_00018801,Pocillopora_meandrina_HIv1___RNAseq.g26645.t1,three_way,76.75766666666667,FUN_033788-T1,O15457,MSH4_HUMAN,,MutS protein homolog 4 (hMSH4),Homo sapiens (Human),45.6,439.0,4e-90,333.2,sp|O15457|MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens OX=9606 GN=MSH4 PE=1 SV=2,GO:0000795; GO:0001541; GO:0003677; GO:0003690; GO:0005524; GO:0005634; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0030983; GO:0140664,female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283],chromosome [GO:0005694]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; DNA recombination; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_07385,FUN_033812-T1,Peve_00028718,Pocillopora_meandrina_HIv1___RNAseq.g26345.t1,three_way,82.21633333333334,FUN_033812-T1,Q9C040,TRIM2_HUMAN,,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),Homo sapiens (Human),28.2,550.0,1.4000000000000001e-59,232.6,sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_07437,FUN_033927-T1,Peve_00022641,Pocillopora_meandrina_HIv1___RNAseq.g26588.t2,three_way,72.48533333333333,FUN_033927-T1,Q8IZU3,SYCP3_HUMAN,,Synaptonemal complex protein 3 (SCP-3),Homo sapiens (Human),41.9,167.0,1e-25,118.6,sp|Q8IZU3|SYCP3_HUMAN Synaptonemal complex protein 3 OS=Homo sapiens OX=9606 GN=SYCP3 PE=1 SV=1,GO:0000775; GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007141; GO:0007286; GO:0035092; GO:0051301; GO:0051321,cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286],"chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]",DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140013,DNA binding; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_07474,FUN_033989-T1,Peve_00004922,Pocillopora_meandrina_HIv1___RNAseq.g26102.t1,three_way,69.42083333333333,FUN_033989-T1,E9Q2Z1,CECR2_MOUSE,,Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog),Mus musculus (Mouse),46.8,571.0,1.8e-84,316.2,sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1,GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658,chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338],CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634],ATP-dependent chromatin remodeler activity [GO:0140658],GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"catalytic activity; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07488,FUN_034015-T1,Peve_00007012,Pocillopora_meandrina_HIv1___RNAseq.g26080.t1,three_way,77.31,FUN_034015-T1,A5PK16,CCNF_BOVIN,,Cyclin-F,Bos taurus (Bovine),40.1,619.0,3.5e-119,430.6,sp|A5PK16|CCNF_BOVIN Cyclin-F OS=Bos taurus OX=9913 GN=CCNF PE=2 SV=1,GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005814; GO:0005815; GO:0010826; GO:0016538; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301; GO:0051726,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],centriole [GO:0005814]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],GO:0005634; GO:0005815; GO:0030163; GO:0043226; GO:0098772,nucleus; microtubule organizing center; protein catabolic process; organelle; molecular function regulator activity
OG_07490,FUN_034017-T1,Peve_00007018,Pocillopora_meandrina_HIv1___RNAseq.g26077.t1,three_way,88.351,FUN_034017-T1,Q0VCN3,IFT27_BOVIN,,Intraflagellar transport protein 27 homolog (IFT27) (Putative GTP-binding protein RAY-like) (Rab-like protein 4),Bos taurus (Bovine),53.0,185.0,8.5e-54,211.5,sp|Q0VCN3|IFT27_BOVIN Intraflagellar transport protein 27 homolog OS=Bos taurus OX=9913 GN=IFT27 PE=2 SV=1,GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030154; GO:0030992; GO:0036126; GO:0042073,cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0016192; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; GTPase activity; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; vesicle-mediated transport; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_07541,FUN_034122-T1,Peve_00039585,Pocillopora_meandrina_HIv1___RNAseq.g25947.t1,three_way,51.35716666666666,FUN_034122-T1,Q8BUR3,FOXJ3_MOUSE,,Forkhead box protein J3,Mus musculus (Mouse),44.5,155.0,4.5000000000000003e-23,110.9,sp|Q8BUR3|FOXJ3_MOUSE Forkhead box protein J3 OS=Mus musculus OX=10090 GN=Foxj3 PE=1 SV=1,GO:0001228; GO:0005634; GO:0007141; GO:0007283; GO:0030154; GO:1990837,cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140110,DNA binding; nucleus; reproductive process; cell differentiation; organelle; meiotic nuclear division; transcription regulator activity
OG_07562,FUN_034205-T1,Peve_00027539,Pocillopora_meandrina_HIv1___TS.g18923.t1,three_way,65.39233333333334,FUN_034205-T1,A6NJV1,CMI2C_HUMAN,,Ciliary microtubule inner protein 2C,Homo sapiens (Human),39.5,129.0,1.8e-17,90.9,sp|A6NJV1|CMI2C_HUMAN Ciliary microtubule inner protein 2C OS=Homo sapiens OX=9606 GN=CIMIP2C PE=1 SV=1,GO:0005634; GO:0005879; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_07567,FUN_034229-T1,Peve_00040765,Pocillopora_meandrina_HIv1___RNAseq.g28437.t1,three_way,83.228,FUN_034229-T1,Q8IWQ3,BRSK2_HUMAN,,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),Homo sapiens (Human),50.3,650.0,3.5e-169,596.7,sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3,GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0019901; GO:0021953; GO:0030010; GO:0030036; GO:0030182; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807,"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell division [GO:0051301]; central nervous system neuron differentiation [GO:0021953]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005783; GO:0005815; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; microtubule organizing center; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07600,FUN_034314-T1,Peve_00027985,Pocillopora_meandrina_HIv1___RNAseq.g28491.t2,three_way,44.29716666666666,FUN_034314-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),24.8,367.0,3.3e-21,105.1,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_07628,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_07650,FUN_034483-T1,Peve_00038716,Pocillopora_meandrina_HIv1___RNAseq.g16114.t1,three_way,74.1005,FUN_034483-T1,Q0P595,SIR7_BOVIN,,NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7),Bos taurus (Bovine),58.2,328.0,1.5e-101,371.3,sp|Q0P595|SIR7_BOVIN NAD-dependent protein deacetylase sirtuin-7 OS=Bos taurus OX=9913 GN=SIRT7 PE=2 SV=1,GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006281; GO:0006357; GO:0006476; GO:0007129; GO:0009303; GO:0010526; GO:0010821; GO:0031397; GO:0034979; GO:0035861; GO:0036055; GO:0045722; GO:0045943; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0097372; GO:0106230; GO:0106231; GO:0140861; GO:1901836; GO:2000234,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop processing [GO:0062176]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]; transposable element silencing [GO:0010526],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],"chromatin binding [GO:0003682]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-succinyllysine desuccinylase activity [GO:0036055]",GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006325; GO:0006351; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_07665,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.9e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07676,FUN_034785-T1,Peve_00029735,Pocillopora_meandrina_HIv1___RNAseq.g12280.t2,three_way,53.20216666666666,FUN_034785-T1,O08699,PGDH_RAT,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Rattus norvegicus (Rat),39.5,205.0,1.4e-37,157.9,sp|O08699|PGDH_RAT 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Rattus norvegicus OX=10116 GN=Hpgd PE=1 SV=2,GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]",GO:0003824; GO:0005615; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0022414; GO:0048856; GO:0060089,catalytic activity; extracellular space; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; reproductive process; anatomical structure development; molecular transducer activity
OG_07678,FUN_034796-T1,Peve_00007518,Pocillopora_meandrina_HIv1___RNAseq.g12296.t1,three_way,97.267,FUN_034796-T1,Q60779,DRC4_MOUSE,,Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8),Mus musculus (Mouse),52.8,462.0,1.3e-114,414.8,sp|Q60779|DRC4_MOUSE Dynein regulatory complex subunit 4 OS=Mus musculus OX=10090 GN=Gas8 PE=1 SV=2,GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0008104; GO:0015630; GO:0030317; GO:0031267; GO:0031514; GO:0035082; GO:0036064; GO:0036126; GO:0045880; GO:0051649; GO:0097386; GO:0097729; GO:1903566; GO:1904526,axoneme assembly [GO:0035082]; brain development [GO:0007420]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; regulation of microtubule binding [GO:1904526],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017]; small GTPase binding [GO:0031267],GO:0005576; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870,extracellular region; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility
OG_07694,FUN_034822-T1,Peve_00040546,Pocillopora_meandrina_HIv1___RNAseq.g27205.t1,three_way,72.92,FUN_034822-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),32.0,294.0,1.1e-26,122.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_07757,FUN_034950-T1,Peve_00036669,Pocillopora_meandrina_HIv1___TS.g15196.t1,three_way,81.33766666666666,FUN_034950-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,219.0,6.2e-40,166.0,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_07762,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07769,FUN_034972-T1,Peve_00028365,Pocillopora_meandrina_HIv1___RNAseq.g12164.t1,three_way,71.28216666666667,FUN_034972-T1,Q91820,AURAA_XENLA,,Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265),Xenopus laevis (African clawed frog),63.3,341.0,1.5e-121,437.6,sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis OX=8355 GN=aurka-a PE=1 SV=1,GO:0000212; GO:0000776; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0007052; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0032133; GO:0032465; GO:0046777; GO:0051233; GO:0051301; GO:0090307; GO:0106310,cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_07774,FUN_034986-T1,Peve_00009289,Pocillopora_meandrina_HIv1___RNAseq.g27118.t1,three_way,87.63316666666667,FUN_034986-T1,Q9BUN8,DERL1_HUMAN,,Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1),Homo sapiens (Human),61.0,249.0,1.3e-81,304.3,sp|Q9BUN8|DERL1_HUMAN Derlin-1 OS=Homo sapiens OX=9606 GN=DERL1 PE=1 SV=1,GO:0002020; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006986; GO:0016020; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0042802; GO:0043161; GO:0044322; GO:0044877; GO:0045184; GO:0051117; GO:0071218; GO:1990381,"cellular response to misfolded protein [GO:0071218]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]",Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; late endosome [GO:0005770]; membrane [GO:0016020],ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381],GO:0005768; GO:0005783; GO:0006886; GO:0030163; GO:0031410; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; intracellular protein transport; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity
OG_07793,FUN_035020-T1,Peve_00024635,Pocillopora_meandrina_HIv1___RNAseq.g27768.t1,three_way,45.82483333333333,FUN_035020-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),36.2,149.0,5.9e-19,97.1,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_07794,FUN_035021-T1,Peve_00024634,Pocillopora_meandrina_HIv1___RNAseq.g27767.t1,three_way,74.369,FUN_035021-T1,P47033,PRY3_YEAST,,Cell wall protein PRY3 (Pathogenesis-related protein 3),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),36.5,148.0,3e-16,87.4,sp|P47033|PRY3_YEAST Cell wall protein PRY3 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY3 PE=1 SV=1,GO:0000747; GO:0005615; GO:0009277; GO:0015908; GO:0015918; GO:0019953; GO:0071944; GO:0098552,conjugation with cellular fusion [GO:0000747]; fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],cell periphery [GO:0071944]; extracellular space [GO:0005615]; fungal-type cell wall [GO:0009277]; side of membrane [GO:0098552],,GO:0005615; GO:0005618; GO:0022414; GO:0030312,extracellular space; cell wall; reproductive process; external encapsulating structure
OG_07805,FUN_035042-T1,Peve_00044753,Pocillopora_meandrina_HIv1___RNAseq.g27744.t1,three_way,66.28966666666666,FUN_035042-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.0,338.0,3.8e-41,170.6,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_07849,FUN_035191-T1,Peve_00044663,Pocillopora_meandrina_HIv1___RNAseq.g27959.t1,three_way,74.12833333333333,FUN_035191-T1,Q9VZF4,FBXW7_DROME,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago),Drosophila melanogaster (Fruit fly),28.8,198.0,1.8e-18,95.5,sp|Q9VZF4|FBXW7_DROME F-box/WD repeat-containing protein 7 OS=Drosophila melanogaster OX=7227 GN=ago PE=1 SV=1,GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381,"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]",nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381],GO:0005634; GO:0006260; GO:0030163; GO:0043226; GO:0048856,nucleus; DNA replication; protein catabolic process; organelle; anatomical structure development
OG_07873,FUN_035233-T1,Peve_00044494,Pocillopora_meandrina_HIv1___RNAseq.g27904.t1,three_way,73.75433333333334,FUN_035233-T1,Q3T0C2,PGDH_BOVIN,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Bos taurus (Bovine),40.9,257.0,7.100000000000001e-48,192.2,sp|Q3T0C2|PGDH_BOVIN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Bos taurus OX=9913 GN=HPGD PE=2 SV=1,GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957],GO:0003824; GO:0006629; GO:0016491; GO:0022414; GO:0060089,catalytic activity; lipid metabolic process; oxidoreductase activity; reproductive process; molecular transducer activity
OG_07880,FUN_035243-T1,Peve_00042228,Pocillopora_meandrina_HIv1___RNAseq.g27896.t1,three_way,91.40466666666669,FUN_035243-T1,Q6Q137,SEPT7_BOVIN,,Septin-7 (CDC10 protein homolog),Bos taurus (Bovine),67.9,330.0,2.2e-129,463.8,sp|Q6Q137|SEPT7_BOVIN Septin-7 OS=Bos taurus OX=9913 GN=SEPTIN7 PE=2 SV=2,GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0042802; GO:0060090; GO:0060271; GO:0061640; GO:0097227; GO:0097730; GO:1902857,cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005856; GO:0005929; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0060090,cytokinesis; catalytic activity; GTPase activity; nucleus; cytoskeleton; cilium; hydrolase activity; reproductive process; cell differentiation; organelle; cilium organization; molecular adaptor activity
OG_07887,FUN_035265-T1,Peve_00032654,Pocillopora_meandrina_HIv1___RNAseq.g27870.t1,three_way,70.16533333333334,FUN_035265-T1,Q2LKW6,NL1B1_MOUSE,,"NACHT, LRR and PYD domains-containing protein 1b allele 1 (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1b, C-terminus (Nlrp1b1-CT); NACHT, LRR and PYD domains-containing protein 1b, N-terminus (Nlrp1b1-NT)]",Mus musculus (Mouse),24.6,346.0,2.5e-09,65.9,"sp|Q2LKW6|NL1B1_MOUSE NACHT, LRR and PYD domains-containing protein 1b allele 1 OS=Mus musculus OX=10090 GN=Nlrp1b PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0008233; GO:0012501; GO:0016020; GO:0030163; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0070269; GO:0072558,innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic process [GO:0042981],cytoplasm [GO:0005737]; membrane [GO:0016020]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_07938,FUN_035444-T1,Peve_00002174,Pocillopora_meandrina_HIv1___RNAseq.g27111.t1,three_way,85.51933333333334,FUN_035444-T1,Q8BZZ3,WWP1_MOUSE,,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Mus musculus (Mouse),57.0,910.0,8.499999999999999e-234,811.6,sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2,GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07946,FUN_035466-T1,Peve_00012134,Pocillopora_meandrina_HIv1___RNAseq.g11796.t1,three_way,51.17766666666667,FUN_035466-T1,Q9JIL9,NBN_RAT,,Nibrin (Nijmegen breakage syndrome protein 1 homolog),Rattus norvegicus (Rat),26.3,753.0,1.1e-56,223.0,sp|Q9JIL9|NBN_RAT Nibrin OS=Rattus norvegicus OX=10116 GN=Nbn PE=1 SV=2,GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001701; GO:0001832; GO:0003684; GO:0005634; GO:0005657; GO:0005730; GO:0006302; GO:0007095; GO:0007405; GO:0008284; GO:0009410; GO:0016605; GO:0030870; GO:0031848; GO:0031860; GO:0032206; GO:0035861; GO:0042393; GO:0042405; GO:0043247; GO:0043539; GO:0045190; GO:0045665; GO:0046597; GO:0048145; GO:0050885; GO:0051321; GO:0062176; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0097681; GO:0110025; GO:0140031; GO:0140297; GO:0140463; GO:1904354; GO:1990166; GO:2000781,blastocyst growth [GO:0001832]; DNA damage checkpoint signaling [GO:0000077]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of symbiont invasion [GO:0046597]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of fibroblast proliferation [GO:0048145]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosome, telomeric region [GO:0000781]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0002376; GO:0003677; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0022414; GO:0032200; GO:0042393; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleolus; DNA repair; DNA recombination; chromatin organization; reproductive process; telomere organization; histone binding; organelle; anatomical structure development; nervous system process; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_07947,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_07960,FUN_035513-T1,Peve_00039975,Pocillopora_meandrina_HIv1___RNAseq.g26972.t1,three_way,86.628,FUN_035513-T1,Q0P5Y3,TPPP2_MOUSE,,Tubulin polymerization-promoting protein family member 2,Mus musculus (Mouse),45.7,164.0,1.1000000000000002e-28,127.9,sp|Q0P5Y3|TPPP2_MOUSE Tubulin polymerization-promoting protein family member 2 OS=Mus musculus OX=10090 GN=Tppp2 PE=2 SV=1,GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0036126; GO:0046785; GO:1901317,cell differentiation [GO:0030154]; microtubule polymerization [GO:0046785]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; sperm flagellum [GO:0036126],tubulin binding [GO:0015631],GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0065003,cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; protein-containing complex assembly
OG_07976,FUN_035554-T2,Peve_00036915,Pocillopora_meandrina_HIv1___TS.g15372.t1,three_way,93.07433333333334,FUN_035554-T2,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),67.4,4652.0,0.0,6165.9,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_08025,FUN_035680-T1,Peve_00025447,Pocillopora_meandrina_HIv1___RNAseq.g28147.t1,three_way,66.779,FUN_035680-T1,Q6J2U6,RN114_RAT,,E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 313),Rattus norvegicus (Rat),44.8,203.0,2.4e-47,190.3,sp|Q6J2U6|RN114_RAT E3 ubiquitin-protein ligase RNF114 OS=Rattus norvegicus OX=10116 GN=Rnf114 PE=2 SV=1,GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0007283; GO:0008270; GO:0030154; GO:0061630,cell differentiation [GO:0030154]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_08040,FUN_035717-T1,Peve_00044097,Pocillopora_meandrina_HIv1___TS.g3184.t1,three_way,69.33633333333333,FUN_035717-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),33.9,245.0,1.3e-32,141.7,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_08056,FUN_035751-T1,Peve_00044197,Pocillopora_meandrina_HIv1___RNAseq.g11877.t1,three_way,71.535,FUN_035751-T1,P54802,ANAG_HUMAN,,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],Homo sapiens (Human),50.3,708.0,3.1e-214,746.5,sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2,GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097696; GO:0099022; GO:1904389; GO:1904390,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020],alpha-N-acetylglucosaminidase activity [GO:0004561],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0006629; GO:0006914; GO:0007040; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; lipid metabolic process; autophagy; lysosome organization; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; carbohydrate derivative metabolic process
OG_08087,FUN_035819-T1,Peve_00037795,Pocillopora_meandrina_HIv1___RNAseq.g11925.t1,three_way,66.42033333333333,FUN_035819-T1,Q9CVD2,ATX3_MOUSE,,Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog),Mus musculus (Mouse),53.3,152.0,9.399999999999999e-39,161.8,sp|Q9CVD2|ATX3_MOUSE Ataxin-3 OS=Mus musculus OX=10090 GN=Atxn3 PE=1 SV=2,GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0006515; GO:0010810; GO:0016363; GO:0030036; GO:0031625; GO:0031966; GO:0034198; GO:0034605; GO:0035520; GO:0035640; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904262; GO:1904294; GO:1904327; GO:1990380; GO:2000060,actin cytoskeleton organization [GO:0030036]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex [GO:1904327]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08093,FUN_035828-T1,Peve_00002588,Pocillopora_meandrina_HIv1___RNAseq.g11936.t1,three_way,67.353,FUN_035828-T1,Q60751,IGF1R_MOUSE,,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],Mus musculus (Mouse),48.0,275.0,4.300000000000001e-71,271.6,sp|Q60751|IGF1R_MOUSE Insulin-like growth factor 1 receptor OS=Mus musculus OX=10090 GN=Igf1r PE=1 SV=3,GO:0000165; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005886; GO:0007420; GO:0008544; GO:0009887; GO:0016020; GO:0030238; GO:0030315; GO:0030325; GO:0030879; GO:0031017; GO:0032869; GO:0043235; GO:0043409; GO:0043410; GO:0043491; GO:0043548; GO:0043560; GO:0045840; GO:0045893; GO:0046777; GO:0048009; GO:0048639; GO:0051446; GO:0051897; GO:0051898; GO:0060740; GO:0071333; GO:0098794; GO:0098978; GO:0099170; GO:0120162; GO:0140014,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; insulin-like growth factor receptor signaling pathway [GO:0048009]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; mitotic nuclear division [GO:0140014]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prostate gland epithelium morphogenesis [GO:0060740]; protein autophosphorylation [GO:0046777],glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; T-tubule [GO:0030315],ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005886; GO:0006355; GO:0016740; GO:0022414; GO:0048856; GO:0060089; GO:0140014; GO:0140096,"catalytic activity; structural molecule activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; reproductive process; anatomical structure development; molecular transducer activity; mitotic nuclear division; catalytic activity, acting on a protein"
OG_08098,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08112,FUN_035865-T1,Peve_00012613,Pocillopora_meandrina_HIv1___RNAseq.g11977.t1,three_way,77.13466666666666,FUN_035865-T1,Q8TEL6,TP4AP_HUMAN,,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),Homo sapiens (Human),37.4,768.0,3.2e-131,470.7,sp|Q8TEL6|TP4AP_HUMAN Short transient receptor potential channel 4-associated protein OS=Homo sapiens OX=9606 GN=TRPC4AP PE=1 SV=2,GO:0005262; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756,calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005215; GO:0005829; GO:0005886; GO:0030163; GO:0055085; GO:0060090,transporter activity; cytosol; plasma membrane; protein catabolic process; transmembrane transport; molecular adaptor activity
OG_08130,FUN_035890-T2,Peve_00029398,Pocillopora_meandrina_HIv1___RNAseq.g12007.t1,three_way,73.41116666666667,FUN_035890-T2,Q8TEB1,DCA11_HUMAN,,DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23),Homo sapiens (Human),51.1,493.0,1.3e-147,524.6,sp|Q8TEB1|DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1,GO:0003016; GO:0005654; GO:0006979; GO:0007613; GO:0010467; GO:0016567; GO:0035640; GO:0043161; GO:0050821; GO:0080008,exploration behavior [GO:0035640]; gene expression [GO:0010467]; memory [GO:0007613]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; respiratory system process [GO:0003016]; response to oxidative stress [GO:0006979],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654],,GO:0003016; GO:0005654; GO:0030163; GO:0050877,respiratory system process; nucleoplasm; protein catabolic process; nervous system process
OG_08136,FUN_035898-T1,Peve_00029392,Pocillopora_meandrina_HIv1___RNAseq.g12022.t1,three_way,92.744,FUN_035898-T1,A2APC3,TTLL9_MOUSE,,Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9),Mus musculus (Mouse),68.2,444.0,1.6e-175,617.1,sp|A2APC3|TTLL9_MOUSE Probable tubulin polyglutamylase TTLL9 OS=Mus musculus OX=10090 GN=Ttll9 PE=1 SV=2,GO:0005524; GO:0005737; GO:0005874; GO:0030317; GO:0031514; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438,flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005929; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; cilium; microtubule-based movement; ligase activity; reproductive process; organelle; cell motility; catalytic activity, acting on a protein"
OG_08141,FUN_035903-T1,Peve_00006709,Pocillopora_meandrina_HIv1___RNAseq.g12028.t1,three_way,63.929,FUN_035903-T1,Q3TQF0,FBX31_MOUSE,,F-box only protein 31,Mus musculus (Mouse),32.1,448.0,2.8e-57,224.2,sp|Q3TQF0|FBX31_MOUSE F-box only protein 31 OS=Mus musculus OX=10090 GN=Fbxo31 PE=1 SV=1,GO:0005737; GO:0006974; GO:0016567; GO:0019005; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0034599; GO:0043025; GO:0043161; GO:1990756,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to oxidative stress [GO:0034599]; DNA damage response [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_08171,FUN_035978-T1,Peve_00045087,Pocillopora_meandrina_HIv1___RNAseq.g12340.t1,three_way,89.63966666666667,FUN_035978-T1,Q9Y2E8,SL9A8_HUMAN,,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),Homo sapiens (Human),56.9,568.0,1.0999999999999999e-166,588.2,sp|Q9Y2E8|SL9A8_HUMAN Sodium/hydrogen exchanger 8 OS=Homo sapiens OX=9606 GN=SLC9A8 PE=1 SV=4,GO:0000139; GO:0001669; GO:0001675; GO:0006811; GO:0015385; GO:0015386; GO:0016324; GO:0032585; GO:0032588; GO:0035725; GO:0051453; GO:0071805; GO:1902600; GO:1905526,acrosome assembly [GO:0001675]; monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725],acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0022414; GO:0031410; GO:0043226; GO:0055085,transporter activity; reproductive process; cytoplasmic vesicle; organelle; transmembrane transport
OG_08232,FUN_036108-T1,Peve_00003698,Pocillopora_meandrina_HIv1___RNAseq.g27428.t1,three_way,57.653666666666666,FUN_036108-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),49.7,143.0,6.2e-36,153.3,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08269,FUN_036181-T1,Peve_00015589,Pocillopora_meandrina_HIv1___RNAseq.10483_t,three_way,61.40083333333333,FUN_036181-T1,A9JTG5,HOIL1_DANRE,,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog),Danio rerio (Zebrafish) (Brachydanio rerio),38.2,610.0,1.3e-119,432.2,sp|A9JTG5|HOIL1_DANRE RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Danio rerio OX=7955 GN=rbck1 PE=2 SV=1,GO:0004842; GO:0008270; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0048701; GO:0071600; GO:0071797; GO:0097039,defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],LUBAC complex [GO:0071797],ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_08281,FUN_036205-T1,Peve_00038741,Pocillopora_meandrina_HIv1___RNAseq.g27357.t1,three_way,76.24883333333334,FUN_036205-T1,O88554,PARP2_MOUSE,,Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-),Mus musculus (Mouse),55.8,545.0,8.2e-169,595.5,sp|O88554|PARP2_MOUSE Poly [ADP-ribose] polymerase 2 OS=Mus musculus OX=10090 GN=Parp2 PE=1 SV=3,GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006284; GO:0016779; GO:0030592; GO:0031491; GO:0046697; GO:0061051; GO:0070212; GO:0070213; GO:0072572; GO:0090649; GO:0090734; GO:0097191; GO:0110088; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140861; GO:0160004; GO:1990404,base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006325; GO:0012501; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; chromatin organization; programmed cell death; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08285,FUN_036212-T1,Peve_00025926,Pocillopora_meandrina_HIv1___RNAseq.g27384.t1,three_way,79.80799999999999,FUN_036212-T1,Q96RK4,BBS4_HUMAN,,BBSome complex member BBS4 (Bardet-Biedl syndrome 4 protein),Homo sapiens (Human),38.6,451.0,2.1999999999999998e-75,284.6,sp|Q96RK4|BBS4_HUMAN BBSome complex member BBS4 OS=Homo sapiens OX=9606 GN=BBS4 PE=1 SV=2,GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001782; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016055; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034101; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:0120316; GO:1902855; GO:1903546; GO:1905515,adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000910; GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060090,cytokinesis; immune system process; nucleus; microtubule organizing center; cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular adaptor activity
OG_08286,FUN_036221-T1,Peve_00025940,Pocillopora_meandrina_HIv1___RNAseq.g27543.t1,three_way,83.386,FUN_036221-T1,F1MM41,ZNRF1_BOVIN,,E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1),Bos taurus (Bovine),57.0,93.0,2.6e-26,120.2,sp|F1MM41|ZNRF1_BOVIN E3 ubiquitin-protein ligase ZNRF1 OS=Bos taurus OX=9913 GN=ZNRF1 PE=3 SV=2,GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0008270; GO:0016020; GO:0030672; GO:0034145; GO:0043161; GO:0043231; GO:0061630; GO:0070936; GO:0160177,positive regulation of autophagosome-lysosome fusion [GO:0160177]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; cytosol; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08301,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_08318,FUN_036742-T1,Peve_00018098,Pocillopora_meandrina_HIv1___RNAseq.g12110.t1,three_way,78.11333333333333,FUN_036742-T1,Q86U44,MTA70_HUMAN,,N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70),Homo sapiens (Human),40.3,442.0,2.4000000000000003e-80,300.8,sp|Q86U44|MTA70_HUMAN N(6)-adenosine-methyltransferase catalytic subunit METTL3 OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204,"cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098542; GO:0140098,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; chromatin organization; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on RNA"
OG_08335,FUN_036831-T1,Peve_00006966,Pocillopora_meandrina_HIv1___RNAseq.g10632.t1,three_way,76.47966666666666,FUN_036831-T1,O95470,SGPL1_HUMAN,,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),Homo sapiens (Human),52.1,94.0,7.9e-25,114.4,sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3,GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190,androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117],GO:0003824; GO:0005783; GO:0006629; GO:0016829; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870,catalytic activity; endoplasmic reticulum; lipid metabolic process; lyase activity; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility
OG_08344,FUN_036870-T1,Peve_00004117,Pocillopora_meandrina_HIv1___RNAseq.g10622.t1,three_way,59.571666666666665,FUN_036870-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),23.8,298.0,1.7e-06,55.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_08367,FUN_036919-T1,Peve_00018354,Pocillopora_meandrina_HIv1___RNAseq.g10824.t1,three_way,88.945,FUN_036919-T1,Q8BWT1,THIM_MOUSE,,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)",Mus musculus (Mouse),65.7,394.0,5.2e-149,528.9,"sp|Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus OX=10090 GN=Acaa2 PE=1 SV=3",GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0006635; GO:0016604; GO:0036064; GO:0047617; GO:0071456; GO:1901029; GO:1902109,cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],ciliary basal body [GO:0036064]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617],GO:0003824; GO:0005739; GO:0005815; GO:0006629; GO:0007005; GO:0016740; GO:0016787; GO:0043226; GO:0061024,catalytic activity; mitochondrion; microtubule organizing center; lipid metabolic process; mitochondrion organization; transferase activity; hydrolase activity; organelle; membrane organization
OG_08372,FUN_036925-T1,Peve_00040016,Pocillopora_meandrina_HIv1___TS.g13354.t1,three_way,76.31133333333334,FUN_036925-T1,Q91618,PMYT1_XENLA,,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase),Xenopus laevis (African clawed frog),38.5,550.0,3.8e-86,320.5,sp|Q91618|PMYT1_XENLA Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Xenopus laevis OX=8355 GN=pkmyt1 PE=1 SV=1,GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0007088; GO:0010972; GO:0046872; GO:0051321; GO:0106310; GO:0110031,meiotic cell cycle [GO:0051321]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; regulation of mitotic nuclear division [GO:0007088],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_08388,FUN_036996-T1,Peve_00002148,Pocillopora_meandrina_HIv1___RNAseq.g26772.t1,three_way,73.63133333333333,FUN_036996-T1,O43826,G6PT1_HUMAN,,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),Homo sapiens (Human),40.1,421.0,3.3000000000000003e-80,300.4,sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513,gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152],GO:0005215; GO:0005783; GO:0005975; GO:0043226; GO:0055085,transporter activity; endoplasmic reticulum; carbohydrate metabolic process; organelle; transmembrane transport
OG_08403,FUN_037054-T1,Peve_00042415,Pocillopora_meandrina_HIv1___RNAseq.g26787.t1,three_way,89.36016666666667,FUN_037054-T1,Q3UIK4,MET14_MOUSE,,N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 (Methyltransferase-like protein 14),Mus musculus (Mouse),60.6,436.0,4e-148,526.2,sp|Q3UIK4|MET14_MOUSE N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 OS=Mus musculus OX=10090 GN=Mettl14 PE=1 SV=1,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0016556; GO:0019827; GO:0021861; GO:0031667; GO:0036396; GO:0042063; GO:0045664; GO:0045727; GO:0048255; GO:0061157; GO:1901533,"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; regulation of neuron differentiation [GO:0045664]; response to nutrient levels [GO:0031667]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_08406,FUN_037057-T1,Peve_00018391,Pocillopora_meandrina_HIv1___RNAseq.g26784.t1,three_way,86.48433333333334,FUN_037057-T1,P43332,SNRPA_DROME,,U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A) (Sex determination protein snf),Drosophila melanogaster (Fruit fly),70.9,234.0,2.4e-69,263.5,sp|P43332|SNRPA_DROME U1 small nuclear ribonucleoprotein A OS=Drosophila melanogaster OX=7227 GN=snf PE=1 SV=1,GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0007539; GO:0008266; GO:0008380; GO:0019099; GO:0030532; GO:0030619; GO:0030620; GO:0032991; GO:0035614; GO:0042802; GO:0048477; GO:0071011; GO:0071013; GO:0097158; GO:1990904,"female germ-line sex determination [GO:0019099]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686],identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620],GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856,RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development
OG_08409,FUN_037060-T1,Peve_00018394,Pocillopora_meandrina_HIv1___RNAseq.g26777.t1,three_way,73.381,FUN_037060-T1,Q5ZK10,NSF1C_CHICK,,NSFL1 cofactor p47 (p97 cofactor p47),Gallus gallus (Chicken),51.3,388.0,2.1e-70,267.7,sp|Q5ZK10|NSF1C_CHICK NSFL1 cofactor p47 OS=Gallus gallus OX=9031 GN=NSFL1C PE=2 SV=1,GO:0000045; GO:0000132; GO:0005634; GO:0005795; GO:0005813; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730,autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730],lipid binding [GO:0008289]; ubiquitin binding [GO:0043130],GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0030163; GO:0043226; GO:0061024,nucleus; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; protein catabolic process; organelle; membrane organization
OG_08410,FUN_037061-T1,Peve_00018395,Pocillopora_meandrina_HIv1___RNAseq.g26778.t1,three_way,63.92483333333333,FUN_037061-T1,Q5U2U2,CRKL_RAT,,Crk-like protein,Rattus norvegicus (Rat),37.5,293.0,5.8e-46,186.0,sp|Q5U2U2|CRKL_RAT Crk-like protein OS=Rattus norvegicus OX=10116 GN=Crkl PE=1 SV=1,GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404,acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0005654; GO:0005829; GO:0006629; GO:0007163; GO:0012501; GO:0022414; GO:0048856; GO:0048870; GO:0060090,immune system process; nucleoplasm; cytosol; lipid metabolic process; establishment or maintenance of cell polarity; programmed cell death; reproductive process; anatomical structure development; cell motility; molecular adaptor activity
OG_08428,FUN_037090-T1,Peve_00004757,Pocillopora_meandrina_HIv1___RNAseq.g11094.t1,three_way,85.29466666666666,FUN_037090-T1,Q5THR3,EFCB6_HUMAN,,EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP),Homo sapiens (Human),19.6,678.0,3.4e-23,112.1,sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1,GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005654; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleoplasm; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_08432,FUN_037097-T1,Peve_00031943,Pocillopora_meandrina_HIv1___RNAseq.g11082.t1,three_way,73.8455,FUN_037097-T1,Q6GN08,CND3L_XENLA,,Condensin-2 complex subunit D3-L,Xenopus laevis (African clawed frog),37.1,1165.0,4.2e-193,676.8,sp|Q6GN08|CND3L_XENLA Condensin-2 complex subunit D3-L OS=Xenopus laevis OX=8355 GN=ncapd3.L PE=1 SV=1,GO:0000779; GO:0000796; GO:0005634; GO:0007076; GO:0010032; GO:0042393; GO:0051301,cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076],"condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; nucleus [GO:0005634]",histone binding [GO:0042393],GO:0005634; GO:0022414; GO:0042393; GO:0043226,nucleus; reproductive process; histone binding; organelle
OG_08462,FUN_037231-T1,Peve_00006214,Pocillopora_meandrina_HIv1___RNAseq.g11018.t1,three_way,95.307,FUN_037231-T1,P61092,SIA1A_MOUSE,,E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a),Mus musculus (Mouse),84.6,266.0,2.4e-135,483.0,sp|P61092|SIA1A_MOUSE E3 ubiquitin-protein ligase SIAH1A OS=Mus musculus OX=10090 GN=Siah1a PE=1 SV=1,GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0009791; GO:0016567; GO:0019005; GO:0030154; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; programmed cell death; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08506,FUN_037409-T1,Peve_00028255,Pocillopora_meandrina_HIv1___RNAseq.g10935.t1,three_way,69.74066666666667,FUN_037409-T1,Q9C8L4,ETHE1_ARATH,,"Persulfide dioxygenase ETHE1 homolog, mitochondrial (EC 1.13.11.18) (Glyoxalase II) (Glx II) (Sulfur dioxygenase ETHE1)",Arabidopsis thaliana (Mouse-ear cress),59.1,242.0,8.899999999999999e-75,281.6,"sp|Q9C8L4|ETHE1_ARATH Persulfide dioxygenase ETHE1 homolog, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=GLY3 PE=1 SV=3",GO:0005634; GO:0005739; GO:0006749; GO:0009793; GO:0009960; GO:0016788; GO:0046872; GO:0048316; GO:0050313,embryo development ending in seed dormancy [GO:0009793]; endosperm development [GO:0009960]; glutathione metabolic process [GO:0006749]; seed development [GO:0048316],mitochondrion [GO:0005739]; nucleus [GO:0005634],"hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; sulfur dioxygenase activity [GO:0050313]",GO:0003824; GO:0005634; GO:0005739; GO:0006575; GO:0006790; GO:0016491; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; nucleus; mitochondrion; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_08530,FUN_037477-T1,Peve_00020433,Pocillopora_meandrina_HIv1___RNAseq.g1391.t1,three_way,71.99733333333333,FUN_037477-T1,Q3TDN2,FAF2_MOUSE,,FAS-associated factor 2 (UBX domain-containing protein 8),Mus musculus (Mouse),45.3,267.0,3.1e-59,230.3,sp|Q3TDN2|FAF2_MOUSE FAS-associated factor 2 OS=Mus musculus OX=10090 GN=Faf2 PE=1 SV=2,GO:0005783; GO:0005811; GO:0006986; GO:0030674; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035617; GO:0036503; GO:0043130; GO:0043161; GO:0055102,"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005783; GO:0005811; GO:0006886; GO:0030163; GO:0043226; GO:0060090; GO:0098772,endoplasmic reticulum; lipid droplet; intracellular protein transport; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_08543,FUN_037496-T1,Peve_00028565,Pocillopora_meandrina_HIv1___RNAseq.g1312.t1,three_way,79.1105,FUN_037496-T1,P36895,BMR1A_MOUSE,,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (BMP-2/BMP-4 receptor) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),Mus musculus (Mouse),53.0,487.0,2.7e-145,516.9,sp|P36895|BMR1A_MOUSE Bone morphogenetic protein receptor type-1A OS=Mus musculus OX=10090 GN=Bmpr1a PE=1 SV=1,GO:0001525; GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003007; GO:0003148; GO:0003151; GO:0003161; GO:0003171; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0005025; GO:0005524; GO:0005901; GO:0006955; GO:0007179; GO:0007389; GO:0007398; GO:0007399; GO:0007492; GO:0007507; GO:0009897; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010629; GO:0014032; GO:0014912; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048339; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0048598; GO:0048863; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0051216; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060412; GO:0060896; GO:0060914; GO:0060928; GO:0061626; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:2000772,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cartilage development [GO:0051216]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart development [GO:0007507]; heart formation [GO:0060914]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; neural plate pattern specification [GO:0060896]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm structural organization [GO:0048352]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell differentiation [GO:0048863]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025],"ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0002376; GO:0003824; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"immune system process; catalytic activity; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_08609,FUN_037756-T1,Peve_00014342,Pocillopora_meandrina_HIv1___RNAseq.27166_t,three_way,81.311,FUN_037756-T1,Q9D3W1,RSP14_MOUSE,,Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1),Mus musculus (Mouse),49.6,224.0,8.4e-52,205.3,sp|Q9D3W1|RSP14_MOUSE Radial spoke head 14 homolog OS=Mus musculus OX=10090 GN=Rsph14 PE=1 SV=1,GO:0001534; GO:0003351; GO:0005576; GO:0007618; GO:0030317; GO:0036126; GO:0097729,epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618],9+2 motile cilium [GO:0097729]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],,GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_08617,FUN_037768-T1,Peve_00014328,Pocillopora_meandrina_HIv1___RNAseq.g1480.t1,three_way,79.92966666666668,FUN_037768-T1,O35552,F263_RAT,,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",Rattus norvegicus (Rat),53.4,440.0,1.1000000000000001e-130,468.4,"sp|O35552|F263_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 OS=Rattus norvegicus OX=10116 GN=Pfkfb3 PE=2 SV=1",GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006096; GO:0006110; GO:0006915; GO:0010001; GO:0061744,"apoptotic process [GO:0006915]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; motor behavior [GO:0061744]; regulation of glycolytic process [GO:0006110]",cytosol [GO:0005829]; nucleoplasm [GO:0005654],"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; programmed cell death; transferase activity; hydrolase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08628,FUN_037796-T1,Peve_00026135,Pocillopora_meandrina_HIv1___RNAseq.g1556.t1,three_way,91.083,FUN_037796-T1,Q9CWF6,BBS2_MOUSE,,BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog),Mus musculus (Mouse),66.9,718.0,8.9e-285,980.7,sp|Q9CWF6|BBS2_MOUSE BBSome complex member BBS2 OS=Mus musculus OX=10090 GN=Bbs2 PE=1 SV=1,GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515,adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0003012; GO:0003013; GO:0005815; GO:0005929; GO:0007010; GO:0016192; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,muscle system process; circulatory system process; microtubule organizing center; cilium; cytoskeleton organization; vesicle-mediated transport; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_08636,FUN_037808-T1,Peve_00003982,Pocillopora_meandrina_HIv1___RNAseq.g1570.t1,three_way,66.05983333333333,FUN_037808-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.6,308.0,5.2e-66,253.4,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08637,FUN_037809-T1,Peve_00018926,Pocillopora_meandrina_HIv1___RNAseq.g1571.t1,three_way,92.06116666666668,FUN_037809-T1,Q99496,RING2_HUMAN,,E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2),Homo sapiens (Human),59.6,339.0,1.6e-98,360.9,sp|Q99496|RING2_HUMAN E3 ubiquitin-protein ligase RING2 OS=Homo sapiens OX=9606 GN=RNF2 PE=1 SV=1,GO:0000122; GO:0000151; GO:0000278; GO:0000791; GO:0001702; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0007281; GO:0008270; GO:0009948; GO:0010467; GO:0016567; GO:0016604; GO:0031519; GO:0035102; GO:0040029; GO:0043433; GO:0061630; GO:0071339; GO:0071535; GO:0140862,anterior/posterior axis specification [GO:0009948]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151],chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0000278; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08645,FUN_037836-T1,Peve_00000570,Pocillopora_meandrina_HIv1___RNAseq.g1460.t1,three_way,80.37733333333334,FUN_037836-T1,P12004,PCNA_HUMAN,,Proliferating cell nuclear antigen (PCNA) (Cyclin),Homo sapiens (Human),65.3,259.0,5e-100,365.5,sp|P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1,GO:0000122; GO:0000307; GO:0000701; GO:0000781; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0006325; GO:0007507; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990,"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0048856; GO:0098772; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; reproductive process; cell differentiation; telomere organization; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA"
OG_08678,FUN_037917-T1,Peve_00013499,Pocillopora_meandrina_HIv1___RNAseq.g26497.t1,three_way,94.88433333333332,FUN_037917-T1,Q8IVV7,GID4_HUMAN,,Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog),Homo sapiens (Human),79.3,188.0,5.6e-91,335.1,sp|Q8IVV7|GID4_HUMAN Glucose-induced degradation protein 4 homolog OS=Homo sapiens OX=9606 GN=GID4 PE=1 SV=1,GO:0000151; GO:0005829; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_08683,FUN_037923-T2,Peve_00004174,Pocillopora_meandrina_HIv1___RNAseq.g26228.t1,three_way,76.59416666666667,FUN_037923-T2,P51178,PLCD1_HUMAN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)",Homo sapiens (Human),30.7,792.0,1.8000000000000002e-86,322.4,"sp|P51178|PLCD1_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 OS=Homo sapiens OX=9606 GN=PLCD1 PE=1 SV=2",GO:0001786; GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0046488; GO:0070062; GO:0070300; GO:0141212,lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C/protein kinase C signal transduction [GO:0141212]; phospholipid metabolic process [GO:0006644],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phosphatidylserine binding [GO:0001786]",GO:0003824; GO:0005886; GO:0006629; GO:0008289; GO:0016787; GO:0043226,catalytic activity; plasma membrane; lipid metabolic process; lipid binding; hydrolase activity; organelle
OG_08720,FUN_037973-T1,Peve_00013891,Pocillopora_meandrina_HIv1___RNAseq.g26182.t1,three_way,74.1255,FUN_037973-T1,Q9UPN4,CP131_HUMAN,,Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1),Homo sapiens (Human),42.9,688.0,9.3e-66,253.8,sp|Q9UPN4|CP131_HUMAN Centrosomal protein of 131 kDa OS=Homo sapiens OX=9606 GN=CEP131 PE=1 SV=3,GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007288; GO:0008284; GO:0010824; GO:0015630; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042803; GO:0043231; GO:0044877; GO:0045171; GO:0060271; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953,cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288],acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212],protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006886; GO:0007010; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,microtubule organizing center; cytosol; cytoskeleton; cilium; intracellular protein transport; cytoskeleton organization; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_08734,FUN_037991-T1,Peve_00023489,Pocillopora_meandrina_HIv1___RNAseq.g26268.t1,three_way,49.46833333333333,FUN_037991-T1,Q9D666,SUN1_MOUSE,,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),Mus musculus (Mouse),45.6,206.0,2.7e-47,191.0,sp|Q9D666|SUN1_MOUSE SUN domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sun1 PE=1 SV=2,GO:0000781; GO:0002080; GO:0002081; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0016020; GO:0021817; GO:0034993; GO:0042802; GO:0051642; GO:0070197; GO:0090292; GO:0140444,centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283],"acrosomal membrane [GO:0002080]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]",cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521],GO:0005634; GO:0005635; GO:0007018; GO:0022414; GO:0043226; GO:0060090; GO:0061024,nucleus; nuclear envelope; microtubule-based movement; reproductive process; organelle; molecular adaptor activity; membrane organization
OG_08757,FUN_038028-T1,Peve_00002131,Pocillopora_meandrina_HIv1___TS.g19287.t1a,three_way,79.5965,FUN_038028-T1,Q80U30,CL16A_MOUSE,,Protein CLEC16A,Mus musculus (Mouse),42.5,1092.0,9.9e-206,718.8,sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2,GO:0006914; GO:0031648; GO:0032434; GO:0032435; GO:0036020; GO:0043161; GO:1901098; GO:1901525,autophagy [GO:0006914]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],endolysosome membrane [GO:0036020],,GO:0006914; GO:0030163,autophagy; protein catabolic process
OG_08793,FUN_038089-T1,Peve_00007107,Pocillopora_meandrina_HIv1___RNAseq.g816.t1,three_way,59.5495,FUN_038089-T1,P22981,LET60_CAEEL,,Ras protein let-60 (EC 3.6.5.2) (Abnormal cell lineage protein 34) (Lethal protein 60),Caenorhabditis elegans,31.4,169.0,7.5e-17,89.0,sp|P22981|LET60_CAEEL Ras protein let-60 OS=Caenorhabditis elegans OX=6239 GN=let-60 PE=1 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005886; GO:0005938; GO:0007173; GO:0007265; GO:0007517; GO:0007614; GO:0008306; GO:0019003; GO:0022414; GO:0031344; GO:0040026; GO:0040028; GO:0042659; GO:0043274; GO:0048477; GO:0072327; GO:0120283; GO:1902685,associative learning [GO:0008306]; epidermal growth factor receptor signaling pathway [GO:0007173]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of vulval development [GO:0040026]; Ras protein signal transduction [GO:0007265]; regulation of cell fate specification [GO:0042659]; regulation of cell projection organization [GO:0031344]; regulation of vulval development [GO:0040028]; reproductive process [GO:0022414]; short-term memory [GO:0007614]; vulval cell fate specification [GO:0072327],cell cortex [GO:0005938]; plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phospholipase binding [GO:0043274]; protein serine/threonine kinase binding [GO:0120283],GO:0003824; GO:0003924; GO:0005886; GO:0016787; GO:0022414; GO:0048856; GO:0050877,catalytic activity; GTPase activity; plasma membrane; hydrolase activity; reproductive process; anatomical structure development; nervous system process
OG_08815,FUN_038142-T1,Peve_00015889,Pocillopora_meandrina_HIv1___RNAseq.g755.t1,three_way,74.73966666666666,FUN_038142-T1,Q8IWF2,FXRD2_HUMAN,,FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation),Homo sapiens (Human),53.4,597.0,5.4e-181,636.0,sp|Q8IWF2|FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=FOXRED2 PE=1 SV=1,GO:0004497; GO:0005788; GO:0036503; GO:0050660,ERAD pathway [GO:0036503],endoplasmic reticulum lumen [GO:0005788],flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497],GO:0003824; GO:0016491; GO:0030163,catalytic activity; oxidoreductase activity; protein catabolic process
OG_08829,FUN_038166-T1,Peve_00025794,Pocillopora_meandrina_HIv1___RNAseq.g1069.t1,three_way,75.97183333333332,FUN_038166-T1,P85037,FOXK1_HUMAN,,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),Homo sapiens (Human),48.9,499.0,9.7e-110,399.1,sp|P85037|FOXK1_HUMAN Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837,canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005975; GO:0006091; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140110; GO:1901135,DNA binding; nucleus; nucleoplasm; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; transcription regulator activity; carbohydrate derivative metabolic process
OG_08833,FUN_038171-T1,Peve_00025782,Pocillopora_meandrina_HIv1___RNAseq.g1075.t1,three_way,73.20766666666667,FUN_038171-T1,Q3U829,AP5Z1_MOUSE,,AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5),Mus musculus (Mouse),37.1,528.0,6.7e-83,310.5,sp|Q3U829|AP5Z1_MOUSE AP-5 complex subunit zeta-1 OS=Mus musculus OX=10090 GN=Ap5z1 PE=2 SV=1,GO:0000045; GO:0000724; GO:0005634; GO:0005737; GO:0005764; GO:0005770; GO:0006886; GO:0006914; GO:0007030; GO:0007040; GO:0010467; GO:0016192; GO:0016197; GO:0016607; GO:0034499; GO:0044599; GO:0061564; GO:1905146,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon development [GO:0061564]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; late endosome to Golgi transport [GO:0034499]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear speck [GO:0016607]; nucleus [GO:0005634],,GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0006886; GO:0006914; GO:0007040; GO:0016192; GO:0030163; GO:0031410; GO:0043226,nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; intracellular protein transport; autophagy; lysosome organization; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle
OG_08836,FUN_038180-T1,Peve_00009434,Pocillopora_meandrina_HIv1___RNAseq.g964.t1,three_way,80.498,FUN_038180-T1,E3SCZ8,BIRC5_CAVPO,,Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor survivin),Cavia porcellus (Guinea pig),50.4,125.0,7.1e-31,134.8,sp|E3SCZ8|BIRC5_CAVPO Baculoviral IAP repeat-containing protein 5 OS=Cavia porcellus OX=10141 GN=BIRC5 PE=1 SV=1,GO:0000226; GO:0000775; GO:0000776; GO:0004869; GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0007059; GO:0007127; GO:0007346; GO:0007605; GO:0030496; GO:0043066; GO:0043524; GO:0046872; GO:0051233; GO:0051301; GO:0061178; GO:0061469,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiosis I [GO:0007127]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of mitotic cell cycle [GO:0007346]; regulation of type B pancreatic cell proliferation [GO:0061469]; sensory perception of sound [GO:0007605],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]",cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872],GO:0005634; GO:0007010; GO:0007059; GO:0012501; GO:0022414; GO:0043226; GO:0050877; GO:0098772; GO:0140013,nucleus; cytoskeleton organization; chromosome segregation; programmed cell death; reproductive process; organelle; nervous system process; molecular function regulator activity; meiotic nuclear division
OG_08837,FUN_038181-T1,Peve_00009435,Pocillopora_meandrina_HIv1___TS.g5496.t3,three_way,80.30433333333333,FUN_038181-T1,Q8TAT6,NPL4_HUMAN,,Nuclear protein localization protein 4 homolog (Protein NPL4),Homo sapiens (Human),53.6,616.0,7.4e-203,708.4,sp|Q8TAT6|NPL4_HUMAN Nuclear protein localization protein 4 homolog OS=Homo sapiens OX=9606 GN=NPLOC4 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0051117; GO:0070530,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006886; GO:0030163; GO:0043226,nucleus; nucleoplasm; endoplasmic reticulum; cytosol; intracellular protein transport; protein catabolic process; organelle
OG_08853,FUN_038218-T1,Peve_00038844,Pocillopora_meandrina_HIv1___RNAseq.g902.t1,three_way,77.83533333333334,FUN_038218-T1,Q08BA6,ALKB5_DANRE,,RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),Danio rerio (Zebrafish) (Brachydanio rerio),59.5,222.0,1.7999999999999996e-68,260.8,sp|Q08BA6|ALKB5_DANRE RNA demethylase ALKBH5 OS=Danio rerio OX=7955 GN=alkbh5 PE=1 SV=1,GO:0001666; GO:0005634; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0035515; GO:0042382; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931,membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283],nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515],GO:0003824; GO:0005634; GO:0016071; GO:0016491; GO:0022414; GO:0043226; GO:0060090; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; oxidoreductase activity; reproductive process; organelle; molecular adaptor activity; catalytic activity, acting on RNA"
OG_08869,FUN_038265-T1,Peve_00007997,Pocillopora_meandrina_HIv1___RNAseq.g914.t1,three_way,86.61366666666667,FUN_038265-T1,A6HD62,CHIP_RAT,,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),Rattus norvegicus (Rat),58.4,238.0,7.000000000000001e-75,282.0,sp|A6HD62|CHIP_RAT E3 ubiquitin-protein ligase CHIP OS=Rattus norvegicus OX=10116 GN=Stub1 PE=1 SV=1,GO:0000151; GO:0000165; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006513; GO:0006515; GO:0010614; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030512; GO:0030544; GO:0030911; GO:0030968; GO:0031072; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032436; GO:0034392; GO:0034393; GO:0034450; GO:0034605; GO:0035359; GO:0036503; GO:0042405; GO:0042803; GO:0043066; GO:0043161; GO:0045862; GO:0046332; GO:0050821; GO:0051087; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070412; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031; GO:1901526; GO:1904294; GO:1904694,cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018],enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003013; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006914; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"circulatory system process; catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; DNA repair; autophagy; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08879,FUN_038279-T1,Peve_00041709,Pocillopora_meandrina_HIv1___RNAseq.g28314.t1,three_way,89.11583333333333,FUN_038279-T1,Q4G0X9,CCD40_HUMAN,,Coiled-coil domain-containing protein 40,Homo sapiens (Human),30.7,969.0,3.8e-100,367.9,sp|Q4G0X9|CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2,GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0031514; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0061512; GO:0070286; GO:0071907; GO:0071910,axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514],,GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003,extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly
OG_08883,FUN_038285-T1,Peve_00041722,Pocillopora_meandrina_HIv1___RNAseq.g28309.t1a,three_way,84.59233333333333,FUN_038285-T1,A7SE05,UBE2S_NEMVE,,Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S),Nematostella vectensis (Starlet sea anemone),74.8,206.0,2.1e-82,306.6,sp|A7SE05|UBE2S_NEMVE Ubiquitin-conjugating enzyme E2 S OS=Nematostella vectensis OX=45351 GN=v1g237158 PE=3 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08884,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_08917,FUN_038373-T1,Peve_00000079,Pocillopora_meandrina_HIv1___RNAseq.g1092.t1,three_way,85.541,FUN_038373-T1,Q9UBX3,DIC_HUMAN,,Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10),Homo sapiens (Human),58.7,286.0,3.7e-91,336.3,sp|Q9UBX3|DIC_HUMAN Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 GN=SLC25A10 PE=1 SV=2,GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006869; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0046166; GO:0070221; GO:0071422; GO:0071423; GO:1902358,"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; monoatomic ion transport [GO:0006811]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transmembrane transport [GO:1902358]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117],GO:0005215; GO:0005634; GO:0005654; GO:0005739; GO:0005975; GO:0006790; GO:0043226; GO:0055085; GO:1901135,transporter activity; nucleus; nucleoplasm; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; organelle; transmembrane transport; carbohydrate derivative metabolic process
OG_08953,FUN_038427-T1,Peve_00000113,Pocillopora_meandrina_HIv1___RNAseq.g1177.t1,three_way,70.89833333333333,FUN_038427-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),41.5,82.0,9.1e-08,59.3,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08955,FUN_038430-T1,Peve_00000108,Pocillopora_meandrina_HIv1___RNAseq.g1061.t1,three_way,76.83583333333334,FUN_038430-T1,Q6P4S8,INT1_MOUSE,,Integrator complex subunit 1 (Int1),Mus musculus (Mouse),39.8,2366.0,0.0,1481.8,sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2,GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240,blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; U2 snRNA 3'-end processing [GO:0034474],INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634],,GO:0005634; GO:0016073; GO:0022414; GO:0043226,nucleus; snRNA metabolic process; reproductive process; organelle
OG_08963,FUN_038457-T1,Peve_00032632,Pocillopora_meandrina_HIv1___RNAseq.g28255.t1,three_way,73.14583333333333,FUN_038457-T1,Q8R0H9,GGA1_MOUSE,,"ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)",Mus musculus (Mouse),40.6,712.0,5.1e-115,416.8,sp|Q8R0H9|GGA1_MOUSE ADP-ribosylation factor-binding protein GGA1 OS=Mus musculus OX=10090 GN=Gga1 PE=1 SV=1,GO:0005654; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006893; GO:0008104; GO:0030163; GO:0031267; GO:0031901; GO:0032991; GO:0034394; GO:0035091; GO:0042147; GO:0043001; GO:0043130; GO:0045732; GO:1903441,"Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802],phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130],GO:0005654; GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0030163; GO:0031410; GO:0043226; GO:0072659,nucleoplasm; endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle; protein localization to plasma membrane
OG_08964,FUN_038464-T1,Peve_00010728,Pocillopora_meandrina_HIv1___RNAseq.g28234.t1,three_way,87.458,FUN_038464-T1,P14604,ECHM_RAT,,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)",Rattus norvegicus (Rat),65.4,295.0,1.3e-101,370.9,"sp|P14604|ECHM_RAT Enoyl-CoA hydratase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Echs1 PE=1 SV=1",GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092,fatty acid beta-oxidation [GO:0006635],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; crotonyl-CoA hydratase activity [GO:0120092]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300],GO:0003824; GO:0005739; GO:0006629; GO:0016829; GO:0016853; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; lyase activity; isomerase activity; organelle
OG_08970,FUN_038475-T1,Peve_00013533,Pocillopora_meandrina_HIv1___RNAseq.g28226.t1,three_way,95.814,FUN_038475-T1,Q8BS45,IFT56_MOUSE,,Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26),Mus musculus (Mouse),80.8,557.0,3.3999999999999995e-271,935.3,sp|Q8BS45|IFT56_MOUSE Intraflagellar transport protein 56 OS=Mus musculus OX=10090 GN=Ift56 PE=1 SV=1,GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0046530; GO:0060271; GO:0061512; GO:0120170; GO:1905198,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005],intraciliary transport particle B binding [GO:0120170],GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development
OG_08997,FUN_038533-T1,Peve_00013531,Pocillopora_meandrina_HIv1___RNAseq.g28191.t1,three_way,83.86566666666667,FUN_038533-T1,O00116,ADAS_HUMAN,,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",Homo sapiens (Human),58.7,623.0,3.6e-226,785.8,"sp|O00116|ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1",GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949,ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; transferase activity; organelle
OG_08998,FUN_038535-T1,Peve_00009817,Pocillopora_meandrina_HIv1___TS.g7943.t1,three_way,65.10233333333333,FUN_038535-T1,Q9JIA7,SPHK2_MOUSE,,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),Mus musculus (Mouse),34.2,547.0,3.6e-73,277.3,sp|Q9JIA7|SPHK2_MOUSE Sphingosine kinase 2 OS=Mus musculus OX=10090 GN=Sphk2 PE=1 SV=2,GO:0000786; GO:0001568; GO:0002720; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008283; GO:0008284; GO:0008481; GO:0016020; GO:0017050; GO:0030308; GO:0032736; GO:0032755; GO:0032760; GO:0033008; GO:0035556; GO:0038036; GO:0042393; GO:0043065; GO:0043122; GO:0043306; GO:0045815; GO:0046512; GO:1903426; GO:1904628; GO:1904959; GO:2000304; GO:2001169,blood vessel development [GO:0001568]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; female pregnancy [GO:0007565]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; histone binding [GO:0042393]; sphingosine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006325; GO:0006629; GO:0016740; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0060089,catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; plasma membrane; chromatin organization; lipid metabolic process; transferase activity; reproductive process; histone binding; organelle; anatomical structure development; molecular transducer activity
OG_09086,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_09127,FUN_039433-T1,Peve_00012689,Pocillopora_meandrina_HIv1___RNAseq.g15609.t1,three_way,76.06366666666666,FUN_039433-T1,Q9D411,TSSK4_MOUSE,,Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1),Mus musculus (Mouse),45.5,191.0,2.9999999999999996e-42,173.3,sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus OX=10090 GN=Tssk4 PE=1 SV=1,GO:0000287; GO:0001669; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0031514; GO:0032793; GO:0036126; GO:0042802; GO:0042803; GO:0044877; GO:0106310; GO:1990443,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005929; GO:0006355; GO:0007018; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cilium; regulation of DNA-templated transcription; microtubule-based movement; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09128,FUN_039434-T1,Peve_00012688,Pocillopora_meandrina_HIv1___RNAseq.g15607.t1,three_way,52.38966666666666,FUN_039434-T1,Q27312,NADA_APLKU,,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase),Aplysia kurodai (Kuroda's sea hare),36.9,260.0,1.9e-40,167.9,sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1,GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809,positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]",GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0016829; GO:0022414; GO:0031410; GO:0043226,catalytic activity; plasma membrane; transferase activity; hydrolase activity; lyase activity; reproductive process; cytoplasmic vesicle; organelle
OG_09198,FUN_039883-T1,Peve_00011734,Pocillopora_meandrina_HIv1___RNAseq.g7356.t1,three_way,74.50316666666667,FUN_039883-T1,Q6GQB9,EDEM3_XENLA,,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",Xenopus laevis (African clawed frog),59.0,761.0,5.3e-264,912.1,sp|Q6GQB9|EDEM3_XENLA ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Xenopus laevis OX=8355 GN=edem3 PE=2 SV=2,GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0030968; GO:0044322; GO:0097466; GO:1904380,carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_09200,FUN_039885-T1,Peve_00021850,Pocillopora_meandrina_HIv1___TS.g1125.t1,three_way,87.84066666666666,FUN_039885-T1,D3Z902,FBXW7_RAT,,F-box/WD repeat-containing protein 7,Rattus norvegicus (Rat),61.1,216.0,4.6e-73,277.3,sp|D3Z902|FBXW7_RAT F-box/WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxw7 PE=1 SV=2,GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005694; GO:0005730; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; chromosome; nucleolus; mitochondrion; endoplasmic reticulum; Golgi apparatus; DNA repair; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_09228,FUN_039965-T1,Peve_00039032,Pocillopora_meandrina_HIv1___RNAseq.g7516.t1,three_way,86.89633333333333,FUN_039965-T1,P28700,RXRA_MOUSE,,Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha),Mus musculus (Mouse),37.9,340.0,1.9999999999999998e-53,211.1,sp|P28700|RXRA_MOUSE Retinoic acid receptor RXR-alpha OS=Mus musculus OX=10090 GN=Rxra PE=1 SV=1,GO:0000122; GO:0000977; GO:0000978; GO:0001162; GO:0001223; GO:0001701; GO:0001890; GO:0001893; GO:0002157; GO:0003007; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0006355; GO:0006357; GO:0007507; GO:0007566; GO:0008270; GO:0009755; GO:0010467; GO:0010629; GO:0030501; GO:0031490; GO:0042789; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0045994; GO:0048384; GO:0055007; GO:0055010; GO:0055012; GO:0060038; GO:0060485; GO:0060528; GO:0060687; GO:0060978; GO:0061032; GO:0070564; GO:0090575,angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; camera-type eye development [GO:0043010]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hormone-mediated signaling pathway [GO:0009755]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; mesenchyme development [GO:0060485]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of thyroid hormone receptor signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation by iron [GO:0045994]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral serous pericardium development [GO:0061032],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016071; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09232,FUN_039973-T1,Peve_00000409,Pocillopora_meandrina_HIv1___RNAseq.g7541.t1,three_way,75.81366666666666,FUN_039973-T1,A0A1L8GVF0,RA50S_XENLA,,DNA repair protein RAD50.S (EC 3.6.-.-),Xenopus laevis (African clawed frog),38.8,1313.0,5.3e-182,640.2,sp|A0A1L8GVF0|RA50S_XENLA DNA repair protein RAD50.S OS=Xenopus laevis OX=8355 GN=rad50.S PE=1 SV=1,GO:0000722; GO:0000729; GO:0000781; GO:0000794; GO:0003691; GO:0005524; GO:0006302; GO:0007004; GO:0016887; GO:0030870; GO:0035861; GO:0043047; GO:0043539; GO:0046872; GO:0051310; GO:0051880; GO:0062176; GO:0070192; GO:0110025,chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein serine/threonine kinase activator activity [GO:0043539]; single-stranded telomeric DNA binding [GO:0043047],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity
OG_09240,FUN_040028-T1,Peve_00004957,Pocillopora_meandrina_HIv1___RNAseq.g8435.t1,three_way,50.78683333333333,FUN_040028-T1,Q8C1B2,PARPT_MOUSE,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase),Mus musculus (Mouse),32.0,453.0,8.3e-47,190.3,sp|Q8C1B2|PARPT_MOUSE Protein mono-ADP-ribosyltransferase TIPARP OS=Mus musculus OX=10090 GN=Tiparp PE=2 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09242,FUN_040031-T1,Peve_00025983,Pocillopora_meandrina_HIv1___RNAseq.g8450.t1,three_way,77.15466666666667,FUN_040031-T1,Q5T1B0,AXDN1_HUMAN,,Axonemal dynein light chain domain-containing protein 1,Homo sapiens (Human),29.0,1055.0,1.3e-109,399.4,sp|Q5T1B0|AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=AXDND1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0036064; GO:1905198,manchette assembly [GO:1905198]; spermatogenesis [GO:0007283],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829],,GO:0005815; GO:0005829; GO:0005929; GO:0022414; GO:0043226,microtubule organizing center; cytosol; cilium; reproductive process; organelle
OG_09266,FUN_040071-T1,Peve_00021006,Pocillopora_meandrina_HIv1___RNAseq.g7693.t1,three_way,74.35883333333334,FUN_040071-T1,P17439,GBA1_MOUSE,,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Mus musculus (Mouse),48.2,500.0,5.9999999999999985e-140,499.2,sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1,GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295],GO:0002376; GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006091; GO:0006629; GO:0006914; GO:0007005; GO:0007040; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:1901135,immune system process; catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; generation of precursor metabolites and energy; lipid metabolic process; autophagy; mitochondrion organization; lysosome organization; programmed cell death; transferase activity; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; cell motility; nervous system process; carbohydrate derivative metabolic process
OG_09285,FUN_040106-T1,Peve_00037279,Pocillopora_meandrina_HIv1___RNAseq.g8725.t1,three_way,92.27733333333332,FUN_040106-T1,Q9R1A8,COP1_MOUSE,,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Mus musculus (Mouse),62.3,648.0,1.5e-230,800.4,sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2,GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09286,FUN_040107-T1,Peve_00037281,Pocillopora_meandrina_HIv1___RNAseq.g8724.t1,three_way,86.47783333333334,FUN_040107-T1,Q0VCX2,BIP_BOVIN,,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),Bos taurus (Bovine),83.2,637.0,9.8e-294,1010.4,sp|Q0VCX2|BIP_BOVIN Endoplasmic reticulum chaperone BiP OS=Bos taurus OX=9913 GN=HSPA5 PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030291; GO:0030335; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034663; GO:0035437; GO:0036503; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0051085; GO:0051787; GO:0071353; GO:0140662; GO:1903895; GO:1903898,"cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]",cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006886; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0098772; GO:0140657,catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; protein folding; intracellular protein transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_09301,FUN_040154-T1,Peve_00038141,Pocillopora_meandrina_HIv1___RNAseq.g8495.t1,three_way,69.84266666666667,FUN_040154-T1,Q3UHC7,DAB2P_MOUSE,,Disabled homolog 2-interacting protein (DAB2-interacting protein) (ASK-interacting protein 1) (DOC-2/DAB-2 interactive protein),Mus musculus (Mouse),30.2,1068.0,1.5e-116,422.5,sp|Q3UHC7|DAB2P_MOUSE Disabled homolog 2-interacting protein OS=Mus musculus OX=10090 GN=Dab2ip PE=1 SV=1,GO:0000122; GO:0001525; GO:0005096; GO:0005123; GO:0005737; GO:0005886; GO:0006954; GO:0006986; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0016525; GO:0017124; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032266; GO:0032809; GO:0033209; GO:0034144; GO:0034260; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0042177; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043123; GO:0043124; GO:0043184; GO:0043254; GO:0043409; GO:0043410; GO:0043539; GO:0043548; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0048147; GO:0048812; GO:0050679; GO:0050680; GO:0051721; GO:0051726; GO:0051898; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071889; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1990032; GO:1990597; GO:2001224; GO:2001235,angiogenesis [GO:0001525]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cell cycle [GO:0051726]; regulation of GTPase activity [GO:0043087]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886],14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184],GO:0002376; GO:0005886; GO:0006355; GO:0006954; GO:0008289; GO:0030163; GO:0031410; GO:0043226; GO:0048870; GO:0060090; GO:0098542; GO:0098772,immune system process; plasma membrane; regulation of DNA-templated transcription; inflammatory response; lipid binding; protein catabolic process; cytoplasmic vesicle; organelle; cell motility; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_09303,FUN_040171-T1,Peve_00038130,Pocillopora_meandrina_HIv1___RNAseq.g7735.t1,three_way,58.53033333333333,FUN_040171-T1,A2RUS2,DEND3_HUMAN,,DENN domain-containing protein 3,Homo sapiens (Human),25.9,1218.0,7.5e-110,401.0,sp|A2RUS2|DEND3_HUMAN DENN domain-containing protein 3 OS=Homo sapiens OX=9606 GN=DENND3 PE=1 SV=2,GO:0005085; GO:0005829; GO:0008333; GO:0030163; GO:0031410; GO:0032483,endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0016192; GO:0030163; GO:0031410; GO:0043226; GO:0098772,cytosol; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09332,FUN_040271-T1,Peve_00014976,Pocillopora_meandrina_HIv1___RNAseq.g7810.t1,three_way,81.51333333333334,FUN_040271-T1,P36776,LONM_HUMAN,,"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)",Homo sapiens (Human),65.2,838.0,0.0,1104.0,"sp|P36776|LONM_HUMAN Lon protease homolog, mitochondrial OS=Homo sapiens OX=9606 GN=LONP1 PE=1 SV=2",GO:0000002; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0030163; GO:0032042; GO:0034599; GO:0035694; GO:0042645; GO:0042731; GO:0042802; GO:0043531; GO:0043560; GO:0043565; GO:0046627; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407,cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]; negative regulation of insulin receptor signaling pathway [GO:0046627]; oxidation-dependent protein catabolic process [GO:0070407]; protein catabolic process [GO:0030163]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; PH domain binding [GO:0042731]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0007005; GO:0016787; GO:0030163; GO:0043226; GO:0065003; GO:0140096; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; mitochondrion; cytosol; mitochondrion organization; hydrolase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; ATP-dependent activity"
OG_09346,FUN_040329-T1,Peve_00014960,Pocillopora_meandrina_HIv1___TS.g20804.t1,three_way,59.10066666666667,FUN_040329-T1,Q96JI7,SPTCS_HUMAN,,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),Homo sapiens (Human),27.8,1418.0,1.1e-133,480.3,sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3,GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256,autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein kinase binding [GO:0019901],GO:0005730; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0007018; GO:0007040; GO:0012501; GO:0023052; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,nucleolus; endoplasmic reticulum; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; microtubule-based movement; lysosome organization; programmed cell death; signaling; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_09370,FUN_040494-T1,Peve_00015399,Pocillopora_meandrina_HIv1___RNAseq.g6530.t1c,three_way,67.13566666666667,FUN_040494-T1,Q9D2E1,TSSK3_MOUSE,,Testis-specific serine/threonine-protein kinase 3 (TSK-3) (TSSK-3) (Testis-specific kinase 3) (EC 2.7.11.1) (Serine/threonine-protein kinase 22C),Mus musculus (Mouse),48.7,224.0,4.2e-56,219.9,sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus OX=10090 GN=Tssk3 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0007286; GO:0030145; GO:0035556; GO:0036126; GO:0048240; GO:0106310,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; sperm capacitation [GO:0048240]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],sperm flagellum [GO:0036126],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005929; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cilium; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09438,FUN_041410-T1,Peve_00017540,Pocillopora_meandrina_HIv1___RNAseq.g15731.t1,three_way,64.53566666666667,FUN_041410-T1,Q95241,A4_SAISC,,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],Saimiri sciureus (Common squirrel monkey),24.4,737.0,3.4e-45,184.5,sp|Q95241|A4_SAISC Amyloid-beta precursor protein OS=Saimiri sciureus OX=9521 GN=APP PE=2 SV=1,GO:0003677; GO:0004867; GO:0005102; GO:0005576; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005905; GO:0006417; GO:0006878; GO:0006897; GO:0006915; GO:0007155; GO:0007219; GO:0007409; GO:0007417; GO:0007617; GO:0007626; GO:0008088; GO:0008201; GO:0008344; GO:0008542; GO:0009986; GO:0016020; GO:0016199; GO:0016322; GO:0016358; GO:0030198; GO:0030424; GO:0030426; GO:0030546; GO:0031175; GO:0035235; GO:0040014; GO:0043204; GO:0045121; GO:0045931; GO:0046914; GO:0048669; GO:0050803; GO:0055037,adult locomotory behavior [GO:0008344]; apoptotic process [GO:0006915]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; collateral sprouting in absence of injury [GO:0048669]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of multicellular organism growth [GO:0040014]; regulation of synapse structure or activity [GO:0050803]; regulation of translation [GO:0006417]; visual learning [GO:0008542],axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],DNA binding [GO:0003677]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914],GO:0003677; GO:0005576; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0007018; GO:0007155; GO:0012501; GO:0016192; GO:0022414; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0098772,DNA binding; extracellular region; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; microtubule-based movement; cell adhesion; programmed cell death; vesicle-mediated transport; reproductive process; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_09470,FUN_041495-T1,Peve_00017070,Pocillopora_meandrina_HIv1___RNAseq.g15663.t1,three_way,63.118,FUN_041495-T1,Q9H1I8,ASCC2_HUMAN,,Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100),Homo sapiens (Human),41.7,769.0,1.1e-126,455.7,sp|Q9H1I8|ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens OX=9606 GN=ASCC2 PE=1 SV=3,GO:0005634; GO:0005654; GO:0006307; GO:0006355; GO:0016607; GO:0022626; GO:0032790; GO:0043130; GO:0070530; GO:0072344; GO:0180022; GO:1990116; GO:1990391,DNA alkylation repair [GO:0006307]; regulation of DNA-templated transcription [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosolic ribosome [GO:0022626]; DNA repair complex [GO:1990391]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130],GO:0005634; GO:0005654; GO:0005840; GO:0006281; GO:0006355; GO:0030163; GO:0043226,nucleus; nucleoplasm; ribosome; DNA repair; regulation of DNA-templated transcription; protein catabolic process; organelle
OG_09475,FUN_041502-T1,Peve_00021434,Pocillopora_meandrina_HIv1___RNAseq.g15963.t1,three_way,73.652,FUN_041502-T1,Q62623,CDC20_RAT,,Cell division cycle protein 20 homolog (p55CDC),Rattus norvegicus (Rat),51.9,507.0,4.5e-129,463.0,sp|Q62623|CDC20_RAT Cell division cycle protein 20 homolog OS=Rattus norvegicus OX=10116 GN=Cdc20 PE=1 SV=2,GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1904146; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; reproductive process; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_09498,FUN_041540-T1,Peve_00007703,Pocillopora_meandrina_HIv1___RNAseq.g15651.t1,three_way,66.28366666666666,FUN_041540-T1,P51521,OVO_DROME,,Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)],Drosophila melanogaster (Fruit fly),66.4,128.0,4.1e-08,60.8,sp|P51521|OVO_DROME Transcriptional regulator ovo OS=Drosophila melanogaster OX=7227 GN=ovo PE=1 SV=2,GO:0000122; GO:0000978; GO:0000981; GO:0001223; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007010; GO:0008270; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0032196; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048067; GO:0048477; GO:1990837,adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09509,FUN_041557-T1,Peve_00033125,Pocillopora_meandrina_HIv1___RNAseq.g16079.t1,three_way,82.36866666666667,FUN_041557-T1,F1LP64,TRIPC_RAT,,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),Rattus norvegicus (Rat),52.2,1669.0,0.0,1587.8,sp|F1LP64|TRIPC_RAT E3 ubiquitin-protein ligase TRIP12 OS=Rattus norvegicus OX=10116 GN=Trip12 PE=1 SV=1,GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09510,FUN_041562-T1,Peve_00033130,Pocillopora_meandrina_HIv1___RNAseq.g16036.t1,three_way,88.02866666666667,FUN_041562-T1,Q93008,USP9X_HUMAN,,"Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",Homo sapiens (Human),61.0,2508.0,0.0,2993.4,sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4,GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380,"amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]",centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634],co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006281; GO:0006355; GO:0007059; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096; GO:0140313,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; DNA repair; regulation of DNA-templated transcription; chromosome segregation; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein; molecular sequestering activity"
OG_09575,FUN_041710-T1,Peve_00021477,Pocillopora_meandrina_HIv1___RNAseq.g13976.t1,three_way,87.94433333333333,FUN_041710-T1,Q91ZA3,PCCA_MOUSE,,"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)",Mus musculus (Mouse),62.9,642.0,5.4e-229,795.4,"sp|Q91ZA3|PCCA_MOUSE Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Mus musculus OX=10090 GN=Pcca PE=1 SV=2",GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0019899; GO:0046872; GO:1902494,lipid catabolic process [GO:0016042],catalytic complex [GO:1902494]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],GO:0003824; GO:0005739; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; ligase activity; organelle
OG_09578,FUN_041713-T1,Peve_00001623,Pocillopora_meandrina_HIv1___RNAseq.g13949.t1,three_way,68.122,FUN_041713-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),65.5,194.0,1.2e-14,81.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_09579,FUN_041717-T1,Peve_00024455,Pocillopora_meandrina_HIv1___RNAseq.g13945.t1,three_way,63.239333333333335,FUN_041717-T1,O43543,XRCC2_HUMAN,,DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2),Homo sapiens (Human),35.3,252.0,5.1e-35,149.4,sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1,GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269,centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756],centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677],GO:0000278; GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"mitotic cell cycle; DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09583,FUN_041721-T1,Peve_00020371,Pocillopora_meandrina_HIv1___RNAseq.g13941.t1,three_way,81.38799999999999,FUN_041721-T1,Q61205,PA1B3_MOUSE,,Platelet-activating factor acetylhydrolase IB subunit alpha1 (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma),Mus musculus (Mouse),54.5,165.0,4.8e-51,202.2,sp|Q61205|PA1B3_MOUSE Platelet-activating factor acetylhydrolase IB subunit alpha1 OS=Mus musculus OX=10090 GN=Pafah1b3 PE=1 SV=1,GO:0003847; GO:0005737; GO:0007283; GO:0008247; GO:0016042; GO:0042803; GO:0044877; GO:0046982; GO:0047179,lipid catabolic process [GO:0016042]; spermatogenesis [GO:0007283],1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737],1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0006629; GO:0016740; GO:0016787; GO:0022414,catalytic activity; lipid metabolic process; transferase activity; hydrolase activity; reproductive process
OG_09606,FUN_041760-T1,Peve_00041568,Pocillopora_meandrina_HIv1___RNAseq.g15241.t1,three_way,74.42366666666666,FUN_041760-T1,A6H7H7,FBX3_BOVIN,,F-box only protein 3,Bos taurus (Bovine),45.3,391.0,5.5e-96,352.8,sp|A6H7H7|FBX3_BOVIN F-box only protein 3 OS=Bos taurus OX=9913 GN=FBXO3 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032496; GO:1990756,protein ubiquitination [GO:0016567]; response to lipopolysaccharide [GO:0032496]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0030163; GO:0043226; GO:0060090,nucleus; protein catabolic process; organelle; molecular adaptor activity
OG_09624,FUN_041788-T1,Peve_00038539,Pocillopora_meandrina_HIv1___RNAseq.g15771.t1,three_way,71.78066666666666,FUN_041788-T1,Q8BX90,FND3A_MOUSE,,Fibronectin type-III domain-containing protein 3A,Mus musculus (Mouse),35.3,996.0,1.6e-163,578.6,sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3,GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609,cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506],,GO:0005829; GO:0007155; GO:0022414; GO:0031410; GO:0043226; GO:0048856,cytosol; cell adhesion; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development
OG_09626,FUN_041790-T1,Peve_00038533,Pocillopora_meandrina_HIv1___RNAseq.g15769.t1,three_way,61.01483333333333,FUN_041790-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),30.0,1013.0,6.7e-112,407.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09656,FUN_041861-T1,Peve_00030447,Pocillopora_meandrina_HIv1___RNAseq.g15124.t1,three_way,98.80966666666669,FUN_041861-T1,P62333,PRS10_HUMAN,,26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),Homo sapiens (Human),86.2,385.0,1e-189,664.1,sp|P62333|PRS10_HUMAN 26S proteasome regulatory subunit 10B OS=Homo sapiens OX=9606 GN=PSMC6 PE=1 SV=1,GO:0000502; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016234; GO:0016887; GO:0022624; GO:0030674; GO:0031597; GO:0036402; GO:0036503; GO:0042802; GO:0043161; GO:0045899; GO:0070062; GO:0090261; GO:1901800,ERAD pathway [GO:0036503]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; protein catabolic process; organelle; molecular adaptor activity; ATP-dependent activity
OG_09657,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_09663,FUN_041874-T1,Peve_00040563,Pocillopora_meandrina_HIv1___RNAseq.g15106.t3,three_way,72.21516666666666,FUN_041874-T1,P49959,MRE11_HUMAN,,Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),Homo sapiens (Human),55.2,538.0,4.6e-166,586.3,sp|P49959|MRE11_HUMAN Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3,GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008283; GO:0008296; GO:0008408; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0062176; GO:0070533; GO:0097552; GO:0098687; GO:0110025; GO:2000781; GO:2001033,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; cadherin binding [GO:0045296]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; catalytic activity, acting on DNA"
OG_09664,FUN_041875-T1,Peve_00040575,Pocillopora_meandrina_HIv1___RNAseq.g15107.t1,three_way,97.13533333333334,FUN_041875-T1,P49841,GSK3B_HUMAN,,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),Homo sapiens (Human),88.7,212.0,1.4000000000000003e-111,403.7,sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2,GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0003170; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007005; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030154; GO:0030336; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031398; GO:0031625; GO:0032007; GO:0032092; GO:0032436; GO:0032886; GO:0034236; GO:0034452; GO:0034976; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043525; GO:0045597; GO:0045668; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060070; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097110; GO:0097191; GO:0097192; GO:0098793; GO:0098794; GO:0098978; GO:0099171; GO:0106027; GO:0106310; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904339; GO:1904646; GO:1904781; GO:1990909; GO:2000077; GO:2000466; GO:2000740,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; response to endoplasmic reticulum stress [GO:0034976]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0007005; GO:0007163; GO:0008092; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; mitochondrion organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_09665,FUN_041877-T1,Peve_00000883,Pocillopora_meandrina_HIv1___TS.g10136.t1,three_way,95.18533333333332,FUN_041877-T1,B5DF89,CUL3_RAT,,Cullin-3,Rattus norvegicus (Rat),75.7,760.0,0.0,1124.4,sp|B5DF89|CUL3_RAT Cullin-3 OS=Rattus norvegicus OX=10116 GN=Cul3 PE=1 SV=2,GO:0000122; GO:0000209; GO:0000278; GO:0000902; GO:0000922; GO:0001701; GO:0001822; GO:0001831; GO:0005112; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005886; GO:0006357; GO:0006511; GO:0006513; GO:0006888; GO:0006954; GO:0007080; GO:0007229; GO:0007369; GO:0010467; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030163; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0032480; GO:0034599; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070936; GO:0071230; GO:0071630; GO:0072576; GO:0072686; GO:0098794; GO:0098978; GO:0140252; GO:0160072; GO:1900076; GO:1901992; GO:1904263,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cellular response to amino acid stimulus [GO:0071230]; cellular response to oxidative stress [GO:0034599]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon production [GO:0032480]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation protein catabolic process at postsynapse [GO:0140252]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0003824; GO:0005634; GO:0005794; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0006954; GO:0007010; GO:0012501; GO:0016192; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0065003; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; Golgi apparatus; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; inflammatory response; cytoskeleton organization; programmed cell death; vesicle-mediated transport; transferase activity; protein catabolic process; organelle; anatomical structure development; cell motility; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_09681,FUN_041906-T1,Peve_00007893,Pocillopora_meandrina_HIv1___RNAseq.g15370.t2,three_way,66.65266666666666,FUN_041906-T1,Q8TEB9,RHBL4_HUMAN,,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),Homo sapiens (Human),41.0,300.0,2.9e-57,224.2,sp|Q8TEB9|RHBL4_HUMAN Rhomboid-related protein 4 OS=Homo sapiens OX=9606 GN=RHBDD1 PE=1 SV=1,GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211,"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966],endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005783; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; programmed cell death; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09682,FUN_041907-T1,Peve_00007890,Pocillopora_meandrina_HIv1___TS.g10677.t1,three_way,73.91533333333334,FUN_041907-T1,Q64560,TPP2_RAT,,Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II),Rattus norvegicus (Rat),51.1,1253.0,0.0,1293.9,sp|Q64560|TPP2_RAT Tripeptidyl-peptidase 2 OS=Rattus norvegicus OX=10116 GN=Tpp2 PE=2 SV=3,GO:0004177; GO:0004252; GO:0005634; GO:0005829; GO:0006508; GO:0008240; GO:0030163; GO:0042277; GO:0042802; GO:0080144,intracellular amino acid homeostasis [GO:0080144]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cytosol [GO:0005829]; nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09702,FUN_041933-T1,Peve_00023581,Pocillopora_meandrina_HIv1___RNAseq.g15700.t1,three_way,61.377,FUN_041933-T1,P52594,AGFG1_HUMAN,,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),Homo sapiens (Human),57.9,183.0,3.4e-54,214.9,sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109,acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643],DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005829; GO:0006913; GO:0007010; GO:0022414; GO:0031410; GO:0043226; GO:0098772,DNA binding; RNA binding; cytosol; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09717,FUN_041963-T1,Peve_00043506,Pocillopora_meandrina_HIv1___RNAseq.g15912.t1,three_way,78.311,FUN_041963-T1,O35547,ACSL4_RAT,,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4),Rattus norvegicus (Rat),53.7,706.0,2.6e-220,766.5,sp|O35547|ACSL4_RAT Long-chain-fatty-acid--CoA ligase 4 OS=Rattus norvegicus OX=10116 GN=Acsl4 PE=1 SV=2,GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0030182; GO:0031957; GO:0031966; GO:0032024; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672,dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005739; GO:0005777; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0006790; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140657,catalytic activity; mitochondrion; peroxisome; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; sulfur compound metabolic process; ligase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_09728,FUN_041981-T1,Peve_00001546,Pocillopora_meandrina_HIv1___RNAseq.g15162.t1,three_way,54.784666666666666,FUN_041981-T1,P06400,RB_HUMAN,,Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110),Homo sapiens (Human),27.8,857.0,8.2e-74,280.0,sp|P06400|RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006366; GO:0006469; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0014009; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051276; GO:0051301; GO:0051402; GO:0051726; GO:0060090; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234,"aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]",chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514],disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_09801,FUN_042611-T1,Peve_00031582,Pocillopora_meandrina_HIv1___RNAseq.24516_t,three_way,71.33033333333334,FUN_042611-T1,Q18248,DMD4_CAEEL,,Doublesex- and mab-3-related transcription factor dmd-4,Caenorhabditis elegans,34.5,174.0,2.7e-16,87.8,sp|Q18248|DMD4_CAEEL Doublesex- and mab-3-related transcription factor dmd-4 OS=Caenorhabditis elegans OX=6239 GN=dmd-4 PE=1 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0043130; GO:0046872; GO:0098883,regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; synapse pruning [GO:0098883],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin binding [GO:0043130]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0034330; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell junction organization; organelle; transcription regulator activity
OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09823,FUN_042656-T1,Peve_00031588,Pocillopora_meandrina_HIv1___RNAseq.g4910.t1a,three_way,75.37983333333334,FUN_042656-T1,Q5VYK3,ECM29_HUMAN,,Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog),Homo sapiens (Human),44.3,1886.0,0.0,1510.7,sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628,ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248],centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502],molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005815; GO:0030163; GO:0031410; GO:0043226; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; microtubule organizing center; protein catabolic process; cytoplasmic vesicle; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09839,FUN_042820-T1,Peve_00019572,Pocillopora_meandrina_HIv1___RNAseq.g7438.t1,three_way,89.72666666666667,FUN_042820-T1,P40424,PBX1_HUMAN,,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),Homo sapiens (Human),69.0,407.0,9.8e-132,471.9,sp|P40424|PBX1_HUMAN Pre-B-cell leukemia transcription factor 1 OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1,GO:0000086; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001228; GO:0001654; GO:0001655; GO:0001658; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006694; GO:0007420; GO:0007548; GO:0009887; GO:0009952; GO:0009954; GO:0010971; GO:0030278; GO:0030325; GO:0030326; GO:0035162; GO:0043433; GO:0045665; GO:0045944; GO:0048536; GO:0048538; GO:0048568; GO:0048666; GO:0048706; GO:0072089; GO:0090575; GO:0140297; GO:1990837; GO:2000648,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; G2/M transition of mitotic cell cycle [GO:0000086]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006629; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09882,FUN_042955-T1,Peve_00025634,Pocillopora_meandrina_HIv1___RNAseq.g7125.t1,three_way,73.877,FUN_042955-T1,Q8BMI0,FBX38_MOUSE,,F-box only protein 38 (Modulator of KLF7 activity) (MoKA),Mus musculus (Mouse),42.1,439.0,9.499999999999999e-99,362.8,sp|Q8BMI0|FBX38_MOUSE F-box only protein 38 OS=Mus musculus OX=10090 GN=Fbxo38 PE=1 SV=1,GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0031146; GO:0050870; GO:0070936; GO:1990756,adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0005634; GO:0005829; GO:0030163; GO:0043226; GO:0060090,immune system process; nucleus; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_09917,FUN_043027-T1,Peve_00026962,Pocillopora_meandrina_HIv1___TS.g790.t1,three_way,57.98016666666667,FUN_043027-T1,Q8AYG3,TTK_DANRE,,Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap),Danio rerio (Zebrafish) (Brachydanio rerio),30.7,960.0,1.6999999999999998e-92,342.4,sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2,GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310,anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246],kinetochore [GO:0000776]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09959,FUN_043130-T1,Peve_00013596,Pocillopora_meandrina_HIv1___TS.g613.t1,three_way,62.32033333333334,FUN_043130-T1,Q9JI70,MKKS_MOUSE,,Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog),Mus musculus (Mouse),30.4,586.0,6.2e-74,280.0,sp|Q9JI70|MKKS_MOUSE Molecular chaperone MKKS OS=Mus musculus OX=10090 GN=Mkks PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0033210; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902140; GO:1902636; GO:1905515,artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082],GO:0003012; GO:0003013; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006457; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0065003,muscle system process; circulatory system process; nucleus; microtubule organizing center; cytosol; cilium; protein folding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein-containing complex assembly
OG_09968,FUN_043149-T1,Peve_00011390,Pocillopora_meandrina_HIv1___RNAseq.g6853.t1,three_way,78.382,FUN_043149-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),35.3,1002.0,3.1000000000000004e-157,558.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09974,FUN_043158-T1,Peve_00011401,Pocillopora_meandrina_HIv1___RNAseq.g6840.t1,three_way,89.59033333333333,FUN_043158-T1,A0A087WRI3,CFA77_MOUSE,,Cilia- and flagella-associated protein 77,Mus musculus (Mouse),37.8,238.0,7.1e-40,165.6,sp|A0A087WRI3|CFA77_MOUSE Cilia- and flagella-associated protein 77 OS=Mus musculus OX=10090 GN=Cfap77 PE=1 SV=1,GO:0030317; GO:0036126; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_09979,FUN_043165-T1,Peve_00036509,Pocillopora_meandrina_HIv1___RNAseq.g6824.t1,three_way,76.43816666666667,FUN_043165-T1,Q9NPC3,CIP1_HUMAN,,E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1),Homo sapiens (Human),49.5,105.0,2.4e-25,117.5,sp|Q9NPC3|CIP1_HUMAN E3 ubiquitin-protein ligase CCNB1IP1 OS=Homo sapiens OX=9606 GN=CCNB1IP1 PE=1 SV=1,GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0008270; GO:0016567; GO:0042802; GO:0051026; GO:0061630,blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286],synaptonemal complex [GO:0000795],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0006310; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; DNA recombination; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_10001,FUN_043234-T1,Peve_00001448,Pocillopora_meandrina_HIv1___RNAseq.g6754.t1,three_way,72.01266666666666,FUN_043234-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),39.5,309.0,3.7e-52,207.2,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_10009,FUN_043244-T1,Peve_00001455,Pocillopora_meandrina_HIv1___RNAseq.g8844.t1,three_way,80.65866666666668,FUN_043244-T1,Q5ZJF4,PRDX6_CHICK,,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx),Gallus gallus (Chicken),69.4,219.0,2.4e-87,323.2,sp|Q5ZJF4|PRDX6_CHICK Peroxiredoxin-6 OS=Gallus gallus OX=9031 GN=PRDX6 PE=2 SV=3,GO:0004601; GO:0004623; GO:0005615; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920,cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042],cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0006629; GO:0016209; GO:0016491; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; lysosome; vacuole; cytosol; lipid metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; hydrolase activity; organelle
OG_10020,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_10048,FUN_043322-T1,Peve_00007511,Pocillopora_meandrina_HIv1___RNAseq.g8949.t1,three_way,57.72333333333333,FUN_043322-T1,Q03146,DDR1_MOUSE,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Mus musculus (Mouse),49.6,373.0,3.5e-93,344.7,sp|Q03146|DDR1_MOUSE Epithelial discoidin domain-containing receptor 1 OS=Mus musculus OX=10090 GN=Ddr1 PE=2 SV=2,GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10073,FUN_043379-T1,Peve_00027430,Pocillopora_meandrina_HIv1___RNAseq.g8985.t1,three_way,83.51266666666666,FUN_043379-T1,Q5F3K4,WDR48_CHICK,,WD repeat-containing protein 48 (USP1-associated factor 1),Gallus gallus (Chicken),62.4,697.0,1.0999999999999999e-189,664.8,sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1,GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168,DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283],late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130],GO:0003677; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_10087,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10105,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10184,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10185,FUN_043600-T1,Peve_00007617,Pocillopora_meandrina_HIv1___RNAseq.g6950.t1,three_way,63.14633333333333,FUN_043600-T1,Q3UDW8,HGNAT_MOUSE,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Mus musculus (Mouse),37.9,504.0,4.2e-82,307.0,sp|Q3UDW8|HGNAT_MOUSE Heparan-alpha-glucosaminide N-acetyltransferase OS=Mus musculus OX=10090 GN=Hgsnat PE=1 SV=2,GO:0005765; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0043202; GO:0051259,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10194,FUN_043618-T2,Peve_00008246,Pocillopora_meandrina_HIv1___RNAseq.g6933.t1,three_way,53.74066666666667,FUN_043618-T2,P34821,BMP8A_MOUSE,,Bone morphogenetic protein 8A (BMP-8A) (Osteogenic protein 2) (OP-2),Mus musculus (Mouse),32.2,345.0,3.1e-34,147.5,sp|P34821|BMP8A_MOUSE Bone morphogenetic protein 8A OS=Mus musculus OX=10090 GN=Bmp8a PE=2 SV=1,GO:0001649; GO:0005125; GO:0005615; GO:0007179; GO:0007281; GO:0007283; GO:0008083; GO:0051216,cartilage development [GO:0051216]; germ cell development [GO:0007281]; osteoblast differentiation [GO:0001649]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular space [GO:0005615],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_10198,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_10201,FUN_043629-T1,Peve_00008240,Pocillopora_meandrina_HIv1___RNAseq.g6901.t1,three_way,72.333,FUN_043629-T1,B2GUY0,MA1B1_RAT,,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1)",Rattus norvegicus (Rat),48.4,674.0,2.1e-163,577.4,"sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2",GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0031410; GO:0036503; GO:0044322,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0031410; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_10225,FUN_044376-T1,Peve_00012020,Pocillopora_meandrina_HIv1___RNAseq.g28947.t1,three_way,72.203,FUN_044376-T1,P14618,KPYM_HUMAN,,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58),Homo sapiens (Human),60.0,518.0,1.8999999999999998e-173,610.5,sp|P14618|KPYM_HUMAN Pyruvate kinase PKM OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=4,GO:0000287; GO:0003713; GO:0003723; GO:0003729; GO:0004713; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0012501; GO:0023026; GO:0030955; GO:0031982; GO:0032869; GO:0034774; GO:0035402; GO:0042803; GO:0043231; GO:0045296; GO:0045944; GO:0061621; GO:0062023; GO:0070062; GO:1903561; GO:1903672; GO:1904813; GO:2000767,canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501],cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982],ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone H3T11 kinase activity [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005576; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0005929; GO:0005975; GO:0006091; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:0140096; GO:0140110; GO:1901135,"RNA binding; catalytic activity; extracellular region; nucleus; mitochondrion; endoplasmic reticulum; cytosol; cilium; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity; carbohydrate derivative metabolic process"
OG_10238,FUN_044487-T1,Peve_00001359,Pocillopora_meandrina_HIv1___RNAseq.g17370.t1,three_way,94.9875,FUN_044487-T1,Q6GL04,TERA_XENTR,,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),85.7,799.0,0.0,1355.9,sp|Q6GL04|TERA_XENTR Transitional endoplasmic reticulum ATPase OS=Xenopus tropicalis OX=8364 GN=vcp PE=2 SV=1,GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0007626; GO:0008289; GO:0010494; GO:0010498; GO:0010506; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030239; GO:0032434; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043009; GO:0043161; GO:0044877; GO:0055013; GO:0060047; GO:0061857; GO:0097352; GO:1903843; GO:1905634,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; chordate embryonic development [GO:0043009]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; heart contraction [GO:0060047]; interstrand cross-link repair [GO:0036297]; locomotory behavior [GO:0007626]; macroautophagy [GO:0016236]; myofibril assembly [GO:0030239]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005829; GO:0006281; GO:0006914; GO:0007010; GO:0008289; GO:0016192; GO:0016787; GO:0030163; GO:0043226; GO:0048856,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; cytosol; DNA repair; autophagy; cytoskeleton organization; lipid binding; vesicle-mediated transport; hydrolase activity; protein catabolic process; organelle; anatomical structure development
OG_10240,FUN_044499-T2,Peve_00001930,Pocillopora_meandrina_HIv1___RNAseq.g11528.t1,three_way,64.94266666666667,FUN_044499-T2,A2AM05,CNTLN_MOUSE,,Centlein (Centrosomal protein),Mus musculus (Mouse),22.4,420.0,4.2e-11,72.4,sp|A2AM05|CNTLN_MOUSE Centlein OS=Mus musculus OX=10090 GN=Cntln PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007283; GO:0007338; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0032880; GO:0033365; GO:0065003; GO:0120212,centriole-centriole cohesion [GO:0010457]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212],protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674],GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0060090; GO:0065003,nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; molecular adaptor activity; protein-containing complex assembly
OG_10242,FUN_044507-T1,Peve_00044058,Pocillopora_meandrina_HIv1___TS.g7422.t1b,three_way,83.77,FUN_044507-T1,Q5R7B8,KLH20_PONAB,,Kelch-like protein 20,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),42.1,335.0,2.8e-77,291.2,sp|Q5R7B8|KLH20_PONAB Kelch-like protein 20 OS=Pongo abelii OX=9601 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle
OG_10243,FUN_044513-T1,Peve_00023829,Pocillopora_meandrina_HIv1___RNAseq.g8575.t1,three_way,63.514833333333335,FUN_044513-T1,Q6DFA8,GLD2B_XENLA,,Poly(A) RNA polymerase GLD2-B (xGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4-B),Xenopus laevis (African clawed frog),41.2,337.0,1.1e-58,229.2,sp|Q6DFA8|GLD2B_XENLA Poly(A) RNA polymerase GLD2-B OS=Xenopus laevis OX=8355 GN=tent2-b PE=1 SV=1,GO:0005524; GO:0005737; GO:0006397; GO:0031123; GO:0046872; GO:0048477; GO:1990817; GO:2000626,mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA 3'-end processing [GO:0031123],cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0016071; GO:0016740; GO:0022414; GO:0048856,catalytic activity; mRNA metabolic process; transferase activity; reproductive process; anatomical structure development
OG_10252,FUN_044594-T1,Peve_00042021,Pocillopora_meandrina_HIv1___RNAseq.g20152.t1,three_way,81.90666666666667,FUN_044594-T1,O94889,KLH18_HUMAN,,Kelch-like protein 18,Homo sapiens (Human),45.6,320.0,2.5e-75,284.6,sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3,GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756,cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_10262,FUN_044704-T2,Peve_00032831,Pocillopora_meandrina_HIv1___TS.g17454.t1,three_way,75.62033333333333,FUN_044704-T2,Q53G59,KLH12_HUMAN,,Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog) (hDKIR),Homo sapiens (Human),61.7,329.0,7.4e-117,422.5,sp|Q53G59|KLH12_HUMAN Kelch-like protein 12 OS=Homo sapiens OX=9606 GN=KLHL12 PE=1 SV=2,GO:0005737; GO:0005829; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0034451; GO:0042802; GO:0043161; GO:0043231; GO:0048208; GO:1990756,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055],centriolar satellite [GO:0034451]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005829; GO:0016192; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0065003,cytosol; vesicle-mediated transport; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_10273,FUN_044853-T1,Peve_00039149,Pocillopora_meandrina_HIv1___RNAseq.g22449.t1,three_way,85.593,FUN_044853-T1,Q92890,UFD1_HUMAN,,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),Homo sapiens (Human),64.2,293.0,3.3e-95,349.7,sp|Q92890|UFD1_HUMAN Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3,GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; intracellular protein transport; hydrolase activity; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10276,FUN_044866-T1,Peve_00000207,Pocillopora_meandrina_HIv1___RNAseq.g334.t1,three_way,47.43566666666667,FUN_044866-T1,Q8WZ60,KLHL6_HUMAN,,Kelch-like protein 6,Homo sapiens (Human),28.0,289.0,1.0999999999999998e-24,116.3,sp|Q8WZ60|KLHL6_HUMAN Kelch-like protein 6 OS=Homo sapiens OX=9606 GN=KLHL6 PE=1 SV=3,GO:0002467; GO:0005737; GO:0009617; GO:0031463; GO:0043161; GO:0050853; GO:1990756,B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to bacterium [GO:0009617],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0030163; GO:0060090,immune system process; protein catabolic process; molecular adaptor activity
OG_10286,FUN_045068-T1,Peve_00043993,Pocillopora_meandrina_HIv1___RNAseq.g4720.t1,three_way,68.57933333333332,FUN_045068-T1,O94889,KLH18_HUMAN,,Kelch-like protein 18,Homo sapiens (Human),41.2,320.0,3.3000000000000004e-60,234.2,sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3,GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756,cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_10293,FUN_045150-T1,Peve_00027328,Pocillopora_meandrina_HIv1___RNAseq.g19152.t1,three_way,62.7535,FUN_045150-T1,Q8CDF7,EXD1_MOUSE,,piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1),Mus musculus (Mouse),40.2,264.0,5.400000000000001e-44,180.6,sp|Q8CDF7|EXD1_MOUSE piRNA biogenesis protein EXD1 OS=Mus musculus OX=10090 GN=Exd1 PE=1 SV=1,GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:1990923,meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated gene silencing [GO:0031047],P granule [GO:0043186]; PET complex [GO:1990923],protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723],GO:0003723; GO:0022414; GO:0031047; GO:0043226,RNA binding; reproductive process; regulatory ncRNA-mediated gene silencing; organelle
OG_10296,FUN_045186-T1,Peve_00006550,Pocillopora_meandrina_HIv1___RNAseq.g23143.t1,three_way,90.09616666666666,FUN_045186-T1,Q6TDP4,KLH17_HUMAN,,Kelch-like protein 17 (Actinfilin),Homo sapiens (Human),59.9,322.0,1.1e-107,392.1,sp|Q6TDP4|KLH17_HUMAN Kelch-like protein 17 OS=Homo sapiens OX=9606 GN=KLHL17 PE=1 SV=1,GO:0003779; GO:0005615; GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031463; GO:0043161; GO:0060090; GO:1990756,actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; molecular adaptor activity [GO:0060090]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005615; GO:0005856; GO:0007010; GO:0008092; GO:0030163; GO:0043226; GO:0060090,extracellular space; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; protein catabolic process; organelle; molecular adaptor activity
OG_10300,FUN_045329-T1,Peve_00024386,Pocillopora_meandrina_HIv1___RNAseq.g15029.t1,three_way,80.72066666666667,FUN_045329-T1,Q3UXZ9,KDM5A_MOUSE,,Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A),Mus musculus (Mouse),54.5,319.0,3.7e-84,313.5,sp|Q3UXZ9|KDM5A_MOUSE Lysine-specific demethylase 5A OS=Mus musculus OX=10090 GN=Kdm5a PE=1 SV=2,GO:0000122; GO:0000976; GO:0003682; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032453; GO:0032922; GO:0032993; GO:0034647; GO:0036211; GO:0042393; GO:0140718,circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; male gonad development [GO:0008584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein modification process [GO:0036211]; spermatogenesis [GO:0007283],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993],chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0016491; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; oxidoreductase activity; reproductive process; histone binding; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_10309,FUN_045467-T1,Peve_00034135,Pocillopora_meandrina_HIv1___RNAseq.g26021.t1,three_way,81.107,FUN_045467-T1,Q4U0Y4,NPL1A_XENLA,,Nucleosome assembly protein 1-like 1-A (xNAP1L-A) (Nucleosome assembly protein 1) (NAP-1) (NAP1) (xNAP-1) (xNAP1),Xenopus laevis (African clawed frog),55.9,340.0,7.4e-103,375.6,sp|Q4U0Y4|NPL1A_XENLA Nucleosome assembly protein 1-like 1-A OS=Xenopus laevis OX=8355 GN=nap1l1-a PE=1 SV=1,GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030332; GO:0042393; GO:0042802; GO:0045944; GO:0060215,nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; identical protein binding [GO:0042802],GO:0005634; GO:0006325; GO:0006355; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; reproductive process; histone binding; organelle; anatomical structure development; protein-containing complex assembly
OG_10319,FUN_045539-T1,Peve_00006628,Pocillopora_meandrina_HIv1___RNAseq.g12333.t1,three_way,77.75733333333334,FUN_045539-T1,Q08BL9,KL24A_DANRE,,Kelch-like protein 24a (Kelch-like family member 24a),Danio rerio (Zebrafish) (Brachydanio rerio),33.1,305.0,1.8e-39,165.6,sp|Q08BL9|KL24A_DANRE Kelch-like protein 24a OS=Danio rerio OX=7955 GN=klhl24a PE=2 SV=1,GO:0005737; GO:0005912; GO:0007507; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:1990756,heart development [GO:0007507]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0048856; GO:0060090,protein catabolic process; anatomical structure development; molecular adaptor activity
OG_10327,FUN_045608-T1,Peve_00041697,Pocillopora_meandrina_HIv1___RNAseq.g28319.t1,three_way,52.1635,FUN_045608-T1,Q14781,CBX2_HUMAN,,Chromobox protein homolog 2,Homo sapiens (Human),75.5,49.0,3.8e-17,90.9,sp|Q14781|CBX2_HUMAN Chromobox protein homolog 2 OS=Homo sapiens OX=9606 GN=CBX2 PE=1 SV=2,GO:0000122; GO:0000791; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0030154; GO:0031519; GO:0035064; GO:0035102; GO:0045137; GO:0062072,cell differentiation [GO:0030154]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122],euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K9me2/3 reader activity [GO:0062072]; methylated histone binding [GO:0035064],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; molecular adaptor activity
OG_10329,FUN_045611-T1,Peve_00000004,Pocillopora_meandrina_HIv1___RNAseq.g1184.t1,three_way,87.42933333333333,FUN_045611-T1,Q08DK3,KLH20_BOVIN,,Kelch-like protein 20,Bos taurus (Bovine),45.9,314.0,4.4e-77,290.4,sp|Q08DK3|KLH20_BOVIN Kelch-like protein 20 OS=Bos taurus OX=9913 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226; GO:0060090,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle; molecular adaptor activity
OG_10343,FUN_045818-T1,Peve_00039040,Pocillopora_meandrina_HIv1___TS.g848.t1,three_way,69.99266666666666,FUN_045818-T1,Q9Y6Y0,NS1BP_HUMAN,,Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39),Homo sapiens (Human),26.4,406.0,8.3e-35,150.2,sp|Q9Y6Y0|NS1BP_HUMAN Influenza virus NS1A-binding protein OS=Homo sapiens OX=9606 GN=IVNS1ABP PE=1 SV=3,GO:0005654; GO:0005667; GO:0005681; GO:0005737; GO:0005829; GO:0005856; GO:0006383; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:0097193; GO:1990756; GO:2001243,intrinsic apoptotic signaling pathway [GO:0097193]; mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005829; GO:0005856; GO:0006351; GO:0016071; GO:0030163; GO:0043226; GO:0060090,nucleoplasm; cytosol; cytoskeleton; DNA-templated transcription; mRNA metabolic process; protein catabolic process; organelle; molecular adaptor activity
OG_10345,FUN_045821-T1,Peve_00026304,Pocillopora_meandrina_HIv1___RNAseq.g7895.t1,three_way,91.27066666666668,FUN_045821-T1,Q08DK3,KLH20_BOVIN,,Kelch-like protein 20,Bos taurus (Bovine),75.9,323.0,4.6e-146,519.6,sp|Q08DK3|KLH20_BOVIN Kelch-like protein 20 OS=Bos taurus OX=9913 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226; GO:0060090,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle; molecular adaptor activity
OG_10419,FUN_001179-T1,Peve_00034698,,apul_peve,69.176,FUN_001179-T1,P26779,SAP_BOVIN,,Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)],Bos taurus (Bovine),33.7,178.0,1.6e-16,88.2,sp|P26779|SAP_BOVIN Prosaposin OS=Bos taurus OX=9913 GN=PSAP PE=1 SV=3,GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0016020; GO:0019216; GO:0060736; GO:0060742,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0006629; GO:0022414; GO:0030154; GO:0031410; GO:0043226,extracellular region; extracellular space; lysosome; endosome; vacuole; lipid metabolic process; reproductive process; cell differentiation; cytoplasmic vesicle; organelle
OG_10445,FUN_001421-T1,Peve_00008800,,apul_peve,42.675,FUN_001421-T1,A2AKX3,SETX_MOUSE,,Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog),Mus musculus (Mouse),30.7,866.0,9.7e-84,314.7,sp|A2AKX3|SETX_MOUSE Probable helicase senataxin OS=Mus musculus OX=10090 GN=Setx PE=1 SV=1,GO:0000228; GO:0000781; GO:0001147; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:2000144; GO:2000806,"cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140657,nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; ATP-dependent activity
OG_10445,FUN_001421-T1,Peve_00008800,,apul_peve,42.675,FUN_001421-T1,A2AKX3,SETX_MOUSE,,Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog),Mus musculus (Mouse),30.4,312.0,2.6e-36,157.1,sp|A2AKX3|SETX_MOUSE Probable helicase senataxin OS=Mus musculus OX=10090 GN=Setx PE=1 SV=1,GO:0000228; GO:0000781; GO:0001147; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:2000144; GO:2000806,"cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140657,nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; ATP-dependent activity
OG_10469,FUN_001762-T1,Peve_00019398,,apul_peve,56.304,FUN_001762-T1,C5G6D7,CABC2_BACT4,,Chondroitin sulfate ABC exolyase (EC 4.2.2.21) (Chondroitin ABC exoeliminase) (Chondroitin ABC lyase II) (Chondroitin sulfate ABC lyase II) (ChS ABC lyase II) (Chondroitinase ABC II) (cABC II) (Exochondroitinase ABC),Bacteroides thetaiotaomicron,27.6,783.0,3.4e-50,202.2,sp|C5G6D7|CABC2_BACT4 Chondroitin sulfate ABC exolyase OS=Bacteroides thetaiotaomicron OX=818 GN=chonabc PE=1 SV=2,GO:0000287; GO:0005509; GO:0005576; GO:0005975; GO:0006027; GO:0030209; GO:0030246; GO:0034000; GO:0034001; GO:0042597,carbohydrate metabolic process [GO:0005975]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027],extracellular region [GO:0005576]; periplasmic space [GO:0042597],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; chondroitin-sulfate-ABC endolyase activity [GO:0034000]; chondroitin-sulfate-ABC exolyase activity [GO:0034001]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005576; GO:0005975; GO:0016829; GO:0030163; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; lyase activity; protein catabolic process; carbohydrate derivative metabolic process
OG_10478,FUN_001906-T1,Peve_00024471,,apul_peve,65.4085,FUN_001906-T1,Q9H0J4,QRIC2_HUMAN,,Glutamine-rich protein 2,Homo sapiens (Human),23.5,549.0,1.4e-15,86.7,sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1,GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_10590,FUN_004040-T1,Peve_00008963,,apul_peve,44.61,FUN_004040-T1,Q5TAX3,TUT4_HUMAN,,Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11),Homo sapiens (Human),53.8,420.0,1.0999999999999999e-121,439.9,sp|Q5TAX3|TUT4_HUMAN Terminal uridylyltransferase 4 OS=Homo sapiens OX=9606 GN=TUT4 PE=1 SV=3,GO:0001556; GO:0003723; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0141008; GO:1990074,miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005615; GO:0005730; GO:0005829; GO:0016071; GO:0016740; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; extracellular space; nucleolus; cytosol; mRNA metabolic process; transferase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_10597,FUN_004083-T1,Peve_00019549,,apul_peve,78.788,FUN_004083-T1,Q9ET22,DPP2_MOUSE,,Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase),Mus musculus (Mouse),52.3,444.0,5.5000000000000005e-126,452.6,sp|Q9ET22|DPP2_MOUSE Dipeptidyl peptidase 2 OS=Mus musculus OX=10090 GN=Dpp7 PE=1 SV=2,GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0006508; GO:0008239; GO:0031410; GO:0070008; GO:1905146,lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005794; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular region; lysosome; vacuole; Golgi apparatus; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_10602,FUN_004122-T1,Peve_00009571,,apul_peve,94.664,FUN_004122-T1,Q9D180,CFA57_MOUSE,,Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65),Mus musculus (Mouse),69.7,865.0,2.6e-169,597.4,sp|Q9D180|CFA57_MOUSE Cilia- and flagella-associated protein 57 OS=Mus musculus OX=10090 GN=Cfap57 PE=1 SV=3,GO:0005737; GO:0005856; GO:0007338; GO:0036126; GO:0044782; GO:0070286; GO:0120316,axonemal dynein complex assembly [GO:0070286]; cilium organization [GO:0044782]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],,GO:0005856; GO:0005929; GO:0022414; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; cilium; reproductive process; organelle; cilium organization; protein-containing complex assembly
OG_10607,FUN_004157-T1,Peve_00012142,,apul_peve,88.1945,FUN_004157-T1,Q12834,CDC20_HUMAN,,Cell division cycle protein 20 homolog (p55CDC),Homo sapiens (Human),56.2,507.0,1.5e-148,527.7,sp|Q12834|CDC20_HUMAN Cell division cycle protein 20 homolog OS=Homo sapiens OX=9606 GN=CDC20 PE=1 SV=2,GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008284; GO:0010997; GO:0016567; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922],anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; reproductive process; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_10633,FUN_004418-T1,Peve_00033987,,apul_peve,82.6085,FUN_004418-T1,P09661,RU2A_HUMAN,,U2 small nuclear ribonucleoprotein A' (U2 snRNP A'),Homo sapiens (Human),59.9,257.0,4.500000000000001e-74,279.3,sp|P09661|RU2A_HUMAN U2 small nuclear ribonucleoprotein A' OS=Homo sapiens OX=9606 GN=SNRPA1 PE=1 SV=2,GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0071005; GO:0071007; GO:0071013; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0022414; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; reproductive process; organelle; protein-containing complex assembly
OG_10639,FUN_004449-T1,Peve_00024323,,apul_peve,81.159,FUN_004449-T1,Q9Y547,IFT25_HUMAN,,Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Heat shock protein family B member 11) (Placental protein 25) (PP25),Homo sapiens (Human),54.8,135.0,1.6000000000000002e-33,143.7,sp|Q9Y547|IFT25_HUMAN Intraflagellar transport protein 25 homolog OS=Homo sapiens OX=9606 GN=IFT25 PE=1 SV=1,GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0015031; GO:0030154; GO:0030324; GO:0030992; GO:0035720; GO:0046872; GO:0060271; GO:0070986; GO:0097542,cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992],metal ion binding [GO:0046872],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development
OG_10641,FUN_004483-T1,Peve_00008404,,apul_peve,77.866,FUN_004483-T1,P28472,GBRB3_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Homo sapiens (Human),28.1,281.0,1.3e-25,118.2,sp|P28472|GBRB3_HUMAN Gamma-aminobutyric acid receptor subunit beta-3 OS=Homo sapiens OX=9606 GN=GABRB3 PE=1 SV=1,GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0045211; GO:0051932; GO:0060021; GO:0060022; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_10648,FUN_004524-T1,Peve_00044055,,apul_peve,51.9255,FUN_004524-T1,Q9NS56,TOPRS_HUMAN,,E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),Homo sapiens (Human),42.7,192.0,3.9e-29,131.3,sp|Q9NS56|TOPRS_HUMAN E3 ubiquitin-protein ligase Topors OS=Homo sapiens OX=9606 GN=TOPORS PE=1 SV=1,GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006351; GO:0006511; GO:0006513; GO:0006974; GO:0008270; GO:0008630; GO:0010842; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0030496; GO:0032391; GO:0034504; GO:0035845; GO:0036064; GO:0042127; GO:0042771; GO:0043066; GO:0043161; GO:0044547; GO:0045893; GO:0051457; GO:0061630; GO:0070936,DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of DNA-templated transcription [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; ubiquitin-dependent protein catabolic process [GO:0006511],centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151],antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006351; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_10751,FUN_005997-T1,Peve_00036049,,apul_peve,74.038,FUN_005997-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),49.4,648.0,1.4e-175,617.8,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_10768,FUN_006277-T1,Peve_00032495,,apul_peve,62.109,FUN_006277-T1,P14207,FOLR2_HUMAN,,"Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)",Homo sapiens (Human),38.2,228.0,8.7e-45,182.2,sp|P14207|FOLR2_HUMAN Folate receptor beta OS=Homo sapiens OX=9606 GN=FOLR2 PE=1 SV=4,GO:0005542; GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0007342; GO:0008284; GO:0009897; GO:0009986; GO:0015884; GO:0035036; GO:0038023; GO:0061714,cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023],GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0022414; GO:0038024; GO:0060089; GO:0061024,extracellular region; plasma membrane; inflammatory response; cell adhesion; reproductive process; cargo receptor activity; molecular transducer activity; membrane organization
OG_10783,FUN_006582-T1,Peve_00031279,,apul_peve,45.578,FUN_006582-T1,P98160,PGBM_HUMAN,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide],Homo sapiens (Human),21.7,423.0,1e-09,67.4,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031100; GO:0043005; GO:0043202; GO:0050750; GO:0062023; GO:0070052; GO:0070062; GO:0072359; GO:0098797,angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797],amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750],GO:0005198; GO:0005576; GO:0005615; GO:0005886; GO:0006629; GO:0006954; GO:0016192; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048856,structural molecule activity; extracellular region; extracellular space; plasma membrane; lipid metabolic process; inflammatory response; vesicle-mediated transport; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_10801,FUN_006797-T1,Peve_00019181,,apul_peve,69.57900000000001,FUN_006797-T1,Q9WTN3,SRBP1_MOUSE,,Sterol regulatory element-binding protein 1 (SREBP-1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)],Mus musculus (Mouse),39.9,920.0,1.6e-156,555.4,sp|Q9WTN3|SRBP1_MOUSE Sterol regulatory element-binding protein 1 OS=Mus musculus OX=10090 GN=Srebf1 PE=1 SV=4,GO:0000122; GO:0000139; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0006355; GO:0006357; GO:0006366; GO:0006695; GO:0007584; GO:0007623; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0009750; GO:0010867; GO:0010883; GO:0012507; GO:0016020; GO:0019217; GO:0019901; GO:0030073; GO:0030324; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0043565; GO:0044877; GO:0045089; GO:0045444; GO:0045471; GO:0045542; GO:0045723; GO:0045893; GO:0045944; GO:0046676; GO:0046889; GO:0046983; GO:0050796; GO:0051591; GO:0071398; GO:0090209; GO:1901524; GO:1902895; GO:1903214,cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol biosynthetic process [GO:0006695]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; insulin secretion [GO:0030073]; lipid biosynthetic process [GO:0008610]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of innate immune response [GO:0045089]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of DNA-templated transcription [GO:0006355]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to fructose [GO:0009750]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sterol response element binding [GO:0032810]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]",GO:0003677; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006629; GO:0016071; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; lipid metabolic process; mRNA metabolic process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_10851,FUN_007698-T1,Peve_00028500,,apul_peve,59.921,FUN_007698-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),24.9,345.0,5.5e-14,80.5,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_10852,FUN_007711-T1,Peve_00018588,,apul_peve,38.177,FUN_007711-T1,Q5R7B8,KLH20_PONAB,,Kelch-like protein 20,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.0,112.0,4.2e-10,67.0,sp|Q5R7B8|KLH20_PONAB Kelch-like protein 20 OS=Pongo abelii OX=9601 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle
OG_10891,FUN_007999-T2,Peve_00022013,,apul_peve,69.12049999999999,FUN_007999-T2,Q8NDG6,TDRD9_HUMAN,,ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9),Homo sapiens (Human),43.3,1223.0,2.2e-273,943.7,sp|Q8NDG6|TDRD9_HUMAN ATP-dependent RNA helicase TDRD9 OS=Homo sapiens OX=9606 GN=TDRD9 PE=1 SV=3,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0034587; GO:0071547; GO:0141006; GO:0141196,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0031047; GO:0043226; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10900,FUN_008052-T1,Peve_00005980,,apul_peve,83.299,FUN_008052-T1,Q5R7H0,DHTK1_PONAB,,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),57.6,904.0,4.2e-311,1068.5,sp|Q5R7H0|DHTK1_PONAB 2-oxoadipate dehydrogenase complex component E1 OS=Pongo abelii OX=9601 GN=DHTKD1 PE=2 SV=1,GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0030976; GO:0160166,generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],2-oxoadipate dehydrogenase activity [GO:0160166]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005739; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_10902,FUN_008056-T2,Peve_00005977,,apul_peve,69.29050000000001,FUN_008056-T2,O14678,ABCD4_HUMAN,,Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),Homo sapiens (Human),51.9,509.0,3.6e-137,490.0,sp|O14678|ABCD4_HUMAN Lysosomal cobalamin transporter ABCD4 OS=Homo sapiens OX=9606 GN=ABCD4 PE=1 SV=1,GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042802; GO:0043190; GO:0055085; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760],ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324],GO:0003824; GO:0005215; GO:0005777; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; peroxisome; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_10935,FUN_008422-T2,Peve_00033726,,apul_peve,79.52250000000001,FUN_008422-T2,Q6RT24,CENPE_MOUSE,,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10),Mus musculus (Mouse),51.6,436.0,7.599999999999999e-107,391.0,sp|Q6RT24|CENPE_MOUSE Centromere-associated protein E OS=Mus musculus OX=10090 GN=Cenpe PE=1 SV=1,GO:0000775; GO:0000776; GO:0000940; GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0007018; GO:0007057; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0019901; GO:0031647; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051301; GO:0051310; GO:0051315; GO:0051984; GO:0051987; GO:0099607,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle [GO:0005819]",ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901],GO:0003774; GO:0003824; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0022414; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; reproductive process; organelle; ATP-dependent activity
OG_10974,FUN_008891-T1,Peve_00002345,,apul_peve,64.103,FUN_008891-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),31.2,327.0,1.6e-27,125.2,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_10985,FUN_008987-T2,Peve_00001697,,apul_peve,92.606,FUN_008987-T2,E1BKH1,EFHC1_BOVIN,,EF-hand domain-containing protein 1 (Myoclonin-1),Bos taurus (Bovine),59.7,551.0,1.2e-199,697.6,sp|E1BKH1|EFHC1_BOVIN EF-hand domain-containing protein 1 OS=Bos taurus OX=9913 GN=EFHC1 PE=1 SV=1,GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0021795; GO:0030317; GO:0036126; GO:0043014; GO:0051302; GO:0060285; GO:0072686; GO:0160111,cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509],GO:0000910; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048870,cytokinesis; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cell motility
OG_11122,FUN_011278-T1,Peve_00030532,,apul_peve,56.818,FUN_011278-T1,P08253,MMP2_HUMAN,,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX],Homo sapiens (Human),54.0,50.0,5.8e-10,65.9,sp|P08253|MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens OX=9606 GN=MMP2 PE=1 SV=2,GO:0001525; GO:0001541; GO:0001542; GO:0001553; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007162; GO:0007507; GO:0007567; GO:0008237; GO:0008270; GO:0009410; GO:0009612; GO:0014012; GO:0014823; GO:0016477; GO:0022617; GO:0030017; GO:0030163; GO:0030198; GO:0030335; GO:0030574; GO:0032526; GO:0034614; GO:0035094; GO:0035987; GO:0042542; GO:0043627; GO:0045906; GO:0048013; GO:0048246; GO:0048771; GO:0051602; GO:0055093; GO:0060325; GO:0060346; GO:0060740; GO:0061450; GO:0062023; GO:0071230; GO:0071347; GO:0071392; GO:0071492; GO:0071498; GO:1903378; GO:1904645; GO:1904707,angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; macrophage chemotaxis [GO:0048246]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell migration [GO:0030335]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771]; trophoblast cell migration [GO:0061450],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017],endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"immune system process; circulatory system process; catalytic activity; extracellular region; extracellular space; nucleus; mitochondrion; plasma membrane; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; extracellular matrix organization; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_11174,FUN_012131-T1,Peve_00035466,,apul_peve,62.338,FUN_012131-T1,P14780,MMP9_HUMAN,,Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9],Homo sapiens (Human),54.5,44.0,1.3e-06,55.5,sp|P14780|MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens OX=9606 GN=MMP9 PE=1 SV=3,GO:0001501; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0006915; GO:0007566; GO:0008233; GO:0008237; GO:0008270; GO:0016477; GO:0022617; GO:0030198; GO:0030225; GO:0030574; GO:0035987; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0045742; GO:0048013; GO:0051549; GO:0062023; GO:0070062; GO:0071222; GO:0071492; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258,apoptotic process [GO:0006915]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; extracellular space; programmed cell death; hydrolase activity; reproductive process; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_11180,FUN_012182-T1,Peve_00020511,,apul_peve,89.845,FUN_012182-T1,Q62388,ATM_MOUSE,,Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog),Mus musculus (Mouse),56.8,565.0,6.3e-177,622.1,sp|Q62388|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus OX=10090 GN=Atm PE=1 SV=2,GO:0000077; GO:0000425; GO:0000724; GO:0000729; GO:0000781; GO:0001541; GO:0001756; GO:0002331; GO:0002376; GO:0003677; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0006281; GO:0006302; GO:0006974; GO:0007094; GO:0007095; GO:0007140; GO:0007143; GO:0007292; GO:0007420; GO:0007507; GO:0008340; GO:0008585; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0030335; GO:0030889; GO:0032212; GO:0033151; GO:0034614; GO:0035264; GO:0035861; GO:0035979; GO:0042159; GO:0042770; GO:0042802; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0048538; GO:0048599; GO:0051402; GO:0070192; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090399; GO:0097694; GO:0097695; GO:0098850; GO:0106310; GO:1904262; GO:1904354; GO:1904884; GO:1990391; GO:2000781,"brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; chromosome organization involved in meiotic cell cycle [GO:0070192]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; immune system process [GO:0002376]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pexophagy [GO:0000425]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; replicative senescence [GO:0090399]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; extrinsic component of synaptic vesicle membrane [GO:0098850]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; site of double-strand break [GO:0035861]; spindle [GO:0005819]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0006281; GO:0006310; GO:0006355; GO:0006914; GO:0012501; GO:0016071; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; microtubule organizing center; DNA repair; DNA recombination; regulation of DNA-templated transcription; autophagy; programmed cell death; mRNA metabolic process; transferase activity; reproductive process; protein catabolic process; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_11189,FUN_012226-T1,Peve_00036352,,apul_peve,70.42,FUN_012226-T1,P08289,PPBT_RAT,,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)",Rattus norvegicus (Rat),48.2,481.0,3.9e-118,426.8,"sp|P08289|PPBT_RAT Alkaline phosphatase, tissue-nonspecific isozyme OS=Rattus norvegicus OX=10116 GN=Alpl PE=1 SV=2",GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005615; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031214; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0065010; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383,biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280],extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0022414; GO:0030312; GO:0031012; GO:0043226; GO:0048856,catalytic activity; extracellular space; plasma membrane; hydrolase activity; reproductive process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_11254,FUN_012709-T1,Peve_00004158,,apul_peve,65.29849999999999,FUN_012709-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),36.2,345.0,2.4e-49,198.0,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_11292,FUN_013133-T1,Peve_00013809,,apul_peve,56.98,FUN_013133-T1,Q99542,MMP19_HUMAN,,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),Homo sapiens (Human),46.1,241.0,1.6e-47,191.4,sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1,GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0022414; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; reproductive process; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_11347,FUN_014488-T1,Peve_00013876,,apul_peve,68.471,FUN_014488-T1,Q15056,IF4H_HUMAN,,Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein),Homo sapiens (Human),39.3,239.0,1.8e-32,141.4,sp|Q15056|IF4H_HUMAN Eukaryotic translation initiation factor 4H OS=Homo sapiens OX=9606 GN=EIF4H PE=1 SV=5,GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0008135; GO:0016020; GO:0016281; GO:0019953; GO:0033592; GO:0034057; GO:0043024; GO:0045296; GO:0048471; GO:0048589; GO:0097010,developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953],cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471],"cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]",GO:0003723; GO:0003824; GO:0005829; GO:0016853; GO:0022414; GO:0065003; GO:0140098,"RNA binding; catalytic activity; cytosol; isomerase activity; reproductive process; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_11388,FUN_014919-T1,Peve_00003533,,apul_peve,55.2655,FUN_014919-T1,P27139,CAH2_RAT,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Rattus norvegicus (Rat),38.6,264.0,1.2999999999999998e-43,178.3,sp|P27139|CAH2_RAT Carbonic anhydrase 2 OS=Rattus norvegicus OX=10116 GN=Ca2 PE=1 SV=2,GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0018820; GO:0030316; GO:0030424; GO:0030641; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0044849; GO:0045124; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070050; GO:0071498; GO:1904404; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; estrous cycle [GO:0044849]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of bone resorption [GO:0045124]; regulation of cellular pH [GO:0030641]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; response to estrogen [GO:0043627]; response to formaldehyde [GO:1904404]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]",apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0022414; GO:0030154; GO:0048856,catalytic activity; extracellular space; cytosol; plasma membrane; hydrolase activity; lyase activity; reproductive process; cell differentiation; anatomical structure development
OG_11396,FUN_015029-T1,Peve_00004802,,apul_peve,43.823,FUN_015029-T1,A0A8J1M587,FANCJ_XENLA,,Fanconi anemia group J protein homolog (EC 5.6.2.3) (BRCA1-interacting protein C-terminal helicase homolog 1.L) (BRCA1-interacting protein homolog 1.L) (DNA 5'-3' helicase FANCJ),Xenopus laevis (African clawed frog),57.1,198.0,2.1e-64,248.8,sp|A0A8J1M587|FANCJ_XENLA Fanconi anemia group J protein homolog OS=Xenopus laevis OX=8355 GN=brip1.L PE=3 SV=2,GO:0003677; GO:0005524; GO:0005634; GO:0006289; GO:0016818; GO:0043139; GO:0046872; GO:0051539; GO:0106300; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300],nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_11422,FUN_015328-T1,Peve_00005924,,apul_peve,49.677,FUN_015328-T1,A5A4L1,GHSR_MUSPF,,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),Mustela putorius furo (European domestic ferret) (Mustela furo),26.0,319.0,1e-06,55.8,sp|A5A4L1|GHSR_MUSPF Growth hormone secretagogue receptor type 1 OS=Mustela putorius furo OX=9669 GN=GHSR PE=2 SV=1,GO:0001616; GO:0005886; GO:0008154; GO:0008343; GO:0009755; GO:0009986; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0040018; GO:0043005; GO:0043568; GO:0045121; GO:0046697; GO:0048009; GO:0050728; GO:0051963,actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094],cell surface [GO:0009986]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_11435,FUN_015468-T1,Peve_00001857,,apul_peve,56.593,FUN_015468-T1,Q6ZQF0,TOPB1_MOUSE,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Mus musculus (Mouse),28.4,250.0,2.0000000000000002e-23,112.8,sp|Q6ZQF0|TOPB1_MOUSE DNA topoisomerase 2-binding protein 1 OS=Mus musculus OX=10090 GN=Topbp1 PE=1 SV=2,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006281; GO:0006974; GO:0007131; GO:0010212; GO:0015629; GO:0016605; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; protein localization to site of double-strand break [GO:1990166]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0022414; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; reproductive process; organelle; molecular adaptor activity; molecular function regulator activity
OG_11468,FUN_015997-T2,Peve_00023992,,apul_peve,70.547,FUN_015997-T2,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),27.5,501.0,3.3e-22,109.8,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_11474,FUN_016061-T1,Peve_00012779,,apul_peve,61.708,FUN_016061-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),40.9,584.0,3.1e-110,400.6,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_11484,FUN_016202-T1,Peve_00030471,,apul_peve,65.288,FUN_016202-T1,P51587,BRCA2_HUMAN,,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),Homo sapiens (Human),32.6,1293.0,1.9999999999999997e-152,543.5,sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens OX=9606 GN=BRCA2 PE=1 SV=4,GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0007141; GO:0007283; GO:0007420; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0030330; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0045893; GO:0045931; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001,"brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA-templated transcription [GO:0006355]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006355; GO:0008092; GO:0016740; GO:0022414; GO:0031410; GO:0032200; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; reproductive process; cytoplasmic vesicle; telomere organization; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_11498,FUN_016369-T1,Peve_00019685,,apul_peve,71.3195,FUN_016369-T1,Q9DBR1,XRN2_MOUSE,,5'-3' exoribonuclease 2 (EC 3.1.13.-) (Protein Dhm1),Mus musculus (Mouse),55.6,989.0,3.8e-289,995.7,sp|Q9DBR1|XRN2_MOUSE 5'-3' exoribonuclease 2 OS=Mus musculus OX=10090 GN=Xrn2 PE=1 SV=1,GO:0001147; GO:0004534; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006369; GO:0006397; GO:0007017; GO:0007283; GO:0008270; GO:0008409; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0060041,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369],aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],5'-3' exonuclease activity [GO:0008409]; 5'-3' RNA exonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016071; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; nucleolus; DNA repair; DNA recombination; mRNA metabolic process; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_11527,FUN_016600-T1,Peve_00003403,,apul_peve,50.98,FUN_016600-T1,P21956,MFGM_MOUSE,,Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47),Mus musculus (Mouse),31.7,161.0,2.2e-17,92.8,sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0043277; GO:0050766; GO:0062023,"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]",acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786],GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0061024,extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; membrane organization
OG_11602,FUN_017880-T1,Peve_00001923,,apul_peve,64.733,FUN_017880-T1,Q9VH19,LMLN_DROME,,Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin),Drosophila melanogaster (Fruit fly),41.7,631.0,2.2e-136,487.6,sp|Q9VH19|LMLN_DROME Leishmanolysin-like peptidase OS=Drosophila melanogaster OX=7227 GN=Invadolysin PE=2 SV=2,GO:0004222; GO:0005737; GO:0006338; GO:0006508; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:0051881,brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]; regulation of mitochondrial membrane potential [GO:0051881],cytoplasm [GO:0005737]; membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233],GO:0003824; GO:0006091; GO:0006325; GO:0007010; GO:0007155; GO:0016787; GO:0022414; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; generation of precursor metabolites and energy; chromatin organization; cytoskeleton organization; cell adhesion; hydrolase activity; reproductive process; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_11636,FUN_018400-T1,Peve_00003132,,apul_peve,64.176,FUN_018400-T1,Q96DZ1,ERLEC_HUMAN,,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),Homo sapiens (Human),39.0,459.0,2.5e-91,337.4,sp|Q96DZ1|ERLEC_HUMAN Endoplasmic reticulum lectin 1 OS=Homo sapiens OX=9606 GN=ERLEC1 PE=1 SV=1,GO:0005788; GO:0030968; GO:0030970; GO:0036503; GO:0044322; GO:0051082; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]",endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322],unfolded protein binding [GO:0051082],GO:0006886; GO:0030163,intracellular protein transport; protein catabolic process
OG_11686,FUN_019349-T1,Peve_00013972,,apul_peve,55.008,FUN_019349-T1,Q10656,EGL15_CAEEL,,Myoblast growth factor receptor egl-15 (EC 2.7.10.1) (Egg-laying defective protein 15),Caenorhabditis elegans,26.6,707.0,1.1e-52,209.9,sp|Q10656|EGL15_CAEEL Myoblast growth factor receptor egl-15 OS=Caenorhabditis elegans OX=6239 GN=egl-15 PE=1 SV=1,GO:0002119; GO:0004672; GO:0004714; GO:0005524; GO:0005886; GO:0007517; GO:0008284; GO:0008543; GO:0016477; GO:0018991; GO:0031344; GO:0031647; GO:0043235; GO:0043410; GO:0046716; GO:0046872; GO:0048546,cell migration [GO:0016477]; digestive tract morphogenesis [GO:0048546]; egg-laying behavior [GO:0018991]; fibroblast growth factor receptor signaling pathway [GO:0008543]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell projection organization [GO:0031344]; regulation of protein stability [GO:0031647],plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005886; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_11710,FUN_020735-T1,Peve_00032907,,apul_peve,95.556,FUN_020735-T1,Q9DAM2,EFCB9_MOUSE,,EF-hand calcium-binding domain-containing protein 9,Mus musculus (Mouse),47.7,149.0,1.4e-36,154.1,sp|Q9DAM2|EFCB9_MOUSE EF-hand calcium-binding domain-containing protein 9 OS=Mus musculus OX=10090 GN=Efcab9 PE=1 SV=2,GO:0005509; GO:0005516; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283],CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228],calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calmodulin binding [GO:0005516],GO:0007018; GO:0022414; GO:0048870; GO:0098772; GO:0140299,microtubule-based movement; reproductive process; cell motility; molecular function regulator activity; molecular sensor activity
OG_11755,FUN_022000-T1,Peve_00039769,,apul_peve,60.559,FUN_022000-T1,P10090,WHITE_DROME,,Protein white (EC 7.6.2.-) (EC 7.6.2.6) (ATP-binding cassette transporter sub-family G member white) (Broad substrate specificity ATP-binding cassette transporter white),Drosophila melanogaster (Fruit fly),43.3,635.0,5.7e-140,499.6,sp|P10090|WHITE_DROME Protein white OS=Drosophila melanogaster OX=7227 GN=w PE=1 SV=2,GO:0005275; GO:0005524; GO:0005886; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015208; GO:0015827; GO:0015842; GO:0015854; GO:0016887; GO:0022857; GO:0030659; GO:0031409; GO:0031410; GO:0032217; GO:0032218; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0042906; GO:0042907; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090741; GO:0098793; GO:1905948,aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; guanine transport [GO:0015854]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085]; tryptophan transport [GO:0015827]; xanthine transport [GO:0042906],cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; pigment granule [GO:0048770]; pigment granule membrane [GO:0090741]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"ABC-type 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ABC-type guanine transporter activity [GO:0008558]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; guanine transmembrane transporter activity [GO:0015208]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; riboflavin transmembrane transporter activity [GO:0032217]; transmembrane transporter activity [GO:0022857]; xanthine transmembrane transporter activity [GO:0042907]",GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0050877; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport; ATP-dependent activity
OG_11772,FUN_022219-T2,Peve_00027149,,apul_peve,48.555,FUN_022219-T2,Q8K2C7,OS9_MOUSE,,Protein OS-9,Mus musculus (Mouse),42.9,133.0,9.4e-25,117.1,sp|Q8K2C7|OS9_MOUSE Protein OS-9 OS=Mus musculus OX=10090 GN=Os9 PE=1 SV=2,GO:0000836; GO:0002020; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030968; GO:0034976; GO:0036503; GO:0140032; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511]",endoplasmic reticulum lumen [GO:0005788]; Hrd1p ubiquitin ligase complex [GO:0000836],carbohydrate binding [GO:0030246]; glycosylation-dependent protein binding [GO:0140032]; protease binding [GO:0002020],GO:0030163,protein catabolic process
OG_11824,FUN_022629-T1,Peve_00012282,,apul_peve,61.1675,FUN_022629-T1,Q8BRH4,KMT2C_MOUSE,,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog),Mus musculus (Mouse),25.4,5464.0,1.2e-141,508.1,sp|Q8BRH4|KMT2C_MOUSE Histone-lysine N-methyltransferase 2C OS=Mus musculus OX=10090 GN=Kmt2c PE=1 SV=2,GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007338; GO:0008270; GO:0010468; GO:0016746; GO:0032259; GO:0035097; GO:0035264; GO:0042054; GO:0042800; GO:0044666; GO:0048146; GO:0061029; GO:0140945; GO:0140999,eyelid development in camera-type eye [GO:0061029]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone methyltransferase activity [GO:0042054]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_11881,FUN_023196-T1,Peve_00009999,,apul_peve,59.239,FUN_023196-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),37.5,152.0,2.0000000000000002e-24,114.0,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_11895,FUN_023340-T1,Peve_00023291,,apul_peve,62.796,FUN_023340-T1,O94993,SOX30_HUMAN,,Transcription factor SOX-30,Homo sapiens (Human),64.0,86.0,3.4e-26,120.9,sp|O94993|SOX30_HUMAN Transcription factor SOX-30 OS=Homo sapiens OX=9606 GN=SOX30 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837,negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286],chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0061024; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; membrane organization; transcription regulator activity
OG_11904,FUN_023432-T2,Peve_00019223,,apul_peve,56.66,FUN_023432-T2,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),36.4,165.0,1.4e-20,102.4,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_11917,FUN_023583-T1,Peve_00035144,,apul_peve,40.016000000000005,FUN_023583-T1,Q58EK5,TDRD1_DANRE,,Tudor domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),26.2,854.0,5.5e-65,251.9,sp|Q58EK5|TDRD1_DANRE Tudor domain-containing protein 1 OS=Danio rerio OX=7955 GN=tdrd1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546],piRNA binding [GO:0034584]; zinc ion binding [GO:0008270],GO:0003723; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,RNA binding; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_11918,FUN_023593-T2,Peve_00032462,,apul_peve,60.526,FUN_023593-T2,Q6PIW4,FIGL1_HUMAN,,Fidgetin-like protein 1 (EC 3.6.4.-),Homo sapiens (Human),30.5,469.0,1.2e-40,169.1,sp|Q6PIW4|FIGL1_HUMAN Fidgetin-like protein 1 OS=Homo sapiens OX=9606 GN=FIGNL1 PE=1 SV=2,GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243,ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568],GO:0000228; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0055086; GO:0140013; GO:0140096; GO:0140657; GO:1901135,"nuclear chromosome; catalytic activity; nucleus; nucleoplasm; chromosome; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; nucleobase-containing small molecule metabolic process; meiotic nuclear division; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_11919,FUN_023618-T1,Peve_00034085,,apul_peve,57.554,FUN_023618-T1,P47032,PRY1_YEAST,,Protein PRY1 (Pathogenesis-related protein 1),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),37.9,140.0,1.8e-14,81.6,sp|P47032|PRY1_YEAST Protein PRY1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY1 PE=1 SV=1,GO:0000287; GO:0000324; GO:0005504; GO:0005576; GO:0005615; GO:0005635; GO:0005783; GO:0015485; GO:0015908; GO:0015918; GO:0019953; GO:0032934,fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fungal-type vacuole [GO:0000324]; nuclear envelope [GO:0005635],cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]; magnesium ion binding [GO:0000287]; sterol binding [GO:0032934],GO:0005576; GO:0005615; GO:0005635; GO:0005773; GO:0005783; GO:0008289; GO:0022414; GO:0043226,extracellular region; extracellular space; nuclear envelope; vacuole; endoplasmic reticulum; lipid binding; reproductive process; organelle
OG_11934,FUN_024006-T1,Peve_00031281,,apul_peve,67.0255,FUN_024006-T1,Q9UBS3,DNJB9_HUMAN,,DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1),Homo sapiens (Human),44.5,227.0,2.1e-25,117.5,sp|Q9UBS3|DNJB9_HUMAN DnaJ homolog subfamily B member 9 OS=Homo sapiens OX=9606 GN=DNAJB9 PE=1 SV=1,GO:0002639; GO:0005730; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0006986; GO:0030183; GO:0030544; GO:0034976; GO:0036503; GO:0051087; GO:0051787; GO:0070062; GO:1903895,B cell differentiation [GO:0030183]; ERAD pathway [GO:0036503]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; positive regulation of immunoglobulin production [GO:0002639]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730],Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005730; GO:0005783; GO:0030154; GO:0030163; GO:0043226,immune system process; nucleolus; endoplasmic reticulum; cell differentiation; protein catabolic process; organelle
OG_11995,FUN_024708-T1,Peve_00012724,,apul_peve,50.523,FUN_024708-T1,Q6NZG4,DDIAS_MOUSE,,DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein),Mus musculus (Mouse),31.1,132.0,5.5e-13,76.6,sp|Q6NZG4|DDIAS_MOUSE DNA damage-induced apoptosis suppressor protein OS=Mus musculus OX=10090 GN=Ddias PE=2 SV=1,GO:0005634; GO:0005737; GO:0006974; GO:0007286; GO:0030097; GO:0034644; GO:0044346; GO:0051726; GO:0071345; GO:0071447; GO:0071480; GO:1902230; GO:2000270,cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; fibroblast apoptotic process [GO:0044346]; hemopoiesis [GO:0030097]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of cell cycle [GO:0051726]; spermatid development [GO:0007286],cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0012501; GO:0022414; GO:0043226; GO:0048856,nucleus; programmed cell death; reproductive process; organelle; anatomical structure development
OG_12000,FUN_024764-T1,Peve_00026073,,apul_peve,80.901,FUN_024764-T1,O60879,DIAP2_HUMAN,,Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2),Homo sapiens (Human),44.9,1086.0,5.5e-183,643.3,sp|O60879|DIAP2_HUMAN Protein diaphanous homolog 2 OS=Homo sapiens OX=9606 GN=DIAPH2 PE=1 SV=1,GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477,actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477],actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730],actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005730; GO:0005768; GO:0005783; GO:0005829; GO:0008092; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0065003,nucleolus; endosome; endoplasmic reticulum; cytosol; cytoskeletal protein binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_12049,FUN_025514-T1,Peve_00002248,,apul_peve,72.165,FUN_025514-T1,P24392,PEX2_RAT,,Peroxisome biogenesis factor 2 (EC 2.3.2.27) (EC 2.3.2.36) (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1) (PAF-1),Rattus norvegicus (Rat),38.4,198.0,1.6999999999999996e-31,137.5,sp|P24392|PEX2_RAT Peroxisome biogenesis factor 2 OS=Rattus norvegicus OX=10116 GN=Pex2 PE=2 SV=1,GO:0000038; GO:0000425; GO:0001764; GO:0005777; GO:0005778; GO:0006513; GO:0006635; GO:0006699; GO:0007031; GO:0007399; GO:0008270; GO:0016558; GO:0016562; GO:0016593; GO:0031648; GO:0034614; GO:0042632; GO:0045540; GO:0048147; GO:0050680; GO:0061630; GO:1990928,"bile acid biosynthetic process [GO:0006699]; cellular response to reactive oxygen species [GO:0034614]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein monoubiquitination [GO:0006513]; regulation of cholesterol biosynthetic process [GO:0045540]; response to amino acid starvation [GO:1990928]; very long-chain fatty acid metabolic process [GO:0000038]",Cdc73/Paf1 complex [GO:0016593]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005777; GO:0006629; GO:0006886; GO:0006914; GO:0007031; GO:0016740; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0140096,"catalytic activity; peroxisome; lipid metabolic process; intracellular protein transport; autophagy; peroxisome organization; transferase activity; organelle; anatomical structure development; cell motility; transmembrane transport; catalytic activity, acting on a protein"
OG_12094,FUN_025837-T1,Peve_00028308,,apul_peve,46.477,FUN_025837-T1,Q6GX86,HROB_RAT,,Homologous recombination OB-fold protein,Rattus norvegicus (Rat),33.3,309.0,3.5e-29,131.3,sp|Q6GX86|HROB_RAT Homologous recombination OB-fold protein OS=Rattus norvegicus OX=10116 GN=Hrob PE=2 SV=1,GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0006974; GO:0007292; GO:0036297; GO:0048232; GO:0090734,DNA damage response [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725],nucleus [GO:0005634]; site of DNA damage [GO:0090734],single-stranded DNA binding [GO:0003697],GO:0003677; GO:0005634; GO:0006281; GO:0006310; GO:0022414; GO:0043226,DNA binding; nucleus; DNA repair; DNA recombination; reproductive process; organelle
OG_12113,FUN_026080-T1,Peve_00016851,,apul_peve,82.917,FUN_026080-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),62.5,275.0,6.6e-95,348.6,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_12117,FUN_026141-T1,Peve_00014869,,apul_peve,41.699,FUN_026141-T1,Q5IS54,CASP3_PANTR,,Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Pan troglodytes (Chimpanzee),33.2,289.0,1.9e-32,142.5,sp|Q5IS54|CASP3_PANTR Caspase-3 OS=Pan troglodytes OX=9598 GN=CASP3 PE=2 SV=1,GO:0001782; GO:0001818; GO:0004175; GO:0004190; GO:0004197; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0008047; GO:0008627; GO:0009411; GO:0009611; GO:0014069; GO:0016485; GO:0030163; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0031647; GO:0034349; GO:0043029; GO:0043525; GO:0044346; GO:0045165; GO:0045786; GO:0046007; GO:0048011; GO:0051402; GO:0061713; GO:0070269; GO:0072734; GO:0097194; GO:0098693; GO:0098978; GO:0140639; GO:1902004; GO:1904019,anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to staurosporine [GO:0072734]; DNA damage response [GO:0006974]; epithelial cell apoptotic process [GO:1904019]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production [GO:0001818]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of protein stability [GO:0031647]; regulation of synaptic vesicle cycle [GO:0098693]; response to UV [GO:0009411]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029],cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; enzyme activator activity [GO:0008047],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0012501; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0050877; GO:0051604; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; inflammatory response; programmed cell death; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; nervous system process; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_12129,FUN_026313-T1,Peve_00036862,,apul_peve,65.673,FUN_026313-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),48.5,97.0,5.7e-23,111.3,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_12159,FUN_026618-T1,Peve_00043916,,apul_peve,69.258,FUN_026618-T1,Q76HN1,HYAL1_RAT,,Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1),Rattus norvegicus (Rat),40.9,303.0,7.4e-63,242.3,sp|Q76HN1|HYAL1_RAT Hyaluronidase-1 OS=Rattus norvegicus OX=10116 GN=Hyal1 PE=2 SV=1,GO:0000302; GO:0004415; GO:0005615; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0030207; GO:0030212; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0044344; GO:0045766; GO:0045785; GO:0046677; GO:0051216; GO:0052757; GO:0060272; GO:0071347; GO:0071356; GO:0071467; GO:0071493; GO:1900106,carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; embryonic skeletal joint morphogenesis [GO:0060272]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615],cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosome [GO:0005764],chondroitin hydrolase activity [GO:0052757]; hyalurononglucosaminidase activity [GO:0004415],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005975; GO:0006954; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; carbohydrate metabolic process; inflammatory response; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_12242,FUN_027751-T1,Peve_00041522,,apul_peve,65.589,FUN_027751-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),51.3,958.0,6.5e-81,305.1,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_12389,FUN_029546-T1,Peve_00023345,,apul_peve,70.732,FUN_029546-T1,Q8BQS5,PAQR2_MOUSE,,Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II),Mus musculus (Mouse),51.6,283.0,2.7e-82,307.0,sp|Q8BQS5|PAQR2_MOUSE Adiponectin receptor protein 2 OS=Mus musculus OX=10090 GN=Adipor2 PE=1 SV=2,GO:0005886; GO:0007507; GO:0007565; GO:0007584; GO:0009410; GO:0009750; GO:0009755; GO:0010629; GO:0014075; GO:0019395; GO:0030308; GO:0032496; GO:0033211; GO:0038023; GO:0042593; GO:0042802; GO:0045471; GO:0046326; GO:0046872; GO:0055100; GO:0061042; GO:0061871; GO:0071398; GO:0097003; GO:0120162,adiponectin-activated signaling pathway [GO:0033211]; cellular response to fatty acid [GO:0071398]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatic stellate cell migration [GO:0061871]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of D-glucose import [GO:0046326]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; vascular wound healing [GO:0061042],plasma membrane [GO:0005886],adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023],GO:0005886; GO:0006629; GO:0022414; GO:0048856; GO:0060089,plasma membrane; lipid metabolic process; reproductive process; anatomical structure development; molecular transducer activity
OG_12392,FUN_029578-T1,Peve_00028950,,apul_peve,56.012,FUN_029578-T1,Q9C040,TRIM2_HUMAN,,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),Homo sapiens (Human),21.8,550.0,5.800000000000001e-30,135.2,sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_12393,FUN_029598-T1,Peve_00023403,,apul_peve,60.822,FUN_029598-T1,Q6PFY8,TRI45_MOUSE,,E3 ubiquitin-protein ligase TRIM45 (EC 2.3.2.27) (RING finger protein 99) (Tripartite motif-containing protein 45),Mus musculus (Mouse),22.9,485.0,1.2e-24,116.7,sp|Q6PFY8|TRI45_MOUSE E3 ubiquitin-protein ligase TRIM45 OS=Mus musculus OX=10090 GN=Trim45 PE=1 SV=2,GO:0005654; GO:0005829; GO:0008270; GO:0043161; GO:0045171; GO:0050728; GO:0060348; GO:0061630; GO:0070936,bone development [GO:0060348]; negative regulation of inflammatory response [GO:0050728]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0030163; GO:0048856; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein"
OG_12424,FUN_030063-T1,Peve_00021149,,apul_peve,63.974,FUN_030063-T1,Q08879,FBLN1_MOUSE,,Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90),Mus musculus (Mouse),53.3,45.0,4.1e-07,61.2,sp|Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus OX=10090 GN=Fbln1 PE=1 SV=2,GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007566; GO:0016504; GO:0030198; GO:0042802; GO:0062023; GO:0070051; GO:0070373; GO:0071953; GO:0072378; GO:1900025; GO:2000146; GO:2000647,"blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]",basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504],GO:0005198; GO:0005615; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0051604; GO:0098772,structural molecule activity; extracellular space; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; protein maturation; molecular function regulator activity
OG_12492,FUN_031290-T1,Peve_00026524,,apul_peve,53.4785,FUN_031290-T1,Q8IYD8,FANCM_HUMAN,,Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog),Homo sapiens (Human),45.7,932.0,6.5e-203,710.7,sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2,GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0005829; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:1902527,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0140097; GO:0140098; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12492,FUN_031290-T1,Peve_00026524,,apul_peve,53.4785,FUN_031290-T1,Q8IYD8,FANCM_HUMAN,,Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog),Homo sapiens (Human),39.3,229.0,4.6e-39,166.4,sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2,GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0005829; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:1902527,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0140097; GO:0140098; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12504,FUN_031510-T2,Peve_00045256,,apul_peve,68.1455,FUN_031510-T2,Q8CCP0,NEMF_MOUSE,,Ribosome quality control complex subunit NEMF (Nuclear export mediator factor),Mus musculus (Mouse),63.9,679.0,1.0000000000000001e-226,788.5,sp|Q8CCP0|NEMF_MOUSE Ribosome quality control complex subunit NEMF OS=Mus musculus OX=10090 GN=Nemf PE=1 SV=2,GO:0005634; GO:0005829; GO:0022626; GO:0043023; GO:0051168; GO:0065003; GO:0140708; GO:1904678; GO:1990112; GO:1990116,CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RQC complex [GO:1990112],alpha-aminoacyl-tRNA binding [GO:1904678]; ribosomal large subunit binding [GO:0043023],GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0006913; GO:0030163; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; ribosome; nucleocytoplasmic transport; protein catabolic process; organelle; protein-containing complex assembly
OG_12525,FUN_031716-T1,Peve_00039097,,apul_peve,56.4915,FUN_031716-T1,P58283,RN216_MOUSE,,E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1),Mus musculus (Mouse),36.6,506.0,2.6e-84,314.7,sp|P58283|RN216_MOUSE E3 ubiquitin-protein ligase RNF216 OS=Mus musculus OX=10090 GN=Rnf216 PE=1 SV=3,GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0016740; GO:0030136; GO:0032648; GO:0043161; GO:0050691; GO:0070936; GO:0098685; GO:0098793; GO:0098843; GO:0098978; GO:0099149; GO:0099546,"apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; postsynaptic endocytic zone [GO:0098843]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0012501; GO:0016740; GO:0030163; GO:0031410; GO:0043226,catalytic activity; nucleoplasm; cytosol; programmed cell death; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_12528,FUN_031730-T1,Peve_00029896,,apul_peve,66.197,FUN_031730-T1,Q55BP0,H33C_DICDI,,"Histone H3.3 type c (Histone 3, variant 3 type c)",Dictyostelium discoideum (Social amoeba),54.3,92.0,7.5e-20,98.6,sp|Q55BP0|H33C_DICDI Histone H3.3 type c OS=Dictyostelium discoideum OX=44689 GN=H3c PE=1 SV=1,GO:0000786; GO:0003677; GO:0005634; GO:0019954; GO:0030527; GO:0034644; GO:0040029; GO:0046982,asexual reproduction [GO:0019954]; cellular response to UV [GO:0034644]; epigenetic regulation of gene expression [GO:0040029],nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0006325; GO:0022414; GO:0043226,DNA binding; structural molecule activity; nucleus; chromatin organization; reproductive process; organelle
OG_12578,FUN_032244-T1,Peve_00014124,,apul_peve,59.02,FUN_032244-T1,Q6DFX2,ANTR2_MOUSE,,Anthrax toxin receptor 2,Mus musculus (Mouse),30.2,490.0,1.4e-53,212.2,sp|Q6DFX2|ANTR2_MOUSE Anthrax toxin receptor 2 OS=Mus musculus OX=10090 GN=Antxr2 PE=1 SV=1,GO:0007338; GO:0009897; GO:0009986; GO:0016020; GO:0030199; GO:0038023; GO:0046872; GO:0060065,collagen fibril organization [GO:0030199]; single fertilization [GO:0007338]; uterus development [GO:0060065],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020],metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023],GO:0022414; GO:0030198; GO:0048856; GO:0060089,reproductive process; extracellular matrix organization; anatomical structure development; molecular transducer activity
OG_12602,FUN_032563-T1,Peve_00010107,,apul_peve,69.097,FUN_032563-T1,Q6P4F1,OFUT3_HUMAN,,"GDP-fucose protein O-fucosyltransferase 3 (EC 2.4.1.221) (Alpha-(1,3)-fucosyltransferase 10) (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)",Homo sapiens (Human),26.9,349.0,5.8e-23,110.5,sp|Q6P4F1|OFUT3_HUMAN GDP-fucose protein O-fucosyltransferase 3 OS=Homo sapiens OX=9606 GN=FUT10 PE=1 SV=2,GO:0000139; GO:0005654; GO:0005764; GO:0005783; GO:0005789; GO:0005794; GO:0006457; GO:0006486; GO:0006605; GO:0007399; GO:0008417; GO:0009312; GO:0009566; GO:0021799; GO:0030097; GO:0036065; GO:0036071; GO:0036445; GO:0042060; GO:0042355; GO:0046920; GO:0046922; GO:0050714; GO:0097150; GO:0097402,cerebral cortex radially oriented cell migration [GO:0021799]; fertilization [GO:0009566]; fucosylation [GO:0036065]; hemopoiesis [GO:0030097]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; neuroblast migration [GO:0097402]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of protein secretion [GO:0050714]; protein folding [GO:0006457]; protein glycosylation [GO:0006486]; protein targeting [GO:0006605]; wound healing [GO:0042060],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005654; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0005975; GO:0006457; GO:0006486; GO:0016740; GO:0022414; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleoplasm; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein folding; protein glycosylation; transferase activity; reproductive process; wound healing; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_12609,FUN_032640-T1,Peve_00015952,,apul_peve,58.209,FUN_032640-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),21.4,322.0,1.5e-08,62.0,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_12629,FUN_032835-T1,Peve_00014561,,apul_peve,57.269,FUN_032835-T1,Q38912,RAC3_ARATH,,Rac-like GTP-binding protein ARAC3 (AtRAC1) (GTPase protein ROP6),Arabidopsis thaliana (Mouse-ear cress),36.8,190.0,1.2e-19,98.6,sp|Q38912|RAC3_ARATH Rac-like GTP-binding protein ARAC3 OS=Arabidopsis thaliana OX=3702 GN=ARAC3 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005819; GO:0005886; GO:0007264; GO:0009734; GO:0009958; GO:0010928; GO:0019003; GO:0030427; GO:0043622; GO:0048446; GO:0048766; GO:0048767; GO:0051211,anisotropic cell growth [GO:0051211]; auxin-activated signaling pathway [GO:0009734]; cortical microtubule organization [GO:0043622]; petal morphogenesis [GO:0048446]; positive gravitropism [GO:0009958]; regulation of auxin mediated signaling pathway [GO:0010928]; root hair elongation [GO:0048767]; root hair initiation [GO:0048766]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; spindle [GO:0005819],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005730; GO:0005886; GO:0007010; GO:0016787; GO:0022414; GO:0043226,catalytic activity; GTPase activity; nucleus; nucleolus; plasma membrane; cytoskeleton organization; hydrolase activity; reproductive process; organelle
OG_12659,FUN_033298-T1,Peve_00025356,,apul_peve,54.605,FUN_033298-T1,Q5S006,LRRK2_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),Mus musculus (Mouse),22.1,384.0,1.8e-11,73.2,sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2,GO:0000139; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007005; GO:0007029; GO:0007030; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0031965; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; multivesicular body, internal vesicle [GO:0097487]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; nucleoplasm; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_12728,FUN_034253-T2,Peve_00031517,,apul_peve,48.8715,FUN_034253-T2,Q04589,FGFR1_RAT,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Rattus norvegicus (Rat),26.7,472.0,1.3e-26,122.9,sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Fgfr1 PE=1 SV=1,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0002931; GO:0004713; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007565; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010966; GO:0010976; GO:0017134; GO:0019827; GO:0021769; GO:0021827; GO:0021847; GO:0021954; GO:0022028; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0031667; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0043536; GO:0043583; GO:0044344; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050839; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071222; GO:0071344; GO:0071420; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:1990090; GO:2000491; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to histamine [GO:0071420]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nerve growth factor stimulus [GO:1990090]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; female pregnancy [GO:0007565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postnatal olfactory bulb interneuron migration [GO:0021827]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; regulation of stem cell proliferation [GO:0072091]; response to ischemia [GO:0002931]; response to nutrient levels [GO:0031667]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_12736,FUN_034315-T1,Peve_00016717,,apul_peve,64.49,FUN_034315-T1,Q8NI77,KI18A_HUMAN,,Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A),Homo sapiens (Human),44.0,659.0,7.4e-141,503.1,sp|Q8NI77|KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens OX=9606 GN=KIF18A PE=1 SV=2,GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023,cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520],caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726],actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463],GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0007018; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140013; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; microtubule-based movement; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; meiotic nuclear division; ATP-dependent activity
OG_12742,FUN_034358-T1,Peve_00026452,,apul_peve,92.053,FUN_034358-T1,A3RL54,SL9C1_STRPU,,Sperm-specific sodium:proton exchanger (Solute carrier family 9 member C1) (Voltage-gated Na(+)/H(+) exchanger),Strongylocentrotus purpuratus (Purple sea urchin),58.3,533.0,3.1e-165,583.2,sp|A3RL54|SL9C1_STRPU Sperm-specific sodium:proton exchanger OS=Strongylocentrotus purpuratus OX=7668 GN=SLC9C1 PE=1 SV=1,GO:0005886; GO:0007338; GO:0015385; GO:0015386; GO:0030552; GO:0030553; GO:0036126; GO:0042803; GO:0051453; GO:0061827; GO:0071805; GO:0098719,potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion import across plasma membrane [GO:0098719],plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827],cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; potassium:proton antiporter activity [GO:0015386]; protein homodimerization activity [GO:0042803]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005886; GO:0005929; GO:0022414; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; reproductive process; organelle; transmembrane transport
OG_12743,FUN_034360-T1,Peve_00036162,,apul_peve,80.0,FUN_034360-T1,Q3SZW1,TSSK1_BOVIN,,Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1),Bos taurus (Bovine),49.5,307.0,1.1e-69,265.0,sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1,GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005929; GO:0007010; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cilium; cytoskeleton organization; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_12792,FUN_035025-T1,Peve_00024647,,apul_peve,61.017,FUN_035025-T1,P47032,PRY1_YEAST,,Protein PRY1 (Pathogenesis-related protein 1),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),37.8,143.0,3.2e-14,81.3,sp|P47032|PRY1_YEAST Protein PRY1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY1 PE=1 SV=1,GO:0000287; GO:0000324; GO:0005504; GO:0005576; GO:0005615; GO:0005635; GO:0005783; GO:0015485; GO:0015908; GO:0015918; GO:0019953; GO:0032934,fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fungal-type vacuole [GO:0000324]; nuclear envelope [GO:0005635],cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]; magnesium ion binding [GO:0000287]; sterol binding [GO:0032934],GO:0005576; GO:0005615; GO:0005635; GO:0005773; GO:0005783; GO:0008289; GO:0022414; GO:0043226,extracellular region; extracellular space; nuclear envelope; vacuole; endoplasmic reticulum; lipid binding; reproductive process; organelle
OG_12861,FUN_035606-T1,Peve_00027475,,apul_peve,43.773,FUN_035606-T1,Q01177,PLMN_RAT,,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Rattus norvegicus (Rat),39.2,120.0,2e-15,86.3,sp|Q01177|PLMN_RAT Plasminogen OS=Rattus norvegicus OX=10116 GN=Plg PE=2 SV=2,GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005615; GO:0006508; GO:0007596; GO:0009897; GO:0009986; GO:0010812; GO:0016485; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1990405,"blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685],apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0022414; GO:0023052; GO:0030154; GO:0030198; GO:0048856; GO:0048870; GO:0051604; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; reproductive process; signaling; cell differentiation; extracellular matrix organization; anatomical structure development; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_12897,FUN_035946-T1,Peve_00036634,,apul_peve,38.79,FUN_035946-T1,O14544,SOCS6_HUMAN,,Suppressor of cytokine signaling 6 (SOCS-6) (Cytokine-inducible SH2 protein 4) (CIS-4) (Suppressor of cytokine signaling 4) (SOCS-4),Homo sapiens (Human),44.4,162.0,1.1e-27,125.9,sp|O14544|SOCS6_HUMAN Suppressor of cytokine signaling 6 OS=Homo sapiens OX=9606 GN=SOCS6 PE=1 SV=2,GO:0001772; GO:0005737; GO:0005829; GO:0006952; GO:0007259; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0035591; GO:0040008; GO:0050868,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008],cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772],signaling adaptor activity [GO:0035591],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_12908,FUN_036034-T1,Peve_00011098,,apul_peve,59.0655,FUN_036034-T1,Q587J7,TDR12_HUMAN,,Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12),Homo sapiens (Human),27.4,742.0,9.7e-78,293.9,sp|Q587J7|TDR12_HUMAN Putative ATP-dependent RNA helicase TDRD12 OS=Homo sapiens OX=9606 GN=TDRD12 PE=1 SV=2,GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923,fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],PET complex [GO:1990923],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724],GO:0003824; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0140013; GO:0140098; GO:0140657,"catalytic activity; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12918,FUN_036148-T1,Peve_00000293,,apul_peve,99.105,FUN_036148-T1,Q3MHM5,TBB4B_BOVIN,,Tubulin beta-4B chain (Tubulin beta-2C chain),Bos taurus (Bovine),99.3,430.0,4.6e-255,881.3,sp|Q3MHM5|TBB4B_BOVIN Tubulin beta-4B chain OS=Bos taurus OX=9913 GN=TUBB4B PE=1 SV=1,GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005879; GO:0030317; GO:0036126; GO:0045171; GO:0046872; GO:0072686,flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; sperm flagellum [GO:0036126],double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003723; GO:0003824; GO:0003924; GO:0005198; GO:0005929; GO:0007010; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048870,mitotic cell cycle; RNA binding; catalytic activity; GTPase activity; structural molecule activity; cilium; cytoskeleton organization; microtubule-based movement; hydrolase activity; reproductive process; organelle; cell motility
OG_12971,FUN_037091-T1,Peve_00004756,,apul_peve,81.046,FUN_037091-T1,A2CEI6,PIWL2_DANRE,,Piwi-like protein 2 (EC 3.1.26.-),Danio rerio (Zebrafish) (Brachydanio rerio),49.3,762.0,1.4999999999999996e-229,797.7,sp|A2CEI6|PIWL2_DANRE Piwi-like protein 2 OS=Danio rerio OX=7955 GN=piwil2 PE=1 SV=2,GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007276; GO:0007283; GO:0010628; GO:0030718; GO:0031047; GO:0034584; GO:0034587; GO:0043186; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060392; GO:0071546; GO:0140965; GO:0141005; GO:0141196; GO:1990923,gamete generation [GO:0007276]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of SMAD protein signal transduction [GO:0060392]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by heterochromatin formation [GO:0141005]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; PET complex [GO:1990923]; pi-body [GO:0071546],metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; RNA endonuclease activity [GO:0004521],GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_12972,FUN_037103-T1,Peve_00003257,,apul_peve,56.855,FUN_037103-T1,P42695,CNDD3_HUMAN,,Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3),Homo sapiens (Human),22.1,195.0,4.2e-09,63.2,sp|P42695|CNDD3_HUMAN Condensin-2 complex subunit D3 OS=Homo sapiens OX=9606 GN=NCAPD3 PE=1 SV=2,GO:0000779; GO:0000794; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0042393; GO:0051301; GO:0051984; GO:0140117; GO:1905820; GO:1905821,cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820],"condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]",histone binding [GO:0042393]; histone H4K20me1 reader activity [GO:0140117],GO:0000228; GO:0005654; GO:0005694; GO:0022414; GO:0042393; GO:0043226; GO:0060090,nuclear chromosome; nucleoplasm; chromosome; reproductive process; histone binding; organelle; molecular adaptor activity
OG_12991,FUN_037307-T1,Peve_00015039,,apul_peve,97.143,FUN_037307-T1,P40946,ARF6_DROME,,ADP-ribosylation factor 6 (ARF6) (ADP ribosylation factor at 51F) (ADP-ribosylation factor 3),Drosophila melanogaster (Fruit fly),90.8,174.0,1.7e-91,336.7,sp|P40946|ARF6_DROME ADP-ribosylation factor 6 OS=Drosophila melanogaster OX=7227 GN=Arf6 PE=1 SV=3,GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007112; GO:0007269; GO:0007283; GO:0007476; GO:0007520; GO:0008047; GO:0010628; GO:0016192; GO:0030036; GO:0032154; GO:0048149; GO:0048488; GO:0055037; GO:0097305; GO:0098793,actin cytoskeleton organization [GO:0030036]; behavioral response to ethanol [GO:0048149]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; myoblast fusion [GO:0007520]; neurotransmitter secretion [GO:0007269]; positive regulation of gene expression [GO:0010628]; response to alcohol [GO:0097305]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037],enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000910; GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772,cytokinesis; catalytic activity; GTPase activity; endosome; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_13009,FUN_037450-T1,Peve_00007928,,apul_peve,52.792,FUN_037450-T1,Q9VXD9,MTH1_DROME,,Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1),Drosophila melanogaster (Fruit fly),27.1,203.0,8.8e-08,58.9,sp|Q9VXD9|MTH1_DROME Probable G-protein coupled receptor Mth-like 1 OS=Drosophila melanogaster OX=7227 GN=mthl1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016020; GO:0042594; GO:0043519; GO:0048383; GO:0070252,actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0048870; GO:0060089,plasma membrane; anatomical structure development; cell motility; molecular transducer activity
OG_13022,FUN_037559-T4,Peve_00030227,,apul_peve,51.288,FUN_037559-T4,Q61382,TRAF4_MOUSE,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),Mus musculus (Mouse),27.6,475.0,2e-58,228.0,sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; defense response to other organism
OG_13040,FUN_037839-T1,Peve_00000572,,apul_peve,65.7885,FUN_037839-T1,Q3UHH1,ZSWM8_MOUSE,,Zinc finger SWIM domain-containing protein 8,Mus musculus (Mouse),35.1,2133.0,1.2e-277,958.4,sp|Q3UHH1|ZSWM8_MOUSE Zinc finger SWIM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Zswim8 PE=1 SV=1,GO:0005829; GO:0008270; GO:0016567; GO:0031461; GO:0031463; GO:0043161; GO:1990756; GO:2000627,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_13130,FUN_038936-T1,Peve_00028761,,apul_peve,88.489,FUN_038936-T1,Q7ZUY3,H2AX_DANRE,,Histone H2AX (H2a/x) (Histone H2A.X),Danio rerio (Zebrafish) (Brachydanio rerio),78.2,142.0,6e-52,204.9,sp|Q7ZUY3|H2AX_DANRE Histone H2AX OS=Danio rerio OX=7955 GN=h2ax PE=2 SV=3,GO:0000786; GO:0003677; GO:0005634; GO:0005694; GO:0005813; GO:0006281; GO:0006310; GO:0006974; GO:0030527; GO:0031507; GO:0046982; GO:0051321,DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; heterochromatin formation [GO:0031507]; meiotic cell cycle [GO:0051321],centrosome [GO:0005813]; chromosome [GO:0005694]; nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0005694; GO:0005815; GO:0006281; GO:0006310; GO:0006325; GO:0022414; GO:0043226,DNA binding; structural molecule activity; nucleus; chromosome; microtubule organizing center; DNA repair; DNA recombination; chromatin organization; reproductive process; organelle
OG_13172,FUN_039655-T1,Peve_00034507,,apul_peve,62.23,FUN_039655-T1,Q5GLZ8,HERC4_HUMAN,,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),Homo sapiens (Human),22.4,379.0,1.7e-08,62.8,sp|Q5GLZ8|HERC4_HUMAN Probable E3 ubiquitin-protein ligase HERC4 OS=Homo sapiens OX=9606 GN=HERC4 PE=1 SV=1,GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630,cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0140096,"catalytic activity; cytosol; transferase activity; reproductive process; cell differentiation; catalytic activity, acting on a protein"
OG_13182,FUN_039775-T1,Peve_00030562,,apul_peve,88.194,FUN_039775-T1,E1BNS6,SPAG8_BOVIN,,Sperm-associated antigen 8,Bos taurus (Bovine),40.7,177.0,7e-27,122.1,sp|E1BNS6|SPAG8_BOVIN Sperm-associated antigen 8 OS=Bos taurus OX=9913 GN=SPAG8 PE=1 SV=3,GO:0001669; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0005879; GO:0007283; GO:0007338; GO:0008017; GO:0030154; GO:0030317; GO:0036126; GO:0045944; GO:0160111,cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005634; GO:0005815; GO:0005929; GO:0006355; GO:0007018; GO:0008092; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048870,nucleus; microtubule organizing center; cilium; regulation of DNA-templated transcription; microtubule-based movement; cytoskeletal protein binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cell motility
OG_13199,FUN_039992-T1,Peve_00004419,,apul_peve,71.87049999999999,FUN_039992-T1,Q08431,MFGM_HUMAN,,Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin],Homo sapiens (Human),36.2,188.0,2.8e-17,91.3,sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0043277; GO:0062023; GO:0070062; GO:1903561,angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338],acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020],integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786],GO:0005576; GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0043226,extracellular region; extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; organelle
OG_13205,FUN_040016-T1,Peve_00004959,,apul_peve,48.2285,FUN_040016-T1,Q7Z3E1,PARPT_HUMAN,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (Poly [ADP-ribose] polymerase 7) (PARP-7) (TCDD-inducible poly [ADP-ribose] polymerase),Homo sapiens (Human),37.0,235.0,1.3e-38,163.7,sp|Q7Z3E1|PARPT_HUMAN Protein mono-ADP-ribosyltransferase TIPARP OS=Homo sapiens OX=9606 GN=TIPARP PE=1 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612; GO:1990404,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_13207,FUN_040081-T1,Peve_00041164,,apul_peve,68.058,FUN_040081-T1,Q99999,G3ST1_HUMAN,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Homo sapiens (Human),34.8,356.0,3.8e-45,184.1,sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1,GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665],Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886],galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005886; GO:0006629; GO:0009101; GO:0016740; GO:0022414; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_13227,FUN_040270-T1,Peve_00008067,,apul_peve,53.094,FUN_040270-T1,Q95254,GHSR_PIG,,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),Sus scrofa (Pig),24.5,302.0,5.1e-11,70.1,sp|Q95254|GHSR_PIG Growth hormone secretagogue receptor type 1 OS=Sus scrofa OX=9823 GN=GHSR PE=2 SV=1,GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0008154; GO:0009725; GO:0009755; GO:0009986; GO:0016520; GO:0032691; GO:0032715; GO:0032720; GO:0040018; GO:0043005; GO:0045121; GO:0046697; GO:0050728,actin polymerization or depolymerization [GO:0008154]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of multicellular organism growth [GO:0040018]; response to hormone [GO:0009725],cell surface [GO:0009986]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_13352,FUN_041942-T1,Peve_00023592,,apul_peve,71.0395,FUN_041942-T1,E9Q5M6,CFA44_MOUSE,,Cilia- and flagella-associated protein 44,Mus musculus (Mouse),44.1,1785.0,0.0,1172.1,sp|E9Q5M6|CFA44_MOUSE Cilia- and flagella-associated protein 44 OS=Mus musculus OX=10090 GN=Cfap44 PE=2 SV=1,GO:0000226; GO:0000902; GO:0005930; GO:0006997; GO:0007283; GO:0007288; GO:0008233; GO:0030317; GO:0031514; GO:0044782,cell morphogenesis [GO:0000902]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; motile cilium [GO:0031514],peptidase activity [GO:0008233],GO:0003824; GO:0005929; GO:0007010; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096,"catalytic activity; cilium; cytoskeleton organization; microtubule-based movement; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein"
OG_13392,FUN_042582-T1,Peve_00034295,,apul_peve,80.2,FUN_042582-T1,Q5JTW2,CEP78_HUMAN,,Centrosomal protein of 78 kDa (Cep78),Homo sapiens (Human),36.7,586.0,1.1e-91,339.0,sp|Q5JTW2|CEP78_HUMAN Centrosomal protein of 78 kDa OS=Homo sapiens OX=9606 GN=CEP78 PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0030317; GO:0031397; GO:0036064; GO:0044782; GO:0061512; GO:0071539,cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; negative regulation of protein ubiquitination [GO:0031397]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],,GO:0005815; GO:0005829; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,microtubule organizing center; cytosol; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_13411,FUN_042987-T1,Peve_00036063,,apul_peve,67.976,FUN_042987-T1,Q60HG2,TOR1A_MACFA,,Torsin-1A (Dystonia 1 protein) (Torsin ATPase 1) (EC 3.6.4.-) (Torsin family 1 member A),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),48.5,307.0,5.2e-86,319.3,sp|Q60HG2|TOR1A_MACFA Torsin-1A OS=Macaca fascicularis OX=9541 GN=TOR1A PE=2 SV=1,GO:0000338; GO:0005524; GO:0005635; GO:0005788; GO:0005789; GO:0005856; GO:0006998; GO:0007155; GO:0008021; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051085; GO:0051584; GO:0061077; GO:0071763; GO:0140662; GO:1900244; GO:2000008,"cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]",cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894],GO:0003824; GO:0005635; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048870; GO:0061024; GO:0140657,catalytic activity; nuclear envelope; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; cell motility; membrane organization; ATP-dependent activity
OG_13436,FUN_043219-T1,Peve_00037103,,apul_peve,51.6115,FUN_043219-T1,Q969U6,FBXW5_HUMAN,,F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5),Homo sapiens (Human),31.5,565.0,1.1e-63,245.7,sp|Q969U6|FBXW5_HUMAN F-box/WD repeat-containing protein 5 OS=Homo sapiens OX=9606 GN=FBXW5 PE=1 SV=1,GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005],protein kinase binding [GO:0019901],GO:0005829; GO:0030163,cytosol; protein catabolic process
OG_13460,FUN_043419-T2,Peve_00005570,,apul_peve,79.09700000000001,FUN_043419-T2,Q80ZI6,LRSM1_MOUSE,,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase),Mus musculus (Mouse),38.8,730.0,3.9e-70,267.7,sp|Q80ZI6|LRSM1_MOUSE E3 ubiquitin-protein ligase LRSAM1 OS=Mus musculus OX=10090 GN=Lrsam1 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786,autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016192; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; autophagy; vesicle-mediated transport; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_13482,FUN_043580-T2,Peve_00018891,,apul_peve,85.3375,FUN_043580-T2,Q5T4S7,UBR4_HUMAN,,E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600),Homo sapiens (Human),47.4,5166.0,0.0,4017.2,sp|Q5T4S7|UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1,GO:0004842; GO:0005516; GO:0005654; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0007032; GO:0008270; GO:0010508; GO:0016020; GO:0035579; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0061630; GO:0070821; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0101003; GO:0140455; GO:0141191; GO:0141198,cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; endosome; microtubule organizing center; cytosol; plasma membrane; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_13685,FUN_045277-T2,Peve_00034973,,apul_peve,73.526,FUN_045277-T2,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),52.5,897.0,3.2e-77,291.6,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_13818,FUN_000956-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2481.t1,apul_ptua,40.741,FUN_000956-T1,D2X8K2,PA2_CONGI,,Phospholipase A2 A2-actitoxin-Cgg2a (A2-AITX-Cgg2a) (EC 3.1.1.4) (CgPLA2) (Phosphatidylcholine 2-acylhydrolase),Condylactis gigantea (Giant Caribbean anemone) (Condylactis passiflora),40.5,116.0,1.5e-21,105.9,sp|D2X8K2|PA2_CONGI Phospholipase A2 A2-actitoxin-Cgg2a OS=Condylactis gigantea OX=47073 PE=1 SV=1,GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0042151; GO:0044398; GO:0044470; GO:0044522; GO:0047498; GO:0050482; GO:0090729,arachidonate secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; venom-mediated edema in another organism [GO:0044398]; venom-mediated myocyte killing in another organism [GO:0044522]; venom-mediated suppression of blood coagulation [GO:0044470],extracellular region [GO:0005576]; nematocyst [GO:0042151],calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729],GO:0003824; GO:0005576; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0090729,catalytic activity; extracellular region; lipid metabolic process; lipid binding; hydrolase activity; organelle; toxin activity
OG_13822,FUN_001040-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29633.t1,apul_ptua,64.899,FUN_001040-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),41.8,404.0,2.7e-92,340.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_13848,FUN_001352-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1873.t1,apul_ptua,78.788,FUN_001352-T1,Q6P926,SPA24_MOUSE,,Spermatogenesis-associated protein 24 (TATA-binding protein-like factor-interacting protein) (TLF-interacting protein) (TRF2-interacting protein in testis) (Testis protein T6441 homolog),Mus musculus (Mouse),39.5,172.0,1.8e-25,117.5,sp|Q6P926|SPA24_MOUSE Spermatogenesis-associated protein 24 OS=Mus musculus OX=10090 GN=Spata24 PE=1 SV=1,GO:0001673; GO:0003677; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154; GO:0042802,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0022414; GO:0030154; GO:0043226,DNA binding; nucleus; nucleoplasm; nucleolus; cytosol; reproductive process; cell differentiation; organelle
OG_13874,FUN_001786-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1b,apul_ptua,62.6245,FUN_001786-T1,P25054,APC_HUMAN,,Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5),Homo sapiens (Human),52.6,460.0,7.4e-119,430.6,sp|P25054|APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens OX=9606 GN=APC PE=1 SV=2,GO:0000281; GO:0000776; GO:0001708; GO:0003170; GO:0003203; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0006974; GO:0007026; GO:0007094; GO:0007155; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019887; GO:0019901; GO:0030027; GO:0030335; GO:0030877; GO:0031274; GO:0031625; GO:0032587; GO:0032886; GO:0043065; GO:0043161; GO:0045295; GO:0045732; GO:0045736; GO:0048471; GO:0051010; GO:0051988; GO:0060632; GO:0065003; GO:0070830; GO:0070840; GO:0090090; GO:0120162; GO:1902807; GO:1904781; GO:1990909; GO:2000134,bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of microtubule-based movement [GO:0060632]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909],beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625],GO:0000910; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007155; GO:0008092; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:0098772,cytokinesis; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cell adhesion; cytoskeletal protein binding; protein catabolic process; cell junction organization; organelle; anatomical structure development; cell motility; protein-containing complex assembly; molecular function regulator activity
OG_13927,FUN_003387-T3,,Pocillopora_meandrina_HIv1___RNAseq.g20740.t1,apul_ptua,49.246,FUN_003387-T3,P48052,CBPA2_HUMAN,,Carboxypeptidase A2 (EC 3.4.17.15),Homo sapiens (Human),36.9,398.0,1e-73,278.9,sp|P48052|CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens OX=9606 GN=CPA2 PE=1 SV=3,GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270,protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773],carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; vacuole; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_13943,FUN_003846-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11166.t3,apul_ptua,49.3895,FUN_003846-T1,Q96MU7,YTDC1_HUMAN,,YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B),Homo sapiens (Human),60.8,171.0,3.2999999999999996e-53,211.5,sp|Q96MU7|YTDC1_HUMAN YTH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=YTHDC1 PE=1 SV=3,GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247,"dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005886; GO:0006325; GO:0006913; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0065003,RNA binding; nucleus; nucleoplasm; plasma membrane; chromatin organization; nucleocytoplasmic transport; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_13945,FUN_003896-T1,,Pocillopora_meandrina_HIv1___TS.g8775.t2,apul_ptua,54.7705,FUN_003896-T1,Q3MSQ8,DDX4_PELLE,,Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog),Pelophylax lessonae (Pool frog) (Rana lessonae),54.3,477.0,2.3e-139,498.0,sp|Q3MSQ8|DDX4_PELLE Probable ATP-dependent RNA helicase DDX4 OS=Pelophylax lessonae OX=45623 GN=ddx4 PE=2 SV=1,GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007141; GO:0007283; GO:0016887; GO:0034587; GO:0048477; GO:0071546; GO:0071547; GO:0141006; GO:0141196,male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],pi-body [GO:0071546]; piP-body [GO:0071547],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724],GO:0003824; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"catalytic activity; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_13947,FUN_003928-T1,,Pocillopora_meandrina_HIv1___TS.g7826.t1,apul_ptua,52.244,FUN_003928-T1,Q08345,DDR1_HUMAN,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Homo sapiens (Human),32.4,148.0,7.8e-10,67.8,sp|Q08345|DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens OX=9606 GN=DDR1 PE=1 SV=1,GO:0001558; GO:0001952; GO:0004714; GO:0005518; GO:0005524; GO:0005615; GO:0005886; GO:0007155; GO:0007169; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0010976; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0051897; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:0070062; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005615; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular space; plasma membrane; cell adhesion; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_13957,FUN_004122-T2,,Pocillopora_meandrina_HIv1___RNAseq.g11570.t2,apul_ptua,92.822,FUN_004122-T2,Q9D180,CFA57_MOUSE,,Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65),Mus musculus (Mouse),63.1,1238.0,5.1000000000000005e-272,939.1,sp|Q9D180|CFA57_MOUSE Cilia- and flagella-associated protein 57 OS=Mus musculus OX=10090 GN=Cfap57 PE=1 SV=3,GO:0005737; GO:0005856; GO:0007338; GO:0036126; GO:0044782; GO:0070286; GO:0120316,axonemal dynein complex assembly [GO:0070286]; cilium organization [GO:0044782]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],,GO:0005856; GO:0005929; GO:0022414; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; cilium; reproductive process; organelle; cilium organization; protein-containing complex assembly
OG_13958,FUN_004161-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16769.t1,apul_ptua,76.712,FUN_004161-T1,Q9Z2X8,KEAP1_MOUSE,,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2),Mus musculus (Mouse),40.2,179.0,4.7e-32,140.2,sp|Q9Z2X8|KEAP1_MOUSE Kelch-like ECH-associated protein 1 OS=Mus musculus OX=10090 GN=Keap1 PE=1 SV=1,GO:0000122; GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032991; GO:0034451; GO:0034599; GO:0042802; GO:0043161; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:0140416; GO:1902883; GO:1990756,cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511],actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005783; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleoplasm; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_14012,FUN_005266-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8153.t1,apul_ptua,40.282,FUN_005266-T1,Q8BH97,RCN3_MOUSE,,Reticulocalbin-3,Mus musculus (Mouse),28.0,250.0,6.4e-16,86.3,sp|Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus musculus OX=10090 GN=Rcn3 PE=1 SV=1,GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509],GO:0005783; GO:0030163; GO:0043226; GO:0048856,endoplasmic reticulum; protein catabolic process; organelle; anatomical structure development
OG_14114,FUN_007868-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18304.t1,apul_ptua,73.74,FUN_007868-T1,O15315,RA51B_HUMAN,,DNA repair protein RAD51 homolog 2 (R51H2) (RAD51 homolog B) (Rad51B) (RAD51-like protein 1),Homo sapiens (Human),52.7,353.0,6.3e-96,352.4,sp|O15315|RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens OX=9606 GN=RAD51B PE=1 SV=2,GO:0000724; GO:0001832; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0006281; GO:0006310; GO:0007131; GO:0008094; GO:0008284; GO:0010971; GO:0016887; GO:0033063; GO:0061053; GO:0140664,blastocyst growth [GO:0001832]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; somite development [GO:0061053],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_14118,FUN_007999-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18156.t1,apul_ptua,67.61,FUN_007999-T1,Q8NDG6,TDRD9_HUMAN,,ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9),Homo sapiens (Human),43.0,1263.0,1.9e-278,960.7,sp|Q8NDG6|TDRD9_HUMAN ATP-dependent RNA helicase TDRD9 OS=Homo sapiens OX=9606 GN=TDRD9 PE=1 SV=3,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0034587; GO:0071547; GO:0141006; GO:0141196,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0031047; GO:0043226; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_14120,FUN_008022-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30347.t1,apul_ptua,52.604,FUN_008022-T1,P47033,PRY3_YEAST,,Cell wall protein PRY3 (Pathogenesis-related protein 3),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),33.7,163.0,9.2e-14,78.6,sp|P47033|PRY3_YEAST Cell wall protein PRY3 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY3 PE=1 SV=1,GO:0000747; GO:0005615; GO:0009277; GO:0015908; GO:0015918; GO:0019953; GO:0071944; GO:0098552,conjugation with cellular fusion [GO:0000747]; fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],cell periphery [GO:0071944]; extracellular space [GO:0005615]; fungal-type cell wall [GO:0009277]; side of membrane [GO:0098552],,GO:0005615; GO:0005618; GO:0022414; GO:0030312,extracellular space; cell wall; reproductive process; external encapsulating structure
OG_14124,FUN_008056-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30158.t2,apul_ptua,65.494,FUN_008056-T1,O14678,ABCD4_HUMAN,,Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),Homo sapiens (Human),50.5,610.0,3.4e-160,566.6,sp|O14678|ABCD4_HUMAN Lysosomal cobalamin transporter ABCD4 OS=Homo sapiens OX=9606 GN=ABCD4 PE=1 SV=1,GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042802; GO:0043190; GO:0055085; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760],ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324],GO:0003824; GO:0005215; GO:0005777; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; peroxisome; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_14144,FUN_008410-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18039.t1,apul_ptua,53.674,FUN_008410-T1,Q95254,GHSR_PIG,,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),Sus scrofa (Pig),28.2,337.0,7.4e-11,69.7,sp|Q95254|GHSR_PIG Growth hormone secretagogue receptor type 1 OS=Sus scrofa OX=9823 GN=GHSR PE=2 SV=1,GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0008154; GO:0009725; GO:0009755; GO:0009986; GO:0016520; GO:0032691; GO:0032715; GO:0032720; GO:0040018; GO:0043005; GO:0045121; GO:0046697; GO:0050728,actin polymerization or depolymerization [GO:0008154]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of multicellular organism growth [GO:0040018]; response to hormone [GO:0009725],cell surface [GO:0009986]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_14146,FUN_008422-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14381.t1,apul_ptua,45.717,FUN_008422-T1,Q6RT24,CENPE_MOUSE,,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10),Mus musculus (Mouse),51.6,436.0,8e-107,391.0,sp|Q6RT24|CENPE_MOUSE Centromere-associated protein E OS=Mus musculus OX=10090 GN=Cenpe PE=1 SV=1,GO:0000775; GO:0000776; GO:0000940; GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0007018; GO:0007057; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0019901; GO:0031647; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051301; GO:0051310; GO:0051315; GO:0051984; GO:0051987; GO:0099607,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle [GO:0005819]",ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901],GO:0003774; GO:0003824; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0022414; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; reproductive process; organelle; ATP-dependent activity
OG_14149,FUN_008588-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12771.t1,apul_ptua,75.037,FUN_008588-T1,Q5U3U3,CPT2_DANRE,,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)",Danio rerio (Zebrafish) (Brachydanio rerio),53.9,668.0,3.5e-206,719.5,"sp|Q5U3U3|CPT2_DANRE Carnitine O-palmitoyltransferase 2, mitochondrial OS=Danio rerio OX=7955 GN=cpt2 PE=2 SV=2",GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458,fatty acid beta-oxidation [GO:0006635],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_14168,FUN_008987-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3900.t1,apul_ptua,90.829,FUN_008987-T1,E1BKH1,EFHC1_BOVIN,,EF-hand domain-containing protein 1 (Myoclonin-1),Bos taurus (Bovine),59.7,551.0,9.2e-200,698.0,sp|E1BKH1|EFHC1_BOVIN EF-hand domain-containing protein 1 OS=Bos taurus OX=9913 GN=EFHC1 PE=1 SV=1,GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0021795; GO:0030317; GO:0036126; GO:0043014; GO:0051302; GO:0060285; GO:0072686; GO:0160111,cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509],GO:0000910; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048870,cytokinesis; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cell motility
OG_14235,FUN_011067-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22324.t1,apul_ptua,66.887,FUN_011067-T1,Q9W074,HBS1_DROME,,Protein HBS1 (EC 3.6.5.-),Drosophila melanogaster (Fruit fly),34.8,161.0,5.8e-10,66.2,sp|Q9W074|HBS1_DROME Protein HBS1 OS=Drosophila melanogaster OX=7227 GN=HBS1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006417; GO:0007291; GO:0016441; GO:0045089; GO:0048137; GO:0050829,defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]; post-transcriptional gene silencing [GO:0016441]; regulation of translation [GO:0006417]; sperm individualization [GO:0007291]; spermatocyte division [GO:0048137]; translation [GO:0006412],cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016787; GO:0022414,catalytic activity; GTPase activity; hydrolase activity; reproductive process
OG_14267,FUN_012174-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23409.t1,apul_ptua,51.073,FUN_012174-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,50.9,57.0,4.2e-12,73.6,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_14285,FUN_012484-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23997.t1,apul_ptua,73.333,FUN_012484-T1,Q6DFA8,GLD2B_XENLA,,Poly(A) RNA polymerase GLD2-B (xGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4-B),Xenopus laevis (African clawed frog),38.1,320.0,2.3e-46,187.6,sp|Q6DFA8|GLD2B_XENLA Poly(A) RNA polymerase GLD2-B OS=Xenopus laevis OX=8355 GN=tent2-b PE=1 SV=1,GO:0005524; GO:0005737; GO:0006397; GO:0031123; GO:0046872; GO:0048477; GO:1990817; GO:2000626,mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA 3'-end processing [GO:0031123],cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0016071; GO:0016740; GO:0022414; GO:0048856,catalytic activity; mRNA metabolic process; transferase activity; reproductive process; anatomical structure development
OG_14299,FUN_012663-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22888.t1,apul_ptua,38.9695,FUN_012663-T1,Q6IR42,ZCPW1_MOUSE,,Zinc finger CW-type PWWP domain protein 1,Mus musculus (Mouse),34.4,270.0,3.6e-31,138.7,sp|Q6IR42|ZCPW1_MOUSE Zinc finger CW-type PWWP domain protein 1 OS=Mus musculus OX=10090 GN=Zcwpw1 PE=1 SV=2,GO:0001741; GO:0005634; GO:0007127; GO:0007129; GO:0007283; GO:0008270; GO:0030154; GO:0045911; GO:0140002; GO:0140003; GO:0140566; GO:1990918; GO:2000781,cell differentiation [GO:0030154]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283],nucleus [GO:0005634]; XY body [GO:0001741],histone H3K36me3 reader activity [GO:0140003]; histone H3K4me3 reader activity [GO:0140002]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270],GO:0005634; GO:0005694; GO:0006281; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0140013,nucleus; chromosome; DNA repair; reproductive process; cell differentiation; organelle; molecular adaptor activity; meiotic nuclear division
OG_14332,FUN_013444-T1,,Pocillopora_meandrina_HIv1___TS.g16004.t1,apul_ptua,35.889,FUN_013444-T1,Q95114,MFGM_BOVIN,,Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47),Bos taurus (Bovine),37.5,120.0,2.9e-16,88.2,sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2,GO:0001525; GO:0002080; GO:0005576; GO:0007155; GO:0007338,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338],acrosomal membrane [GO:0002080]; extracellular region [GO:0005576],,GO:0005576; GO:0007155; GO:0022414,extracellular region; cell adhesion; reproductive process
OG_14336,FUN_013612-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13532.t1,apul_ptua,72.102,FUN_013612-T1,Q5TDH0,DDI2_HUMAN,,Protein DDI1 homolog 2 (EC 3.4.23.-),Homo sapiens (Human),55.9,376.0,4.7e-109,396.4,sp|Q5TDH0|DDI2_HUMAN Protein DDI1 homolog 2 OS=Homo sapiens OX=9606 GN=DDI2 PE=1 SV=1,GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752,cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130],GO:0003824; GO:0005654; GO:0005694; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; nucleoplasm; chromosome; cytosol; hydrolase activity; protein catabolic process; organelle; protein maturation; catalytic activity, acting on a protein"
OG_14398,FUN_015070-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21193.t1,apul_ptua,83.838,FUN_015070-T1,Q969Q5,RAB24_HUMAN,,Ras-related protein Rab-24 (EC 3.6.5.2),Homo sapiens (Human),49.4,170.0,5.1e-41,169.1,sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1,GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0048471; GO:0140013,attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772; GO:0140013,catalytic activity; GTPase activity; mitochondrion; endosome; vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity; meiotic nuclear division
OG_14438,FUN_015997-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21379.t1,apul_ptua,66.741,FUN_015997-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),27.5,501.0,3.4000000000000003e-22,109.8,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_14442,FUN_016069-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21622.t1,apul_ptua,75.72,FUN_016069-T1,P92177,1433E_DROME,,14-3-3 protein epsilon (Suppressor of Ras1 3-9),Drosophila melanogaster (Fruit fly),62.4,234.0,5.7e-74,278.9,sp|P92177|1433E_DROME 14-3-3 protein epsilon OS=Drosophila melanogaster OX=7227 GN=14-3-3epsilon PE=1 SV=2,GO:0000077; GO:0001223; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007165; GO:0007294; GO:0007346; GO:0007411; GO:0007460; GO:0008103; GO:0008104; GO:0008340; GO:0008354; GO:0009411; GO:0035332; GO:0040008; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815; GO:0051012; GO:0140313; GO:0150013,axon guidance [GO:0007411]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; germ cell migration [GO:0008354]; germarium-derived oocyte fate determination [GO:0007294]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; protein localization [GO:0008104]; R8 cell fate commitment [GO:0007460]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; response to UV [GO:0009411]; signal transduction [GO:0007165]; wing disc dorsal/ventral pattern formation [GO:0048190],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],molecular sequestering activity [GO:0140313]; phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription coactivator binding [GO:0001223],GO:0005634; GO:0005654; GO:0005694; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0140313,nucleus; nucleoplasm; chromosome; mitochondrion; microtubule organizing center; cytosol; plasma membrane; microtubule-based movement; reproductive process; organelle; cell motility; molecular sequestering activity
OG_14451,FUN_016218-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5675.t1,apul_ptua,58.427,FUN_016218-T1,Q68CQ4,UTP25_HUMAN,,U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component),Homo sapiens (Human),48.3,87.0,1.1e-16,87.8,sp|Q68CQ4|UTP25_HUMAN U3 small nucleolar RNA-associated protein 25 homolog OS=Homo sapiens OX=9606 GN=UTP25 PE=1 SV=2,GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019; GO:0048568; GO:1902570,"embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]",nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511],GO:0003723; GO:0005654; GO:0005730; GO:0030163; GO:0043226; GO:0048856,RNA binding; nucleoplasm; nucleolus; protein catabolic process; organelle; anatomical structure development
OG_14482,FUN_016990-T1,,Pocillopora_meandrina_HIv1___TS.g23426.t1,apul_ptua,43.823,FUN_016990-T1,G5EDW2,LPLT1_CAEEL,,Latrophilin-like protein 1,Caenorhabditis elegans,21.8,422.0,4.3e-15,87.0,sp|G5EDW2|LPLT1_CAEEL Latrophilin-like protein 1 OS=Caenorhabditis elegans OX=6239 GN=lat-1 PE=1 SV=1,GO:0004175; GO:0004888; GO:0004930; GO:0005886; GO:0007166; GO:0009792; GO:0009952; GO:0019953; GO:0030246; GO:0097264,anterior/posterior pattern specification [GO:0009952]; cell surface receptor signaling pathway [GO:0007166]; embryo development ending in birth or egg hatching [GO:0009792]; self proteolysis [GO:0097264]; sexual reproduction [GO:0019953],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888],GO:0003824; GO:0005886; GO:0016787; GO:0022414; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; reproductive process; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_14496,FUN_017712-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25377.t1,apul_ptua,96.97,FUN_017712-T1,P60604,UB2G2_HUMAN,,Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2),Homo sapiens (Human),85.5,165.0,1.7e-77,290.0,sp|P60604|UB2G2_HUMAN Ubiquitin-conjugating enzyme E2 G2 OS=Homo sapiens OX=9606 GN=UBE2G2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0035458; GO:0036503; GO:0042802; GO:0061631; GO:0070936; GO:1904153,"cellular response to interferon-beta [GO:0035458]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005783; GO:0005811; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; lipid droplet; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_14530,FUN_018400-T2,,Pocillopora_meandrina_HIv1___RNAseq.g9956.t1,apul_ptua,69.748,FUN_018400-T2,Q96DZ1,ERLEC_HUMAN,,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),Homo sapiens (Human),39.9,316.0,1.2e-63,245.0,sp|Q96DZ1|ERLEC_HUMAN Endoplasmic reticulum lectin 1 OS=Homo sapiens OX=9606 GN=ERLEC1 PE=1 SV=1,GO:0005788; GO:0030968; GO:0030970; GO:0036503; GO:0044322; GO:0051082; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]",endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322],unfolded protein binding [GO:0051082],GO:0006886; GO:0030163,intracellular protein transport; protein catabolic process
OG_14570,FUN_019724-T1,,Pocillopora_meandrina_HIv1___TS.g27818.t1,apul_ptua,91.061,FUN_019724-T1,Q9DAM2,EFCB9_MOUSE,,EF-hand calcium-binding domain-containing protein 9,Mus musculus (Mouse),47.3,148.0,2.9e-36,153.3,sp|Q9DAM2|EFCB9_MOUSE EF-hand calcium-binding domain-containing protein 9 OS=Mus musculus OX=10090 GN=Efcab9 PE=1 SV=2,GO:0005509; GO:0005516; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283],CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228],calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calmodulin binding [GO:0005516],GO:0007018; GO:0022414; GO:0048870; GO:0098772; GO:0140299,microtubule-based movement; reproductive process; cell motility; molecular function regulator activity; molecular sensor activity
OG_14571,FUN_019802-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14685.t1,apul_ptua,39.779,FUN_019802-T1,P53767,VGFR1_RAT,,Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT),Rattus norvegicus (Rat),30.8,130.0,1.8e-08,61.6,sp|P53767|VGFR1_RAT Vascular endothelial growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Flt1 PE=2 SV=1,GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006940; GO:0007565; GO:0008284; GO:0014823; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0030522; GO:0032355; GO:0035924; GO:0036323; GO:0036332; GO:0042802; GO:0043117; GO:0043235; GO:0043410; GO:0045471; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:0048661; GO:0051897; GO:0060252; GO:0071456; GO:0097421; GO:1901534; GO:1903671; GO:1904046; GO:1905563; GO:1990384,angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; female pregnancy [GO:0007565]; hyaloid vascular plexus regression [GO:1990384]; intracellular receptor signaling pathway [GO:0030522]; liver regeneration [GO:0097421]; monocyte chemotaxis [GO:0002548]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of vascular endothelial growth factor production [GO:1904046]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; regulation of smooth muscle contraction [GO:0006940]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323],endosome [GO:0005768]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0002376; GO:0003013; GO:0003824; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0016740; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; circulatory system process; catalytic activity; extracellular space; nucleus; endosome; plasma membrane; transferase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_14617,FUN_022548-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4157.t1,apul_ptua,30.8655,FUN_022548-T1,V6CLA2,HECD1_CAEEL,,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),Caenorhabditis elegans,34.8,178.0,1.3e-16,89.7,sp|V6CLA2|HECD1_CAEEL E3 ubiquitin-protein ligase hecd-1 OS=Caenorhabditis elegans OX=6239 GN=hecd-1 PE=1 SV=1,GO:0000209; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:1902882; GO:1905936,negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],nuclear speck [GO:0016607],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_14647,FUN_023096-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1669.t1,apul_ptua,66.344,FUN_023096-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),48.3,149.0,5e-33,143.7,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_14655,FUN_023197-T1,,Pocillopora_meandrina_HIv1___RNAseq.g678.t1,apul_ptua,57.436,FUN_023197-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),39.9,148.0,1.1e-22,108.2,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_14660,FUN_023261-T1,,Pocillopora_meandrina_HIv1___RNAseq.g577.t1,apul_ptua,80.805,FUN_023261-T1,Q9H977,WDR54_HUMAN,,WD repeat-containing protein 54,Homo sapiens (Human),39.1,335.0,1.9e-61,237.7,sp|Q9H977|WDR54_HUMAN WD repeat-containing protein 54 OS=Homo sapiens OX=9606 GN=WDR54 PE=1 SV=1,GO:0002091; GO:0005737; GO:0005886; GO:0007338; GO:0007342; GO:0031514; GO:0031982; GO:0042058; GO:0042803; GO:0043408,fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]; single fertilization [GO:0007338],cytoplasm [GO:0005737]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; vesicle [GO:0031982],protein homodimerization activity [GO:0042803],GO:0005886; GO:0005929; GO:0022414; GO:0043226; GO:0061024,plasma membrane; cilium; reproductive process; organelle; membrane organization
OG_14676,FUN_023432-T1,,Pocillopora_meandrina_HIv1___RNAseq.g587.t1,apul_ptua,53.644,FUN_023432-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),36.4,165.0,1.5e-20,102.4,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_14678,FUN_023451-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17629.t1,apul_ptua,54.3595,FUN_023451-T1,Q9Y251,HPSE_HUMAN,,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],Homo sapiens (Human),36.0,469.0,1.6e-76,288.5,sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2,GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0046677; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806,angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to antibiotic [GO:0046677]; vascular wound healing [GO:0061042],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580],beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0007155; GO:0016787; GO:0030163; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0055085; GO:1901135,catalytic activity; extracellular region; extracellular space; nucleus; nucleoplasm; lysosome; vacuole; cell adhesion; hydrolase activity; protein catabolic process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; transmembrane transport; carbohydrate derivative metabolic process
OG_14684,FUN_023583-T2,,Pocillopora_meandrina_HIv1___TS.g9734.t1b,apul_ptua,36.38,FUN_023583-T2,Q58EK5,TDRD1_DANRE,,Tudor domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),26.2,854.0,4.8e-65,251.9,sp|Q58EK5|TDRD1_DANRE Tudor domain-containing protein 1 OS=Danio rerio OX=7955 GN=tdrd1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546],piRNA binding [GO:0034584]; zinc ion binding [GO:0008270],GO:0003723; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,RNA binding; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_14930,FUN_029210-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25542.t1,apul_ptua,50.4485,FUN_029210-T1,Q9VQ91,TDRKH_DROME,,Tudor and KH domain-containing protein homolog (Partner of PIWIs protein),Drosophila melanogaster (Fruit fly),28.4,141.0,8.2e-11,71.2,sp|Q9VQ91|TDRKH_DROME Tudor and KH domain-containing protein homolog OS=Drosophila melanogaster OX=7227 GN=papi PE=1 SV=1,GO:0003723; GO:0005634; GO:0005739; GO:0007283; GO:0010526; GO:0030719; GO:0032991; GO:0034587; GO:0043186; GO:0140990,P granule organization [GO:0030719]; piRNA processing [GO:0034587]; primary piRNA processing [GO:0140990]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526],mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005739; GO:0022414; GO:0043226,RNA binding; nucleus; mitochondrion; reproductive process; organelle
OG_14949,FUN_029544-T2,,Pocillopora_meandrina_HIv1___RNAseq.g17281.t1,apul_ptua,68.595,FUN_029544-T2,Q9UKQ2,ADA28_HUMAN,,"Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)",Homo sapiens (Human),32.5,486.0,4.9e-60,233.8,sp|Q9UKQ2|ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens OX=9606 GN=ADAM28 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005739; GO:0005886; GO:0006508; GO:0007283; GO:0008237; GO:0009986; GO:0034987; GO:0046872,proteolysis [GO:0006508]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],immunoglobulin receptor binding [GO:0034987]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0005739; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; extracellular region; mitochondrion; plasma membrane; hydrolase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_14993,FUN_031347-T1,,Pocillopora_meandrina_HIv1___TS.g23872.t1,apul_ptua,48.045,FUN_031347-T1,Q5SY80,CTSRE_HUMAN,,Cation channel sperm-associated auxiliary subunit epsilon (CatSper-epsilon) (CatSperepsilon),Homo sapiens (Human),28.4,327.0,2.3e-34,147.9,sp|Q5SY80|CTSRE_HUMAN Cation channel sperm-associated auxiliary subunit epsilon OS=Homo sapiens OX=9606 GN=CATSPERE PE=1 SV=1,GO:0030317; GO:0036128; GO:0048240; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240],CatSper complex [GO:0036128]; sperm principal piece [GO:0097228],,GO:0007018; GO:0022414; GO:0048870,microtubule-based movement; reproductive process; cell motility
OG_15001,FUN_031510-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5117.t1,apul_ptua,70.02600000000001,FUN_031510-T1,Q8CCP0,NEMF_MOUSE,,Ribosome quality control complex subunit NEMF (Nuclear export mediator factor),Mus musculus (Mouse),47.1,1137.0,3.6e-232,806.6,sp|Q8CCP0|NEMF_MOUSE Ribosome quality control complex subunit NEMF OS=Mus musculus OX=10090 GN=Nemf PE=1 SV=2,GO:0005634; GO:0005829; GO:0022626; GO:0043023; GO:0051168; GO:0065003; GO:0140708; GO:1904678; GO:1990112; GO:1990116,CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RQC complex [GO:1990112],alpha-aminoacyl-tRNA binding [GO:1904678]; ribosomal large subunit binding [GO:0043023],GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0006913; GO:0030163; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; ribosome; nucleocytoplasmic transport; protein catabolic process; organelle; protein-containing complex assembly
OG_15065,FUN_032610-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29787.t1,apul_ptua,87.903,FUN_032610-T1,Q13188,STK3_HUMAN,,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],Homo sapiens (Human),68.8,490.0,3.6000000000000004e-168,592.8,sp|Q13188|STK3_HUMAN Serine/threonine-protein kinase 3 OS=Homo sapiens OX=9606 GN=STK3 PE=1 SV=2,GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006606; GO:0006915; GO:0007254; GO:0007417; GO:0008625; GO:0032991; GO:0035265; GO:0035329; GO:0035332; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0043491; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0050673; GO:0050680; GO:0050821; GO:0051262; GO:0051897; GO:0060070; GO:0060215; GO:0060706; GO:0060800; GO:0071539; GO:0090090; GO:0097284; GO:0106310; GO:0140537; GO:1902043,apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hippo signaling [GO:0035332]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; transcription regulator activator activity [GO:0140537],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_15079,FUN_032834-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24968.t1,apul_ptua,73.942,FUN_032834-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),44.3,296.0,2.7e-69,264.2,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_15132,FUN_034315-T2,,Pocillopora_meandrina_HIv1___RNAseq.g28489.t2,apul_ptua,62.948,FUN_034315-T2,Q8NI77,KI18A_HUMAN,,Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A),Homo sapiens (Human),44.0,659.0,7.499999999999999e-141,503.1,sp|Q8NI77|KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens OX=9606 GN=KIF18A PE=1 SV=2,GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023,cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520],caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726],actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463],GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0007018; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140013; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; microtubule-based movement; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; meiotic nuclear division; ATP-dependent activity
OG_15160,FUN_034965-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12170.t1,apul_ptua,75.0,FUN_034965-T1,O75521,ECI2_HUMAN,,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)",Homo sapiens (Human),52.9,393.0,1.5e-111,404.4,sp|O75521|ECI2_HUMAN Enoyl-CoA delta isomerase 2 OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=4,GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0009062; GO:0016020; GO:0043231,fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0008289; GO:0016853; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; lipid binding; isomerase activity; organelle
OG_15165,FUN_034970-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12165.t1,apul_ptua,81.614,FUN_034970-T1,Q571E4,GALNS_MOUSE,,N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase),Mus musculus (Mouse),71.2,434.0,4.4e-197,688.7,sp|Q571E4|GALNS_MOUSE N-acetylgalactosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Galns PE=1 SV=2,GO:0005764; GO:0008484; GO:0030207; GO:0043890; GO:0046872,chondroitin sulfate proteoglycan catabolic process [GO:0030207],lysosome [GO:0005764],metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_15216,FUN_036024-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27234.t1,apul_ptua,72.622,FUN_036024-T1,Q61382,TRAF4_MOUSE,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),Mus musculus (Mouse),28.5,487.0,7.3e-64,246.1,sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; defense response to other organism
OG_15226,FUN_036504-T1,,Pocillopora_meandrina_HIv1___TS.g14409.t1,apul_ptua,60.191,FUN_036504-T1,Q08J23,NSUN2_HUMAN,,"RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) (tRNA methyltransferase 4 homolog) (hTrm4)",Homo sapiens (Human),38.2,872.0,5.1e-160,566.6,sp|Q08J23|NSUN2_HUMAN RNA cytosine C(5)-methyltransferase NSUN2 OS=Homo sapiens OX=9606 GN=NSUN2 PE=1 SV=2,GO:0000049; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006397; GO:0006400; GO:0007286; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736,cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; RNA binding [GO:0003723]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006399; GO:0016071; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; tRNA metabolic process; mRNA metabolic process; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_15304,FUN_038220-T1,,Pocillopora_meandrina_HIv1___RNAseq.g904.t1,apul_ptua,63.504,FUN_038220-T1,P42125,ECI1_MOUSE,,"Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)",Mus musculus (Mouse),40.2,256.0,1.8e-47,191.0,"sp|P42125|ECI1_MOUSE Enoyl-CoA delta isomerase 1, mitochondrial OS=Mus musculus OX=10090 GN=Eci1 PE=1 SV=2",GO:0004165; GO:0005739; GO:0005743; GO:0005759; GO:0006635,fatty acid beta-oxidation [GO:0006635],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165],GO:0003824; GO:0005739; GO:0006629; GO:0016853; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; isomerase activity; organelle
OG_15321,FUN_038597-T1,,Pocillopora_meandrina_HIv1___RNAseq.g992.t1,apul_ptua,65.672,FUN_038597-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),33.2,184.0,7.5e-10,65.9,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_15374,FUN_039983-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7549.t1,apul_ptua,72.727,FUN_039983-T1,P00747,PLMN_HUMAN,,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Homo sapiens (Human),45.2,228.0,8.9e-45,181.8,sp|P00747|PLMN_HUMAN Plasminogen OS=Homo sapiens OX=9606 GN=PLG PE=1 SV=2,GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0008236; GO:0008285; GO:0009897; GO:0009986; GO:0010812; GO:0016485; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031093; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051702; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0062023; GO:0070062; GO:0071674; GO:0072562; GO:0098685; GO:0098978; GO:0099183; GO:1990405; GO:2000048,"biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; protein processing [GO:0016485]; proteolysis [GO:0006508]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; Schaffer collateral - CA1 synapse [GO:0098685],apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0022414; GO:0023052; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0051604; GO:0140096,"immune system process; catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; reproductive process; signaling; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_15376,FUN_040016-T3,,Pocillopora_meandrina_HIv1___RNAseq.g8431.t1,apul_ptua,42.0545,FUN_040016-T3,Q7Z3E1,PARPT_HUMAN,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (Poly [ADP-ribose] polymerase 7) (PARP-7) (TCDD-inducible poly [ADP-ribose] polymerase),Homo sapiens (Human),37.4,235.0,1.1999999999999999e-39,167.2,sp|Q7Z3E1|PARPT_HUMAN Protein mono-ADP-ribosyltransferase TIPARP OS=Homo sapiens OX=9606 GN=TIPARP PE=1 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612; GO:1990404,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_15458,FUN_041811-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15861.t1,apul_ptua,49.578,FUN_041811-T1,Q811B3,ATS12_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-),Mus musculus (Mouse),29.8,961.0,3.2e-102,374.8,sp|Q811B3|ATS12_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Mus musculus OX=10090 GN=Adamts12 PE=2 SV=2,GO:0001503; GO:0002062; GO:0004222; GO:0005576; GO:0006029; GO:0007160; GO:0016477; GO:0030167; GO:0030199; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0007155; GO:0016787; GO:0030154; GO:0030163; GO:0030198; GO:0048870; GO:0140096; GO:1901135,"catalytic activity; extracellular region; cell adhesion; hydrolase activity; cell differentiation; protein catabolic process; extracellular matrix organization; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_15483,FUN_042101-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21790.t1,apul_ptua,46.969,FUN_042101-T1,Q6ZQF0,TOPB1_MOUSE,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Mus musculus (Mouse),28.0,250.0,2.9e-22,109.0,sp|Q6ZQF0|TOPB1_MOUSE DNA topoisomerase 2-binding protein 1 OS=Mus musculus OX=10090 GN=Topbp1 PE=1 SV=2,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006281; GO:0006974; GO:0007131; GO:0010212; GO:0015629; GO:0016605; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; protein localization to site of double-strand break [GO:1990166]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0022414; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; reproductive process; organelle; molecular adaptor activity; molecular function regulator activity
OG_15509,FUN_042857-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7243.t1,apul_ptua,88.0,FUN_042857-T1,Q1JQB2,BUB3_BOVIN,,Mitotic checkpoint protein BUB3,Bos taurus (Bovine),74.7,320.0,2.8e-145,516.2,sp|Q1JQB2|BUB3_BOVIN Mitotic checkpoint protein BUB3 OS=Bos taurus OX=9913 GN=BUB3 PE=2 SV=1,GO:0000776; GO:0005654; GO:0007059; GO:0007094; GO:0033597; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298,cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of chromosome segregation [GO:0051983],bub1-bub3 complex [GO:1990298]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654],ubiquitin binding [GO:0043130],GO:0005654; GO:0007059; GO:0022414; GO:0043226,nucleoplasm; chromosome segregation; reproductive process; organelle
OG_15523,FUN_043219-T2,,Pocillopora_meandrina_HIv1___RNAseq.g6779.t1,apul_ptua,52.456,FUN_043219-T2,Q9QXW2,FBXW5_MOUSE,,F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5),Mus musculus (Mouse),31.5,569.0,2.6e-65,251.1,sp|Q9QXW2|FBXW5_MOUSE F-box/WD repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Fbxw5 PE=1 SV=1,GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005],protein kinase binding [GO:0019901],GO:0030163,protein catabolic process
OG_15536,FUN_043419-T3,,Pocillopora_meandrina_HIv1___RNAseq.g7832.t1,apul_ptua,77.451,FUN_043419-T3,Q80ZI6,LRSM1_MOUSE,,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase),Mus musculus (Mouse),38.8,730.0,3.9e-70,267.7,sp|Q80ZI6|LRSM1_MOUSE E3 ubiquitin-protein ligase LRSAM1 OS=Mus musculus OX=10090 GN=Lrsam1 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786,autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016192; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; autophagy; vesicle-mediated transport; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_15538,FUN_043493-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7960.t1,apul_ptua,80.645,FUN_043493-T1,Q3SZB4,ACADM_BOVIN,,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)",Bos taurus (Bovine),72.0,403.0,2.4e-168,593.2,"sp|Q3SZB4|ACADM_BOVIN Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ACADM PE=2 SV=1",GO:0003995; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0033539; GO:0050660; GO:0051793; GO:0070991,fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_15549,FUN_043580-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7014.t1,apul_ptua,80.775,FUN_043580-T1,Q5T4S7,UBR4_HUMAN,,E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600),Homo sapiens (Human),47.1,5346.0,0.0,4162.1,sp|Q5T4S7|UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1,GO:0004842; GO:0005516; GO:0005654; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0007032; GO:0008270; GO:0010508; GO:0016020; GO:0035579; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0061630; GO:0070821; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0101003; GO:0140455; GO:0141191; GO:0141198,cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; endosome; microtubule organizing center; cytosol; plasma membrane; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_15639,FUN_045504-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27766.t1,apul_ptua,49.541,FUN_045504-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),25.7,342.0,2.5e-23,111.3,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_15647,FUN_045620-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26421.t1,apul_ptua,64.346,FUN_045620-T1,O94889,KLH18_HUMAN,,Kelch-like protein 18,Homo sapiens (Human),32.1,343.0,8.2e-42,173.3,sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3,GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756,cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
